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Abstract 
Teenage and young adult (TYA) cancer patients describe debilitating fatigue. The impact of fatigue is 
particularly detrimental at this age because it hinders key developmental needs, such as independence. 
Although exercise and psychological treatments are the most effective management approaches in 
older adults, TYAs have unique healthcare needs and research findings cannot be extrapolated to 
younger patients. The aim of this programme of research was to increase understanding of cancer-
related fatigue (CRF) in TYAs, in order to develop a non-pharmacological fatigue intervention. 
 
Three multimethod studies have been conducted, underpinned by self-efficacy theory. 1) A systematic 
literature review synthesised existing research evidence. 2) A multicentre electronic survey evaluated 
the experience of TYA CRF and its current management across the UK. 3) A multiphase, longitudinal, 
qualitative study, involving patient-parent dyads, has led to the co-design of a fatigue intervention. 
 
This work has confirmed that fatigue is the most prevalent and distressing symptom experienced by 
TYAs with cancer, and is an independent predictor of poor quality of life. Fatigue persists long after the 
end of cancer treatment, perpetuated by vicious cycles of emotional and behavioural responses to the 
symptom. Cognitive fatigue has a particularly negative impact and influences the ability to work, be in 
education or socialise. Parents also experience adverse consequences, including fatigue-related 
interpersonal tensions. Despite the enormity of the problem, fatigue is currently inadequately managed. 
TYAs described extensive, age-related intervention needs, including a preference for videos over written 
information. The co-designed intervention is predominantly cognitive in approach with, for example, 
mindfulness techniques being more acceptable than energy conservation. TYAs require structured 
activity support, given the physical reserve of youth and fear that activity may worsen fatigue. 
 
Young patients have inspired, and helped drive, this programme of work. Engagement with the research 
process was high, and participants embraced the innovative research methods. Information has been 
generated that will optimise the design of the future definitive trial to test intervention effectiveness. 
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1 Introduction 
1.1 Context 
1.1.1 Cancer-related fatigue 
1.1.1.1 Definitions 
Fatigue is recognised to be one of the most common and debilitating symptoms experienced by 
patients with cancer. Cancer-related fatigue (CRF) has been defined by the National Comprehensive 
Cancer Network as ‘a distressing, persistent, subjective sense of physical, emotional and/or cognitive 
tiredness or exhaustion, in relation to cancer or cancer treatment, that is not proportional to recent 
activity and interferes with usual functioning’[1].  
 
Fatigue is a multidimensional symptom, and the range of perceptions may include feelings of 
weakness, inability to perform tasks, decreased motivation, low mood, and difficulty thinking clearly 
[2]. It differs from fatigue felt by healthy individuals in that it is more severe and incompletely 
relieved by rest or sleep [3,4]. 
 
Definition of a ‘fatigue case’ is hindered by the symptom’s multidimensional and subjective nature. In 
clinical practice, a score of 5 or more, in an 11-item fatigue severity numerical rating scale (NRS), has 
been recommended as a screening tool to define clinically significant fatigue. Scores of 1-3, 4-6 and 
7-10 define mild, moderate and severe fatigue respectively [1,5,6]. A plethora of unidimensional and 
multidimensional fatigue scales have been developed for research purposes and validated in cancer 
patients [7-10]. They are, however, rarely used in clinical practice due to time limitations and patient 
burden. 
1.1.1.2 Importance 
Cancer-related fatigue is a significant symptom both because of its high prevalence and its 
particularly negative impact. Estimates of prevalence vary widely according to the patient population 
and method of fatigue assessment. However, many surveys suggest a prevalence of over 75%, rising 
close to 100% during cancer treatment [11-14]. In studies comparing symptom prevalence rates 
amongst people of any age with cancer, fatigue is almost always the most common symptom, and 
patients consistently report that fatigue is the symptom with the most negative impact on quality of 
life [11-13,15]. A survey of almost 400 cancer patients found that virtually all patients reported that 
fatigue altered their daily routine, and prevented a ‘normal life’. Fatigue hindered social activities and 
performance of cognitive tasks. Three-quarters of patients and 40% of caregivers had to change their 
employment status due to the symptom [12]. 
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Although fatigue is typically most severe during cancer treatment, it can persist long after the end of 
treatment [16]. In studies of breast cancer survivors, between a quarter and a third of patients 
experience long-term fatigue, even up to 10 years after diagnosis [17,18]. Furthermore, fatigue 
appears to be a prognostic indicator, predicting lower survival [19,20]. 
 
Despite the magnitude of the problem, CRF is a relatively under-investigated symptom. Patients and 
healthcare professionals have tended to view it as an inevitable and unavoidable consequence of 
cancer and its treatment. Fatigue is, indeed, prevalent in the community generally, with 20-30% of 
healthy people reporting that they ‘always feel tired’ [21]. These factors have led to a degree of 
scepticism, in both clinical and research terms. More than half of cancer patients do not report the 
symptom to their doctor, usually because of the perception that no treatment will be offered [22,23]. 
Healthcare staff, furthermore, underestimate the impact of fatigue. In a large survey of patients and 
oncologists, while 61% of patients reported that fatigue affected their lives more than pain, only 37% 
of oncologists believed this was true [11].  
 
Research into the aetiology and management of fatigue has only begun to accumulate over the last 
decade. The National Cancer Institute (NCI) in the USA has designated CRF as a high-priority research 
area, and it is one of the five highest priority research areas of the NCI Oncology Research Program 
[24]. In the UK in 2018, a National Cancer Research Institute (NCRI) James Lind Alliance Priority 
Setting Partnership has determined that CRF is one of the top ten research priorities [25]. 
1.1.1.3 Pathophysiology 
Until recently, attempts to understand the causes of CRF have focused on biological mechanisms. 
Foremost amongst these is the relationship between fatigue and systemic inflammation [14]. There is 
growing evidence from longitudinal studies that changes in inflammatory markers, particularly the 
inflammatory cytokines interleukin-1, tumour necrosis factor-α and interleukin-6, are associated with 
changes in fatigue over time. This relationship has been shown both during the course of cancer 
treatment [26,27], and also following treatment completion [28]. Both the cancer itself and cancer 
treatment appear to activate the pro-inflammatory cytokine system [29]. 
 
Two other important biological mechanisms are hypothalamic-pituitary-adrenal (HPA) axis and 
autonomic nervous system (ANS) dysregulation. Breast cancer survivors with persistent fatigue have 
elevated evening cortisol levels with reduced diurnal variation, along with blunted cortisol responses 
to psychological stress [30,31]. Similar longitudinal relationships have been found in patients with 
ovarian cancer, with HPA dysregulation following a comparable temporal pattern to that of the 
fatigue [32]. In relation to the ANS, lower heart rate variability, indicating reduced parasympathetic 
3 
activity, has been associated with fatigue in breast cancer survivors [33]. Interestingly, both these 
mechanisms may be mediated by systemic inflammation, in that inflammatory processes both 
influence, and are influenced by, the HPA and ANS [34,35]. 
 
Biological mechanisms, however, cannot be the only cause of CRF. Fatigue severity varies to an 
extent that cannot be explained fully by biological factors, such as the degree of systemic 
inflammation. Indeed, although inflammation consistently associates with fatigue when measured as 
a category, there tends to be no relationship when evaluated using a continuous measure [14,36]. 
Important emerging evidence from longitudinal studies suggests that psychological and behavioural 
factors may influence the experience of fatigue. Depression and anxiety before cancer treatment, for 
example, have been shown to predict CRF severity [37-40]. In patients with breast and prostate 
cancer receiving radiotherapy, pre-treatment sleep disturbance is associated with worse fatigue 
through, and after, treatment [37,39]. Similar outcomes have been found in gynaecological cancers 
[41]. Furthermore, low activity levels before cancer diagnosis have been shown to predict persistent 
fatigue [42]. Fatigue, therefore, appears to be a consequence both of biological, and a range of 
psycho-behavioural, factors. 
1.1.1.4 Management 
The first step in the management of any symptom is to assess for, and reverse, any treatable 
underlying medical cause, an approach endorsed by multiple guidelines [1,6,43]. Anaemia, 
electrolyte imbalance, endocrine disorders and infections are examples of the myriad of potential 
medical problems that could be contributing to fatigue and may be amenable to treatment [1,43]. 
 
Concurrent symptom management is also important. In a landmark study, de Raaf and colleagues 
revealed that careful attention to general symptom management can significantly improve fatigue 
severity in adults with cancer [44]. Fatigue tends to co-occur with a number of physical and 
psychological symptoms, including pain, breathlessness, anorexia, nausea, anxiety and depression 
[45]. Fatigue, depression and pain form a prevalent symptom cluster[46], as do fatigue, insomnia and 
pain [47]. Although it has not been established whether the symptoms cluster due to causal inter-
relationships or shared aetiological pathways such as systemic inflammation, the finding that 
concurrent symptom management is effective suggests that other symptoms may be contributing to 
the perception of fatigue [43]. 
 
Beyond the management of underlying medical causes and concurrent symptoms, a diverse range of 
treatment approaches have been used for CRF in adults. These include pharmacological treatments, 
physical activity and psychological interventions. The lack of an accepted ‘gold standard’ treatment 
for CRF has been attributed to the complex and poorly understood nature of this symptom [14]. 
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Pharmacological treatments 
A recent meta-analysis has found that drug treatment does not ameliorate cancer-related fatigue 
[48]. Central nervous system (CNS) stimulants, such as methylphenidate, are the most evaluated 
pharmacological approach. Whilst two systematic reviews have found small statistically significant 
benefits from these drugs [49,50], the changes did not reach a clinically important threshold [51]. 
Furthermore, a subsequent larger study, not included in the reviews, has found no benefit from 
methylphenidate [52]. Previous work from Spathis and colleagues has revealed lack of benefit from 
the CNS stimulant modafinil, and there is no evidence to support the use of antidepressants [53,54]. 
Given the possible inflammatory basis for CRF, small phase 2 studies have been undertaken 
evaluating anti-inflammatory drugs, again with little evidence of benefit [14]. One short-term 
controlled trial, in patients with advanced cancer in a hospice setting, did find benefit from 
dexamethasone, but this finding has not been replicated [55].  
 
Non-pharmacological treatments 
Unlike drug approaches, there is consistent evidence to support the effectiveness of exercise and 
psychological approaches. Two meta-analyses have been recently published, comparing a range of 
approaches. Mustian and colleagues evaluated 113 high quality randomised controlled trials. The 
weighted effect sizes for the broad treatment categories of exercise, psychological interventions 
(cognitive-behavioural approaches or education), exercise plus psychological interventions, and 
pharmacological approaches were 0.30 (p<0.001), 0.27 (p<0.001), 0.26 (p<0.001) and 0.09 (p=0.05) 
respectively [48]. During primary cancer treatment, exercise was the most effective intervention. In 
contrast, after cancer treatment, psychological approaches, and combined exercise with 
psychological approaches, were the most effective. 
 
In a second meta-analysis involving 245 randomised and quasi-randomised controlled trials, Hilfiker 
and colleagues confirmed the effectiveness of a range of psychological and exercise approaches [56]. 
Relaxation, massage, and cognitive behavioural therapy (CBT) combined with physical activity were 
the three most effective approaches during cancer treatment. After treatment, yoga, combined 
aerobic and resistance training, and CBT combined with physical activity were the three most 
effective approaches. These findings cannot easily be compared with those of the preceding meta-
analysis because individual treatments were evaluated, rather than broad treatment categories.  
 
A systematic review of meta-analyses of exercise for fatigue in adults with cancer has further 
confirmed the effectiveness of this approach, although recalculations, using random-effects models 
and prediction intervals rather than confidence intervals, suggest that the benefits may be smaller 
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than previously reported [57]. Number need to treat (NNT) values are between 3 and 16 [57]. 
Bennett and colleagues have undertaken a systematic review of educational interventions for CRF in 
adults, and have found that education alone has a small effect on reducing fatigue severity, impact 
and distress [58]. 
1.1.2 Teenage and young adult health 
1.1.2.1 Terminology of age 
Numerous terms have been used to describe young people in the transition between childhood and 
adulthood. A summary of definitions is provided in table 1.1. 
 
Table 1.1 Definition of key age-related terms (adapted from [24]) 
Term Age Details 
Child < 18 Defined by the Convention of the Rights of a Child; can have a 
younger threshold in countries where majority is attained below 18. 
Adolescence 10-19 Defined by the World Health Organisation; ‘adolescens’ means 
‘growing up’ in Latin, and ‘adultus’ means ‘grown up’. 
Teenager 13-19 Term first used in the USA in 1920s, and widely used in popular 
culture after the second World War. 
Youth 15-24 United Nations definition developed in the lead up to the 
International Youth Year of 1985. 
Young people 10-24 Less formally defined term, used by the WHO. 
 
Adolescent and 
young adult (AYA) 
10-24 Less formally defined term, with a range that varies according to 
context; the age range for AYA oncology in the USA is 15-39 [59]. 
Teenage and 
young adult (TYA) 
13-24 Term used predominantly in the UK in oncology [60]. 
 
The definition of ‘adolescence’ has been controversial. Adolescence is viewed as the phase during 
which transition from childhood to adulthood occurs, encompassing changes in physical, 
psychological and social development; it lasts from puberty to the age when mature social roles are 
undertaken [61]. Puberty is, however, occurring increasingly early, with the average age of menarche 
now 12-13 in high income countries [62]. Furthermore, transitions to mature roles, such as marriage, 
completion of education, and parenthood, are increasingly delayed to well into the third decade of 
life. It has, therefore, been recently argued, both in healthcare literature and in the media, that the 
term ‘adolescence’ should be expanded beyond the ages of 10-19, to include those up to the age of 
24 [63]. 
 
The term ‘teenage and young adult’ (TYA) will be used in relation to the cohort of young patients 
involved in the research described in this thesis, as it is the prevailing term used for young cancer 
patients in the UK. However, much of the research conducted in a non-oncology setting, and virtually 
all work conducted outside the UK, uses other terms, particularly ‘adolescent and young adult’ (AYA) 
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and ‘young people’. Therefore, a broader range of terms will be needed in the discussion sections of 
this work. 
1.1.2.2 Importance of this age 
The current generation of young people is the largest in history. There are 11.7 million young people 
aged 10-24 in the UK, one in five of the population; the 1.8 billion across the world comprise a 
quarter of the global population [64,65]. Any attempt to meet the needs of this cohort has, 
therefore, immense potential for impact. 
 
The transition between childhood and adulthood is one of the most rapid phases of human 
development. Extensive changes in physical, cognitive, emotional, social and behavioural 
development occur, as summarised in table 1.2. 
 
Table 1.2 Overview of developmental changes in adolescence (adapted from [64,66] and [67]) 
Developmental area Key changes 
Physical  Growth spurt 
 Puberty and maturation of reproductive organs 
 Development of secondary sex characteristics, and menarche (girls) 
Cognitive  Increasing abstract thought 
 Increased capacity for setting goals 
 Interest in moral reasoning 
Emotional  Intense self-involvement 
 Developing self-identity 
 Emotional reactivity and conflict 
Social  Seeking independence and responsibility 
 Distancing from parents and seeking relationships outside family 
 Influenced strongly by peer group 
Behavioural  Regression to child-like behaviour when under strain 
 Seeking out novel experiences and making risky choices 
 Establishing life-long behaviours 
 
Young people form a group with substantial and distinct needs that differ both from those of 
younger children and from older adults. The characteristics of young people are not simply those that 
would be expected if there was a smooth continuum from child to adulthood. At a 
neurodevelopmental level, the changes of adolescence are non-linear [66]. In a widely accepted 
neurobiological model of adolescence, the features of this age can be explained by the differential 
rates of development of the limbic system and prefrontal cortical regions of the brain. The 
subcortical limbic system matures early, a part of the brain involved in emotional reactivity, reward 
seeking and behavioural motivation. In contrast, the controlling prefrontal cortex, involved in 
executive function, planning and impulse control, develops relatively slowly, only reaching full 
maturation towards the middle of the third decade of life [66]. 
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The mismatch between limbic and prefrontal cortical development, along with overproduction of 
axons and synapses before the rapid pruning that occurs in late adolescence, results in a unique 
stage of brain functioning [68]. In recent years, rather than viewing this period as a negative phase of 
suboptimal decisions and inappropriate risk-taking, it has been recognised that such programming of 
the adolescent brain may indeed be advantageous in evolutionary terms [66,69]. It has been 
convincingly argued that high-risk behaviour is needed, in order to leave the parental home and take 
the steps necessary to find a partner. Increased emotional reactivity enhances scanning for, and 
responses to, threats as adolescents move from a safe to a novel environment [66]. 
 
Nonetheless, this stage of young life is undeniably a period of vulnerability, this being particularly 
evident with respect to health [65,70]. Impulsive and emotionally-driven decisions, influenced by the 
modern unprecedented social forces of electronic media and marketing, can impact negatively on 
health. In 2015, an estimated 1.2 million adolescents worldwide died from largely preventable 
causes, more than two-thirds of adolescent deaths being due to injuries, both unintentional such as 
road traffic accidents and drowning, and intentional such as homicide and suicide [71]. Moreover, 
adolescence is associated with a surge in mental health disorders, with half of lifetime mental 
disorders starting by the age of 14; such disorders are considered to be the single largest contributor 
to the non-fatal disease burden experienced by young people [64]. Emerging evidence suggests that 
inadvertent consequences of social media, such as increased potential for comparison with peers, 
may be contributing significantly to the increasing incidence of depression and anxiety in the young 
[72].  
 
Whereas childhood mortality has declined by more than 80% in the last half century, that of 
adolescents has improved only marginally [67,73]. The mortality of adolescents aged 10-19 is greater 
than that of children aged 1-4 years [74]. In the UK, healthcare outcomes for patients aged 10-24 are 
amongst the worst in Europe, and the number of emergency presentations of older adolescents to 
hospital has increased more than three-fold over the last decade [75-77].  
 
Adolescence is a formative age; the changes in adolescence have health-related consequences with 
an impact, not only during adolescence, but also lifelong [71]. Many of the unhealthy behaviours that 
tend to start in adolescence, such as smoking, alcohol use and physical inactivity, are believed to be 
contributing to the so-called ‘epidemic of non-communicable disease’ occurring in modern adult 
society [78]. Young people become parents and, in turn, influence the health and health-related 
attitudes of the next generation. Improvements in adolescent health, therefore, impact not only 
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directly on this large cohort of vulnerable people, but also have the potential to improve global 
health across every generation [71]. 
 
It is unsurprising, therefore, that promotion of adolescent health is a key international healthcare 
priority [65]. Over the last five years, the World Health Organisation (WHO) has been driving global 
accelerated action to improve health in adolescents [71]. The unique nature of adolescence 
mandates specific and explicit age-focused healthcare policy and services. Eight global standards 
have been created to define the required level of quality in the delivery of adolescent healthcare; 
those most relevant to this work are summarised in table 1.3 [79]. 
 
Table 1.3 Selected global standards for quality health services for adolescents (adapted from [79]) 
Adolescents’ 
health literacy 
Standard 1. Systems are needed to ensure that adolescents understand their 
own health, and know how to access health care services. 
Appropriate 
services 
Standard 3. Services need to fulfil the needs of all adolescents. 
Quality 
improvement 
Standard 7. Service data is collected, analysed and used to support quality 
improvement. 
Adolescents’ 
participation 
Standard 8. Adolescents are involved in the planning and evaluation of health 
services, as well as in certain appropriate aspects of service provision. 
 
In the UK, national policy now recognises the comparatively poor outcomes in adolescents, and the 
need for age-appropriate care [80]. In 2014, the Royal College of Physicians (RCP) issued a position 
statement on the care of adolescent and young adult patients, expressing commitment to 
‘developmentally appropriate care, tailored to reflect the unique needs of patients during adolescent 
and young adulthood’ [81]. Importantly, the RCP also advocates ‘further research to improve our 
understanding of young adults’ and adolescents’ health, their experiences of care and their health 
outcomes’ [81]. Evidence is mounting for improved outcomes and cost-effectiveness with specialist 
age-appropriate support, as increasing numbers of adult and paediatric services attempt to adapt to 
the specific needs of adolescents [82,83]. In the UK, 10% of adolescents, irrespective of diagnosis, 
receive healthcare in specialist adolescent units, and report receiving better care than in either 
paediatric or adult healthcare settings [84].  
1.1.3 Teenage and young adult cancer 
Adolescents living with chronic illness are globally recognised to be a particularly vulnerable group 
[71]. Young people living with long-term conditions are exposed to a major psychosocial burden and 
to social marginalisation [85]. At a neurobiological level, it is known that the developing adolescent 
brain is adversely affected by such stressors, with cognitive regression and even more limited 
recruitment of the relatively immature pre-frontal cortex [86]. Furthermore, enforced changes to 
plans and expectations challenge the adolescent developmental needs of autonomy and self-identity 
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[87]. Risk-taking behaviour appears to be even greater in young people with, rather than without, 
chronic conditions[88], and such behaviour may manifest as poor adherence to treatment [89,90].  
 
Teenage and young adult cancer is relatively rare, with less than 3000 new cases each year, 
accounting for less than 1% of the total number of cancer cases in the UK (2013-15) [91]. However, 
the 5-year survival is over 80%, meaning that large numbers of TYAs are living with, and beyond, 
cancer. At the end of 2013, it was calculated that there were approximately 33,000 people living in 
the UK who had been diagnosed with a cancer aged 15-24 [92]. This number is set to grow steadily, 
as both the incidence of cancer and its survival are increasing [91,93]. Crucially, over two-thirds of 
TYA cancer survivors suffer from at least one additional chronic health problem, including 
detrimental long-term sequelae from cancer treatment, such as cardiovascular disease and 
osteoporosis [94,95].  
 
Figure 1.1 Teenage and young adult cancer by diagnostic group 2000-2009 (UK, age 15-24)[91] 
 
 
 
The experience of TYAs with cancer differs both from that of older adults and from children, and is 
recognised to be particularly challenging [60,96]. The cancer profile is different; young people 
experience late onset paediatric cancers, early onset adult cancers and so-called ‘true adolescent 
cancers’ (figure 1.1) [91,97]. The latter cancers include Hodgkin’s lymphoma, germ cell tumours, and 
soft tissue sarcomas, many requiring particularly long and intensive treatment regimens. The 
prognosis for some cancers, including sarcoma, is less good than that for children or older adults for 
reasons that are, as yet, not well understood [91]. Many TYAs experience pervasive despair. The 
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inevitable distress of a cancer diagnosis is compounded by the threat of young death and by parents’ 
understandable anguish, along with the many challenges to adolescent developmental needs, 
including altered self-image and isolation from peers [98]. Young people with cancer are recognised 
as being ‘uniquely vulnerable’, experiencing a ‘dual crisis’ when the ‘normative developmental 
stressors derived from the tasks of transitioning from adolescent to young adulthood combine with 
the challenges associated with an unexpected cancer diagnosis’ [60]. 
 
Unsurprisingly, given the significant challenges, TYAs with cancer experience considerable unmet 
healthcare needs [99]. In parallel with the global drive to improve adolescent health, there have 
been international efforts to develop specific and age-appropriate cancer services, initiated in the UK 
in 1995 with the Calman Hine Report [100-103]. The National Institute of Health and Care Excellence 
(NICE) subsequently published the ‘Children and Young People’s Improving Outcomes Guidance’ in 
2005, requiring the development of national TYA Principal Treatment Centres that every young 
person with a cancer diagnosis must be able to access [104]. The Teenage Cancer Trust (TCT), a 
charity dedicated to supporting and advocating for TYAs with cancer, has opened 28 specialist TCT 
units throughout the UK, staffed by healthcare professionals with specific expertise in the 
management of young cancer patients [105].  
 
Along with recognition of the need for age-appropriate cancer services, there has been a national 
drive to increase research in this young patient group [104]. Evidence relating to TYA cancer is 
considerably less robust than that for paediatric and for adult cancer; neither the TYA age-bracket, 
nor the types of cancers experienced by TYAs, fit neatly into the agendas of the established cancer 
research groups for children and older adults [60].  
 
The UK NCRI TYA Clinical Studies Group was established in 2005, to promote research specifically in 
TYAs with cancer. However, this group has tended to focus on the biology of TYA cancer, on cancer 
registration and on clinical trials of cancer treatments, with evaluation of patient experience and 
quality of life tending to lag behind [106]. Of note, in a recent TCT and James Lind Alliance Priority 
Setting Partnership, young people themselves have convincingly demonstrated that their research 
priorities relate more to their quality of life, with a desire for research evaluating psychosocial 
support, management of cancer treatment-related adverse effects and facilitation of return to 
education and work [107].  
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1.1.4 Teenage and young adult cancer-related fatigue 
Even without a cancer diagnosis, young people are particularly susceptible to fatigue. It is a prevalent 
subjective symptom, and studies evaluating fatigue in the general population suggest that 15-30% of 
adolescents experience fatigue [108-110]. The prevalence is particularly high in females and, in 
longitudinal studies, fatigue onset tends to be preceded by depression or anxiety [111]. Only a 
minority, less than 3% of young people, meet criteria for diagnosis with Chronic Fatigue 
Syndrome/Myalgic Encephalomyelitis (CFS/ME). This illness is characterised by severe and disabling 
fatigue lasting at least six months, and accompanied by a range of rheumatological and 
neuropsychiatric symptoms; no unifying aetiology has yet emerged [112]. Although the prevalence of 
CFS/ME is slightly higher in adolescents than in older adults, the prognosis is better, with 75% 
recovering within 2-3 years [113-115]. 
 
Young people appear to be particularly prone to fatigue for both developmental and behavioural 
reasons. During this important phase of brain maturation, the developmental need for longer sleep is 
hindered by circadian rhythm shifts, with later melatonin secretion and sleep phase delay limiting 
sleep, in the context of early rise times for school or work [116,117]. Further, young people may 
develop unhelpful sleep habits, such as alcohol and caffeine consumption, and late evening social 
commitments. Over the last decade, blue light emitting electronic devices in the bedroom appear to 
be compounding the problem, by delaying melatonin secretion and sleep onset [118,119]. 
 
In the context of cancer, a meta-synthesis of literature evaluating TYA experiences has revealed that 
fatigue is the symptom featuring most prominently [98]. This is unsurprising given that fatigue is the 
most prevalent and debilitating symptom in older adults with cancer, and young people have an 
inherent propensity to develop fatigue. It seems that the dual risk factors for fatigue, cancer and 
young age, combine to create a particularly significant problem. Studies suggest a TYA CRF 
prevalence of well over 50%, rising to 90-100% during cancer treatment [120,121].  
 
TYAs appear to experience worse CRF than both older adults [122] and children [123]. Even within a 
cohort of older adults, there is an inverse correlation between fatigue and age [124]. Not only is the 
fatigue itself severe at the TYA age, its impact appears to be particularly detrimental, hindering many 
key adolescent developmental needs, such as autonomy and development of peer-relationships 
[125,126].  
 
Research focusing on CRF in young people has only begun to emerge in the last 15-20 years. Hinds 
and colleagues, in the USA, undertook much of the original work defining and starting to assess the 
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problem [127-129]. Using evidence from qualitative research, they have generated the following 
conceptual definition of cancer-related fatigue in 13-18 year olds: 
 
‘Fatigue is a complex, changing state of exhaustion that at times seems to be a physical 
condition, at other times a mental state, and still other times to be a combination of physical 
and mental tiredness. It is influenced by environmental, personal/behavioural, and treatment-
related factors, and results in the adolescent not being able to maintain usual involvement 
with friends, academics, or sports, experiencing negative emotions like anger, preferring not to 
be bothered by others, and strong desire to lie down or rest. This changing state of exhaustion 
can be acute, episodic, or chronic and is relieved by changing the environment, rest, 
distraction, and medical/pharmacological interventions’ [130]. 
 
Subsequently, a number of researchers have continued this work, investigating the prevalence and 
impact of this debilitating symptom [125,131-134]. Nonetheless, despite the international drive to try 
to meet the unique needs of adolescents, research evaluating TYA CRF lags far behind that relating to 
fatigue in older adults [127].  
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1.2 Research programme rationale 
1.2.1 Brief overview of programme 
This thesis describes a programme of research investigating the prevalence, impact and management 
of cancer-related fatigue in teenagers and young adults. Three sequential and closely-related studies 
have been undertaken, involving multiple methods. 
 
Study 1 A systematic literature review of teenage and young adult cancer-related fatigue  
This broad and comprehensive review provides a systematic overview of existing research. Studies 
evaluating any aspect of fatigue were included. The work was undertaken between November 2013 
and March 2014, and was published in 2015. It was subsequently updated in April 2018, and is 
described in chapter 2. 
 
Study 2 Fatigue in Focus survey: a multicentre electronic survey evaluating the prevalence, impact 
and management of teenage and young adult cancer-related fatigue 
An electronic survey was undertaken, recruiting young participants from three of the thirteen TYA 
cancer Principal Treatment Centres in the UK. It evaluated the experience of current patients, 
focusing on the prevalence and severity of fatigue, the impact of fatigue on TYAs and their carers, 
and existing fatigue management approaches. This predominantly quantitative survey was 
conducted between December 2014 and October 2015, and published in 2017. It is detailed in 
chapter 3. 
 
Study 3 Fatigue Intervention Co-design Study (FICS) in teenagers and young adults with cancer 
A multiphase, multi-perspective, qualitative study was undertaken in one centre, to develop a ‘trial 
ready’ complex intervention that meets the needs of fatigued TYAs and their parents. Individual 
interviews and focus groups were conducted involving patient-parent dyads. Participants then 
received a prototype intervention, and subsequently provided feedback, allowing further 
intervention development. This longitudinal study commenced in March 2016, with data analysis 
ending in March 2018. It is described in detail in chapter 4. 
 
The intention is for the three studies to lead towards the development of an intervention that can be 
tested in future feasibility and definitive randomised controlled trials, as summarised in figure 1.2. 
Studies 1, 2 and 3 form the basis of this thesis, with studies 4 and 5 expected to occur during 2019-
2024. 
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Figure 1.2 Overview of research programme and intentions 
 
Preliminary studies 
 
 
 
 
 
Interventional studies 
 
 
 
 
 
 
 
The interventional studies 3, 4 and 5 represent the three phases of research defined in the Medical 
Research Council (MRC) Framework of Complex Interventions as ‘intervention development’, 
‘feasibility assessment’ and ‘intervention evaluation’ respectively [135]. The final study described in 
this thesis, study 3, therefore represents the first phase of intervention development. 
1.2.2 Overview of patient and public involvement 
This programme of research has been inspired, and indeed driven, by young cancer patients, since its 
inception. The topic importance was identified in 2010, at a Cambridge TYA cancer service review 
focus group. Participants ranked ‘fatigue management’ as their top priority. The TYA service lead 
consultant therefore ran Fatigue Workshops during 2011; every participant rated the workshop with 
the highest score of 5/5 for usefulness and relevance, and reported improved coping with fatigue.  
 
Laura Abbas (name used with consent) is a former TYA cancer patient who has experienced severe 
fatigue. She has been the patient and public involvement (PPI) lead for this programme of work. Until 
2015, she was the Cambridge TCT Youth Support Co-ordinator, putting her in an ideal position to 
provide advice from a patient perspective, as well as co-ordinate and support PPI. She reported 
receiving weekly emails from patients wanting help with fatigue, and has been a dedicated 
proponent of this programme of work. Her roles in studies 2 and 3 are described in sections 3.4.7.2 
(page 55) and 4.4.7.2 (page 107). 
 
A TYA research programme Focus Group, involving five TYA cancer patients, provided strong 
endorsement and detailed design advice. An ‘e-Focus Group’ corresponded by email to give specific 
advice in relation to study materials for participants. Patients and parents at a TYA service Family Day 
Study 1: Systematic literature review 
 
Study 2: Fatigue in Focus survey 
 
Study 3:  
Fatigue Intervention      
Co-design Study (FICS) 
Study 5:  
Definitive trial to evaluate 
effectiveness of fatigue 
intervention 
Study 4:  
Feasibility randomised 
controlled trial of            
co-designed intervention  
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in June 2013 also validated the proposed research approach, and provided advice. The service 
consultant lead undertook pre-pilot work and found that 16 of the 18 patients she consulted during 
outpatient clinics would have wanted to know more about fatigue and would, on principle, be 
prepared to take part in interventional research. 
 
Young people are particularly keen to take an active part in research, to influence and to provide 
advice [136-138]. The Fatigue Intervention Co-design Study (FICS) was, in itself, an exercise in patient 
involvement (and led to a University of Cambridge Vice-Chancellor’s Public Engagement with 
Research Award: section 7.1.2, page 69). Participants were able to guide the content of the interview 
and focus group discussions, as well as fundamentally influence the design of the intervention 
prototype and subsequent ‘trial ready’ intervention. It has been well-established that co-production 
work with patients reaps benefits in terms of the value and usefulness of the research, and also in 
terms of patient satisfaction [138]. 
1.2.3 Justification for research 
The rationale for this programme of research has already be considered in relation to the research 
context and the patient involvement, as described in sections 1.1 and 1.2.2 respectively. However, 
the salient points are summarised below for clarity: 
 
Cancer-related fatigue appears to be particularly problematic in TYAs 
Fatigue is established as the commonest symptom in adults with cancer. Healthy TYAs experience 
more fatigue than adults for developmental and behavioural reasons. The combination of a cancer 
diagnosis and TYA age may, therefore, be a dual risk factor for fatigue, making TYAs particularly 
vulnerable to the development of CRF. The impact of CRF appears to be magnified by young age. The 
symptom appears to directly hinder TYA developmental needs and may influence life course through 
its impact on education, employment and relationships. Behaviours learned at this age tend to form 
a life-long pattern. TYAs potentially have more of their life ahead of them than older adults, 
increasing the duration of impact and compounding the fatigue burden. 
 
Research outcomes cannot be extrapolated from older adults to TYAs 
Over the last five years the WHO has been driving action to improve adolescent health, mandating 
age-focused healthcare policy, services and standards, underpinned by specific research. There is an 
international imperative to undertake age-appropriate research for TYAs with cancer. Although there 
is an emerging evidence base to support the effective treatment of CRF in older adults, such evidence 
cannot be directly applied to TYAs with their distinct needs.  
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TYAs with cancer want this research to happen so that fatigue can be effectively treated 
Cambridge TYA cancer patients have identified fatigue treatment as their healthcare priority. They 
have initiated, driven, supported and influenced this research. On a national level, young cancer 
patients’ research priorities relate to reversing cancer treatment adverse effects, psychosocial 
support and facilitating return to education and work. Given that fatigue is a predominant treatment 
effect, and that the main adverse impact of fatigue is psychosocial, there is clear alignment of 
regional and national research priorities. 
1.2.4 Theoretical basis 
This work is underpinned by Bandura’s Self-Efficacy Theory, and two subsequent conceptual models 
that apply this theory to the field of cancer-related fatigue. Bandura was an eminent psychologist 
from the USA who introduced the concept of ‘self-efficacy’ in a highly influential article published in 
1977 [139]. He is considered an early ‘cognitivist’, with interest in cognitive processes such as 
perception, information processing, reasoning and direction of attention, rather than a 
‘behaviourist’, focusing on determinants and change of behaviour. Bandura defined ‘self-efficacy’ as 
‘people’s beliefs about their capabilities to produce effects’ [140]. It is a measure of confidence in the 
ability to achieve specific goals, high self-efficacy being associated with being prepared to make a 
greater effort and persist despite obstacles [141]. He identified self-efficacy as a key mediator of 
health-promoting behaviours, such as symptom self-management, a finding that has since been 
extensively corroborated across many fields of healthcare [142-144].  
 
Hoffman and colleagues have subsequently developed a middle-range Theory of Symptom Self-
Management, derived in part from Bandura’s Self-Efficacy Theory, and applied to the self-
management of cancer-related fatigue [145]. Fatigue was the symptom chosen because of the 
central importance of active self-care within fatigue management, there being no effective 
pharmacological or other ‘passive’ approaches. Worse CRF was found to be associated with low self-
efficacy for fatigue self-management, and perceived self-efficacy mediated the relationship between 
the fatigue severity and functional status [146,147]. A 6-item measure of Perceived Self-Efficacy for 
Fatigue Self-Management (PSEFSM) was developed, with the intention of facilitating development of 
interventions to increase self-efficacy [148]. 
 
Foster and Fenlon have subsequently developed a conceptual framework for the recovery of health 
and wellbeing following primary cancer treatment [149]. Cancer-related self-efficacy is central to the 
framework, mediating successful self-management and subjective recovery. Of note, self-efficacy for 
fatigue management was the lowest across a range of self-management tasks, in a survey of patients 
who had completed cancer-treatment in the past 12 months [150].  
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Overall, therefore, Bandura’s Self-Efficacy Theory and the two related conceptual models suggest 
that perceived self-efficacy is an important mediator of self-management behaviours, and a concept 
of relevance to CRF. Patients with long-term conditions consider self-efficacy to be a valuable 
outcome and, interestingly, would be prepared to trade a substantial reduction in health-related 
quality of life in return for an improvement in self-efficacy [151]. Research in adolescents with 
diabetes and juvenile rheumatoid arthritis has shown that the concept of self-efficacy is a relevant 
concept to young patients with chronic disease, and high self-efficacy for self-management is 
associated with improved quality of life [152]. 
 
Of particular importance given the intention to develop a fatigue intervention, self-efficacy does 
appear to be amenable to change. A number of studies evaluating self-management or psychological 
interventions have demonstrated the potential to increase domain-specific self-efficacy, with self-
efficacy, in turn, mediating improved health outcomes [153-155]. In the context of adult CRF, recent 
feasibility studies, involving a web-based intervention and a post-surgical exercise intervention to 
support fatigue self-management, suggested improvement in self-efficacy and outcomes [156,157]. 
 
A final justification for underpinning this work in Self-Efficacy Theory is that self-efficacy has the 
potential to alter rapidly over days, mediating the subsequent behaviour change and the impact of 
such change [158]. The Theory of Change is a design and evaluation tool that has been integrated 
into the MRC Framework of Complex Interventions to try to enhance the likelihood of developing an 
effective complex intervention [159]. This tool requires specification of intermediate outcomes, in 
order to facilitate achievement of the desired long-term outcomes. Perceived self-efficacy is an ideal 
candidate for this intermediate step because of its mediating role. A theory-based logic model for the 
proposed research is provided below. 
 
Figure 1.3 Theory-based logic model  
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1.3 Aim and objectives 
1.3.1 Aim 
The overall aim of this programme of research was to increase understanding of the cancer-related 
fatigue in teenagers and young adults, in order to be able to develop an effective non-
pharmacological fatigue intervention. 
1.3.2 Objectives 
The specific objectives of each of the three studies described in this thesis are stated in each chapter 
introduction. However, the broad objectives of this work, as a whole, were as follows: 
 
1) To review existing literature evaluating any aspect of TYA cancer-related fatigue, providing a 
synthesis of current research knowledge in this field. 
 
2) To survey current TYA patients with cancer to gain a national overview of current fatigue 
prevalence, impact and management.  
 
3) To work with young TYA cancer patients and their parents to co-design an acceptable non-
pharmacological fatigue intervention that meets the needs of this age group. 
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2 Systematic literature review 
2.1 Title 
A systematic literature review of teenage and young adult cancer-related fatigue 
2.2 Rationale 
Despite the apparent high prevalence and adverse impact of TYA CRF, at the time of review initiation 
in 2013, there had been only one previous attempt to synthesise the relevant literature.   
 
In 2004, Erickson reviewed the literature relating to fatigue in adolescents with cancer, using a 
systematic search strategy, although without considering unpublished work or other ‘grey’ literature 
[160]. Using very broad search terms, one being that the studies simply needed to include one or 
more patients aged 12-19, fifteen studies were incorporated in the review. Nine of these evaluated 
adolescent symptoms generally; the remaining six focused on fatigue. All generated qualitative data, 
other than one study demonstrating the properties of the PedsQL™ Multidimensional Fatigue Scale 
(MFS) [161]. No interventional studies were found. The review concluded by suggesting that 
clinicians assess for the presence of fatigue, support patients with this symptom and, importantly, 
work with researchers to ‘promote the most coordinated and efficient research to... test specific 
interventions for fatigue management’ [160]. 
 
In this context, and given the number of relevant papers published since 2004, it was clear that a 
further systematic review of the literature was required. Broad eligibility criteria for inclusion were 
used to ensure a comprehensive overview of existing literature. 
2.3 Aim and objectives 
2.3.1 Aim 
The aim of this literature review was to provide a systematic review and synthesis of existing 
research knowledge concerning TYA cancer-related fatigue. 
2.3.2 Objectives 
To undertake a systematic review and narrative synthesis of existing evidence in relation to: 
1. The prevalence of cancer-related fatigue in TYA patients a) during treatment, b) after treatment. 
2. The impact of fatigue on the quality of life of TYA patients. 
3. The experience of parents of fatigued TYA patients. 
4. Correlates of cancer-related fatigue in TYA patients. 
5. The effectiveness of interventions to manage the symptom. 
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2.4 Methods 
2.4.1 Timeline 
The review was initiated in November 2013, completed by March 2014, and published in the Journal 
of Adolescent and Young Adult Oncology (appendix 7.1.4, page 271). The work was subsequently 
updated in April 2018, and this chapter presents the revised literature review and synthesis.  
2.4.2 Literature search strategy 
MEDLINE, EMBASE, PsycINFO, and CINAHL databases were searched for relevant literature, from 
1981 through to October 2013, and subsequently to May 2018. Preliminary searches revealed no 
literature of relevance published prior to 1981. The search strategy is detailed in table 2.1.  
 
Reference and citation searches were also undertaken, with manual searching of all issues of a key 
journal, the Journal of Adolescent and Young Adult Oncology (volume 1 issue 1 to volume 7 issue 2), 
and the proceedings of the 2012, 2014 and 2016 Teenage Cancer Trust International Conferences. 
Related systematic reviews were searched, including reviews evaluating symptoms experienced by 
teenagers with cancer, fatigue in lymphoma patients, and interventions for fatigue in children and 
adults [162-165]. Experts in the field of TYA cancer-related fatigue were also contacted. 
 
Table 2.1 Search terms 
#1 exp fatigue/ 
#2 fatigue* or tire* or exhaust* or lethargy* (title or abstract) 
#3 exp neoplasm/ 
#4 
neoplasm* or cancer* or carcinoma* or lymphoma* or leukaemia* or leukemia* (title or 
abstract) 
#5 1 or 2 
#6 3 or 4 
#7 5 and 6 
#8 limit 7 to ‘adolescent’ or ‘young adult' 
#9 tya* or teenage* or “young adult”* (title or abstract) 
#10 7 and 9  
#11 8 or 10 
 
2.4.3 Selection criteria 
The key inclusion criteria were that all study participants had malignant disease, and that either the 
majority were aged 13–24 years-old at the time of cancer diagnosis or treatment, or that the results 
for this age subgroup were presented separately. Included studies could investigate any aspect of 
CRF, use any outcome measure, and employ quantitative or qualitative methods. Exclusion criteria 
included non-English language publication, absence of original empirical data, phase I/II clinical trials, 
trials involving fewer than 10 patients, case reports and retrospective case note reviews. Studies of 
TYA-aged survivors of paediatric cancer were not included. 
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2.4.4 Quality assessment and data analysis 
Gough’s Weight of Evidence Framework was employed to assess article quality, relevance, and bias, 
and to generate an overall judgment about contribution [166]. This framework includes analysis of 
‘fitness for purpose’ and relevance to the research question, providing a more applied synthesis of 
evidence than simply assessing the generic quality of each article. Scores of ‘low’, ‘medium’ or ‘high’ 
are given for each of the following:  
 Weight of Evidence A: integrity of the evidence on its own terms. 
 Weight of Evidence B: appropriateness of method for answering the review questions. 
 Weight of Evidence C: appropriateness of the focus or relevance for answering the review 
questions. 
 Weight of Evidence D: overall rating generated by combining the A, B, and C scores. 
 
All articles, irrespective of relevance and quality, were included in the review. However, those rated 
‘medium’ and ‘high’ were given greater weight in the synthesis. 
 
The searches conducted in 2013 produced 2388 unique titles that were initially screened by one 
researcher (Anna Spathis). After 566 abstracts were reviewed by two researchers (Anna Spathis and 
Sarah Grove), 343 full articles were read by one researcher (Anna Spathis), who excluded many of 
them on the basis of the participants’ ages. Two researchers (Anna Spathis and Sara Booth) read the 
remaining articles, with disagreements resolved by discussion. The final number of included articles 
was 69 (figure 2.1). The updated search in 2018, conducted by one researcher (Anna Spathis), added 
nine of these papers. A narrative synthesis was undertaken in relation to each of the review 
questions. 
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Figure 2.1 PRISMA flowchart of included articles 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
 
2.4.5 Study team and roles 
Anna Spathis led this work and every step of the study conduct including: responsibility for study 
design, writing protocol, all literature searches and data analysis. Stephen Barclay and Sara Booth, 
MD supervisors, provided regular guidance and advice throughout the study. Sara Booth read some 
of the papers from the 2013 search, as described in the preceding section. In addition, a number of 
other colleagues made specific contributions as shown below. 
 
Table 2.2 Roles of other team members in review 
Sarah Grove  Specialty Trainee in Palliative Medicine, 
Cambridge University Hospitals 
Abstract review to assess eligibility 
Helen Hatcher  Consultant Medical Oncologist, TYA service lead, 
Cambridge University Hospitals 
Contribution to review design 
Isla Kuhn  Medical Librarian, University of Cambridge Guidance and support in relation to 
optimising search strategy 
 
  
Search update 
2018 
 
Other searches 
2013 
 
Database searches 
2013 
 
Included papers n=5 
 
Included papers n=55 
 
Titles n=2388 
 
Abstracts n=566 
 
Papers n=343 
 
Included papers n=9 
 
Total included papers n=69 
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2.5 Results 
2.5.1 Description of articles 
Forty-three of the 69 included articles were from the USA or Canada, eight were from Norway, 
Sweden or Germany, three were from the UK, and one each from Taiwan and Australia. All were 
published between 1992 and 2017. The 69 articles encompassed a total of 61 separate studies, as 
four pairs of articles [125,132,167-172] and two groups of three articles [134,173-177] were 
publications describing different aspects of the same study’s data set. It was decided to handle these 
as different studies, because of their distinct areas of focus. Therefore, for the purposes of this 
review, the 69 articles were viewed as 69 separate studies. 
 
Forty-one studies were cross-sectional and observational. Of the 28 prospective longitudinal studies, 
seven were interventional clinical trials. Most studies involved only quantitative methods, though 
seven were qualitative and ten employed a mixed-methods design. Most were rated as medium or 
poor on Gough’s Weight of Evidence Framework. Although 16 were of high quality on Weight of 
Evidence A (integrity of the evidence on its own terms) [168,176,178-191], only three were judged to 
be of high overall quality by Weight of Evidence D [168,178,184]. 
 
All participants, aside from those in some of the control groups, had a cancer diagnosis. Seven 
studies only recruited patients with lymphoma and/or leukemia [132,169,182,190-193], and one 
involved only patients with extremity bone tumors [194]. All the remaining studies investigated more 
than one cancer type. The majority of participants were in the 13–24 age range in 52 studies; 
subgroup data for this age range was presented separately in the remaining 17 papers. The number 
of patients within each study ranged from eight [195] to 1202 [191], and the median or mean time 
since diagnosis ranged from two months [196] to 20 years [132]. 
 
Fatigue was the study focus and the first outcome measure described in the results for only 20 
studies [123,125,129-132,134,168,169,172,179,183,184,187,194,197-201]. Two of these involved 
validating symptom measures [129,183] and none were interventional. Across the 69 included 
studies, the most commonly used fatigue outcome measures were the Fatigue Scale-Adolescent (FS-
A) [129], the Multidimensional Fatigue Scale (MFS) [161], and the Memorial Symptom Assessment 
Scale (MSAS 10-18) [202], used in 16, 15 and nine studies, respectively.  Thirteen studies used a 
range of other validated fatigue measures: the Chalder Fatigue Questionnaire, Piper Fatigue Scale, 
Functional Assessment in Chronic Illness Therapy (FACIT) fatigue scale, Edmonton Symptom 
Assessment Scale and the EORTC CQC-C30. Nine studies used unvalidated measures, and the 
remaining seven studies were entirely qualitative in design. Table 2.3 provides further detail on the 
more commonly used measures. 
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Table 2.3 Summary of key fatigue outcome measures 
Name of measure Description 
Chalder Fatigue Questionnaire 
[7] 
11-item multidimensional fatigue scale developed for use in adult 
epidemiological studies of patients with chronic disease, and to find 
fatigue ‘cases.’ It is scored using a 4-point verbal rating scale, with a 
case defined as a score of ≥4 with dichotomized bimodal scoring. 
Edmonton Symptom Assessment 
Scale [203] 
A series of ten numerical rating scales (each 0-10) evaluating nine 
symptoms, one being ‘tired’. It was developed for use in cancer 
patients in a palliative care context, but is not widely used in 
different conditions and contexts. 
EORTC CQC-C30 [204] This scale was developed for the assessment of the quality of life of 
cancer patients in international clinical trials. The scale includes five 
functional scales, three symptom scales (fatigue, pain, and nausea 
and vomiting), and a global health and quality of life scale. 
Fatigue Scale-Adolescent [129] 14-item multidimensional scale developed specifically to assess CRF 
in adolescents aged 13-18. It is scored using a 5-point verbal rating 
scale, and parent and staff proxy versions have been developed. 
Functional Assessment in 
Chronic Illness Therapy fatigue 
scale [10] 
Initially developed as a multidimensional measure of fatigue in adult 
oncology patients with anaemia, its use has been widened to include 
fatigue assessment in chronic illness. It is a standalone scale within 
the wider FACIT measurement system. It has 13 items, scored using a 
5-point verbal rating scale. 
Memorial Symptom Assessment 
Scale [178] 
32-item scale developed to assess the frequency, severity, and 
associated distress of 32 common symptoms, including fatigue, in 
adult cancer patients. Each symptom is measured with 4-point 
(frequency and severity) or 5-point (distress) numerical rating scales. 
It has been modified for use in patients aged 10-18 (30-item) and 
aged 7-12 (8-item); a number of other revised versions also exist. 
Multidimensional Fatigue Scale 
[161] 
18-item scale developed to measure fatigue in paediatric cancer 
patients and now used as a generic multidimensional measure in all 
paediatric patient populations. It is a module of the PedsQL™ 
measurement model, which assesses paediatric quality of life. 
Versions are available for patients aged 5-7, 8-12, 13-18 and 18-24, 
with associated parent proxy versions. It provides general (physical), 
cognitive and sleep/rest fatigue subscale scores. 
Piper Fatigue Scale [8] Multidimensional fatigue scale developed for use in adult cancer 
patients. A number of versions exist, including the original 40-item 
scale and a revised 22-item scale. Each item is scored with a 0-10 
numerical rating scale. It assesses four domains of fatigue: 
behavioural/severity, affective meaning, sensory and 
cognitive/mood; it generates a score for each domain as well as a 
total score. 
Symptom Distress Scale [205] 11-item scale that measures distress related to symptoms, including 
fatigue, scored using a 5-point verbal rating scale. It was developed 
specifically to identify the concerns of adult patients receiving cancer 
treatment. 
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2.5.2 Fatigue prevalence 
Twenty-seven studies investigated the prevalence of TYA CRF (table 2.4). Fatigue was measured 
during treatment in 15 studies, after treatment in five studies, and in a mixed population of patients 
both during and after treatment in six studies. In one study, the treatment status of the patient 
population was not defined [206]. A ‘fatigue case’ was most commonly defined as fatigue being 
scored as ‘present’ using the MSAS, a score of anything other than ‘no fatigue’ on a 5-point Likert 
scale, or a dichotomized score of ≥4 on the Chalder Fatigue Scale [7]. 
 
The heterogeneity of study populations, outcome measures, and definitions of ‘fatigue case’ 
hindered comparison of prevalence data between studies and prevented meta-analysis. Fatigue 
prevalence ranged from 7% [184] to 100% [207] during treatment, 9% [187] to 67% [120] after 
treatment, and between 31%[208] and 100%[209] in mixed populations. As detailed in table 2.4, the 
prevalence of fatigue and other symptoms were compared on 22 occasions in 12 studies; it was the 
most prevalent symptom on 11 occasions [121,170,171,178,207,210-212] and the second-most 
prevalent on seven occasions [178,206,212-214]. 
 
Two studies, both evaluating survivor populations, included a healthy control group; non-
contemporaneous controls were used in both studies. Aksnes and colleagues found a fatigue 
prevalence of 14% in extremity bone tumor survivors, which was not significantly different from that 
of age- and gender-matched cases from healthy population surveys (p=0.30) [194]. In contrast, 
Hamre and colleagues reported a fatigue prevalence of 34% in survivors of Hodgkin’s lymphoma, 
compared to 8% in an unmatched healthy control population (p<0.001) [132]. 
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Table 2.4 Studies evaluating fatigue prevalence, grouped by relationship to cancer treatment 
  
Study Aim(s) Participants (mixed 
tumors unless stated) 
Study design and 
fatigue assessments 
Definition of 
fatigue ‘case’ 
Fatigue prevalence (rank 
compared to other symptoms) 
Weight of 
Evidence D  
During treatment 
Ameringer and 
colleagues.20
13 [196] 
 
Examine the 
trajectory of 
symptoms across a 
chemotherapy 
cycle 
 n=9 
 Mean age: 15.3 years 
 Mean since diagnosis: 
2.6 months 
 Longitudinal 
observational pilot 
 FS-A 
Not described  All participants experienced 
some fatigue at every time point 
Low 
Ameringer and 
colleagues. 
2015 [189] 
Examine symptom 
experiences, 
clusters and 
perceived causes 
 n=70 
 Mean age: 18.5 years 
 Mean since diagnosis:  
3 months 
 Cross-sectional 
observational 
 MSAS 10-18 
Presence of 
‘lack of 
energy’ in last 
week on MSAS 
 55.6% (4 of 31) Medium 
Atay and 
colleagues. 
2012 [214] 
 
Determine 
symptom 
prevalence 1, 2, 
and 3 months after 
diagnosis 
 n=54 
 61% 13-18 years 
 Longitudinal 
observational 
 MSAS 10-18 
Presence of 
‘lack of 
energy’ in last 
week on MSAS 
 Month 1: 66.7% (5 of 30) 
 Month 2: 75.9% (2 of 30) 
 Month 3: 63% (joint 2 of 30) 
Medium 
Baggott and 
colleagues. 
2010 [212] 
Describe changes 
in symptoms at 
weekly intervals 
from D1 
 n=66 
 Mean age: 14.8 years 
 Mean since diagnosis: 
16.3 months 
 Longitudinal 
observational 
 Revised MSAS 10-18 
Presence of 
‘lack of 
energy’ in last 
week on MSAS 
 Week 0: 75.8% (1 of 31) 
 Week 1: 70.5% (2 of 31) 
 Week 2: 57.4% (2 of 31) 
 Significant linear decrease over 
time 
Medium 
Baggott and 
colleagues. 
2012 [207] 
Describe the 
usefulness of 
eDiary to record 
symptoms over a  
3-week trial 
 n=10 
 Mean age: 18.2 years 
 Mean since diagnosis: 
12.2 months 
 Longitudinal 
observational 
 2 questions from FS-
A in a VAS format 
VAS >30 on 0-
=100 scale on 
at least 1 day 
 Reported fatigue-physical and 
fatigue-mental: 100% (1 of 11) 
 % days that VAS >30 on 0-100 
scale, 64% and 62%, respectively 
(1 of 11) 
Low 
Baggott and 
colleagues. 
2012 [121] 
Evaluate symptom 
clusters 
 n=131 
 Mean age: 14.8 years 
 Median since diagnosis: 
3.3 months 
 Cross-sectional on 
D0 of ≥cycle 2 of 
chemotherapy 
 Revised MSAS 10-18 
Presence of 
‘lack of 
energy’ in last 
week on MSAS 
 75.6% (1 of 31) Medium 
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Study Aim(s) Participants (mixed 
tumors unless stated) 
Study design and 
fatigue assessments 
Definition of 
fatigue ‘case’ 
Fatigue prevalence (rank 
compared to other symptoms) 
Weight of 
Evidence D  
Corey and 
colleagues. 
2008 [208] 
Describe the 
relationship 
between support 
and symptom 
distress 
 n=72 (ARM 2) 
 Mean age: 14.8 years 
(ARM 2) 
 Mean since diagnosis: 
3.75 years (ARM 1, 2) 
 Secondary analysis 
of data from two 
studies 
 Symptom Distress 
Scale 
3-5 on 1-5 
Likert scale 
 ARM 2 (recent diagnosis): 42.5% Medium 
Enskar and 
colleagues. 
2007 [120] 
Evaluate distress, 
coping support, 
and care 
 n=54 
 Mean age: 16.0 years 
 32 were <3 months of 
diagnosis 
 Cross-sectional 
 LSS-A 
Anything other 
than ‘not at 
all’ / ‘do not 
agree at all’ on 
1–5 VRS 
 For 15 patients on treatment: 
93%; significantly more than 
patients off treatment (p<0.05) 
Medium 
Erickson and 
colleagues. 
2010 [125] 
Describe fatigue 
patterns during 
month of 
chemotherapy 
 n=20 
 Mean age: 16.1 years 
 Mean since starting 
chemotherapy: 8.71 
weeks 
 Longitudinal mixed 
methods 
 Daily fatigue NRS, 
MFS 
>0 on 0-10 
NRS 
 Experienced fatigue at some 
point, including during ‘days 
immediately following 
chemotherapy’: 100% 
Medium 
Erickson and 
colleagues. 
2011 [172] 
Describe 
relationship 
between fatigue 
and sleep-wake 
disturbances 
 n=20 
 Mean age: 16.1 years 
 Mean since starting 
chemotherapy: 8.71 
weeks 
 Longitudinal 
observational 
 Weekly MFS from 
D1 for 5 weeks 
‘Feeling tired’ 
‘sometimes,’ 
‘often,’ or 
‘almost 
always’ 
 At some point over study period: 
75% 
Medium 
Hedstrom and 
colleagues. 
2005 [176] 
Investigate 
perceptions of 
distress amongst 
recently-diagnosed 
adolescents 
 n=56 
 Age (years): 13-15, 
n=35; 16-19, n=21 
 Cross-sectional, 
mixed methods 
 Fatigue assessed as 
an aspect of distress 
using Likert scale 
3-5 on 0-5 
Likert scale 
 62% (4 of 20) Medium 
Mandrell and 
colleagues. 
2011 [184] 
Calculate the 
revised FS-A score 
that defines a 
fatigue ‘case’ 
meriting clinical 
intervention 
 n=138 
 Mean age: 14.83-16.27 
years across all studies 
 Analysis of data 
from 9 studies 
 FS-A and FS-P 
>31 on scale of 
13–65 
 ALL: 15%; 7-14%/26-33% (ALL 
off/on DXM) 
 Solid tumor or AML: 10% (D1), 
28% (D2), 50% (D3-4) 
 Mixed diagnoses: 36% (D1); 56% 
(final day); 54% (1 week after 
end) 
High 
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Study Aim(s) Participants (mixed 
tumors unless stated) 
Study design and 
fatigue assessments 
Definition of 
fatigue ‘case’ 
Fatigue prevalence (rank 
compared to other symptoms) 
Weight of 
Evidence D  
Miller and 
colleagues. 
2011 [213] 
Describe 
prevalence, 
frequency, severity, 
and distress of 
multiple symptoms 
 n=39 
 Mean age: 13.5 years 
 Longitudinal 
observational 
 MSAS 10-18 daily 
for 5 days 
evaluating 
symptoms from 
‘past day’ 
Presence of 
‘lack of 
energy’ in last 
week on MSAS 
 49.6% (2 of 31) Medium 
Walker and 
colleagues. 
2010 [210] 
Describe symptoms 
before (T1) and 1 
week after (T2) 
chemotherapy 
 n=51 
 Mean age: 14.2 years 
 Mean since diagnosis: 6 
months 
 Longitudinal 
observational in 2 
centers 
 MSAS 7-12 
Presence of 
‘tiredness’ in 
last week on 
MSAS 7–12 
 T1: 54.3% (1 of 9) 
 T2: 67.4% (1 of 9) 
Medium 
Williams and 
colleagues. 
2012 [211] 
Calibrate the 
Therapy-Related 
Symptom 
Checklist-Children 
 n=163 
 Subgroup of 385 
participants in age 
range 12-17 years  
 Cross-sectional 
 TRSC-C 
Severity of 
‘feeling 
sluggish’ of 
more than 0 
on 0–4 Likert 
 81% (1 of 31) Medium 
After treatment 
Adams and 
colleagues. 
2004 [192] 
Evaluate 
cardiovascular 
function after 
mediastinal RT 
 n=48 HD survivors 
 Median age at 
diagnosis: 14.2 years 
 Median since diagnosis: 
14.3 years 
 Cross-sectional 
 General Health 
Survey (unvalidated 
tool) 
≥1 on 0-4 
Likert scale of 
fatigue 
severity 
 67% Medium 
Aksnes and 
colleagues. 
2007 [194] 
Examine fatigue, 
mental distress, 
and QOL in EBT 
survivors compared 
to matched 
controls 
 n=57 EBT survivors 
 Mean age at diagnosis 
across subgroups: 16-
25 years 
 Mean since diagnosis: 
9–14 years 
 Case-control (non-
contemporaneous 
controls HD, TC, 
NORMS) 
 CFQ 
Sum of ≥4 
using 
dichotomized 
(0, 0, 1, 1) 4-
point Likert 
scale 
 EBT survivors: 14% 
 HD survivors: 21% 
 TC survivors: 16% 
 NORMS: 10%; p=0.3 EBT vs. 
NORMS 
Medium 
Enskar and 
colleagues. 
2007 [120] 
Evaluate distress, 
coping support, 
and care 
 n=54 
 Mean age: 16.0 years 
 32 were <3 months of 
diagnosis 
 Cross-sectional 
 LSS-A 
Anything other 
than ‘not at 
all’ on 1-5 VRS 
 For 39 patients after treatment: 
67%, less than on treatment 
(p<0.05) 
Medium 
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Study Aim(s) Participants (mixed 
tumors unless stated) 
Study design and 
fatigue assessments 
Definition of 
fatigue ‘case’ 
Fatigue prevalence (rank 
compared to other symptoms) 
Weight of 
Evidence D  
Hamre and 
colleagues. 
2013 [132] 
Determine 
prevalence of 
chronic fatigue in 
leukemia/lymphom
a survivors 
 n=92 (subgroup of 
290); all HD 
 Mean age diagnosis: 
14.6 years 
 Mean age at survey: 
35.0 years 
 Cross-sectional 
 CFQ 
Sum of ≥4 
using 
dichotomized 
(0, 0, 1, 1) 4-
point Likert 
scale 
 35% vs. 8% in control group 
(note control group age, 19-50 
years) 
 Adjusted odds ratio of fatigue in 
HD vs. control: 5.9 
Low 
Mulrooney 
and 
colleagues. 
2008 [187] 
Describe 
prevalence and risk 
factors for fatigue 
and sleep 
disturbance 
 n=631 (subgroup of 
1897) 
 Diagnosed age: 15-21 
years 
 >5 years from diagnosis 
 26-center cohort 
study 
 FACIT-fatigue 
Score below 
10th 
percentile for 
sibling cohort 
 8.6% Medium 
Mixed during and after treatment 
Collins and 
colleagues. 
2000 [178] 
Determine 
symptom 
prevalence, 
characteristics, and 
distress 
 n=160 
 70 had chemotherapy 
within last 2-4 weeks, 
58 >4 months ago 
 Mean age: 14.0 years 
 Cross-sectional 
 MSAS 10–18 
Presence of 
‘lack of 
energy’ in last 
week on MSAS 
 Overall: 49.7% (1 of 30) 
 CNS tumor: 66.7% (1 of 30) 
 Lymphoma: 50% (1 of 30) 
 Leukemia: 43.8% (2 of 30) 
 Solid tumor: 53.7% (3 of 30) 
Medium 
Corey and 
colleagues. 
2008 [208] 
Describe 
relationship 
between distress 
and three sources 
of support 
 n=127 (ARM 1) 
 Mean age: 16.4 years 
(ARM 1) 
 Mean since diagnosis: 
3.75 years (ARM 1 and 
2) 
 Secondary analysis 
of data from 2 
studies 
 Symptom Distress 
Scale 
3-5 on 1-5 
Likert scale 
 ARM 1 (mixed population): 
31.4% 
 1-year increase in age increased 
odds of fatigue by 1.23-1.25 
Medium 
Enskar and 
colleagues. 
1997 [209] 
Evaluate 
adolescents’ 
experience of areas 
of life affected by 
the disease 
 n=10 
 Age 13-16 years at 
diagnosis n=8 
 Age at interview: 15-20 
years 
 Cross-sectional 
observational 
 5-point NRS (non-
validated 
questionnaire) 
≥2 on 1-5 NRS  100% Medium 
Nunes and 
colleagues. 
  2015 [200] 
Investigate and 
compare fatigue 
and sleep patterns 
in adolescents and 
children 
 n=18 
 Age 13-17 years 
 Subgroup of 35 hospital 
patients being 
discharged home 
 Cross-sectional 
observational 
 MFS 
MFS score<75  54% Medium 
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ALL, acute lymphatic leukemia; AML, acute myeloid leukemia; ARM 1, Adolescent Resilience Model study 1; ARM 2, Adolescent Resilience Model study 2; 
CFQ, Chalder Fatigue Questionnaire; CNS, central nervous system; D1, D2, etc., day 1, day 2, etc.; DXM, dexamethasone; EBT, extremity bone tumor; ESAS, 
Edmonton Symptom Assessment Scale; FACIT-fatigue, Functional Assessment of Chronic Illness Therapy-Fatigue Scale; FS-A, Fatigue Scale-Adolescent; FS-P, 
Fatigue Scale-Parent; HD, Hodgkin disease; LSS-A, Life Situation Scale for Adolescents; MFS, Multidimensional Fatigue Scale; MSAS (7–12, 10–18), Memorial 
Symptom Assessment Scale (for 7–12 and 10-18 age range); NORMS, healthy controls; NRS, Numerical Rating Scale; QOL, quality of life; RT, radiotherapy; 
T1, T2, etc., time point 1, time point 2, etc.; TC, testicular cancer; TRSC-C, Therapy-Related Symptom Checklist-Children; VAS, Visual Analogue Scale; VRS, 
Verbal Rating Scale
Study Aim(s) Participants (mixed 
tumors unless stated) 
Study design and 
fatigue assessments 
Definition of 
fatigue ‘case’ 
Fatigue prevalence (rank 
compared to other symptoms) 
Weight of 
Evidence D  
Ream and 
colleagues. 
2006 [197] 
Investigate impact 
of fatigue on 
adolescents 
 n=22 
 Age: 13-20 years 
 Longitudinal, mixed 
methods 
 Daily diary entry and 
completion of 
fatigue NRS 
Mention of 
fatigue in diary 
entries 
 Mentioned fatigue during 
treatment: 32; 30% in early 
remission (1-2 years after 
treatment), 10% in late remission 
(>5 years) 
Medium 
Yeh and 
colleagues. 
2008 [170], 
2009 [171] 
Assess symptoms 
in older Taiwanese 
children 
 n=144 
 Mean age: 14.2 years 
 For 108 on treatment, 
mean since diagnosis: 
21.2 months 
 Cross-sectional 
observational 
 MSAS 10-18 
Presence of 
‘lack of 
energy’ in last 
week on MSAS 
 52% (1 of 30) 
 On/off treatment: 52.8%, 50.0% 
 Leukemia: 57.3% 
 Lymphoma: 46.2% 
 Solid tumor: 46.5% 
Medium 
Relationship to treatment unstated 
Hughes and 
colleagues. 
2015 [206] 
Evaluate symptoms 
on referral to 
palliative care 
 n=33 
 Age: 15-25 on diagnosis 
 Cross-sectional 
observational 
 Two palliative non-
contemporaneous 
controls 
 ESAS 
Score of ≥1 in 
0-10 NRS 
 75% (2 of 9) 
 Palliative care controls matched 
by gender and cancer type (not 
age): 76% 
 Unselected palliative care 
controls: 72% 
Medium 
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2.5.3 Fatigue severity 
The severity of fatigue was measured in 38 studies: 21 during treatment, seven after treatment, eight 
with a mixed cohort of patients both during and after treatment, and one that provided data on two 
separate patient cohorts during and after treatment, respectively. A further study did not state the 
treatment status of participants. Ten studies reported relative severity of fatigue in comparison to 
other symptoms; fatigue was most severe in five [171,191,192,210,211], second in two [121,206], 
third in one [213] and fourth most severe in two [176,209]. Fourteen different outcome measures 
were used across these 38 studies. The most commonly used outcome measures were the FS-A, MFS 
and MSAS, in ten, ten and four studies, respectively. Comparison and synthesis of severity scores was 
again not possible due to heterogeneity of study populations, methods of reporting the data (for 
example, absolute score or percentage with score above a defined value), or measures used. 
 
Three studies incorporated a control group for comparison of fatigue severity with healthy 
individuals of a similar age (table 2.5). Controls ranged from contemporaneous recruits to unmatched 
reference data. All three studies showed significantly greater fatigue severity in the TYA cancer 
groups compared to the controls.  
 
Eleven studies compared fatigue severity between younger children and adolescents treated for 
cancer, of which six measured fatigue with both the Fatigue Scale-Adolescent (FS-A) and the Fatigue 
Scale-Child (FS-C) [123,173,193,201,215,216]. The FS-A and FS-C [217] each use 14 age-appropriate 
questions and are validated for 13-18 and 7-12 year olds, respectively. Fatigue was reported as being 
more severe in adolescents than in younger children in all but one of the eleven studies [193].  
 
Many of the studies that used the FS-A outcome also measured parent reports of fatigue 
[128,173,174,184,186,187,215,216], but patient and parent scores are not directly comparable using 
this measure. One study, using the MFS, was able to directly compare the fatigue scores of TYA 
patients with proxy scores from their caregivers, and found that caregivers tended to overestimate 
their fatigue severity [168]. 
 
Fatigue severity was assessed over time in 13 longitudinal studies. All except for one [190] involved 
participants currently receiving chemotherapy [123,125,128,133,172,173,196,201,210,212,216,218]. 
In general, fatigue scores were worse in the two weeks after receiving chemotherapy and then 
improved until the next cycle. One longitudinal study investigated fatigue severity in TYAs with 
Hodgkin’s lymphoma from the end of treatment over a three year period; there was no significant 
change in fatigue scores over this time [190]. A small cross-sectional, observational study of three 
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groups of adolescents during treatment (n=8), 1–2 years after treatment (n=6), and five or more 
years after treatment (n=8) found that fatigue scores were highest during treatment, lowest during 
early remission, and higher again during late remission [197]. 
 
Although studies using the MFS outcome measures could use subscale scores to determine the 
differential severity of general, sleep/rest and cognitive fatigue, only five studies reported the 
subscores. Four found cognitive fatigue to be less severe than the other dimensions, although no 
studies tested the differences for statistical significance [168,172,186,200]. In the only one of these 
studies recruiting patients after cancer treatment, Keats and colleagues found cognitive subscores 
that were of comparable severity to the other two subscales [218].  
2.5.4 Impact of fatigue 
Twenty-two studies reported the impact of fatigue on patients [125,131,170,171,173,175-
180,185,195,197,210,213,214,219-223]. Distress caused by fatigue was the most commonly 
described impact, reported in 11 studies. The MSAS, a scale that allows comparison of the level of 
distress caused by each symptom, was used in six of these studies [170,171,178,210,213,214]. When 
symptoms were ranked in order of distress, fatigue was in the top half with only one exception [178]. 
One study reported that distress was correlated with the frequency and severity of fatigue [171]. The 
remaining five studies used diverse measures of distress [176,180,195,221,222], and fatigue was one 
of the top four most distressing conditions in four of these studies [176,180,221,222].  
 
The second-most frequently described impact of fatigue was that it was a barrier to physical activity 
or exercise, which was reported in six studies [125,179,197,219,220,223]. Fatigue was the first [219] 
and second most [223] significant barrier in one study each. Being unable to take part in exercise led 
to frustration and loss of confidence, with parents becoming ‘over-protective’ and preventing their 
adolescents from taking part in activities that demanded energy [179]. Four studies reported fatigue 
as a barrier to other social activities [125,179,185,197], including returning to school [185]. A 
negative impact on affective state, mood, or anxiety was described in three studies [125,131,173]. 
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Table 2.5 Controlled studies evaluating fatigue severity 
Study Aim(s) Participants 
(mixed tumors unless stated) 
Study design and fatigue 
assessments 
Fatigue severity Weight of 
Evidence D 
score 
Aksnes and 
colleagues. 
2007 [194] 
Examine fatigue, 
mental distress, 
and QOL in EBT 
survivors compared 
to matched 
controls 
 n=57 EBT survivors 
 Mean age at diagnosis within 
different cancer type subgroups: 
16-25 years 
 Mean since diagnosis: 9-14 years 
 Case-control (non-
contemporaneous age- 
and gender-matched 
controls HD, TC, NORMS) 
 CFQ 
 Mean total fatigue: 
 EBT survivors: 13.2 
 HD survivors: 13.4 
 TC survivors: 13.4 
 NORMS: 11.8 
 EBT survivors had significantly more fatigue 
than NORMS (p=0.003), but not more than 
other survivor groups 
Medium 
Daniel and 
colleagues. 
2013 [168] 
Compare 
adolescent and 
parent reports of 
fatigue in patients 
with and without 
cancer 
 n=102 with cancer on treatment 
 Mean age: 15.75 years 
 Mean since diagnosis: 20.4 
months 
 n=97 controls; mean age: 15.55 
years 
 Cross-sectional 
observational 
(contemporaneous 
controls) 
 MFS 
 MFS score in cancer and control groups, 
respectively (lower score representing 
worse fatigue): 58.54 and 71.72 (p<0.001) 
 Total fatigue, general fatigue, and sleep/rest 
fatigue worse, but not cognitive fatigue 
High 
Smith and 
colleagues. 
2013 [188] 
Examine HRQOL of 
AYA patients and 
associated health-
related 
characteristics 
 n=159 
 Age: 15-25 years 
 Subgroup of large AYA HOPE 
study with 523 cancer patients 
aged 15-39 at diagnosis 
 Since diagnosis at survey: 6-14 
months 
 80% not on treatment 
 Cross-sectional 
observational (compared 
to age-range matched 
population norms) 
 MFS 
 Mean MFS scores: 
 Ages 18-25: 61.3, significantly worse than 
reference healthy population score of 71.0 
(p=0.001) 
 Ages 15-17: 59.8, not significantly different 
from ages 18-25 (no reference data for this 
age range) 
Medium 
AYA, adolescent and young adult; AYA HOPE, Adolescent & Young Adult Health Outcomes & Patient Experience study; CFQ, Chalder Fatigue Questionnaire; 
EBT, extremity bone tumor; HD, Hodgkin disease; HRQOL, health-related quality of life; MFS, Multidimensional Fatigue Scale; NORMS, healthy controls; 
QOL, quality of life; TC, testicular cancer 
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2.5.5 Experience of parents 
Although 11 studies collected parent proxy reports of fatigue severity 
[123,128,129,168,173,174,184,186,215,216,224], none investigated the experiences of parents of 
TYAs with CRF. Parent proxy reports of fatigue severity correlated more closely with those of their 
children for parents of cancer patients than for parents of healthy controls, which was attributed to 
the cancer patients’ parents being ‘physically closer’ and ‘more attuned to the needs’ of their 
children [129,168,199]. However, cancer patients’ parents appeared to be less adept than the 
patients themselves at perceiving changes in fatigue over time [123,128]. One study collected staff 
proxy reports of patient fatigue as well as parent proxy reports [129], and found that staff reports 
correlated less closely with patients’ self-reported fatigue, than parents’ reports. 
2.5.6 Fatigue correlates 
Factors correlating with the presence or severity of fatigue were reported in 30 studies, including five 
of the six scoring highest on the Gough’s Weight of Evidence Framework [168,174,184,186,188]. 
 
Thirteen studies highlighted an association between fatigue and physical symptoms, including poor 
sleep [172,173,196,199,200,215,216], being part of a symptom cluster [121,170,189,214], and 
nausea [167,199]. Almost all participants in the four studies that examined symptom clusters were 
receiving chemotherapy [121,170,189,214]. Although there was no consistency in the specific 
symptoms found to cluster with fatigue, the symptoms tended to be chemotherapy-related. While 
receiving chemotherapy [120,123,125,134,181,184] or dexamethasone [182] both correlated with 
increasing fatigue, the evidence for a correlation between fatigue and hospital admission 
[123,184,213] or anaemia [123,183] was conflicting. Even though patients associated fatigue with 
‘doing too many things’ or ‘being too active’ [125,130], two studies revealed a correlation between 
improved performance status and lower fatigue scores [133,183]. 
 
Depression or low mood correlated with fatigue in five studies [129,168,174,199,225]. Negative 
affect [167], global distress [213], anxiety [170,214] and non-specific psychological conditions 
[181,213] were identified as correlates in a further five studies. Consistent with the link with physical 
and psychological symptoms, a high correlation with poor quality of life or satisfaction with life was 
reported in five studies [120,125,168,225,226].  
 
Although some of these correlations might be intuitively considered likely to represent causal 
relationships, such as the relationship between fatigue and poor sleep quality, no studies specifically 
assessed causality. A longitudinal study that observed a predictable fluctuation in fatigue during 
chemotherapy regimens of varying frequency [125] and a study involving planned periods on and off 
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dexamethasone [182] both suggested causal relationships with fatigue. One further study asked 
participants to describe their own views as to the causes of symptoms, and 34/37 free text responses 
suggested that chemotherapy or other medication was considered the main cause of fatigue [189]. 
2.5.7 Interventions to manage fatigue 
Table 2.6 details the seven interventional trials for TYA cancer patients in which fatigue was used as 
an outcome measure [180,215,224,227-229]. Fatigue was not stated to be the primary outcome 
measure in any of the seven. Four studies were uncontrolled [218,224,227,228] and five were 
feasibility studies [215,218,224,227,229].  
 
Four of the studies involved evaluation of a structured activity intervention, and the remaining three 
investigated a self-care coping intervention, massage therapy and yoga. All of the interventions were 
standardized with a degree of individualisation in accordance with each patient’s exercise capacity. 
Two uncontrolled trials found a statistically significant benefit from their interventions [218,228], 
which both involved intensive structured exercise in a gymnasium at weekly intervals for more than 
two months. The remaining two physical activity intervention studies involved bringing portable gym 
equipment to patients’ hospital rooms and did not find any significant effect [215,227]. No evidence 
was generated to suggest that the self-care coping, yoga or massage interventions were effective 
[180,224,229].
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Table 2.6 Studies evaluating fatigue interventions 
Study Aim(s) Participants (mixed 
tumors unless stated) 
Study design and intervention Fatigue assessments Results Weight of 
Evidence D  
Atkinson and 
colleagues. 
2012 [228] 
Determine the 
impact of a 
structured exercise 
intervention 
 n=55 
 Age: 15-25 years 
 Uncontrolled trial 
 2–3 sessions/week individual 
structured exercise in a 
hospital/private gymnasium 
with an exercise physiologist 
over 10 weeks 
 Assessed pre- and 
post-intervention 
 Revised PFS, Ferrans 
and Powers QLI, 
measures of 
functional fitness 
 Improvement in fatigue 
(p≤0.0001), as well as QOL 
and functional 
assessments 
 PFS scores decreased by 
32% 
Medium 
Diorio and 
colleagues. 
2015 [224] 
Determine the 
feasibility of yoga 
for inpatients 
receiving 
chemotherapy 
 n=11 
 Median age: 14.0 
years 
 Uncontrolled trial 
 3 yoga sessions/week for three 
weeks 
 Individualised sessions 
including relaxation, breathing 
and poses of strengthening, 
flexibility and balance 
 Assessed pre- and 
post-intervention, 
days 0 and 21 
 Outcomes included 
parent proxy reports 
of fatigue using MFS 
 No change in proxy reports 
of fatigue  
Low 
Hinds and 
colleagues. 
2000 [180] 
Evaluate effects of 
an educational 
intervention 
designed to 
facilitate self-care 
coping 
 n=78 
 Mean age: 16.0 years 
 Two-centre randomized 
controlled trial 
 40-minute intervention 
between T1 (1-12 days after 
diagnosis) and T2 (5-7 weeks 
after): information on self-care 
coping, video with strategies, 
and rehearsal of strategies 
 Control had equal time to 
discuss any topic 
 Assessed at T1, T2, 3 
months, and 6 
months after 
diagnosis 
 Six outcome 
measures, including 
SDS (includes 5-point 
fatigue severity VRS) 
 No difference in SDS score 
between groups at any 
time point 
 Fatigue 1 of 4 most 
distressing symptoms at 
every time point 
Low 
Hinds and 
colleagues. 
2007 [215] 
Evaluate the 
feasibility of using 
an enhanced 
physical activity 
intervention 
 n=11 
 Subgroup age: 13-18 
years 
 Two-centre pilot randomized 
controlled trial 
 Pedaling a stationary bicycle 
exerciser for 30 minutes twice 
daily for 2-4 days of 
hospitalization with equipment 
brought to hospital room 
 Control spent equal time with 
researcher 
 Assessed daily on 
days 1, 2, and 3 
 Patient, parent, and 
staff fatigue reports 
(FS-C, -A, -P, -S), wrist 
actigraphy, parent 
sleep diary, 
hemoglobin 
 No difference between 
groups 
Medium 
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Study Aim(s) Participants (mixed 
tumors unless stated) 
Study design and intervention Fatigue assessments Results Weight of 
Evidence D  
Jacobs and 
colleagues. 
2016 [229] 
Evaluate the 
feasibility of 
conducting a 
massage 
intervention  
 n=34 
 Age: 12-21 years 
 Single-centre pilot randomized 
controlled trial 
 20-30min massage session on 
2-3 consecutive evenings 
during hospital admission 
 Waitlist control 
 Fatigue assessed daily  
 Patient, parent, 
fatigue reports (FS-A, 
-P), actigraphy, 
measures of anxiety 
and mood 
 No difference between 
groups 
Medium 
Keats and 
colleagues. 
2008 [218] 
Assess feasibility of 
a physical activity 
intervention 
 n=10 
 Age: 14-18 years 
 Mean since diagnosis: 
62.5 months 
 Uncontrolled feasibility study 
 Weekly 90 minutes of group 
education and training for 8 
weeks in gymnasium, then 
variety of non-competitive 
activities over 16 weeks 
 Assessed at baseline, 
week 8, week 16, 3 
months, and 1 year 
 PedsQL, MFS, Leisure 
Score Index, 
FitnessGram (a 
physical fitness test) 
 Improvement in fatigue 
between baseline and 3 
months (p=0.01), but post-
intervention benefits not 
sustained at 3 months and 
1 year 
Medium 
Rosenhagen 
and 
colleagues. 
2011 [227] 
Investigate 
feasibility and 
acceptability of 
sports therapy 
 n=13 
 Mean age: 15.3 years 
 Uncontrolled feasibility study 
(control group gave 
acceptability data only) 
 Individualized exercise using 
ergometer in hospital room 
during isolation phase of SCT 
 Assessed on days 1 
and 14 and on 
discharge after SCT 
 QOL self-assessment, 
MFS 
 Non-significant trend for 
fatigue improvement pre- 
and post-intervention 
Low 
FS-A, Fatigue Scale-Adolescent; FS-C, Fatigue Scale-Child; FS-P, Fatigue Scale-Parent; FS-S, Fatigue Scale-Staff; MFS, Multidimensional Fatigue Scale; PedsQL, 
Paediatric Quality of Life Inventory; PFS, Piper Fatigue Scale; QLI, quality of life index; QOL, quality of life; SDS, Symptom Distress Scale; SCT, stem cell 
transplant; T1, T2, etc., time point 1, time point 2, etc.; VRS, Verbal Rating Scale 
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2.6 Discussion 
2.6.1 Overview of evidence 
This systematic literature review and narrative synthesis provides evidence that supports the 
rationale for this programme of research. It confirms that fatigue is one of the most prevalent and 
severe symptoms experienced by TYA cancer patients, occurring in the majority of patients and 
particularly prevalent during cancer treatment. This finding is consistent with systematic review 
evidence evaluating symptom prevalence in adults with cancer, revealing fatigue to be the most 
prevalent symptom in older patients [13]. 
 
Fatigue was found to be consistently more severe in TYA cancer patients than in younger children 
with cancer. This concords with evidence from healthy teenagers, who have a propensity to develop 
fatigue and daytime sleepiness for developmental and behavioural reasons (section 1.1.4, page 11). 
Although none of the studies eligible for this review compared TYA CRF levels with that in older 
adults with cancer, there have been a number of recent studies, incorporating a wider definition of 
the ‘young adult’ age range (15-39), that are generating such evidence. Singer and colleagues found 
worse fatigue in young cancer patients below 40 years, compared to those over 60 years [230]. Two 
further studies have found equivalent outcomes, when comparing younger and older cancer patients 
with gynaecological cancers [231] and with breast cancer [232]. Overall, therefore, it does appear 
that CRF in TYAs is more severe than in both younger and older age groups, at this time of particular 
vulnerability to fatigue. 
 
This review provides some evidence for long-term persistence of fatigue well beyond the end of 
cancer treatment, both from cross-sectional studies involving cancer survivors and from a single 
longitudinal study. A number of other studies, evaluating cancer survivors falling just outside the age 
criteria for this review, provide further confirmation of persistent fatigue [233-235]. Given high TYA 
cancer survival rates (section 1.1.3, page 9), large numbers of young people are contending with 
long-term morbidity while attempting to rebuild their lives after a cancer diagnosis. 
 
Not only is fatigue prevalent, severe, and persistent in TYAs, this review provides strong evidence 
that the symptom causes significant distress, with a negative impact on quality of life. Fatigue 
impacts on the ability to exercise, on socialization and on school attendance, all consequences that 
could contribute to the reported distress. However, none of the studies focused on trying to 
understand the causes of the distress. 
 
This systematic review has highlighted important ‘gaps’ in the existing literature. Although many 
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studies have revealed associations between fatigue and its correlates, there has been little effort to 
try to understand the aetiology of fatigue in TYAs by trying to assess causality. There has, for 
example, been little longitudinal research investigating the temporal pattern of fatigue and its 
correlates over time beyond the end of cancer treatment. There is a complete dearth of literature on 
the perspectives of parents or others living closely with these young patients. Given the profound 
impact of fatigue on TYA cancer patients, it would be reasonable to hypothesise that parents may 
well also be suffering indirect adverse consequences. 
 
It is concerning that, despite the robust evidence base confirming the magnitude of the problem, 
there have been no published interventional studies with the primary aim of treating TYA CRF. The 
few interventional studies to date are mostly uncontrolled or feasibility studies investigating physical 
activity. Exercise is recognized as an effective treatment in adults with CRF. Although two of the four 
physical activity interventional studies did report significant findings, both were uncontrolled. Given 
the well-established placebo effect that occurs with subjective symptoms such as fatigue [236], the 
existing evidence for intervention effectiveness in the TYA age group is, as yet, extremely limited.  
 
An important finding of this review is that fatigue itself is a key barrier to activity. Qualitative studies, 
both included in this review and closely related, provide anecdotal suggestions from participants that 
‘being too active’ or ‘doing too many things’ may worsen fatigue [125,130], that parents encourage 
rest [179], and that in a mixed population of teenagers and younger children, healthcare 
professionals’ most commonly recommended treatment for fatigue was rest and relaxation [237]. 
Healthy adolescence tends to involve a decline in activity due to conflicting priorities, fear of injury 
and embarrassment [238]. Cancer-related fatigue, in combination with these normal teenage 
inhibitions, appears to present a formidable barrier to activity, paradoxically the very intervention 
that evidence from older adults suggests has the greatest potential to ameliorate fatigue.  
2.6.2 Contextualizing with related systematic reviews 
In the one systematic review that had been published at the time of initiation of this review, Erickson 
and colleagues found 15 relevant articles in 2004, using particularly broad eligibility criteria [160]. 
Although many more studies were included in the current review, and there were only two articles 
incorporated in both reviews [178,209], it is noteworthy that the key findings were not dissimilar: 
fatigue is prevalent and distressing in this young age group and research is needed to test 
intervention. The current review builds on the earlier one, by providing more detail, particularly in 
relation to the correlates and impact of fatigue. 
 
Since 2013, there have been four related systematic reviews, although none focusing on the TYA age 
range of 13-24 years. In 2016, Tomlinson and colleagues published a synthesis of qualitative research 
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to evaluate the ‘lived experience’ of fatigue in children and adolescents with cancer aged 6-19 [239]. 
Nine of the 19 studies incorporated in that review were included in the current one, and the review 
unsurprisingly found similar evidence of the impact of fatigue, again concluding that interventional 
research is needed.   
 
Using the broader definition of adolescent and young adult (AYA) in oncology in the USA (aged 15-
39), Nowe and colleagues recently reviewed quantitative studies [122]. Only one study was eligible 
for both this and the current review [188]. Their review confirmed that fatigue was more severe in 
AYAs than older adults. Three small and uncontrolled interventional studies in adults under 40 years 
were described, two testing a rehabilitation intervention and one an internet-based physical activity 
intervention, with two of the three leading to a reduction in fatigue. 
 
Two studies have systematically reviewed non-pharmacological interventions in children up to 18 
years. Chang and colleagues (2013) analyzed six pilot and feasibility studies. Three led to an 
improvement in fatigue, but with a suggestion that only ‘general’, and not ‘sleep/rest’ or ‘cognitive’, 
fatigue was helped; two of the three were physical activity interventions [165]. Lopes-Junior and 
colleagues (2016) found nine small pilot and feasibility studies, of which only four led to benefit. 
Three of the four involved a physical activity intervention, again leading to the suggestion that 
physical activity may have a role in paediatric fatigue management [240]. In both of these studies, 
limited conclusions could be drawn because of the very low quality and heterogeneity of the 
included studies. Two studies included in the current review were also included in the Chang and 
Lopes-Junior reviews [215,218]; the other studies in these reviews involved younger participants. 
 
Overall, therefore, the current review reinforces and builds on the conclusions of the main previous 
review from 2004. A number of recent systematic reviews have evaluated CRF in adolescents, but 
their focus, either on children up to 18 or on young adults up to 40 years, has limited the 
comparability of the findings. Nevertheless, the findings were broadly similar, confirming the 
prevalence and negative impact of the symptom, and emphasising the need for future high quality 
interventional studies. 
2.6.3 Strengths and limitations 
The main strength of this review is its breadth. Studies were eligible if they investigated any aspect of 
CRF in TYA-aged patients, and even those presenting data from a subgroup of patients aged 13–24 
were included. This has led to this review being particularly comprehensive, evaluating a total of 69 
articles, considerably larger than all other related reviews of this subject. 
 
The included studies, however, were heterogeneous and of relatively low quality, limiting the 
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strength of the findings. Furthermore, the symptom was often not the primary focus of the research. 
Although experts in the field were contacted, literature not published in the form of journal articles 
or conference abstracts (‘grey’ literature) may have been missed. Exclusion of non-English articles 
may also have led to the omission of relevant articles. 
2.6.4 Implications  
2.6.4.1 Clinical practice and policy 
Confirmation of the prevalence of TYA CRF, and the significant distress it causes, should raise 
awareness of this symptom amongst clinicians. In older adult CRF, a degree of therapeutic scepticism 
has developed due the lack of clearly effective pharmacological interventions [54,241]. This may also 
be occurring in younger cancer patients. Simply enquiring about the presence of fatigue in each 
clinical encounter may in itself be helpful, as this can openly acknowledge the problem and provide 
the possibility for peer and professional support. Clinical trials suggest that fatigue is amenable to the 
placebo effect; a recent proof-of-concept trial has confirmed that even non-deceptive open-label 
placebo can lead to a 30% improvement in fatigue [242]. It may that the placebo effect, at least in 
part, is gained simply from the focus and support inherent in research involvement, and it is 
therefore conceivable that simple acknowledgement of the symptom in clinical practice could also be 
of therapeutic value [54]. 
 
Although the evidence base for exercise interventions is very limited, it is likely that encouragement 
of physical activity would be helpful. In adults, it is already well-established that exercise improves 
CRF [243,244]. The wider benefits of keeping active during, and after, cancer treatment include 
increased well-being, functioning, and quality of life, as well as reduced cancer recurrence and 
mortality [245-248].  
2.6.4.2 Future research 
This review has clearly revealed a number of neglected topics that require future research. Future 
prevalence studies need to be controlled, using concurrent, rather than non-contemporaneous, 
controls. Long-term longitudinal cohort studies are needed, to evaluate changes in fatigue from the 
time of cancer treatment through to long-term survivorship. This, along with experimental 
interventional studies and insights from qualitative research, would help elucidate the directionality 
of the complex relationships between fatigue and its correlates. There is already sufficient research 
establishing that many factors correlate with fatigue; future work needs to determine causality, to 
understand the factors contributing to the fatigue and to support effective symptom management. 
 
Fatigue causes significant distress in TYAs. However, there is has been little work to date to establish 
the mechanisms for this distress. The review has generated suggestions, for example, the impact on 
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being able to exercise and on socialization. Further research, particularly with a qualitative design, 
would increase insight.  
 
The complete lack of research evaluating the perspectives of parents, and others close to these 
young patients, also needs addressing. Over the last decade, there has been recognition of the 
importance of addressing the needs of family carers. Support from carers can impact positively on 
patient outcomes, but carers equally experience considerable physical, psychological, social and 
economic burden from their role [249]. Evaluating and addressing the unmet needs of carers of those 
with cancer, ‘caring for the carers’, has become a healthcare priority [250,251]. Recent work has 
begun to consider the needs of parent carers of TYA cancer patients [99]. However, the impact of 
specific problems, such as fatigue, has not yet been evaluated.  
 
This review evidences the need to develop a specific TYA fatigue intervention. Definitive 
interventional research is required, with a rigorous controlled trial design, suitable power to 
determine meaningful outcomes, and a primary focus on ameliorating fatigue. Preliminary research 
to support intervention development will be described in the following chapters. 
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2.7 Key points 
This review has confirmed that TYA cancer-related fatigue is prevalent, persistent and distressing. It 
has highlighted many areas requiring further research, the overall research priority being to develop 
an acceptable, effective treatment for fatigue.  
 
The key findings are summarised in tabular form below. This approach will be taken with each 
subsequent study within this thesis, in order to demonstrate the sequential building and synthesis of 
knowledge. 
 
Table 2.7 Systematic review key points 
TYA CRF topic Study 1: Systematic review 
Prevalence The prevalence range was 9-67% after cancer treatment; fatigue was the first and 
second most prevalent symptom in 11 and 6 of 20 studies respectively. 
Temporal 
pattern 
Only one longitudinal study has evaluated fatigue beyond the end of cancer 
treatment. 
Symptom 
correlates 
Physical and psychological symptoms most commonly associated with fatigue 
were poor sleep and low mood respectively. 
Impact The most commonly reported impact was ‘distress’, followed by fatigue being a 
barrier to physical and to social activities. 
Parents’ 
perspectives 
No past research has evaluated the perspectives of parents or other carers. 
Management No studies have evaluated an intervention with a fatigue related primary 
outcome; current clinical practice, in terms of symptom management, is also 
unknown. 
 45 
3  Fatigue in Focus multicentre survey 
3.1 Title 
The Fatigue in Focus survey: an exploratory multicentre electronic survey of the prevalence, impact 
and management of fatigue in teenage and young adult cancer patients 
3.2 Rationale 
3.2.1 Justification for study 
The preceding systematic literature review has established the size of the problem of TYA cancer-
related fatigue and the need to develop an effective fatigue intervention. Before developing such an 
intervention, preliminary work is needed to investigate current TYA fatigue experience and clinical 
management in the UK.  
 
Building on the review’s overview of the past literature, a description of the current position is 
needed, in order then to develop an appropriate future fatigue intervention. The review established 
that the main impact of fatigue is distress, with qualitative studies describing the impact on exercise 
and socialising (section 2.5.4, page 32). However, there has been no previous quantitative evaluation 
of the impact of fatigue and therefore no prioritisation of the needs of fatigued TYAs. Current clinical 
management of CRF in the TYA age group has not been previously described in the literature. 
 
Stone and colleagues undertook a UK survey almost two decades ago to investigate the experience, 
impact and management of CRF in adult patients (median age 59 years) [23]. Fatigue was the most 
prevalent symptom and the one most affecting adults’ daily lives, particularly in relation to the ability 
to work and enjoy life; only 14% had received fatigue management support. This seminal study raised 
the profile of cancer-related fatigue. Within a few years, many studies were subsequently published 
evaluating CRF treatments in adults (section 1.1.1.4, page 3).  
 
A national clinical snapshot of fatigue experience and management is needed to address the unique 
needs of younger cancer patients. This survey is the first such study to be undertaken. 
3.2.2 Justification for electronic survey method 
Healthcare surveys generally collect a relatively small amount of data from a large sample of 
individuals across the population of interest. Well-suited for descriptive studies, with careful 
sampling a survey can provide a cross-sectional account that allows a degree of generalisation to the 
wider population [252]. 
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Only three studies have previously used survey methods in the field of TYA CRF, all of which were 
included in the literature review. Mulrooney and colleagues examined the prevalence and correlates 
of fatigue and sleep disturbance in almost two thousand adult survivors of childhood cancer, as part 
of the national Childhood Cancer Survivor Study in the USA [187]. Only one third of the participants 
were aged 15-21 at the time of diagnosis, although fatigue and sleep disturbance data were analysed 
separately for this subset. Two subsequent recent studies have used survey methods for follow-up in 
cancer treatment trials; fatigue evaluation was not a primary outcome [190,191]. This survey is 
therefore the first to focus primarily on TYA CRF. 
 
Recent years have seen a rise in the use of electronic survey methods in healthcare research. To date 
the majority of patient electronic surveys have been service evaluations or quality improvement 
initiatives, rather than research. Research electronic surveys have largely involved healthcare 
professionals, rather than patients.  
 
Electronic surveys are recognised to have a number of advantages over traditional paper-based 
surveys [253]. Principal amongst these is the lower cost; a randomised trial of the effect of survey 
response mode on completion of a survey by doctors found that on-line methods reduced costs by 
about one third [254]. This increases the feasibility for large-scale surveys, so increasing outcome 
validity [255]. Further advantages include the increased ease of data analysis and improved data 
integrity, with lower rates of illegible data and reduced transcription errors [253]. Simple 
programming, such as skip logic where the answer to one question determines subsequent 
questions, can speed up questionnaire completion and reduce participant burden.  
 
A potential disadvantage of electronic survey methods is that they generate unrepresentative 
participant samples with better access to, or familiarity, with electronic devices [255]. However, 
internet use has, in recent years, become virtually universal across all age groups; electronic survey 
methods have been found to be acceptable and feasible even in the elderly [256,257]. 
A further concern is that electronic surveys tend to generate lower response rates than paper-based 
methods [253,254]. In the Adolescent and Young Adult Health Outcomes and Patient Experience 
(AYA HOPE) study, participants (aged 15-39) were given a choice between paper, electronic and 
telephone survey mode [258]. Three quarters (76%) of participants chose the paper survey version, 
with only 22% and 2% choosing the online and telephone mode respectively. Two systematic 
literature reviews evaluating factors impacting on survey response rates, albeit with doctor rather 
than patient participants, have shown improved response rates with paper, over electronic, methods 
[259,260]. Factors that improve electronic survey response rates include non-monetary incentives, 
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personalised and short e-questionnaires, and avoidance of the word ‘survey’ in the email subject 
header [261]. 
 
Despite these potential concerns, it was decided that the survey would be undertaken electronically, 
following extensive consultation with current and former TYA cancer patients; they provided clear 
advice that an electronic survey would be preferable to postal questionnaire (section 1.2.2, page 14). 
Teenagers and young adults, so called ‘digital natives’, are very familiar with an electronic 
environment; mobile technology use is virtually ubiquitous amongst young people, and at least 98% 
access the internet ‘on the go’ [262,263]. One of the methodological objectives of this exploratory 
study was examination of the feasibility of using electronic surveys in this patient group. 
3.3 Aim and objectives 
3.3.1 Aim 
The aim was to undertake a national survey of current TYA cancer patients concerning their 
experience of fatigue and its clinical management in practice.  
3.3.2 Objectives 
1. To establish the prevalence and severity of fatigue in TYA cancer patients. 
2. To evaluate the impact of fatigue in this group. 
3. To investigate the current management of fatigue and TYA cancer patients’ perception of the 
effectiveness of such management. 
4. To examine the feasibility of using electronic survey methods with TYA cancer patients. 
  
 48 
3.4 Methods 
3.4.1 Study population 
Cancer patients were recruited from three TYA cancer Principal Treatment Centres (PTCs). In the UK, 
all TYAs with cancer are known to one of the thirteen NHS Trusts in England with PTC status. The 
three participating PTCs (Cambridge, Manchester and Southampton) cover close to a quarter of the 
national TYA population.  
3.4.1.1 Inclusion criteria 
 Care provided by a regional PTC in the UK 
 Email address recorded within the PTC patient database with consent given to use it 
 Diagnosed or treated with cancer aged 13-24 
 Aged 16-27 at the time of completing the survey. 
 
Eligibility was not influenced by cancer treatment status; both those receiving, and having 
completed, cancer treatment were eligible for recruitment. All participants were aged 16 or over at 
the time of survey, as it would not have been feasible to gain parental consent for younger patients 
within this study design. 
3.4.1.2 Exclusion criterion 
 Known to be near the end of life AND the site Principal Investigator believed it would be 
unacceptable to send the survey. 
 
Patients meeting this exclusion criterion were identified in advance to ensure they were not emailed 
about the survey; the number excluded were recorded. People receiving the survey who had 
insufficient English language comprehension, or who did not wish to participate, were self-excluding 
by failing to complete the survey. 
3.4.2 Questionnaire content 
The questionnaire collected demographic data, data from two validated outcome measures, and 
responses to a number of additional questions. 
3.4.2.1 Demographic data 
Age, gender, cancer type, month of diagnosis and treatment status were collected from each 
participant and from the clinical records of all non-responders. 
3.4.2.2 Multidimensional Fatigue Scale 
The PedsQL™ Multidimensional Fatigue Scale (MFS) was chosen as the main measure of fatigue 
severity, as it is the only fatigue scale validated in both teenagers and in young adults [161]. The 
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PedsQL™ instrument is a commonly used quality of life measure used within NCI Children’s Oncology 
Group studies in the USA. The MFS, one of the subscales of the PedsQL™, is widely used 
internationally. The scale consists of three subscales of 6 questions: general (physical) fatigue, 
sleep/rest fatigue and cognitive fatigue. The responses to the 18 questions are marked on a 5-item 
Likert-type verbal rating scale and scored 0-4, with 4 being the most severe. Items are then reverse-
scored and linearly transformed to a 0-100 scale, and the overall score computed as the sum of the 
item scores divided by the number of items answered. Lower scores represent worse fatigue. 
3.4.2.3 Quality of life visual analogue scale 
The survey questionnaire included a single-item measure of quality of life, a quality of life visual 
analogue scale (QOL-VAS). There is evidence from cancer patients that information from a single-
item measure of quality of life is comparable to that from multiple-item global measures, and that 
QOL-VAS more readily captures clinically significant changes in quality of life than multiple-item 
measures [264,265]. The scale was scored in integer increments between 0 and 10. 
3.4.2.4 Additional questions 
The remaining questions were simple, non-validated, questions relevant to the study objectives and 
generated by the research team. The severity of 11 symptoms (anorexia, anxiety, constipation, 
diarrhoea, fatigue, low mood, mucositis, nausea and vomiting, pain, weight gain, weight loss), the 
impact of fatigue on a range of aspects of life and the impact on patients’ carers were quantified 
using a 5-item Likert-type verbal rating scale, ‘not at all’, ‘a little bit’, ‘somewhat’, ‘quite a bit’ and 
‘very much’. The successfulness of each treatment received for fatigue was rated using a 4-item 
scale: ‘entirely successful’, ‘somewhat successful’, ‘helped only a little’ and ‘no effect’. Selection of 
single or multiple best responses was used for a number of further questions, including defining the 
two symptoms most affecting daily life, participant perception of the cause of fatigue, views on 
whether fatigue can be treated, and fatigue treatments received. The full questionnaire is at 
appendix 7.3.6 (page 303).  
 
The wording of three questions, relating to perceived cause of fatigue, views on whether fatigue can 
be treated, and dialogue with healthcare team, was influenced by the questions used in an earlier 
survey of adult cancer patients undertaken by Stone and colleagues, in order to allow comparison 
between TYA and adult findings [23]. The design and detail of the questionnaire were significantly 
influenced by patient feedback (section 1.2.2, page 14). 
 
The survey incorporated skip logic; questions were included or excluded based on the replies given to 
earlier questions. Only the first two questions were made compulsory: the severity of the 11 
symptoms and selecting the two symptoms most affecting daily life. Without completing these two 
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questions, the survey could not be submitted. Any participants answering ‘not at all’, when asked 
how much fatigue had affected them over the past month, were only able to answer questions about 
the severity of the 11 symptoms, the two symptoms most affecting daily life, quality of life score and 
demographic information.  
3.4.3 Survey process 
The survey was built electronically using QuestionPro online survey software. It was cloned using 
individual NHS Trust logos for use at each site. At each site, the study involved a three-step process 
as outlined below. Sites started the process at a time that suited them but, once initiated, a strict 
procedure on a fixed timeline was followed. 
3.4.3.1 Step 1: priming contact 
Pre-notification to raise awareness of a survey is known to increase response rates [261]. Priming 
was undertaken in three ways at each site: a standardised email to potential participants, a survey 
poster and posting of the same information on the TYA cancer service Facebook page (appendix 
7.3.1, page 292). Priming was undertaken by potential participants’ usual clinical healthcare team 
members, not the research team. Staff at each site were at liberty to adapt the wording slightly, as 
long as the content was fundamentally unchanged.  
3.4.3.2 Step 2: survey email 
Seven to fourteen days after the priming contact, an email was sent to all potential participants by a 
member of their usual clinical healthcare team, or an administrator within the team. Good Clinical 
Practice in healthcare research stipulates that the initial approach to recruit research participants 
must be from staff already involved in their clinical care, not from researchers [266]. Using a mail 
merge process, each participant received a single personalised covering email explaining the purpose 
of the survey, an invitation to take part and instructions, the electronic link to the survey, a 
participant’s unique token number and a link to the Participant Information Sheet (PIS). The covering 
email and PIS are in appendices 7.3.2 (page 294) and 7.3.3 (page 295). After clicking on the survey 
link, participants were required to enter their token number and tick a box confirming informed 
consent, before completing the survey electronically. 
3.4.3.3 Step 3: reminder to non-responders 
Non-responders were established by noting which tokens had not been used seven days after the 
initial survey email had been sent. Unused token numbers were sent to the administrator at each 
site, who sent a single reminder email to each non-responder. 
 
Detailed instructions to support this process were created for each site (appendix 7.3.4, page 297). 
Submitted survey data was collated on the QuestionPro platform. Data entry was locked three weeks 
 51 
after the final site had sent out the first survey email. The token numbers of all participants were 
entered into a prize draw. Four prize-winners were randomly selected and received an iPad or one of 
three sets of £50 Amazon vouchers. 
3.4.4 Data management 
3.4.4.1 Data handling and confidentiality 
All study data were in electronic format, and a number of steps were taken to ensure preservation of 
patient confidentiality. A firewall was set up between the site and the central study team. The site 
teams knew the names of the survey recipients and their corresponding token numbers but, 
importantly, had no access to any participant responses. Conversely, the central research team had 
access to patient responses linked to token numbers, but had no way of identifying participants from 
their token numbers.  
 
The mail merge process involves sending multiple individual emails, rather than copying a single 
email, eliminating the risk of participants being able to view others’ email addresses. Electronic data 
were encrypted in transmission via HTTPS (Hypertext Transfer Protocol Secure), and captured on the 
QuestionPro questionnaire survey servers in a pseudo anonymised form. The QuestionPro company 
has an extensive privacy policy and a data security policy, and complies with the USA-EU ‘safe-
harbour framework’.  
 
The participant responses were downloaded and fully anonymised prior to data analysis. Data were 
stored on University of Cambridge servers on a secured network requiring password-authentication 
to access the data server. The University data servers are physically protected in a data centre within 
card-access only buildings. In addition to survey responses, demographic data (age, gender, 
diagnosis, time since last cancer treatment) from non-responders were collated at each site, 
anonymised and emailed by secure NHS mail to the central research team. 
3.4.4.2 Statistical methods 
IBM SPSS software (version 22) was used for all analyses. Non-responder analysis compared 
demographic data of responders and non-responders. Between group differences were evaluated by 
an independent samples t-test for normally distributed continuous variables, or the non-parametric 
equivalent, the Mann-Whitney U test, for variables not normally distributed. Fisher’s Exact Test was 
used with categorical variables. Differences were considered statistically significant where p<0.05. 
Normality was assessed by visually inspecting the data in the format of a histogram, and by 
calculation of z-scores; scores for either skewness or kurtosis of greater than 3.49 were used to 
define a significant departure from normality [267].  
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The response data were analysed using descriptive statistics. The prevalence of each symptom was 
calculated by excluding only those patients responding with ‘not at all’. This is consistent with 
prevalence calculations within the Memorial Symptom Assessment Scale, a widely used scale 
validated in cancer patients [202].  
 
Associates of fatigue were examined using correlations for continuous variables and analysis of 
variance (ANOVA) for categorical variables. When calculating correlation coefficients, all data were 
plotted to check for linearity (Pearson’s and Spearman’s coefficients being calculated for linear and 
non-linear relationships respectively) and to check absence of non-monotonic relationships.   
 
A symptom cluster analysis was performed using Ward’s method [268]. A hierarchical agglomerative 
method was chosen because of the relatively small sample size, and Ward’s method was selected as 
it is considered robust, produces clusters of approximately equal size and is relatively sensitive to 
outliers. This method involves examining all possible pairs of clusters and calculating the sum of the 
squared Euclidian distances within each cluster. This is then summed over all clusters, and the 
combination that gives the lowest sum of squares is chosen. 
 
Linear regression analyses were undertaken using either fatigue severity or quality of life as the 
dependent variable, and using linear regression methods to evaluate the degree to which these 
variables could be predicted by symptom severity scores. The rule of thumb of ten cases per 
predictor was used, to determine the number of variables entered into a regression model [269]. 
Bootstrap confidence intervals and significance values were used to give an accurate estimate of the 
true population value of each B-value, without relying on assumptions of normally distributed 
residuals or homoscedasticity (homogeneity of variance). Regression diagnostics plots were 
generated to look for evidence of bias in each model, and are available in appendix 7.3.8 (page 315).  
 
A ‘successfulness score’ for fatigue treatment was generated by attributing 0, 1, 2 and 3, to the 
ratings ‘no effect’, ‘helped only a little’, ‘somewhat successful’ and ‘entirely successful’ for each 
treatment received, and calculating a mean score. The former two ratings defined an unsuccessful 
treatment and the latter two a successful one. 
3.4.5 Patient and public involvement  
The survey benefited from PPI advice in a number of ways. One member of the central study team is 
a former TYA cancer patient and provided feedback on the survey design, questionnaire content, 
patient information sheet and the survey covering email. The survey was also discussed in outline in 
a face-to-face focus group convened in April 2014; six TYA cancer patients provided advice on the 
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content of the survey and terminology. This group, along with three further patients, were emailed 
the near-final version of the electronic survey to gain further feedback.  
 
The decision to make the survey electronic only, without a concurrent paper version, was an 
important outcome of the PPI process. During the focus group meeting, there was a consensus that 
the survey needed to be relatively short, consistent with existing evidence that short questionnaires 
improve response rates [261]. Advice was given that potential participants needed to know in 
advance that the survey would be short, and there needed to be an option to save progress part way 
through completion. Many other valuable ideas were proffered, including the importance of using 
the word ‘fatigue’, rather than ‘tired’ (the latter being considered such an understatement that it 
would risk people ‘feeling angry’), and the value of clarifying how often the fatigue occurred, its 
relationship to cancer treatment and its impact on daily functioning (‘what it stops you from doing’). 
3.4.6 Ethical considerations 
In line with PPI feedback, the survey was kept as short as possible to avoid burdening vulnerable and 
potentially fatigued participants. During initial testing, it took 5-10 minutes to complete. 
Inconvenience was further limited by ensuring that it could easily be completed on a mobile 
electronic device. 
  
All participants were aged 16 or over, and could therefore give informed consent to taking part in the 
survey. The chair of the regional research ethics committee advised that completion and submission 
of the survey would be sufficient implicit evidence for consent. However, to achieve absolute clarity, 
the first page of the survey included an electronic tick box confirming consent. 
 
The ethics of using a prize draw as an incentive was considered extremely carefully. Non-monetary 
incentives are known to be effective in increasing survey participation [261]. The fact that any 
individual’s chance of winning was small, limited the risk of coercion. Both the covering email and 
patient information sheet included explicit statements that not taking part in the survey would have 
no impact on care. 
3.4.7 Research governance 
3.4.7.1 NHS and ethical approvals 
This work was jointly sponsored by the Cambridge University Hospitals NHS Trust and the University 
of Cambridge, the former providing NHS approval and the latter providing insurance and indemnity. 
Research ethics committee approval was provided through a Proportionate Review process by the 
NRES Committee East of England – Cambridgeshire and Hertfordshire (REC reference: 15/EE/0037; 
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appendix 7.3.5, page 301). The other research sites, Manchester and Southampton, were designated 
as Participant Identification Centres (PICs) as there was no face-to-face recruitment process. 
3.4.7.2 Study team and roles 
Anna Spathis was the Chief Investigator overall, and the Principal Investigator for the Cambridge NHS 
site. She was involved in every step of the study conduct including: responsibility for study design, 
writing protocol and all study related documents, gaining research approvals, recruitment of sites, 
PPI, all communication with site teams including visiting sites, the survey process, IT support and all 
data analysis. 
 
Stephen Barclay and Sara Booth, MD supervisors, provided regular guidance and advice throughout 
the study. In addition, a number of colleagues made specific contributions as detailed in table 3.1. 
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Table 3.1 Roles of other team members in survey 
Laura 
Abbas  
Former TYA cancer patient, former TCT Youth 
Support Co-ordinator, Cambridge University 
Hospitals  
Provided PPI; and co-ordinated PPI 
from other current/former patients 
Matt 
Barclay 
Statistician, University of Cambridge Support with statistical methods and 
use of SPSS software 
James 
Brimicombe  
Data Manager, Department of Public Health 
and Primary Care, University of Cambridge 
Created the survey within 
QuestionPro; generated tokens, 
support with data management 
Rachel 
Campsey 
Clinical research nurse, Christie Hospital, 
Manchester  
Principal Investigator, Manchester; 
identified eligible patients 
Faith 
Gibson  
Professor of Children and Young People’s 
Cancer Care, Great Ormond Street Hospital 
Support with study design and 
questionnaire content 
Helen 
Hatcher  
Consultant Medical Oncologist, TYA service 
lead, Cambridge University Hospitals 
Support with survey design; 
identified eligible patients 
Louise 
Hooker 
Lead nurse TYA cancer service, University 
Hospital Southampton 
Principal Investigator, Southampton; 
identified eligible patients 
Martin 
McCabe 
Clinical senior lecturer in paediatric oncology, 
University of Manchester 
Supported involvement of 
Manchester; facilitated approvals 
Wendy 
Moss 
TYA service administrator, Cambridge 
University Hospitals 
Created database of eligible 
patients; undertook study processes  
Stephanie 
Manning 
Clinical trials administrator, Christie Hospital, 
Manchester 
Created database of eligible 
patients; undertook study processes 
Jane 
Robson 
Lead nurse TYA cancer service, Cambridge 
University Hospitals 
Identified eligible patients in 
Cambridge 
Paddy 
Stone  
Professor of Palliative Medicine, University 
College London 
Support with study design and 
questionnaire content 
Pia 
Thiemann 
Research Associate, University of Cambridge Support with statistical methods and 
use of SPSS software 
Melanie 
Williams 
Research Administrator, University Hospital 
Southampton 
Created database of eligible 
patients; undertook study processes 
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3.5 Results 
3.5.1 Process data 
The Principal Investigator (PI) and administrator at each site created a site-specific database of 
potentially eligible participants. Different methods were used in each site, reflecting the diverse 
administrative arrangements for each service. Priming of potential participants also differed slightly. 
 
In Cambridge, an electronic database of all patients known to the service had already been in use 
since 2009. Data from a separate small database held by the service Youth Support Co-ordinator was 
merged with the main database, increasing the number of patients for whom an email address was 
known. Potential participants were selected by applying the eligibility criteria. Priming used all three 
available methods: poster, information on Facebook and email to potential participants. 
 
In Southampton, all patient data had been held on paper index cards since 2008, the inception of the 
TYA service support team. The PI and administrator transferred data on all potentially eligible 
participants from these cards to a study database. Priming was undertaken by poster and email only, 
as the Facebook page of the TYA service was temporarily unavailable. 
 
In Manchester, although many patients had given their email address to their TYA service, the local 
healthcare team felt that, for all but five patients, consent to use these addresses applied only to use 
for clinical, rather than research, purposes. Therefore, only five patients fulfilled the study eligibility 
criteria and could be sent a priming email. This reduced the number of potential participants 
considerably, and meant that the site relied on patients proactively contacting the clinical team to 
express interest in taking part, having seen study information on Facebook or on a poster. Because 
participants emailed the local PI in this way, it was possible to ascertain the mode of recruitment; of 
the 17 people who expressed an interest, 12 had responded to the Facebook information, four to 
email contact, and one to the poster. 
 
The table below summarises the number of patients involved at each step of the study process 
across the three sites. Only eight potential participants across the three sites were considered 
ineligible because of the single exclusion criterion. The number of patients who were ineligible 
because of not having an email address recorded with consent to use it, but who would otherwise 
have been eligible, was only recorded at Cambridge: 47 out of 193 otherwise eligible patients. 
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Table 3.2 Site process data 
 Cambridge Southampton Manchester 
Number fulfilling 
inclusion/exclusion 
criteria 
143/3 69/5 17/0 
Number of emails sent 
containing survey link 
140 64 17 
Number of emails 
‘undeliverable’ 
12 12 0 
Number sent survey 128 52 17 
Number responders 
(responding to initial 
email/reminder email) 
51 (36/15) 13 (12/1) 16 (10/6) 
 
Overall, across all three sites, the survey link was sent to 197 eligible participants (excluding the 24 
times that the email was returned as ‘undeliverable’). Eighty responses were received, equating to a 
response rate of 41%. 
 
The single reminder email had a clear impact on recruitment, with 22 of the 80 participants 
responding on or after the day of the reminder email, as demonstrated in figure 3.1. Fifty-four out of 
the 80 participants responded on the day of receiving either the initial or reminder email.  
Participants took a mean of 11.4 minutes (median 8.4) to complete the survey. Those with fatigue 
who completed the whole survey (n=68) took a mean of 12.4 minutes (median 9.1, range 3.1-61.3) 
and those without fatigue who only completed part of the survey (n=12) took a mean of 7.7 minutes 
(median 3.0, range 2.1-52.9). There was no relationship between fatigue severity and the time taken 
to complete the survey. Forty-six participants used a smart phone to access and complete the survey, 
25 a desktop or laptop and nine a tablet. 
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Figure 3.1 Number of respondents each day 
 
 
 
There were a total of 4892 potential data entry points amongst the 80 participants, excluding those 
that were explicitly optional (for example, ‘What treatment, if any, was recommended’) or become 
unavailable due to skip logic. Eighty-six data entry points were missing (1.8%).  
 
During data analysis, it was found that two of the options within survey question 13 were associated 
with ambiguous response categories. In response to the question ‘What effect do you feel your 
fatigue has had on this person?’ participants were mistakenly asked to rate ‘No effect’ and ‘Not sure’ 
with the five item verbal rating scale ‘not at all’, ‘a little bit’, ‘somewhat’, ‘quite a bit’, ‘very much’ 
(see appendix 7.3.6, page 311). Excluding these data points, only 51 out of 4758 data entry points 
involved missing data (1.1%). 
3.5.2 Characteristics of participants and non-responders 
Demographic data relating to responders and non-responders are summarised in table 3.3. 
Continuous data are displayed in comparative histograms (figures 3.2-3.3, with further comparative 
data presented in appendix 7.3.7, page 313).  
 
There were two main differences between responders and non-responders. First, more females than 
males responded to the survey email, with 67% of responders and 47% of non-responders being 
female (p=0.004). Second, none of the patients currently receiving cancer treatment responded. The 
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survey was sent to 23 patients on treatment and 173 patients off treatment; none of the 23 receiving 
treatment responded. 
 
The median and interquartile range (IQR) of the ‘months since last treatment’ data were virtually 
identical (table 3.3). However, visual inspection of the non-responder data revealed: a) a peak of 
patients still receiving treatment and b) a longer time since treatment than the responders (figure 
3.2). The combination of these two opposing factors served to generate the similar median values 
between the groups. 
 
A second analysis comparing responders with non-responders, excluding those patients in the non-
responder group still receiving treatment, was therefore undertaken. This confirmed the longer time 
since last treatment between responders and non-responders off treatment, although this finding 
was of only borderline statistical significance (p=0.05). There was no longer a gender difference 
between the two groups, as the non-responders still receiving treatment were predominantly male 
(18 male, 5 female). The non-responders who had completed treatment had a significantly shorter 
cancer treatment duration than the responder group (table 3.3, figure 3.3). 
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Table 3.3 Comparison of responder and non-responder demographic data 
 Responders  
(n=80) 
All non-
responders 
(n=116) 
p * Non-responders 
excluding those on 
treatment (n=93) 
p * 
Off /on treatment 
n (missing data) 
70/0 (10) 90/23 (3) <0.001a 90/0 (3) NA 
Age at survey 
Mean (SD, range) 
22.1 (2.7, 17-27) 21.3 (2.7, 16-27) 0.06b 21.5 (2.6, 16-27) 0.21b 
Age at diagnosis  
Mean (SD, range) 
19.0 (3.1, 12-24) 18.2 (3.3, 9-24) 0.12b 18.0 (3.2, 12-24) 0.06b 
Months since 
diagnosis 
Median (IQR) 
31 (18 to 49) 31 (14 to 58) 0.8 c 37 (21 to 61) 0.19c 
Months since last 
treatment  
Median (IQR) 
18 (10 to 32) 18 (5 to 46) 0.50c 27 (11 to 52) 0.05c 
Months treatment 
duration 
Median (IQR) 
8 (4 to 25) NA NA 6 (4 to 9) 0.006c 
Gender  
n male (%) 
26 (33) 62 (53) 0.005a 44 (47) 0.06a 
Diagnosis, n (%)      
 Leukaemia 20 (25) 20 (17) 0.44a 12 (13) 0.11a 
 Lymphoma 35 (44) 53 (46)  50 (54)  
 Osteosarcoma or 
Ewing’s sarcoma 
6 (8) 9 (8)  3 (3)  
 Brain neoplasm 1 (1) 8 (7)  6 (6)  
 Other** 18 (23) 26 (22)  22 (24)  
*p values comparing preceding column of non-responders with responders; significant p values in 
bold 
** Other diagnosis were as follows: aplastic anaemia (underlying haematological malignancy not 
specified) (1), breast (1), cervical cancer (2), germinoma (2), insulinoma (1), melanoma (1), soft tissue 
sarcoma (3), testicular malignancy (3), teratoma (1), thyroid malignancy (3) 
a Fisher’s Exact Test 
b Independent samples t-test 
c Mann-Whitney U test  
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Figure 3.2 Comparative histogram of time since last treatment for responders and all non-
responders 
 
 
 
 
Figure 3.3 Comparative histogram of cancer treatment duration between responders and non-
responders who had completed treatment 
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3.5.3 Fatigue prevalence and severity 
3.5.3.1 Symptom verbal rating scales (VRS) 
Fatigue was the most prevalent symptom and was experienced by 85% of participants in the 
preceding month (table 3.4, figure 3.4). As described in section 3.3.4.2 (page 51), prevalence was 
calculated by omitting only those participants who had experienced fatigue ‘not at all’.  
 
An alternative way of defining prevalence involves only including those patients with a score that 
reaches a threshold of ‘caseness’. This threshold has not been determined for symptom severity 
verbal rating scales, but has been calculated for 10-item numerical rating scales; scores ≥4 for pain, 
≥5 for fatigue, anxiety and depression and ≥6 for appetite loss, have been found to identify patients 
who report that some relief of the symptom would significantly improve their life [5]. Although these 
findings cannot be directly extrapolated to the five-item VRS used in this survey, a pragmatic 
alternative prevalence of symptom ‘caseness’, counting only the three most severe items in the five-
item scale, is also displayed in table 3.4. 
 
There were no significant differences in the demographic characteristics of those with fatigue 
(68/80), and those without (12/80), as shown in table 3.5. 
 
Bar charts of symptom severity are shown in figure 3.5. Fatigue was ranked as more severe than any 
of the other symptoms experienced by the survey respondents (Wilcoxon matched pairs signed rank 
test; p<0.001 for all symptoms paired with fatigue, except anxiety where p=0.007).  
 
Using a hierarchical symptom cluster analysis, two symptom clusters were found. Fatigue was found 
to cluster most closely with anxiety and low mood. The remaining symptoms formed a second 
cluster. Figure 3.6 represents this as a dendrogram, with rescaled distance (0-25) on the x-axis. As 
smaller distances represent greater degrees of similarity, this cluster analysis represents relatively 
strong clustering, given the small within-cluster distances and large between-cluster distance. A 
further hierarchical clustering analysis was undertaken using the complete linkage (furthest 
neighbour) method, to confirm that the results of the cluster analysis were not sensitive to the 
choice of clustering algorithm. The results were very similar, with two clear clusters, and fatigue 
again clustering with anxiety and low mood. 
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Table 3.4 Symptom prevalence 
Symptom Prevalence (%)* Prevalence of symptom ‘case’ (%)** 
Fatigue 85.0 65.0 
Low mood 80.0 48.7 
Anxiety 76.2 50.0 
Pain 58.7 32.5 
Constipation 42.5 18.7 
Lack of appetite 38.7 21.2 
Weight gain 38.7 17.5 
Weight loss 36.2 12.5 
Nausea and vomiting 33.7 13.7 
Diarrhoea 28.7 20.0 
Mucositis 25.0 8.7 
*Counting four most severe scores in five-item verbal rating scale 
**Counting three most severe scores in five-item verbal rating scale 
 
 
Figure 3.4 Symptom prevalence bar chart 
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Table 3.5 Comparison of demographic data between responders with and without fatigue 
 Fatigue present (n=68) Fatigue absent (n=12) p  
Age at survey 
Mean (SD, range) 
22.0 (2.8, 17-27) 22.5 (2.7, 18-26) 0.61 
Age at diagnosis  
Mean (SD, range) 
19.0 (3.2, 12-24) 18.7 (2.9, 14-24) 0.81 
Months since diagnosis 
Median (IQR) 
28.5(25) 60.0 (53) 0.06 
Months since last treatment  
Median (IQR) 
16.5 (21) 24.0 (36) 0.34 
Months treatment duration 
Median (IQR) 
6.5 (19) 12.0 (31) 0.12 
Gender  
n male (%) 
20 (29) 6 (50) 0.20 
 
 
Figure 3.5 Clustered bar chart of symptom severity 
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Figure 3.6 Dendrogram of hierarchical symptom cluster analysis (Ward's method) 
 
 
 
3.5.3.2 Multidimensional Fatigue Scale (MFS) 
The 68/80 participants who had experienced fatigue in the last month completed the MFS. The mean 
MFS fatigue severity was 44.3 (SD 20.5), and there was little variation between the mean general 
(physical) fatigue, sleep/rest fatigue and cognitive fatigue subscores: 42.4 (SD 23.1), 45.5 (SD 21.2), 
44.9 (SD 28.0) respectively. Fatigue severity was normally distributed (figure 3.7). 
 
Fatigue severity was greater more than one year (M=39.0, SD=19.7, 95% CI 32.3 to 45.6) after last 
oncological treatment, rather than less than one year (M=53.8, SD=19.7, 95% CI 45.0 to 62.5) after 
the last oncological treatment [t(56)=2.8, p=0.007] (figure 3.8). Fatigue was significantly more severe 
in females (M=39.6, SD=19.3, 95% CI 34.1 to 45.2) than males (M=55.6, SD=19.6, 95% CI 46.4 to 64.7) 
[t(66)=3.1, p=0.003]. No statistically significant difference in fatigue severity was found according to 
diagnosis [one-way ANOVA, F(5,62)=0.41, p=0.84]. Fatigue severity was also unrelated to any of the 
other demographic variables: age at survey, age at diagnosis, time since diagnosis or cancer 
treatment duration (table 3.6). 
 
Fatigue severity (MFS score) correlated significantly with the severity (VRS) of all the other 
symptoms, except mucositis, with worse fatigue associated with more severe other symptoms (table 
3.6). The six variables with highest correlations were entered into a multiple linear regression 
Low mood 
Anxiety 
Fatigue 
Lack of appetite 
Weight loss 
Diarrhoea 
Nausea+vomit 
Constipation 
Mucositis 
Weight gain 
Pain 
Rescaled distance cluster combine 
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analysis. Variables with low beta coefficients that did not differ significantly from zero were removed 
from the model, leaving low mood, lack of appetite and pain.  
 
Lack of appetite and low mood predicted 50% of the variation in fatigue severity. Addition of pain 
contributed a small, although statistically significant, change with the model explaining 53% of the 
variation (table 3.7). The final model included just low mood and lack of appetite as predictors of 
fatigue severity. Residuals plots and partial regression plots are in appendix 7.3.8.1 (page 315). There 
were no major departures from normality in the residuals, and as the partial regression plots could fit 
a linear line, this confirmed that it was reasonable to treat the 5-item verbal rating scales of symptom 
severity as continual rather than ordinal data. 
 
Given that low mood and lack of appetite both correlate with gender (worse symptoms in females), 
as well as fatigue, a further linear regression analysis was undertaken controlling for gender as a 
confounding variable. The beta coefficients of low mood and lack of appetite remained significantly 
different from zero, and the R2 change was 0.40 (see table 3.8). As well as showing that lack of 
appetite and low mood still predict fatigue severity after controlling for gender, the model also 
showed that gender no longer had a statistically significant relationship with fatigue after adjusting 
for lack of appetite and low mood. While these results do not rule out an independent gender effect, 
the association between experiencing fatigue and being female appears to be explained by 
symptoms associated with fatigue – lack of appetite and low mood – being more common in females. 
 
Having noted that the model best able to predict fatigue severity involved one symptom from each 
of the three symptom clusters (figure 3.6), a further exploratory regression analysis was undertaken 
using cluster level mean scores. The rationale for doing this was to be able to include all symptom 
data in the analysis, without risking too many predictors and collinearity. This model generated 
comparable findings to the analyses using individual symptom predictors, with the lack of appetite 
and low mood symptom clusters predicting 52% of the variation in fatigue severity (appendix 7.3.9, 
page 320). 
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Figure 3.7 Histogram of MFS scores (n=68) 
 
 
 
 
Figure 3.8 Box plot of fatigue severity according to time after last treatment 
 
 
 
 
*Note that higher MFS scores represent lower fatigue severity  
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Table 3.6 Relationship between fatigue severity (MFS) and continuous independent variables 
 Spearman’s rho Significance (p) 
Demographic variables 
Age at survey -0.075 0.54 
Age at diagnosis -0.052 0.68 
Months since diagnosis -0.074 0.55 
Months since last cancer treatment -0.216 0.10 
Months cancer treatment duration 0.030 0.83 
Symptom variables 
Low mood -0.59 <0.001 
Lack of appetite -0.56 <0.001 
Anxiety -0.56 <0.001 
Pain -0.49 <0.001 
Diarrhoea -0.42 <0.001 
Nausea and vomiting -0.30 0.013 
Weight loss -0.29 0.016 
Weight gain -0.29 0.017 
Constipation -0.26 0.035 
Mucositis -0.22 0.079 
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Table 3.7 Linear model of predictors of fatigue severity (MFS) in fatigued participants 
 B  Beta p Tolerance VIF 
Step 1 
Lack of 
appetite 
-10.57 
(-14.18, -6.97) 
-0.59 <0.001 - - 
Constant 63.91 
(56.09, 71.73) 
- - - - 
Step 2 
Lack of 
appetite 
-7.12 
(-10.60, -3.78) 
-0.40 <0.001 0.83 1.20 
Low mood -7.65 
(-10.79, -4.51) 
-0.46 <0.001 0.83 1.20 
Constant 79.25 
(70.02, 88.47) 
- - - - 
Step 3 
Lack of 
appetite 
-5.28 
(-9.03, -1.53) 
-0.29 0.007 0.65 1.54 
Low mood -7.30 
(-10.37, -4.23) 
-0.44 <0.001 0.83 1.21 
Pain -3.59 
(-6.90, -0.28) 
-0.22 0.034 0.71 1.41 
Constant 82.89 
(73.31, 92.49) 
- - - - 
Step 1 adjusted R2 0.34, Step 2 adjusted R2 0.50 (F change=23.7, p<0.001), Step 3 adjusted R2 0.53 (F 
change=4.67, p=0.034) 
95% bias corrected and accelerated confidence intervals reported in parenthesis 
Confidence intervals and standard errors based on 1000 bootstrap samples 
VIF: Variance Inflation Factor 
 
  
Table 3.8 Linear model of predictors of fatigue severity (MFS) in fatigued participants, controlling 
for gender 
 
 B  Beta p Tolerance VIF 
Step 1 
Gender -15.91  
(-26.19, -5.63) 
-0.36 0.003 - - 
Constant 55.55 
(46.91, 64.19) 
- - - - 
Step 2 
Gender -3.53 
(-12.00, 4.92) 
-0.079 0.407 0.83 1.20 
Lack of 
appetite 
-6.96 
(-10.42, -3.51) 
-0.39 <0.001 0.81 1.23 
Low mood -7.24 
(-10.54, -2.93) 
-0.43 <0.001 0.76 1.32 
Constant 80.15 
(70.65, 89.64) 
- - - - 
Step 1 adjusted R2 0.11, Step 2 adjusted R2 0.50 (F change=26.60, p<0.001) 
95% bias corrected and accelerated confidence intervals reported in parenthesis 
Confidence intervals and standard errors based on 1000 bootstrap samples 
VIF: Variance Inflation Factor 
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3.5.4 Impact of fatigue 
3.5.4.1 Impact on quality of life 
Fatigue (MFS) was associated with poor quality of life among patients who had experienced fatigue 
in the last month (Pearson r=0.62). Fatigue severity alone therefore predicted 38% of the quality of 
life (r2=0.38). The strength of correlation between fatigue severity and quality of life was broadly 
similar across MFS subscales; the correlation coefficients for the general (physical), sleep/rest and 
cognitive subscales were 0.67, 0.46 and 0.46 respectively. There was also a correlation between 
fatigue severity measured with the unidimensional five-item verbal rating scale and quality of life, 
although the strength of the correlation (Spearman’s rho=0.50) was smaller than that with the 
multidimensional MFS (Spearman’s rho=0.62). 
 
Given that low mood and anorexia were both associated with poor quality of life (Spearman’s 
rho=0.52 and 0.52 respectively) as well as with fatigue severity, a linear regression analysis was 
performed to adjust for these potential confounding factors (table 3.9). Fatigue severity was an 
independent predictor of quality of life, after adjusting for low mood and anorexia. Residuals plots 
and partial regression plots are in appendix 7.3.8 (page 317). In a linear regression model using data 
from all the symptoms in the form of the three symptom cluster mean scores, fatigue remained an 
independent predictor of quality of life (appendix 7.3.9, page 321). 
 
Table 3.9 Linear model of predictors of quality of life (QOL VAS) in fatigued participants 
 B  Beta p Tolerance VIF 
Step 1 
Lack of appetite -0.79 
(-1.25, -0.34) 
-0.37 0.001 0.83 1.20 
Low mood -0.72 
 (-1.14, -0.30) 
-0.37 0.001 0.83 1.20 
Constant 11.28 
(10.05, 12.52) 
- - - - 
Step 2 
Fatigue severity 
(MFS) 
0.042 
(0.011, 0.074) 
-0.36 0.010 0.48 2.07 
Lack of appetite -0.49 
(-0.98, 0.003) 
-0.23 0.051 0.65 1.53 
Low mood -0.40 
(-0.86, 0.075) 
-0.20 0.098 0.61 1.64 
Constant 7.92 
(5.14, 10.70) 
- - - - 
Step 1 adjusted R2 0.36, Step 2 adjusted R2 0.42 (F change=7.13, p=0.01) 
95% bias corrected and accelerated confidence intervals reported in parenthesis 
Confidence intervals and standard errors based on 1000 bootstrap samples 
VIF: Variance Inflation Factor 
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3.5.4.2 Impact on daily life relative to other symptoms 
All participants, including those without fatigue, were asked which two out of the 11 symptoms most 
affected daily life. Fatigue was chosen by 79% of all participants, followed by anxiety (31%), low 
mood (30%), pain (21%), weight gain (11%), constipation (8%), nausea and vomiting (6%), diarrhoea 
(4%), weight loss (4%), mucositis (3%), and lack of appetite (1%). Fatigue was chosen significantly 
more often than any other symptom (Wilcoxon signed ranks tests, -7.87<Z<-4.99, all p values <0.001) 
3.5.4.3 Impact on aspects of daily life 
Fatigue was experienced by 65% of the fatigued participants either every day (n=21) or most days 
(n=23). Fatigue frequency correlated strongly with fatigue severity (Spearman’s rho=0.74). The 
greatest impact of fatigue was on the ability to exercise (table 3.10). Fifty of the 68 fatigued 
participants (74%) responded that fatigue affected the ability to exercise ‘somewhat’, ‘quite a bit’ or 
‘very much’. The size of the impact on exercise was significantly greater than all the other impacts 
considered, except for the impact on being able to attend school/study/work. The size of every 
impact correlated significantly with the fatigue severity score (MFS), with worse fatigue (lower MFS 
score) being associated with a greater impact (higher impact VRS). It also correlated with the 
unidimensional 5-item fatigue VRS, although the strengths of the correlations were less strong. 
 
Table 3.10 Impact of fatigue on aspects of daily life 
 Impact VRS response 
‘somewhat’ /‘quite a 
bit’/‘very much’ 
(n=68) 
Paired comparison 
with ability to 
exercise (Z statistic  
p value)** 
Correlation impact 
VRS and MFS fatigue 
severity 
(Spearman’s rho)* 
Correlation impact 
VRS and fatigue 
VRS (Spearman’s 
rho)* 
Ability to 
exercise, n (%) 
50 (74) - -0.53 0.50 
Ability to attend 
school/study/ 
work, n (%) 
44 (65) -1.24, 0.22 -0.69 0.46 
Relationship 
with friends,     
n (%) 
38 (56) -3.67, <0.001 -0.59 0.37 
Ability to 
socialise, n (%) 
38 (56) -3.43, <0.001 -0.70 0.54 
Ability to enjoy 
life, n (%) 
36 (53) -3.85, <0.001 -0.65 0.45 
Ability to be 
independent, 
n (%) 
34 (50) -4.20, <0.001 -0.49 0.29 
Relationship 
with family, 
n (%) 
29 (43) -5.02, <0.001 -0.57 0.35 
*All Spearman’s rho values significant to the 0.05 level (two-tailed) 
** Wilcoxon matched pairs signed rank test  
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3.5.4.4 Impact on other people 
The person most closely involved in participants’ care was a parent (85%, 58/68), another relative 
(9%, 6/68), or a friend (1%, 1/68); 4% (3/68) had no-one closely involved in their care. 45% of 
participants (29/64) felt their fatigue made the person most involved in their care ‘somewhat’, ‘quite 
a bit’ or ‘very much’ upset and 42% (27/64) had the perception that it caused frustration. Two-fifths 
(41%, 26/64) felt that it limited this person’s rest time ‘somewhat’, ‘quite a bit’ or ‘very much’. Only 
13% (8/64) of participants thought there was no impact at all on this person, in terms of causing 
upset, frustration or limiting rest time. There was a moderate, significant correlation between the 
severity of the fatigue and the degree of impact for ‘frustration’ (Spearman’s rho= -0.43) and ‘upset’ 
(Spearman’s rho= -0.38), with worse symptom scores being associated with a greater impact. This 
relationship with fatigue severity was not found for the impact of ‘limiting rest time’. 
 
In response to the question ‘Do you think the effect of fatigue on your life is understood by the 
people around you?’, 64% (43/67) indicated ‘not at all’ or ‘a little bit’ for friends, with the 
corresponding proportion for healthcare professionals and family being 28% (19/68) and 33% (22/67) 
respectively. There was a significant correlation between the fatigue severity and the extent to which 
friends understood it (Spearman’s rho=0.33, p=0.007); friends were perceived as being less likely to 
understand, the worse the participants’ fatigue severity. No such relationship existed between 
symptom severity and the degree of family or healthcarer understanding.  
3.5.5 Management of fatigue 
3.5.5.1 Interpretation of fatigue cause  
The first step in symptom management is understanding its cause. Participants were asked whether 
they thought their fatigue was caused by ‘mainly your illness’, ‘mainly your treatment’ or a 
‘combination of both’. A fourth ‘other’ option led to space for a free text entry. The results are 
tabulated below.  
 
Table 3.11 Interpretation of fatigue cause 
Cause Data entered into survey 
(n=68) 
Recategorised ‘other’ data  
(n=68; 72 responses) 
Mainly illness (n) 4 4 
Mainly treatment (n) 16 24 
Combination of both (n) 30 33 
Other (n) 18 11 
 
Of the 18 participants who indicated ‘other’, 11 of the 18 free text responses could be recategorised 
into one of the three main categories: ‘mainly your illness’, ‘mainly your treatment’ or a ‘combination 
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of both’. As well as the seven that were not recategorised, four of the 11 free text responses that 
were recategorised also included another interpretation of the cause of fatigue, beyond illness or 
treatment. In total, recategorisation of free text data led to 11 ‘other responses’ (table 3.12). 
 
Table 3.12 Other interpretations of the cause of fatigue 
Doing a lot in one day 
Not getting enough physical exercise 
Unsure. Maybe also lack of exercise... 
Sleeping patterns is terrible... also occasionally smoke weed... 
Diagnosed with chronic fatigue syndrome afterwards... 
Weight gain 
University exams 
Studies 
Osteoporosis in my knees... I don’t now feel like exercising at all, gets me down 
It’s hard to pinpoint the cause 
Not sure 
All text is verbatim; some non-contributory words have been omitted 
3.5.5.2 Belief about whether fatigue can be treated  
Only 19% of fatigued participants (13/68) believed that ‘something could be done’ about fatigue. 
38% (26/68) believed it to be a symptom one ‘has to live with’ and 43% (29/68) were not sure. No 
relationship was found between the response to this question and the MFS fatigue severity score 
(independent t-test, t=0.54, p=0.60), participants’ interpretation of the fatigue cause (Fisher’s exact 
test, p=0.28), gender (Fisher’s exact test, p=0.11), diagnosis (Fisher’s exact test, p=0.78), age 
(independent t-test, p=0.73), time since diagnosis (Mann-Whitney U test, p=0.80) or time since last 
treatment (Mann-Whitney U test, p=0.09). 
 
3.5.5.3 Talking to healthcare team about fatigue 
65% of participants (44/68) had talked to a healthcarer about feeling fatigued and 13% (9/68) could 
not remember doing so. Participants were significantly more likely to have talked to a healthcarer if 
they were closer to the time of last treatment (Mann-Whitney U test, p=0.007), as demonstrated in 
figure 3.9. Speaking to a healthcarer was not influenced by interpretation of the cause of the fatigue 
(Fisher’s exact test, p=0.41), gender (Fisher’s exact test, p=0.79), diagnosis (Fisher’s exact test, 
p=0.15), age (independent t-test, t=-0.35, p=0.73), time since diagnosis (Mann-Whitney U test 
p=0.66), or duration of cancer treatment (Mann-Whitney U test p=0.95). 
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Figure 3.9 Box plot of relationship between time of last treatment and speaking to a healthcarer 
 
 
 
The 15 participants who had not talked to a healthcare professional could choose any number from a 
list of seven potential reasons. The most common reason for not talking was believing nothing could 
be done (9/15 participants); 6/15 were never asked, 5/15 believed the symptom to be inevitable, 
4/15 did not think the fatigue was important enough, 3/15 did not want to bother the healthcarer 
and 3/15 thought people may consider them ‘lazy or complaining’.  
3.5.5.4 Treatments given 
Two fifths of participants (41%, 28/68) had had no treatment for fatigue recommended. The 
remaining participants had received a range of 1-7 treatments (median 2.5).  
 
Compared to those who had received fatigue treatment, those who had not were much less likely to 
have talked with a healthcarer (table 3.13). All the 40 participants who had talked with a healthcarer 
had received fatigue treatment, whereas only 4 participants who talked with a healthcarer did not 
receive treatment (Fisher’s Exact Test, p<0.001). In addition, they were significantly more likely to 
believe healthcarers had limited understanding of the effect of fatigue (p=0.004), and were 
significantly further from the time of their last cancer treatment (p=0.023). There was no difference 
in fatigue severity (MFS) between the two groups, nor any difference in any demographic variables, 
other than the time since last cancer treatment. 
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Table 3.13 Comparison of participants according to whether received fatigue treatment 
 No fatigue 
treatment received 
Fatigue treatment 
received 
p value 
Fatigue severity (MFS) 
 
46.6 42.7 0.45 a   
Age at survey (years) 
 
21.9 22.1 0.86 a   
Age at diagnosis (months) 
 
18.3 19.4 0.16 a   
Months since diagnosis 
 
44.2 31.8 0.69 b 
Months since last cancer 
treatment 
37.1 19.1 0.023 b 
Cancer treatment duration 
(months) 
28.2 28.7 0.90 
Gender (male) 
 
8/28 12/40 0.56 c 
Diagnosis 
 
- - 0.10 c 
Belief that ‘something can be 
done’ about fatigue 
3/28 10/40 0.33 c 
Did talk with healthcarer 
about fatigue 
4/28 40/40 <0.001 c 
Perceived low understanding 
of fatigue by healthcarer 
11/28 8/40 0.004 c 
Perceived low understanding 
of fatigue by family 
11/28 11/40 0.47 c 
Perceived low understanding 
of fatigue by friends 
19/28 24/40 0.75 c 
Significant p values highlighted in bold 
*’low’ defined as understanding ‘not at all’ or ‘a little bit’ in 5-item verbal rating scale 
a  Independent t-test 
b Mann-Whitney U test 
c Fisher’s exact test 
 
For those who did receive treatment for fatigue, the most common was exercise (27/40) followed by 
rest/relaxation (22/40). Diet/nutrition (15/40), blood transfusion (14/40) and naps/sleep (14/40) 
were the next most often received treatments, followed by physiotherapy (6/40), complementary 
therapies (6/40) and attendance at a fatigue group (2/40). Seventeen of the 22 people recommended 
rest and relaxation, were also recommended exercise. There was no significant relationship between 
the number of treatments recommended and fatigue severity (Spearman’s rho=-0.15, p=0.21).  
 
For the five most common treatments, an exploratory analysis was undertaken to examine 
relationships with the severity of fatigue and the time since last treatment. Exercise and 
rest/relaxation were significantly more likely to be recommended in those with more severe fatigue, 
whereas blood transfusion was more likely to be recommended a shorter interval after the last 
treatment (table 3.14).  
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Table 3.14 Relationship between fatigue treatments, fatigue severity and time since last cancer 
treatment 
 
Fatigue treatment Fatigue severity 
(MFS), mean 
P valuea Months since last 
cancer treatment, 
mean 
P valueb  
Exercise Received 37.0 0.017 20.7 0.31 
Not received 49.1 30.7 
Rest/relaxation Received 36.8 0.035 19.7 0.22 
Not received 47.9 30.3 
Diet/nutrition Received 40.1 0.37 17.5 0.44 
Not received 45.5 28.8 
Blood 
transfusion 
Received 52.7 0.13 13.3 0.036 
Not received 42.2 29.3 
Naps/sleep Received 43.0 0.78 17.3 0.43 
Not received 44.7 28.6 
P values compare values between those who did or did not receive each fatigue treatment 
Significant values highlighted in bold 
a Independent t-test 
b Mann-Whitney U test 
 
3.5.5.5 Management effectiveness 
Participants rated their perception of the successfulness of fatigue treatments they had received. 
Only blood transfusion was described as successful more often than unsuccessful (table 3.15, figure 
3.10). The mean successfulness score across all participants was 1.3 (SD 0.82), a score of 0 
representing treatment with ‘no effect’ and 3 representing an ‘entirely successful’ treatment. The 
perceived success of fatigue treatment was highly correlated with fatigue severity (r=0.71, p<0.001), 
with higher success being associated with less severe fatigue scores. Successfulness of fatigue 
treatment was significantly lower in participants more than one year from last cancer treatment, 
compared to those less than one year from treatment [t(30)=-2.93, p=0.006]. 
 
Table 3.15 Perceived successfulness of each treatment 
Fatigue treatment Successful Unsuccessful Unsure 
Blood transfusion, n (%) 11 (79) 2 (14) 1 (7) 
Naps / sleep, n (%) 6 (40) 9 (60) 0 
Physiotherapy, n (%) 2 (33) 2 (33) 2 (33) 
Rest / relaxation, n (%) 7 (32) 13 (59) 2 (9) 
Exercise, n (%) 8 (30) 12 (44) 7 (26) 
Diet / nutrition, n (%) 4 (27) 9 (60) 2 (13) 
Complementary therapy, n (%) 1 (17) 4 (67) 1 (17) 
Fatigue group, n (%) 0 1 (50) 1 (50) 
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Figure 3.10 Stacked bar chart showing perceived successfulness of each fatigue treatment 
 
3.5.5.6 Personal view of best treatment(s) for fatigue 
All participants, irrespective of whether they had received fatigue treatment, were asked what they 
personally thought was the single best treatment for fatigue. Most participants chose exercise, 
followed by diet/nutrition, rest/relaxation and naps/sleeping (table 3.16). 6/58 participants indicated 
that they could not answer this question as they had not been given any treatment for fatigue, and 
7/58 provided free text information (table 3.17). 
 
Table 3.16 Personal view of best fatigue treatment 
 Proportion viewing as 
best fatigue treatment 
Number of those recommending a 
treatment having received that treatment 
Exercise  14/58 11/14 
Diet/nutrition 7/58 2/7 
Rest/relaxation 7/58 2/7 
Naps/sleeping 6/58 1/6 
Blood transfusion 4/58 3/4 
Complementary therapies 3/58 1/3 
Physiotherapy 2/58 2/2 
Fatigue group 2/58 1/2 
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Table 3.17 Personal view of best fatigue treatment: free text responses 
Getting to the bottom of the cause and treating that 
End of treatment 
Pacing/support groups/resting when needed/changing medication 
Time 
Health combination of rest/relaxation and exercise 
I have no idea 
I really don’t know 
All text is verbatim 
 
Thirteen of the 16 participants who recommended an active treatment (exercise and physiotherapy), 
had received an active treatment themselves; participants who had received an active treatment 
were significantly more likely to recommend an active treatment as being better than a rest-focused 
treatment for fatigue (Fisher’s Exact Test, p=0.001). However, no evidence was found that those who 
had received a rest-focused treatment (rest/relaxation, naps/sleeping and complementary therapy) 
were more likely to recommend a rest-focused treatment (p=0.62). 
 
Table 3.18 Relationship between receiving and recommending active or rest-focused treatments 
 Recommend active 
‘best treatment’ 
Recommend rest-
focused ‘best 
treatment’ 
p value 
Received active 
treatment 
13 3 0.001 
Received rest-based 
treatment 
8 5 0.62 
p values calculated using Fisher’s exact test 
 
The mean MFS fatigue score for those recommending an active treatment was 50.1, whereas that for 
those recommending a rest-focused treatment was 42.8. This difference was not statistically 
significant (independent t-test, p=0.29). 
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3.5.6 Qualitative data 
Participants were given free text space at the end of the survey to respond to the question ‘Is there 
anything else you would like to tell us that we did not ask?’ Fourteen of the 68 participants provided 
comments, too few for formal qualitative analysis, although all 14 fell within five loose themes. 
Examples are provided below, and the remaining quotes are in appendix 7.3.10, page 322.  
3.5.6.1 Lack of understanding  
Four participants described a perception of a lack of understanding of others, in relation to their 
fatigue. Family, friends, teachers and hospital staff were all implicated. 
‘It's difficult to express to friends or teachers that the fatigue isn't something you're choosing 
to let effect you. As an 18 year old with cancer many of my friends could spend all night out 
and were surprised when even after treatment and the all clear I was very tired. Even if there 
was nothing that could be done about fatigue, to make it a well known fact that the fatigue 
can continue would make life easier, both in a friendship environment and a professional 
one.’  
3.5.6.2 Emotional impact 
 Several quotes alluded to the emotions such as anger, depression, anxiety and guilt, in relation with 
fatigue. 
‘Fatigue is accompanied by low mood and this makes getting angry very easy which is then 
reflected in how you behave towards everything you do in life.’ 
3.5.6.3 Impact on work 
Two of the 14 participants described the impact of, and on, work. 
‘I get up and go to work but after work I'm so tired and mid week I start to tire.’ 
3.5.6.4 Perception activity is helpful 
A few participants suggested that activity was helpful for fatigue. None gave the opposite 
perspective, in favour of rest, although there was a suggestion that healthcare staff may encourage 
rest. 
‘I have found the tiredness doesn't go away day to day, but on occasion if I push through the 
tiredness while walking etc I feel better and more alert the next day.’ 
3.5.6.5 Requests for more research 
Two requests for further research were made. 
‘More research definitely needs to go into this, as it has completely ruined my life :( ’ 
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3.6 Discussion 
This survey provides evidence that fatigue is the most prevalent symptom experienced by TYA cancer 
patients, and it persists long after cancer diagnosis and treatment. It has a highly negative impact, 
being an independent predictor of poor quality of life, with the greatest adverse impact being on the 
ability to exercise. It is therefore unsurprising that most did not find advice to exercise helpful, 
despite exercise being the most evidence-based intervention for fatigue in older adults with cancer 
[56]. Two out of five fatigued participants (41%) had received no fatigue management support. 
 
These key findings are discussed in detail below in the context of the prior systematic review and 
other literature of relevance. 
3.6.1 Fatigue experience 
3.6.1.1 Prevalence 
Fatigue was the most prevalent of eleven symptoms, experienced by 85% of the survey participants 
in the preceding month. As described in the preceding systematic review, only five previous studies 
have evaluated fatigue prevalence after cancer treatment alone, as in this survey. Comparison of 
findings is hindered by heterogeneity in definition of a fatigue ‘case’. However, two of the five 
studies did use the same definition as in this survey (>1 in a 1-5 NRS, or equivalent), both – 
coincidentally – revealing prevalence rates of 67% [120,192]. The alternative definition of a ‘case’ 
described in the survey results (>2 in a 1-5 NRS, or equivalent) has not been used by any preceding 
studies.  
 
While the fatigue prevalence in this survey appears to be consistent with existing literature, this 
finding is limited by the potential for selection bias, and the lack of a control group, as discussed in 
section 3.6.5.2 (page 88). 
3.6.1.2 Fatigue type 
Fatigue is a multidimensional symptom, with physical, cognitive, emotional and sleep-related 
components. The primary fatigue measure used in this survey, the MFS, disaggregates fatigue by 
generating three subscores for general (physical), cognitive and sleep/rest fatigue. Survey 
participants’ responses indicated that all three dimensions were of comparable severity (general, 
cognitive, sleep/rest subscores were 42.4, 44.9, 45.5 respectively). In contrast, most evidence to date 
has suggested that the cognitive component of fatigue is less severe than the other fatigue 
dimensions in young patients. 
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Amongst the 15 studies in the systematic review using the MFS measure, only five reported 
subscores, with four reporting cognitive fatigue to be less severe than the other dimensions 
[168,172,186,200]. Daniel and colleagues, for example, revealed subscores of general, cognitive and 
sleep/rest fatigue of 55.8, 69.2, 51.1 respectively [168]. Only one of the five studies produced similar 
findings to this survey; Keats and colleagues recorded MFS scores in a small study enrolling TYAs to a 
physical activity intervention after cancer treatment, and revealed cognitive subscores that were of 
comparable severity (general, cognitive, sleep/rest subscores: 68.8, 69.4, 62.9 respectively) [218].  
 
In considering potential reasons for these differing findings, it is noteworthy that the two studies 
revealing comparable cognitive fatigue to the other dimensions, this survey and Keats [218], have 
been the only studies involving only those patients who were after completion of cancer treatment. 
The other four studies involved patients during, or predominantly during, cancer treatment. Daniel 
and colleagues hypothesised that the apparently less severe cognitive fatigue during cancer 
treatment may represent ‘reduced cognitive demands given reduced school attendance and overall 
expectations for productivity’ [168]. Compared to during cancer treatment, cognitive fatigue could 
become more apparent after the end of treatment, due to the need to reintegrate with education or 
work. 
 
An important difference between the survey fatigue scores and all the other studies described above 
is that the survey only scored MFS fatigue in those who had experienced some fatigue in the last 
month; the other studies scored fatigue in the whole research cohort, irrespective of whether or not 
participants were experiencing fatigue. As well as providing a potential explanation for why the 
symptom severity subscores appear to be worse in the survey than other studies, it is conceivable 
that the lack of data from the potentially healthier non-fatigued participants could have contributed 
to the worse cognitive fatigue scores in this survey, given that cognitive fatigue is known to be the 
least severe dimension of fatigue in healthy adolescents [168]. Equally, though, Keats and colleagues 
did find significant cognitive fatigue in patients not selected for the presence of fatigue. This, along 
with the notable difference in cognitive fatigue between studies with participants during, compared 
to after, treatment, suggests that the marked cognitive fatigue after cancer treatment found in this 
survey could be a true finding. 
3.6.1.3 Persistence 
An unexpected and interesting finding was that fatigue scores appeared to be worse in those more 
than one year after the end of cancer treatment, compared to those less than one year after 
treatment. As described in the preceding review, cross-sectional studies in cancer survivors have 
suggested that fatigue remains prevalent in patients long after the end of cancer treatment. Only one 
longitudinal study in TYA patients has attempted to investigate the temporal pattern of fatigue 
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beyond the end of cancer treatment; Macpherson and colleagues found that fatigue persisted in 
survivors of Hodgkin’s lymphoma, with no significant changes in fatigue scores between the end of 
treatment and three years later [190].  
 
This survey is the first research in the TYA population to suggest that fatigue levels after the end of 
cancer treatment could worsen over time. In a longitudinal study, Andrykowski and colleagues 
evaluated fatigue in a large cohort of breast cancer patients with a mean age of 55 years; the 
prevalence of fatigue was 9% at 4 months after the end of cancer treatment and rose to 13% at 42 
months [270]. Although the concordance with the survey findings is compelling, the validity of the 
survey outcome is limited by low study power and the risk of increasing selection bias for more 
fatigued patients further from treatment, as will be discussed in section 3.6.6.2 (page 90). Although it 
has therefore not been established that fatigue worsens over time, this survey does provide evidence 
for fatigue persisting long after the end of cancer treatment in TYAs. 
 
Why might it be that fatigue persists long term? Although the survey was not attempting to answer 
this question, the finding that the main impact of fatigue was on the ability to exercise could be of 
relevance, given that physical activity is an effective intervention for CRF in older adults [243,271]. It 
is conceivable that the TYA fatigue is preventing the main approach that could ameliorate it, leading 
to its persistence.  
 
Another possibility, given that fatigue is a subjective and self-reported experience, is that it is 
perceived to persist, because of expectations that it should improve after the end of cancer 
treatment. Again, the survey did not attempt to explore this aspect. However, the survey finding that 
virtually all participants believed fatigue was caused by the cancer and/or its treatment could be 
consistent with this hypothesis. Furthermore, in the free text responses, a few participants referred 
to the lack of understanding that fatigue may persist longer term.  
3.6.1.4 Correlates 
The strength of correlation between the severity of fatigue and that of a wide range of physical and 
psychological symptoms was another noteworthy survey finding. Low mood, lack of appetite and 
anxiety were the three symptoms with the strongest correlation with fatigue severity. The close 
correlation between fatigue and other symptoms is consistent with recent data from the large AYA 
HOPE study, involving 523 adolescents and young adults aged 15-39, that revealed that the strongest 
correlates with fatigue were concurrent symptoms [188]. Furthermore, the psychological symptoms, 
low mood and anxiety, were the two symptoms found to cluster most closely with fatigue in the 
hierarchical symptom cluster analysis. A meta-analysis of correlates of fatigue in adults with cancer 
 83 
has revealed congruent findings, with fatigue correlating more closely with psychological than 
physical symptoms [45]. 
 
These findings are of interest for two reasons. First, they support the view of fatigue as a symptom 
with a significant non-physical dimension. Both anxiety and low mood have previously been shown to 
be independent predictors of the development of CRF in older adults [272,273]. An effective fatigue 
intervention is, therefore, likely to require a psychological component. This is consistent with 
evidence from older adults for the effectiveness of psychological interventions for CRF; indeed, 
Mustian and colleagues found that psychological approaches were the single most effective 
treatment for fatigue after the end of cancer treatment [48,56]. 
 
Second, the close relationship between fatigue and other symptoms could suggest that, if there is a 
causal link, control of the other symptoms might also help ameliorate fatigue. De Raaf and 
colleagues’ randomised older adults with CRF to a complex intervention that involved careful 
management of nine physical symptoms; intervention was found to lead to a significant 
improvement of fatigue [44]. This supports the possibility of causal relationships between fatigue and 
other symptoms in older adults; for example, pain may impact on sleep and therefore lead to fatigue.  
However, the survey findings can only demonstrate an association between symptoms in TYAs, not 
causality. 
3.6.2 Fatigue impact 
3.6.2.1 Impact on quality of life and daily living 
This survey has confirmed the highly detrimental impact of fatigue, including a strong relationship 
with poor quality of life. Although, as described in the systematic review, previous studies have 
revealed a correlation between fatigue and poor quality of life, these findings build on existing 
knowledge in two ways. First, the survey is the first to reveal that fatigue is an independent predictor 
of quality of life in TYA cancer patients. Second, the two previous studies attempting to quantify the 
relationship between fatigue and quality of life used the PedsQL™ measurement system to assess 
both parameters, which could potentially inflate the strength of correlation [168,225]. This survey 
has been the first to measure fatigue and quality of life using separate validated measures. 
 
Furthermore, this survey is the first to quantify the impact of fatigue on daily living. Participants 
revealed that fatigue is the single symptom with the greatest impact on daily life in TYAs. Previous 
research, described in the review, has been qualitative, participants describing the impact on 
exercise and socialising. Quantitative evidence from this survey has allowed ranking of the impact of 
fatigue on the different activities of daily living; the effect on the ability to exercise is the single 
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greatest impact, followed by the impact on the ability to attend school/work, on relationships with 
friends, and on the ability to socialise, enjoy life and be independent. These findings provide insight 
into the unexplained review finding that the main impact of fatigue was distress. Given the 
developmental importance for TYAs of socialising with peers and autonomy (section 1.1.2.2), it is 
perhaps not surprising that fatigue leads to distress in this young patient group. 
 
These findings are not unique to the TYA age range. The distress caused by CRF in older adults has 
also been established [274], as well as its impact on the activities of daily living [23]. In a survey of 
older adults with CRF, Stone and colleagues revealed fatigue to be the symptom with the greatest 
negative impact on daily life, and quantified the impact of fatigue on aspects of daily living [23]. Their 
results are not directly comparable to those of the survey because the questions differed to reflect 
age-related needs: older adults were most concerned about the impact on being able to work, on the 
ability to enjoy life, on sex life, on hope of fighting the illness, and on the ability to take care of 
family.  
 
Although the survey was predominantly quantitative, the free text data gave some limited qualitative 
data on the impact of fatigue. Several participants described their perception of lack of 
understanding of fatigue, the emotional impact and the impact on work, providing further insight 
into the detrimental effects of fatigue on quality of life and daily activities. 
3.6.2.2 Parents’ perspectives 
Parents were, unsurprisingly, reported to be the people most closely involved in caring for TYA 
cancer patients, and this work has provided the first, albeit proxy, evidence for a negative impact on 
parents. Only 13% of participants perceived that the fatigue had no impact on the person closest to 
them, with the remainder indicating that fatigue led to the carer experiencing frustration, upset, or 
limited rest time. Although over the last decade considering the needs of carers of those with long 
term conditions, including cancer, has become highly topical, there has, as yet, been little work 
evaluating the impact of specific symptoms on carers [275,276]. Only one previous study has 
considered the impact of caring for those with CRF; a small study evaluating the needs of spousal 
caregivers of older cancer patients suggested increased depression and strain, and an impact on the 
ability to work [277].  
 
Approximately one third of participants considered that fatigue was not understood by family. 
Although the effect of this perceived misunderstanding was not investigated, it is possible that this 
contributes to the frustration reported to be experienced by parents. Misunderstandings in relation 
to CRF have not previously been described in the literature, in relation to older or younger adults.  
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3.6.3 Fatigue management 
3.6.3.1 Current practice 
This survey provides the first description of current UK clinical practice in TYA fatigue management, 
revealing therapeutic scepticism and under-management. Less than one in five participants (19%) 
believed that ‘something could be done’ about their fatigue. Stone and colleagues, in their survey of 
older adult CRF almost two decades ago, found similar levels of scepticism, with only 22% believing 
something could be done to improve fatigue [23]. There has been no equivalent survey evaluating 
current older adult fatigue management since then. 
 
Nonetheless, there has been some evidence of progress in the intervening years. In the current 
survey , although only two in five participants (41%) had received fatigue management support, the 
equivalent figure in the Stone survey was substantially lower with only 14% receiving help with 
fatigue [23]. Two thirds (65%) of the fatigued survey participants had talked to a healthcarer about 
fatigue and, of those receiving fatigue treatment, 68% had received advice to exercise (the respective 
figures in older adults being 48% and 4%) [23]. It is encouraging that exercise was found to be the 
approach most commonly recommended by healthcare professionals, given that it is the most 
evidence-based treatment, albeit in older adults [56]. Furthermore, most (17/22) of those 
participants encouraged to rest were also encouraged to exercise. 
 
Overall, however, it is concerning that a significant minority of TYA cancer patients (41%) report 
having received no fatigue management support at all. Compared with some cancer-related 
symptoms, such as pain, fatigue appears to be neglected. While evidence from both young and older 
cancer patients suggests that at least 90% receive adequate support for pain management [99,278], 
support for fatigue appears to be more in line with other relatively neglected symptoms, such as 
constipation, depression and insomnia. A large pan-European study, for example, found that 40-80% 
of older adults self-reporting these symptoms disclosed not having received symptom management 
support [279]. Rates of inadequate control of these other neglected symptoms have not been 
reported in the TYA cancer literature. 
3.6.3.2 Perceived successfulness of current approaches  
The perceived successfulness of most fatigue treatments was low, with only blood transfusion 
reported to be more often successful than unsuccessful. Participants reported that most treatments 
were ineffective for fatigue and most believed that fatigue could not be treated.  
 
Interestingly, exercise was recommended as the best fatigue treatment, despite most participants 
finding exercise unhelpful for fatigue. Those who had received active treatments, such as exercise or 
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physiotherapy, were significantly more likely to recommend an active treatment to others, whereas 
there was no evidence that those who had received rest-focused treatment were more likely to 
recommend a rest-focused approach to others. The survey finding, that the single greatest impact of 
fatigue was on the ability to exercise, illuminates this apparent paradox.  
 
The successfulness of fatigue management appeared to be lower in respondents further from the 
end of cancer treatment. Selection bias may limit the validity of this finding; people could be more 
likely to participate in the survey, long after the end of treatment, if their fatigue remains severe, and 
the survey has shown that those with worse fatigue perceived treatment to be less successful. 
Alternatively, this finding might represent a perception caused by an increasing mismatch between 
expectations and reality the further a patient is from the end of fatigue treatment. A third possibility 
is that fatigue management is, indeed, less successful later after the end of cancer treatment. Given 
that fatigue hinders the exercise that has the potential to ameliorate it, it is conceivable that 
inactivity may lead to loss of fitness that, in turn, worsens the fatigue and makes it harder to manage. 
As discussed in section 3.6.6.2 (page 93), further research is needed to investigate this hypothesis. 
 
The successfulness of current fatigue management for TYA cancer patients cannot be compared with 
that of older patients, as this survey is the first to evaluate the successfulness of fatigue management 
in routine clinical practice in cancer patients of any age. Research to date in older adults has involved 
evaluation of the effectiveness of experimental fatigue interventions, rather than observational 
assessment of the perceived successfulness of existing fatigue management.   
3.6.4 Theoretical underpinning 
Although the survey did not explicitly question participants on their self-efficacy for fatigue self-
management, several findings suggested self-efficacy was low. [148] Four out of five participants did 
not believe fatigue could be treated. Furthermore, participants considered current management 
approaches to have limited successfulness; this included exercise, the most evidence-based approach 
for CRF management, and the approach participants most recommended to others. 
 
This suggestion of low perceived self-efficacy has implications for future research, both in terms of 
optimising adherence and promoting engagement with a non-pharmacological intervention, as will 
be discussed in section 3.6.7.2 (page 93).  
  
 87 
3.6.5 Methodological discussion 
The findings discussed so far relate to the first three objectives of this study, establishing the 
prevalence, severity, impact and current management of fatigue. The fourth objective was a 
methodological one: to examine the feasibility of using an electronic, rather than paper, survey 
methodology in TYA cancer patients. 
 
As discussed in section 3.2.2 (page 45), an electronic, rather than paper, survey was undertaken 
following advice from young patients; advantages include the low cost, ease of analysis, high data 
integrity and reduced participant burden, while anticipating potential limitations from lower 
response rates and selection bias. As electronic surveys of patients remain rare in research contexts, 
rather than service evaluations, appraisal of the feasibility of this approach was an integral part of 
this study. 
3.6.5.1 Advantages 
Many of the known benefits of electronic survey methods were confirmed. Data integrity was 
extremely high, with only 1.8% missing data. This compares favourably with postal surveys; a review 
of 285 randomised controlled trials collecting patient reported outcomes, many by postal 
questionnaire, found that 36% of studies reported more than 11% missing data [280].  
 
In this survey, the first two questions were made compulsory, an approach known to reduce missing 
data. Equally, there is evidence that such an approach can reduce response rates, so a pragmatic 
compromise was taken with only the first two questions being mandatory [281]. Data analysis was 
facilitated by direct transfer of electronic data from the QuestionPro platform to the database for 
analysis, without the need for time-consuming, and potentially inaccurate, data transfer from paper 
to electronic format. 
 
The burden of the survey on all parties was low. The survey cost a total of £1568 (travel expenses to 
sites: £240; prizes: £448; site administration costs: £880), excluding the PI salary costs. The extra 
costs of paper, postage and a data manager salary would have rendered a paper questionnaire 
considerably more expensive. Perhaps more importantly, there was indirect evidence of low 
participant burden; participants took a median of eight minutes to complete the survey and no-one 
withdrew part way through. The conditional branching programmed into the questionnaire meant 
that those participants who were not fatigued were able to complete the survey in only three 
minutes. Most participants (46/80) used a smart phone, with associated ease of access. 54/80 
participants responded on the day of the initial or reminder email, suggesting that the electronic 
approach allowed a spontaneous and rapid response, potentially with less of a sense of burden. 
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The participating sites gained a further unanticipated benefit. Clinical staff at the Southampton and 
Cambridge sites gave unsolicited descriptions of the benefit of the research process having required 
them to update their patient database, particularly in relation to ensuring the recording of email 
addresses with consent to use them. 
3.6.5.2 Disadvantages 
The two main concerns about using an electronic survey were the potential for selection bias, due to 
the necessity for access to the internet, and the risk of a low response rate. In this young population, 
the risk of the former, although not measurable in this study, was considered to be low due to the 
ubiquitous access to mobile technology; 99% of 16-34 year olds in the UK are recent internet users 
[263]. However, there was still potential for selection bias. Twenty four of the initial 221 emails sent 
from all three sites were returned as ‘undeliverable’; it is possible that those individuals who had 
changed email address differed in some way to those with an unchanged address. This rate is not 
dissimilar to a previously reported ‘bounce rate’ of 10% in a survey of healthcare professionals [253].  
 
Furthermore, not all patients had given their email address to their cancer service; in Manchester, 
uncertainty over whether patients had given consent for their emails to be used for research, led to 
an unknown proportion of patients not being contacted. In Cambridge, this proportion was known: 
47 out of 193 otherwise eligible patients had not given their email address or had not given consent 
to use it. Those patients without recorded email addresses, or without consent to use them, may 
have differed from the population as a whole in unknown ways, giving further potential for selection 
bias. 
 
The potential for non-response bias was considerable, given the response rate of 41%. Response 
rates reported in the literature vary considerably: published postal surveys are often 50-70%, 
whereas electronic surveys are lower at 20-50% [259,282-285]. The latter figures relate largely to 
electronic research surveys of healthcare professionals, patient satisfaction surveys and evaluation of 
education; electronic research surveys of patients are much less common. 
 
Many of the strategies known to improve response rates were incorporated into the survey design, 
including priming, reminders and incentives [259-261]. There was a suggestion that priming was 
helpful in that the site with most limited priming (Southampton) achieved by far the lowest response 
rate. The loss of service Facebook access in Southampton, combined with the evidence from 
Manchester that 12/16 participants were recruited through Facebook, suggests that social media 
may provide a particularly useful priming platform in this young age range. This is perhaps 
unsurprising, given that social media are increasingly recognised to be highly influential on choices, 
particularly those made by young people [286].  
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In terms of reminders, a pragmatic decision was made to limit this to a single reminder in non-
responders, in order to limit the burden on this potentially vulnerable patient group. As shown in 
figure 3.1 (page 58), the single priming email had a marked impact, appearing to trigger 22 of the 80 
participants to respond. Consistent with this, the literature suggests that the odds of response 
increases by more than a quarter when there is follow up contact, and that response rates increase 
further with each of three successive contacts [287,288]. However, benefit appears to diminish 
incrementally after the first contact, with evidence that second and third reminders do not 
significantly change the overall characteristics of respondents or study outcomes [289]. The balance 
of benefit against burden can be argued therefore to be in favour of one reminder in potentially 
vulnerable patient groups, although in other populations more than one reminder may be 
reasonable. 
 
The survey response rate of 41% does potentially compromise its generalisability. Traditionally, 
response rates of over 50% have arbitrarily been considered acceptable, with corresponding 
influence on potential for publication. However, a change in perspective has occurred in recent 
years, in parallel with declining response rates in healthcare research. Morton and colleagues have 
argued that, in light of recent evidence that lower response rates have little, if any, impact on the 
accuracy of study findings, there should no longer be a defined ‘acceptable response rate’ [290,291]. 
Instead, study validity should be assessed by describing attempts to increase response rates and by 
comparing the characteristics of non-respondents and respondents. 
 
It was possible to gather demographic data concerning non-responders in this survey; fatigue levels 
however could not be determined, meaning that selection bias according to fatigue severity could 
not be excluded. The demographic characteristics of responders and non-responders were broadly 
comparable (section 3.5.2, page 58), supporting survey validity despite the relatively low response 
rate. The key difference between the two groups was that no patients responded to the survey while 
receiving cancer treatment. However, once the data of responders were compared with that of those 
non-responders also off treatment, it was apparent that there were few demographic differences 
between the groups. It is noteworthy that there was no longer a gender difference, given the known 
increased prevalence of CRF in females revealed in this survey (section 3.5.3.2, page 65) and already 
established in the literature [230]. The two remaining differences between the two groups, median 
time since last treatment and treatment duration, were relatively small and unlikely to bias the 
findings significantly. 
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Overall, therefore, electronic survey methods have been shown to be feasible in this young patient 
group. As well as the many apparent benefits of this approach, efforts to improve the response rate, 
along with undertaking a non-responder analysis, partially mitigated the potential negatives. The 
implications of these findings for future research will be described in section 3.6.7.2 (page 93). 
3.6.6 Strengths and limitations 
3.6.6.1 Strengths 
The main strength of this survey was its focus on the specific gaps in the literature identified in the 
systematic review, including the lack of evaluation of parents’ perspectives and limited interventional 
research. The sequential nature of the studies, with the survey being able to build on the review 
findings, has optimised the usefulness of the survey, despite the many limitations that will be 
discussed in detail below. 
 
In statistical terms, a further strength is its relatively large size, recruiting 80 patients across the UK 
from a cohort that is not only relatively small but also particularly vulnerable, due both to young age 
and the serious nature of a cancer diagnosis. Only 17 of the 69 studies in the systematic review 
recruited more participants than this survey. Furthermore, a validated and multidimensional fatigue 
scale was used as the primary outcome, on which a large proportion of the statistical analyses were 
based. This makes the findings more robust, given the controversy over whether it is acceptable for 
data from Likert-type scales to be considered continuous, rather than ordinal [292].  
3.6.6.2 Limitations 
Survey validity and generalisability have been limited by a number of factors. The two most 
important limitations are the risk of response bias and the likelihood of type 1 errors occurring.  
 
Although selection bias was possible in relation to internet access and email address availability, of 
greater concern is the risk of response bias from fatigued people being more interested in taking part 
in the survey. It is well established that people are more likely to respond to a survey if interested in 
the topic in question [293]. The main way to have mitigated this risk would have been to avoid the 
word ‘fatigue’ in the survey title and information, and to have described the survey as evaluating 
symptom management more generally. This was considered, but not pursued, due to ethical 
concerns about loss of transparency, as well as practical matters, such as avoiding a lengthy and 
burdensome questionnaire. Response bias towards more fatigued patients may have exaggerated 
several of the study findings, particularly the data on fatigue prevalence and impact. Furthermore, as 
discussed in sections 3.6.3.2 (page 84) and 3.6.1.3 (page 82), increasing selection bias further from 
the time of the last cancer treatment could have led to the finding that fatigue was worse, and its 
treatment less successful, in those more than a year after the end of treatment.  
 91 
 
Another significant limitation is the risk of type 1 errors having occurred, given the large number of 
statistical tests undertaken. A type 1 error occurs when a null hypothesis is true but is rejected, 
leading to a false positive outcome. Setting a significance level of p= 0.05 means that it was decided 
that it would be acceptable to have a 5% probability of a false positive result. The more tests that are 
undertaken, the more likely it is that a true negative finding would appear to be positive by chance. 
Given that this was an exploratory survey, rather than an attempt to give a definitive answer to a 
specific question, it was considered more important to minimise type 2, than type 1 errors. No 
attempt was therefore made to make statistical adjustments, such as a Bonferroni correction to 
compensate for the multiple comparisons [294]. Overall, therefore, it is possible that some of the 
statistically significant findings in this survey arise from chance alone. Further research, as described 
in section 3.6.7.2 (page 93), is needed to confirm the findings. 
 
Although it was argued above that the size of the study population was relatively large, given the 
small and vulnerable population with a relatively rare problem, the statistical power of the study was 
low, particularly when analysing data from participant subgroups. Post-hoc power calculations were 
undertaken, confirming the relatively low power. The survey found a 14-point worsening of MFS 
fatigue score in those participants more than one year from the end of cancer treatment, compared 
to those within the year after the end of treatment; Varni and colleagues undertook a similar 
comparison, in children aged 2-18 rather than the TYA population, and found a 7-point reduction in 
fatigue (MFS) across the same timescale [161]. A power calculation, using α and β values of 0.05 and 
0.2 respectively, suggested that the survey had only a 27% power to detect a 7-point change in MFS. 
Other survey calculations appear however to have been more robust; the post-hoc power 
calculation, using reference data from a study evaluating MFS scores in young adults with a chronic 
health condition [295], suggested that the survey had 80% power to detect a correlation of 0.31. 
 
In addition to selection and response bias, a further limitation of the survey was the potential for 
recall bias. Participants were asked to remember fatigue therapy over a period, at times, of years. 
Recall bias may have led to some apparently spurious findings, such as more blood transfusions 
having apparently been received by those closer to the end of cancer treatment. 
 
Several other limitations need to be considered. Poor sleep was an important correlate of fatigue in 
the systematic review, and its inclusion in the survey questions would have been valuable. 
Generalisability is hindered by all participants having completed cancer treatment, meaning that 
findings can only be generalised to the post-cancer treatment population. Furthermore, the response 
rate data from Manchester were unreliable. The lack of prior consent to use email addresses for 
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research meant that patients were asked by their clinical team whether they were happy for their 
email address to be used for the survey, which is likely to have increased the apparent response rate. 
However, as Manchester recruited relatively few participants, this is unlikely to have changed the 
overall response rate markedly. 
3.6.7 Implications 
3.6.7.1 Clinical practice and policy 
Although this survey was an exploratory study, there are multiple implications for clinical practice 
and policy, as well as for future research. 
 
Building on the clinical implications of the literature review (section 2.6.4.1, page 42), this survey has 
generated evidence that reinforces the importance of healthcare professionals proactively raising the 
topic of fatigue during clinical consultations. Participants who did speak with a healthcare 
professional were much more likely to receive support with fatigue management; all of the 15 
patients who did not talk with a healthcarer did not receive fatigue support, whereas 40 of the 44 
who did talk received support. The survey revealed a high level of scepticism that fatigue could be 
treated, and at least a third reported that they felt that healthcare professionals misunderstood their 
fatigue. These data suggest that, while talking with healthcare professionals is valuable, therapeutic 
scepticism may inhibit patients from raising the subject.  
 
A solution could be for healthcare staff to raise the topic of fatigue proactively. Fatigue is highly 
prevalent, so proactive questioning is likely to be productive. Such brief intervention would lead to 
fatigue affirmation, reducing the perception of being misunderstood. As discussed in section 2.6.4.1 
(page 42), interventional studies for older adult fatigue have found clinically relevant benefits from 
placebo, suggesting that simply talking about fatigue can be therapeutic in itself [54]. 
 
The evidence for correlation between fatigue and concurrent symptoms is consistent with the 
evidence in adults that careful management of other symptoms can improve CRF [44]. Rigorous 
control of concurrent symptoms should be an existing part of good patient management and may, 
inadvertently but usefully, have a positive impact on fatigue. 
 
The survey has revealed, for the first time, albeit with proxy reporting, the impact on parents, and 
the perception of poor family understanding of fatigue. In this context, it is likely that family 
involvement in clinical discussions about fatigue would be valuable, both for young patients and for 
family members. This could support family insight into the experience of fatigue, and may potentially 
reduce the perceived ‘frustration’ and ‘upset’ reported by young patients. 
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3.6.7.2 Future research 
This survey has provided extensive information on valuable areas of future research. Attempts to 
answer a small number of research objectives have inevitably led to generation of a plethora of 
further questions. As an exploratory study, all outcomes need to be supported by further research 
powered specifically to confirm each finding.  
 
Although a key outcome of the survey has been the high prevalence of TYA CRF, this needs 
confirmation in a study designed to reduce the risk of response bias; for example, a survey could 
evaluate many symptoms, rather than explicitly focusing on fatigue, and could incorporate a control 
group of healthy age-matched young people. A large number of participants would be needed for the 
study to have the power to generate valid findings in relation to just one symptom, fatigue. 
 
The persistence of fatigue, and its apparent worsening further from the end of cancer treatment, 
requires a longitudinal, rather than cross-sectional, study design, in order to evaluate temporal 
patterns. Prospective data collection would reduce the risk of recall bias. Although one such study 
has now been undertaken, Macpherson and colleagues only evaluated fatigue in patients with 
Hodgkin’s lymphoma, and in the three year period from the end of cancer treatment. A longer-term 
study, including the period during cancer treatment, with larger patient numbers and a range of 
diagnoses would provide invaluable information. Furthermore, such a study could explore further the 
hypothesised mechanisms for fatigue perpetuation; fatigue expectations could be tested as 
predictors for symptom perpetuation, and the temporal pattern of fatigue and activity changes could 
infer causality. Qualitative research is needed to provide further insight into participants’ views on 
causality, for example the direction of the relationships between fatigue and activity, and between 
fatigue and other symptoms. 
 
Although this survey has provided novel and valuable data quantifying the impact of fatigue, 
qualitative research is also needed to generate insight into the mechanisms of impact. For example, 
this work has suggested that the cognitive impact of fatigue is particularly problematic after the end 
of cancer treatment. Qualitative research would help clarify the relative impact of the different 
fatigue dimensions of fatigue and could explore a potential mechanism, such as the hypothesis that 
cognitive demands increase after cancer treatment [168]. 
 
Parents’ perspectives have been assessed for the first time in this survey, although only by proxy. 
Direct investigation of parents’ views is needed. Given the evidence that misunderstandings may 
occur, qualitative research could usefully generate insights into the causes and impact of 
misunderstandings, and whether they contribute to TYA perceptions of parental frustration. 
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This survey, by providing an overview of current (inadequate) fatigue management in the UK, has 
firmly established the need for future interventional research. Further, it has highlighted the need for 
such research to evaluate fatigue treatment beliefs and needs in TYAs, to optimise adherence to, and 
engagement with, fatigue intervention. Treatment adherence can be more problematic at a young 
age (section 1.1.3, page 9); a review of adherence in adolescents and young adults with cancer 
estimated treatment non-adherence rates of 27% to 60% [90]. The survey findings of therapeutic 
scepticism and fatigue impacting on activity, raise concerns that intervention adherence may be low; 
health-related beliefs, including perceptions of low therapy efficacy and of obstacles to adherence, 
are known to be important predictors of poor adherence [89,296,297]. Future research needs to 
consider how to promote self-efficacy for fatigue management and, specifically, to determine how 
best to initiate exercise when fatigued. Low intervention engagement is a key barrier to successful 
non-pharmacological symptom self-management [298]. Engagement can only be achieved with an 
acceptable intervention that meets the needs of young people. 
 
The persistence of fatigue, along with its apparent increase in fatigue further from the time of the 
end of cancer treatment, suggests that early fatigue intervention may be valuable, to avoid the 
symptom becoming entrenched and worsening. Future studies need to determine the optimal timing 
of fatigue intervention. Given the significant cognitive and affective impact of the symptom, specific 
research efforts are needed to find out how best to mitigate this component of fatigue, at an age 
when cognitive function at school, college or work can impact considerably on life direction. 
 
Finally, the novel methodological aspects of this survey have research implications. Electronic 
surveys, without concurrent paper or telephone contact, appear to be feasible in TYAs. Further 
research is needed involving patient groups with a lower propensity for mobile technology use.  
Given that all participants had finished cancer treatment, research is needed to find out how best to 
reach those currently receiving cancer treatment. It could be, for example, that supplying electronic 
tablets in hospital could broaden access. The suggestion that priming with social media was 
particularly productive needs further exploration, not only in TYAs, but also at other patient ages.   
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3.7 Key points 
This survey has provided a valuable contemporaneous overview of the experience of fatigue and its 
clinical management amongst current TYA cancer patients in the UK. The symptom is, as suggested 
by the systematic review, prevalent and persistent. The novel findings in relation to the impact on 
young patients and their parents provide insight into the distress caused by fatigue. The survey has 
established the need for interventional research. Intervention development needs to focus on 
supporting treatment adherence, on promoting self-efficacy despite therapeutic scepticism, and on 
initiating activity when hindered by fatigue.  
 
The key findings from this study are summarised in table 3.19. The table includes findings from the 
systematic review, to demonstrate the sequential building and synthesis of research findings. 
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Table 3.19 Fatigue in Focus survey key points in context 
 
TYA CRF topic Study 1: Systematic review Study 2: Fatigue in Focus survey 
Prevalence The prevalence range was 
9-67% after cancer 
treatment; fatigue was the 
first and second most 
prevalent symptom in 11 
and 6 of 20 studies 
respectively. 
Fatigue was the most prevalent symptom 
experienced by 85% of participants after the end of 
cancer treatment. Cognitive fatigue was 
particularly prevalent, compared to previous 
studies evaluating patients during cancer 
treatment. 
Temporal 
pattern 
Only one longitudinal study 
has evaluated fatigue 
beyond the end of cancer 
treatment. 
Fatigue severity was higher more than one year 
after the last cancer treatment, compared to 
during the year after treatment ends. Further 
research is needed to gain insight into the cause(s) 
of fatigue persistence. 
Symptom 
correlates 
Physical and psychological 
symptoms most commonly 
associated with fatigue 
were poor sleep and low 
mood respectively. 
Significant correlation was found between fatigue 
and other symptoms, fatigue forming a symptom 
cluster with low mood and anxiety. It could not be 
determined whether this represents association or 
causal relationships. 
Impact The most commonly 
reported impact was 
‘distress’, followed by 
fatigue being a barrier to 
physical and to social 
activities. 
Fatigue was the symptom with the worst impact on 
daily life, and an independent predictor of poor 
quality of life. The greatest impact was on exercise, 
school/work attendance and socialising, potentially 
suggesting some sources of fatigue-related 
distress. 
Parents’ 
perspectives 
No past research has 
evaluated the perspectives 
of parents or other carers. 
Parents were the main carers. Only 13% of 
participants perceived no negative impact on 
carers, with ‘upset’ and ‘frustration’ occurring 
commonly. A third of parents were perceived to 
misunderstand the symptom, although the causes 
and impact of this have not been established. 
Direct parent views are needed in future research. 
Management No studies have evaluated 
an intervention with a 
fatigue related primary 
outcome; current clinical 
practice, in terms of 
symptom management, is 
also unknown. 
Most participants, almost 3 out of 5, had been 
recommended a fatigue treatment, most 
commonly advice to exercise. Participants 
themselves recommended active treatments more 
than rest-focused ones. However, therapeutic 
scepticism prevails with no treatments apart from 
blood transfusion perceived to be successful.  
Interventional research is needed, with a design 
that promotes adherence.  
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4 Fatigue Intervention Co-design Study 
4.1 Title 
Fatigue Intervention Co-design Study (FICS) in teenagers and young adults with cancer 
4.2 Rationale 
4.2.1 Justification for study 
4.2.1.1 Feedback from scrutiny of an early unsuccessful grant application 
From its inception, the overall aim of this programme of research has been to develop an effective 
fatigue intervention for TYAs with cancer. While the systematic literature review was being 
undertaken in 2014, Anna Spathis led a research team through an application to NIHR Research for 
Patient Benefit for funding of a feasibility interventional trial. The intention, at that time, had been to 
model the intervention on an evidence-based approach for fatigue management in older adults.  
 
Although, as described in section 1.1.1.4 (page 4), recent systematic reviews have shown that 
exercise and psychological approaches are the most effective treatments for older adult CRF [48,56], 
in 2014 the strongest evidence was for exercise, education and activity management, the latter also 
being known as energy conservation [243,299]. This led to the research group developing an 
intervention called the ‘3 Es’: Exercise, Education and Energy conservation. A qualitative process 
evaluation was included in the mixed-methods study to gain feedback on the intervention, as well as 
on trial process, in order to optimise intervention acceptability in a subsequent definitive trial [300]. 
 
The application for funding was not approved. The main concern of the funding panel was the 
‘insufficient detail... about the likely content of the intervention’. It was therefore decided that, 
before seeking funding for a feasibility trial, it was necessary and important to set up a study focused 
entirely on intervention development. This chapter describes that study. 
4.2.1.2 Increasing emphasis on complex intervention development 
A non-pharmacological fatigue intervention fits within the definition of a ‘complex intervention’. 
Complex interventions are defined as interventions having several interacting components, with 
dimensions of complexity including the range of ‘behaviours required by those delivering or receiving 
the intervention’ and the degree of permitted intervention flexibility [135]. The MRC published 
seminal guidance on the evaluation of complex interventions in 2000, which was subsequently 
updated in 2008 [135].  
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A key change in the updated guidance has been the increased weight given to the intervention 
development phase. The guidance suggests that such development needs to be not only 
underpinned by current evidence and appropriate theory but also, if necessary, ‘supplemented by 
new primary research’. Such research may include interviews with ‘stakeholders’, and ‘modelling of 
the intervention’. The development process is further strengthened by understanding how the 
intervention might work [135]. Despite the increasing emphasis on the importance of intervention 
development, it is striking how rarely researchers provide formal descriptions of how this process 
occurred, and there have been calls in literature to increase publication of the intervention 
development process [301,302]. 
 
Careful intervention development may be particularly important in young patients; low treatment 
adherence may be a consequence, at least in part, of failure to recognise their distinct needs [99]. 
Approaches recognised to increase adherence include customising treatments to meet such needs, 
and empowering young people to take control of, and responsibility for, their adherence [296]. 
4.2.1.3 Building on preceding studies 
The two studies described in the preceding chapters have strengthened further the rationale, both 
for the need for an intervention for fatigue in TYAs and for the need for age-appropriate intervention 
development. The systematic literature review established that there have been no previous 
interventional studies in TYA cancer patients using fatigue as a primary outcome, and the survey 
confirmed inadequate current management of the symptom in the UK.  
 
The need for intervention development has been highlighted by the paradoxical survey findings that, 
although participants were most likely to recommend exercise as a fatigue treatment, few 
considered exercise to be helpful; fatigue is itself a barrier to the approach most likely to help it. 
Motivating young people to be physically active is likely to be challenging given that activity tends to 
decline in healthy adolescents [303], activity is particularly low in young people with cancer [304], 
and there is evidence that activity declines significantly during cancer treatment [305]. With fatigue 
further hindering activity, it is clearly vital that young people are involved in intervention 
development, in order to best overcome the many barriers to physical activity.  
 
Beyond the focus on intervention development, several findings from the survey could be usefully 
explored further with qualitative research, as discussed in section 3.6.7.2 (page 93). The survey 
provided preliminary pointers to why fatigue may be so distressing in this young group, including the 
relatively high prevalence of cognitive fatigue after cancer treatment and the negative impact on 
aspects of daily living; qualitative evaluation of experiences could provide further insight into the 
mechanisms of the negative impact of fatigue. Fatigue severity closely correlated with that of other 
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symptoms; qualitative research has potential to determine the direction of causal relationships. The 
survey provided proxy evidence from TYA patients of the impact of fatigue on parents; parents’ 
perspectives could be explored qualitatively while involving them in intervention development. 
4.2.2 Justification for research design  
4.2.2.1 Co-design of complex intervention 
Implementation science is a rapidly developing field that is interested in applying research evidence 
into practice [306]. At the start of its development, a decade ago, the focus was on bridging ‘research 
to practice gaps’ [307]. Increasingly, however, the concept of co-creation is being promoted in order 
to ‘deliver health with integrity of purpose’ [308]. ’Co-creation’ covers two terms that are sometimes 
used interchangeably: ‘co-design’ involves working collaboratively with stakeholders to define 
problems and solutions, whereas ‘co-production’ involves working collaboratively to implement the 
proposed solutions [309]. The stakeholders are the patients who will receive the healthcare; their 
involvement in the co-creation process is vital [306,308].  
 
Experience-based co-design (EBCD) has evolved as a key facet of implementation research [310]. It 
draws on patients’ experiences to innovate and improve the quality of healthcare services, and 
interest in this approach is growing internationally [311]. A review in 2014 revealed over 80 projects 
using, or intending to use, EBCD with increasing evidence of its capacity to improve healthcare 
outcomes [312,313]. Although used initially to improve the quality of services, in recent years a 
number of examples have emerged of EBCD being used in the development of complex interventions 
[314]. 
 
The process of working with users to develop complex interventions is highly variable and still 
evolving. In 2011, Lowes and colleagues co-designed a complex intervention, DEPICTED, for young 
people with diabetes [138]. Young patients, parents and healthcare professionals collaborated to 
develop the intervention during three, day-long, Stakeholder Action Group meetings. All views were 
gathered in a workshop environment, and stakeholders did not receive the intervention themselves. 
 
Ream and colleagues used EBCD to co-design a complex intervention, ‘Take Care’, to enhance the 
role of carers in outpatient chemotherapy [315]. This multiphase study included interviews with 
stakeholders, followed by co-design events that established priorities for intervention components 
and further refined the intervention. The outcome was the development of an intervention 
prototype for testing in a subsequent feasibility trial. Although multiphase in design, the stakeholders 
again did not receive the intervention themselves [316].   
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Building further on this approach, Foster and colleagues co-created a web-based self-management 
intervention to support adult patients living with CRF [302]. Not only did this work apply co-design 
methods to the symptom of fatigue, the innovative multiphase study design incorporated two phases 
of user testing of the intervention, with subsequent further refinement of the prototype. User testing 
involved different participants and a range of methods of qualitative data collection. Having seen the 
utility of this approach in a relevant, albeit older, population of patients with CRF, it was decided to 
use a multiphase iterative approach to co-design, including a phase of user testing and feedback to 
enhance further intervention acceptability. 
4.2.2.2 Qualitative methods  
When developing a complex intervention, the MRC advocates that ‘wherever possible, evidence 
should be combined from a variety of sources that do not share the same weaknesses’ [135]. Having 
already generated quantitative data in the survey, it was decided that predominantly qualitative data 
would be collected in the Fatigue Intervention Co-design Study (FICS).  
 
Qualitative research provides insight into subjective experiences, illuminates causal explanations for 
associations, and is valuable in complex intervention design. There is increasing recognition of the 
role of qualitative research in increasing the depth of understanding of healthcare research, 
particularly in the complexity of real life with the existence of multiple perspectives, different types 
of causal pathways and multiple types of outcomes [306,317-319].  
 
This programme of research is underpinned by Self-Efficacy Theory (section 1.2.4, page 16). The 
survey demonstrated therapeutic scepticism and little confidence that exercise could help the fatigue 
among TYA cancer patients. It is, therefore, important to understand the factors limiting perceived 
self-efficacy, and to establish approaches that improve confidence in the ability to self-manage 
fatigue. Qualitative research methods are best able to generate insight into the complexity of the 
experience of fatigue and into participant perspectives on improving perceived self-efficacy in fatigue 
self-management.  
 
It was decided to conduct both interviews and focus groups, to increase the range of insights. 
Interviews tend to produce a broader range of unique and relevant views, whereas focus groups 
increase elaboration of ideas and debate [320]. A pragmatic view was taken that individual 
interviews would be preferable in the context of discussing potentially personal and sensitive 
information, particularly given adolescent predilection for embarrassment. Equally though, a recent 
study in which participants were randomised between individual interviews and focus groups, found 
that more sensitive themes emerged in the focus groups [320]. Either way, using both methods of 
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data collection was thought to be likely to increase data richness and variety, providing potential for 
triangulation and thus enhancing the validity of the qualitative research process [321]. 
 
The inclusion of parents led to this becoming a multi-perspective qualitative study. Although posing 
potential challenges, in terms of recruitment and data complexity, multi-perspective research leads 
to a deeper understanding of the experiences, perceptions, relationships and needs of all 
participants [322]. It allows the integration of perspectives and optimises recommendations for 
service improvement in a ‘real world’ setting, where young people are embedded in social contexts. 
 
Longitudinal qualitative research has emerged in recent years as a valuable approach [323]. It has the 
capacity to identify trajectories and ‘turning points’, and deepens the interpretative potential of the 
research. Although it gives potential for attrition and further increases data complexity, it was 
decided that a multiphase longitudinal approach would be used, as it would allow the intervention 
prototype to go through a second stage of refinement, enhancing its validity. 
 
Given the potentially large data set from a multiphase, multimethod and multi-perspective study, it 
was decided that the Framework Method would be used for data analysis. Developed by Ritchie and 
Lewis in the 1980s initially for large-scale social policy research, this method has since been 
increasingly used in medical research [324]. The approach is a form of thematic analysis that has, as 
its defining feature, a framework matrix output, with a row for each case and a column for each 
code, and data summarised within each cell. Several features of the Framework Method justify its 
choice [325]. First, it supports the management of large data sets by providing a descriptive overview 
of the entire data set within the generated frameworks. Further, it provides a structure that is well 
suited to semi-structured interviews and focus groups, as these are relatively homogenous in nature, 
and it facilitates inter-case comparison. Finally, the inherent flexibility of the method allows a mixed 
deductive and inductive approach. Although much of the analysis was likely to be deductive, testing 
hypotheses generated from the preceding studies in this programme of research, the freedom to 
induce new concepts and codes iteratively during data analysis was retained.   
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4.3 Aim and objectives 
4.3.1 Aim 
The aim of this study was to co-design a non-pharmacological fatigue intervention with teenagers 
and young adults with cancer, which can subsequently be tested in a controlled trial to evaluate its 
effectiveness in increasing perceived self-efficacy in fatigue self-management. 
4.3.2 Objectives 
1. To investigate the views of TYA cancer patients and their parents on factors that help and worsen 
fatigue and their perception of self-efficacy 
2. To understand the experiences of parents of TYA cancer patients with fatigue 
3. To ascertain the views of TYA cancer patients and parents on optimal intervention design 
4. To evaluate the experience of receiving the prototype intervention, and to amend the 
intervention accordingly. 
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4.4 Methods 
4.4.1 Study population 
Participants were recruited from one centre, the TYA cancer service at Cambridge University Hospital 
NHS Foundation Trust, the regional PTC for TYA cancer patients.  
4.4.1.1 Eligibility criteria 
Patients 
 Aged 16-27 with a diagnosis of cancer 
 Currently or previously known to the Cambridge TYA cancer service  
 Primary cancer treatment completed within one year of recruitment OR on maintenance 
treatment for leukaemia. 
 A screening score of ≥5 in a 10-item NRS of fatigue severity over the last month 
 Able to give informed consent. 
 
Parents 
 A parent of a patient participant, or of a patient who is not participating but would be eligible to 
participate 
 Patient consent to the parent being approached about the study 
 Parent able to give informed consent. 
 
The only exclusion criterion for patients and parents was current active participation in another 
clinical trial. 
4.4.1.2 Sampling and recruitment strategy 
Purposive sampling was used to obtain a maximum variety sample of participants, including age (16-
21/22-27), diagnosis (solid/haematological malignancy) and gender (M/F). Recruitment continued 
until data saturation occurred, with no new themes emerging.   
 
Potential participants were identified and approached by members of their usual clinical team. Study 
information was also made available on the TYA service Facebook page (appendix 7.4.4, page 328). 
Participants could be recruited from any setting including outpatients, inpatient ward, day therapy 
and the Oasis Centre (a non-clinical facility providing support to young cancer patients on the 
hospital site). Recruiting clinicians were aware of the purposive sampling strategy and were 
continually updated on the state of recruitment. Interested patients were contacted by Anna Spathis 
and given information about the study. Patients had at least 24 hours after receiving the Participant 
Information Sheet (PIS), before making a decision about participation (appendix 7.4.1, page 323). 
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All young participants were asked if they consented to one or two of their parents being approached 
to participate. It was made clear that not wishing to give consent to their parents being approached 
did not preclude their own involvement in the study. Parents could be recruited alone with the 
consent of a non-participating young patient, if insufficient parents had been recruited once patient 
recruitment has ceased. The parent PIS and study information for healthcare staff are at appendices 
7.4.2 (page 325) and 7.4.3 (page 327). 
4.4.2 Study schedule 
Phase A: Pre-intervention 
 Individual interviews with patients and with parents. 
 Two focus groups, one for patients and one for parents. 
 
Phase B: Intervention design and delivery 
 Development of prototype intervention, informed by data from phase A. 
 Participants receive the intervention from an allied health professional (AHP). 
 
Phase C: Post-intervention 
 Further individual interviews with patients and with parents, to explore their experience of 
receiving the intervention and to discuss further adaptation. 
 Interview with therapist who provided intervention. 
4.4.3 Methodological considerations 
Interviews were scheduled for the time and place of the participants’ choosing. Patient and parent 
interviews were conducted separately, both in order to respect confidentiality and also to provide 
insight into their potentially differing perspectives. Anna Spathis conducted all interviews, apart from 
eight occasions in phase A, when young participants and parents found it logistically easier to be 
interviewed concurrently; two researchers (Anna Spathis and Amy Chapman) then conducted the 
interviews, in separate rooms. The two focus groups were conducted at the same time, in different 
rooms within one venue, to make it easier for patients and parents to travel together. They were 
undertaken by Anna Spathis and Amy Chapman (parents and patients respectively). Refreshments 
were made available. 
 
The interviews and focus group discussions were semi-structured. They followed a topic guide with 
questions on patient and parent experiences, and participant views about the content, setting and 
delivery of the fatigue intervention (appendices 7.4.8, page 334; 7.4.9, page 336). The topic guide 
was developed predominantly from the research objectives, and also influenced by the literature 
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review and survey findings. The intervention co-design process was necessarily iterative, with 
questions adapted accordingly through the course of the study.  
 
In anticipation of slow recruitment, as is often encountered in research involving vulnerable patient 
populations such as TYA cancer patients [326], several minor amendments were made prior to 
starting the research, to enhance recruitment. Patients with leukaemia on long-term maintenance 
chemotherapy were allowed to be eligible, and the option was provided for the second interview to 
be via telephone to reduce participant burden. 
4.4.4 Data management 
4.4.4.1 Data handling and confidentiality 
Interviews and focus groups were digitally audio-recorded, with the electronic audio files stored on a 
secure, password-protected NHS computer. Audio files were encrypted prior to sending to TypeOut, 
a professional transcription service; a confidentiality agreement was signed. The verbatim transcripts 
were returned in encrypted form, which Anna Spathis checked to decipher inaudible words and to 
fully anonymise the transcript, including respondent quotations. 
 
Each participant was allocated a unique study number and identified by that number throughout the 
course of the study and data analysis. All data transfer was undertaken according to the NHS Code of 
Practice on Confidentiality. Personal contact details were kept by the research team because 
participants’ home addresses were potential research sites. These and all other personal 
information, including the recruitment and screening log, were kept in electronic format on a secure, 
password-protected, NHS computer. The paper consent forms were stored in a locked filing cabinet 
in a secure office on an NHS site. 
4.4.4.2 Data analysis process 
Anonymised transcripts were imported into the qualitative data analysis software, NVivo 11, which 
facilitated management and analysis of the large volume of data.  
 
Patients were assigned numerical codes with the prefix ‘TYA’ (Teenage and Young Adult). Parents 
were given codes with the prefix ‘PAR’ (parent). Healthcare professionals and the research team 
were assigned as ‘HCP’ or as ‘RES’, according to their primary role in the study; the primary role for 
those involved in recruitment and for the AHP delivering the prototype intervention was as ‘HCP’. 
 
Initial transcripts were double-coded to support development of the coding frame. Anna Spathis 
coded four transcripts (two patients, two parents) and generated an initial coding frame. Two of 
these transcripts were independently coded by a non-clinician research assistant, who amended the 
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initial coding frame. Differing views were resolved in a face-to-face meeting. Anna Spathis then 
coded four further transcripts, with the research assistant double coding two. The final coding frame 
was agreed in a second meeting, and subsequently applied by Anna Spathis to all remaining 
transcripts.  
4.4.5 Patient and public involvement 
As a former cancer patient with personal experience of fatigue, the PPI representative within the 
research team, Laura Abbas, provided invaluable support for the study, including providing feedback 
on the design and process, Participant Information Sheets and interview topic guides. A TYA fatigue 
research focus group met in person on one occasion, and undertook further communication, when 
required, by email. 
 
Importantly, as a co-design study, this work was in itself an extensive exercise in patient involvement. 
Recruited participants were both able to guide the content of the interviews and focus groups, as 
well as the design of the prototype and subsequent interventions.   
4.4.6 Ethical considerations 
Beyond participant confidentiality (page 105), a key ethical concern was limiting participant burden. 
Significant effort went into reducing any potential negative impact from taking part including: 
 Participants could choose home-based interviews. 
 Patients could elect to receive the prototype intervention at home. 
 The intervention was safe and highly unlikely to cause distress as it was co-designed with 
participants. 
 Other than patients on leukaemia maintenance treatment, only participants who had completed 
primary cancer treatment were recruited, to avoid having to cope with a recent diagnosis or 
concurrent oncological treatment. 
 Participants who chose to involve a parent could potentially gain support from being involved in 
the research along with a family member. 
 One member of research team was the TYA service TCT Youth Support Co-ordinator (Amy 
Chapman). As her professional role involved support of young service users, she was ideally 
placed to provide additional support to research participants if needed. 
 Participants could choose not to involve a parent if they were concerned about confidentiality, 
burdening their parent or any other reason. 
 Within the prototype intervention, efforts were made to manage unrealistic expectations of 
benefit, given that the primary research purpose was intervention co-design. 
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4.4.7 Research governance 
4.4.7.1 NHS and ethical approvals 
Research ethics committee approval was provided by the London-Chelsea Research Ethics 
Committee (REC reference: 16/LO/0575, appendix 7.4.7, page 331). The study was sponsored by the 
Cambridge University Hospitals NHS Trust, who provided approval following a Site Specific 
Assessment. 
4.4.7.2 Study team and roles 
Anna Spathis was both the Chief Investigator and the Principal Investigator at the NHS site. She was 
involved in every step of the study conduct including: responsibility for study design, writing protocol 
and all study related documents, gaining research approvals, PPI, organising and conducting 
interviews and focus groups, chairing research group meetings, facilitating the co-design process, all 
data analysis and providing feedback of study outcomes to study participants. 
 
Stephen Barclay and Sara Booth, MD supervisors, provided regular guidance and advice throughout 
the study. In addition, a number of colleagues made specific contributions as detailed in table 4.1. 
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Table 4.1 Roles of other team members in FICS  
Laura Abbas  Former TYA cancer patient, former TCT 
Youth Support Co-ordinator, Cambridge 
University Hospitals  
Provided PPI; and co-ordinated PPI 
from other current/former patients 
Sam Barclay Research assistant, Primary Care Unit, 
University of Cambridge 
Initial double coding of transcripts 
Julie Burkin Occupational Therapist, Lead of 
Breathlessness Intervention Service, 
Cambridge University Hospitals 
Contributed to intervention co-
design process; delivered 
prototype intervention to 
participants 
Amy Chapman Current TCT Youth Support Co-ordinator, 
Cambridge University Hospitals 
Recruitment; undertaking eight 
interviews and one focus group; 
participant support; contribution to 
intervention co-design process. 
Faith Gibson  Professor of Children and Young People’s 
Cancer Care, Great Ormond Street Hospital 
Advice on study design  
Helen Hatcher  Consultant Medical Oncologist, TYA service 
lead, Cambridge University Hospitals 
Advice on study design; 
recruitment; contribution to 
intervention co-design process 
Andre Jansen TYA cancer service clinical nurse specialist, 
Cambridge University Hospitals 
Recruitment; contribution to 
intervention co-design process 
Wendy Moss TYA service administrator, Cambridge 
University Hospitals 
Administrative support for 
interviews and focus groups  
Jane Robson Lead nurse TYA cancer service, Cambridge 
University Hospitals 
Recruitment; contribution to 
intervention co-design process 
Paddy Stone  Professor of Palliative Medicine, University 
College London 
Advice on study design 
Ben Uttenthal Consultant Haematologist, Cambridge 
University Hospitals 
Recruitment; contribution to 
intervention co-design process 
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4.5 Results 
4.5.1 Participants 
4.5.1.1 Recruitment 
Thirteen TYA patients and ten parents participated. After seven weeks of recruitment, twelve 
patients and nine parents had agreed to take part and the study closed, as the provisional 
recruitment target had been met and data saturation had been achieved. However, the study was 
opened again to allow recruitment of one further patient-parent dyad, who had heard about the 
study and were particularly keen to be involved. Section 4.5.16.3 (page 197) contains discussion on 
the unanticipated ease of recruitment. One patient declined to take part, but gave consent for a 
parent to be approached [PAR13]. There thus were nine patient-parent dyads, four patients without 
a parent, and one parent alone.  
4.5.1.2 Participant characteristics 
Participant characteristics are summarised in table 4.2. In line with the eligibility criteria, all 
participants were within one year of completion of primary cancer treatment, except for one who 
was within the last month of maintenance treatment for leukaemia at the time of recruitment. Most 
participants were female: 10/13 patients and 9/10 parents. The majority of participants (10/13) had 
a primary haematological malignancy; for two patients the malignancy was likely to have arisen as a 
consequence of immunosuppressive therapy for another medical condition. In order to protect 
confidentiality, individuals’ details are not given and some genders have been changed. 
 
Table 4.2 Overview of participant characteristics 
Patient  characteristics (n=13) 
Age at diagnosis 
Mean (range) 
19.2 (16-23) 
Age at recruitment  
Mean (range) 
21.7 (17-24) 
Screening fatigue score a  
Mean (range) 
7.7 (6-10) 
Female gender  
n (%) 
10 (77) 
Diagnosis  
n (%) 
 
 Lymphoma 6 (46) 
 Leukaemia 4 (31) 
 Osteosarcoma/Ewing’s sarcoma 2 (15) 
 Testicular cancer 1 (8) 
Parent characteristics (n=10) 
Female gender  
n (%) 
9 (90) 
a One data item missing 
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4.5.2 Process measures 
A total of 22 interviews were conducted during phase A: 12 patient interviews, nine parent 
interviews, and one joint patient/parent interview. Although the intention was to interview patients 
and parents individually, one dyad asked for a joint interview. Two focus groups were attended by six 
patients and six parents respectively. 
 
During phase B, the interview co-design meeting was recorded, attended by researchers, healthcare 
professionals and a PPI representative. Prototype intervention guidance for the AHP, an occupational 
therapist, who delivered the intervention, is at appendix 7.4.11 (page 339). Eight patients engaged 
with receiving the intervention. 
 
In phase C, 16 further interviews were conducted, involving nine patients and seven parents. The 
HCP who had delivered the intervention was also interviewed. Three participants could not progress 
to phase C, due to late recruitment after intervention delivery or due to a parent being recruited 
without their child. Four further participants were not involved in phase C, because they could not be 
contacted or were unavailable; the attrition rate was therefore 17% (4/23). 
 
Figure 4.1 Study flow diagram 
 
      
    
 
 
 
 
 
 
   
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
  
Phase A
Patients Parents 
10 interviewed Interview 13 interviewed 
1 withdrawal 
(late recruit) 
1 withdrawal 
(late recruit) 
1 work 
1 DNA 
2 no contact 
Focus group 6 attended 6 attended 
Phase C 
Phase B 
Intervention 8 engaged 
1 busy 
1 avoids groups 
3 work 
1 DNA 
1 busy 
1 avoids groups 
1 withdrawal 
(TYA not 
recruited) 
1 no contact 7 interviewed 9 interviewed 1 work 
2 no contact 
Interview 
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Table 4.3 Overview of study participation  
 Phase A: interview Phase A: focus 
group 
Phase B: 
intervention 
Phase C: interview 
TYA1 
- 
 
- 
 
- 
 
- 
 
- 
TYA2     
PAR2   NA  
TYA3     
PAR3   NA  
TYA4  X X X 
PAR4   NA  
TYA5  X X X 
PAR5  X NA X 
TYA6   X  
PAR6   NA  
TYA7     
PAR7   NA  
TYA8     
PAR8   NA  
TYA9 
- 
 
- 
X 
- 
 
- 
 
- 
TYA10 
- 
 
- 
X 
- 
 
- 
 
- 
TYA11 
- 
 
- 
X 
- 
X 
- 
X 
- 
TYA12  X   
PAR12  X NA  
- 
PAR13 
- 
 
- 
X 
- 
NA 
- 
NA 
TYA14  NA a  NA  NA  
PAR14  NA a NA NA 
a Recruitment occurred after the focus groups had occurred 
 
First interviews with participants were all face-to-face and occurred in the non-clinical facility for TYA 
cancer patients on the hospital site (n=12), on a hospital ward (n=8) and at home (n=3). All second 
interviews were conducted by telephone. The interview with the AHP and the research team meeting 
both occurred in a non-clinical area on the hospital site.  
 
The mean study duration, defined as the time between first (phase A) and second (phase C) 
interviews was 24.6 weeks (range 21-34, n=16). Participants waited a mean of 10 weeks (6-14, n=8) 
from first interview (phase A) to the start of the intervention prototype (phase B) and the mean 
intervention duration (from first to last therapist contact) was 6 weeks (range 0-14, n=8). 
 
The 42 audio files had a total running time of 22 hours and 43 minutes. The mean time of the phase 
A and phase C interviews were 37 minutes and 16 minutes respectively. The mean focus group 
duration was 83 minutes. The AHP interview was 70 minutes and recording of the co-design meeting 
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63 minutes. As well as transcribed audio files with a total word count of 241,000 words, there were a 
number of other sources of data (table 4.4). Contemporaneous field notes were written. 
 
Table 4.4 Summary of data sources 
Source Description Codes 
Phase A 
Pre-intervention interviews 22 audiofiles involving 23 participants,  TYA#, phase A 
PAR#, phase A 
Participant emails 2 unsolicited emails giving further information, 
one TYA, one PAR. 
TYA#, email, phase A 
PAR#, email, phase A 
Focus groups 2 audiofiles, one of TYA and one of PAR focus 
groups 
TYA#, FG, phase A 
PAR#, FG, phase A 
Phase B 
Co-design meeting 1 audiofile of meeting involving 2 researchers, 
5HCPs and 1 PPI representative 
RES, CDM, phase B 
HCP, CDM, phase B 
PPI, CDM, phase B 
Audit of intervention  
 
Audit of notes and patient letters from therapist AUDIT 
Phase C 
Post-intervention interviews 16 audiofiles involving 16 participants TYA#, phase C 
PAR#, phase C 
Therapist interview 1 audiofile from interview with the AHP who 
delivered the intervention 
HCP, phase C 
 
4.5.3 Framework development  
4.5.3.1 Coding process  
The initial coding frame after reading four transcripts (2 TYAs, 2 parents) contained 27 codes in 5 
categories. After an iterative double coding process, which included two face-to-face discussions 
(section 4.4.4.2, page 105) the agreed coding frame expanded to 44 codes in 5 categories. 
 
This coding frame was applied to the remaining data. Subsequently, two pairs of categories were 
merged. ‘TYA experience of fatigue’ and ‘family experience of fatigue’ were combined as the 
experiences were closely related with many shared themes; ‘intervention principles’ and 
‘intervention content’ were merged as the ‘intervention principles’ category was too small. The final 
coding structure contained 41 nodes in three broad categories (see appendix 7.4.10, page 338). 
4.5.3.2 Framework matrices 
A framework matrix was developed for each of the three main categories: 1) experience of fatigue, 2) 
intervention principles and 3) intervention practicalities. The three frameworks each contained four 
sub-categories, as in table 4.5. Within each framework, the coded data were charted for each 
participant, the matrix cells containing case summaries as well as illustrative quotations. One of the 
three frameworks is provided in appendix 7.4.13 (page 340). 
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Table 4.5 Overview of three framework matrices 
Framework  name                
(number of nodes 
incorporated) 
1: Experience of 
fatigue                        
(20) 
2: Intervention 
principles                    
(11) 
3: Intervention 
practicalities                 
(10) 
Framework sub-
categories 
1a. Fatigue patterns 
and influences 
2a. Approach 3a. What? 
1b. Impact of fatigue 2b. Activity 3b. When? 
1c. Information needs 2c. Energy conservation 3c. Where? 
1d. Tensions and 
misunderstandings 
2d. Education 3d. Who? 
 
4.5.4 Relationship between research questions, frameworks and analytical themes 
The frameworks, based on individual participants’ views, were necessarily descriptive rather than 
interpretative. As individuals were responding to questions from a topic guide derived from the 
original research questions, at this predominantly deductive stage in the analysis process, there 
remained a close relationship between the matrix categories and the research questions (table 4.5). 
 
However, given the unrestricted coding, unexpected and interesting themes emerged beyond those 
predicted at the start. Descriptive data within the frameworks exceeded those anticipated from the 
research questions in a number of areas. This significantly influenced analytical theme development, 
with only one of the six analytical themes concerned directly with the features of the ‘trial ready’ 
fatigue intervention (theme A2). An overview of the analytical themes is provided in section 4.5.5 
(page 115), with extensive exploration in the subsequent sections. The longitudinal connection, from 
primary research questions, through to framework categories and beyond to the analytical themes, is 
summarised below and in table 4.6. 
 
Research question 1: To investigate the views of TYA cancer patients and their parents on factors 
that help and worsen fatigue and their perception of self-efficacy 
In response to open questions about their fatigue experience, participants volunteered much 
information relevant to the research question, particularly their perspectives on directional 
relationships: the causes and consequences of fatigue. The perceived impact was greatest on the key 
developmental needs of adolescence and young adulthood which, in turn influenced the experience 
of fatigue. These concepts contributed to three of the six analytical themes developed from the data, 
A1, C1 and C2. 
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Research question 2: To understand the experiences of parents of TYA cancer patients with fatigue 
For many parents, a central part of their experience was the tension occurring between them and 
the young patient. However, dealing with uncertainty, misunderstandings and conflict emerged as a 
broad theme across participants’ social experience, involving the young patient, siblings, healthcare 
professionals and staff at work or educational organisations, as well as parents. Exploration of these 
multilevel tensions led to the development of two more of the analytical themes, B1 and B2. 
 
Research question 3: To ascertain the views of TYA cancer patients and parents on optimal 
intervention design 
Participants were unrestricted and open in their views about the design of an intervention that met 
their needs, providing opinions that went far beyond the relatively restricted research question. They 
particularly expounded on age-relevant matters, such as the need to combine autonomy and 
individuality with specific advice. Analytical theme A2 developed from the expansion of this research 
question. 
 
Research question 4: To evaluate the experience of receiving the prototype intervention, and to 
amend the intervention accordingly. 
While receiving feedback on the prototype intervention enhanced intervention development, it also 
provided, beyond the research question, a rich opportunity to examine longitudinal participant data. 
Interesting patterns emerged between fatigue and symptom responses, and between participant 
characteristics and fatigue outcomes. These unexpected insights underpinned analytical themes C1 
and C2. 
 
Table 4.6 Research questions, framework categories and analytical themes 
Research question Related framework 
sub-categories 
Related analytical 
themes (table 4.7) 
1. To investigate the views of TYA cancer patients and their 
parents on factors that help and worsen fatigue and 
their perception of self-efficacy. 
1a, 1b, 1c A1 
C1, C2 
2. To understand the experiences of parents of TYA cancer 
patients with fatigue. 
1b, 1c, 1d B1, B2 
3. To ascertain the views of TYA cancer patients and 
parents on optimal intervention design. 
2a, 2b, 2c, 2d 
3a, 3b, 3c, 3d 
A2 
4. To evaluate the experience of receiving the prototype 
intervention and to amend the intervention accordingly. 
2a, 2b, 2c, 2d 
3a, 3b, 3c, 3d 
C1, C2 
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4.5.5 Overview of analytical themes 
The three framework matrices, containing summaries of participants’ views on a case by case basis, 
facilitated evaluation of the data beyond a descriptive level. Patterns in the data were sought, finding 
associations between attitudes and behaviours, seeking explanations and formulating new ideas. 
This process, involving both deductive and inductive reasoning, led to the development of the six 
analytical themes, within three broad categories.  
 
Table 4.7 Overview of analytical themes 
A. Young age 1. TYA developmental stage compounds the impact of fatigue 
2. TYA developmental characteristics influence intervention design 
B. Tensions  1. TYAs experience pervasive tensions and misunderstandings 
2. Fatigue-related tensions have a detrimental impact on family 
C. Responses 1. Fatigue may perpetuate with vicious cycles 
2. Responses to fatigue relate to outcomes 
 
Each of these themes is described in detail in the following sections. Evidence is provided in the form 
of quotes from participants, and each section ends with a theme discussion, contextualising and 
evaluating each theme. The themes are integrated, along with other study outcomes, in a final 
discussion in section 4.6 (page 199). 
4.5.6 Theme A1: TYA developmental stage compounds the impact of fatigue 
Participants were universally vocal about the negative impact of fatigue on their lives. There was 
consistent evidence that the fatigue was particularly problematic because of its interaction and 
conflict with the characteristic expectations and needs of this young age. To set the scene, an 
overview of the links between features of the TYA age and the impact of fatigue is provided in table 
4.8. There follows a detailed description of each of the adverse consequences of fatigue. 
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Table 4.8 Summary of relationship between TYA developmental characteristics and the impact of 
fatigue 
 
Developmental 
characteristics of TYA age 
Adverse impact of fatigue 
Cognitive ease with good 
memory  
Hindering cognition: 
The cognitive impact of fatigue on memory and concentration is worse 
than the physical consequences of fatigue. It makes it hard to progress 
in education or work, and hinders socialisation. 
Emotional reactivity Exacerbating emotional reactivity: 
The frustration of living with fatigue compounds the challenges of 
emotional regulation, with anger, irritability and low mood all 
considered features of living with fatigue. 
Need to conform and 
develop peer relationships 
Hampering the need to conform: 
It is hard to feel ‘normal’ when unable to keep up with peers socially. 
Social media paradoxically may increase the since of isolation as it 
highlights what others are still able to do. 
Developing independence 
and life direction 
Dependence and demotivation: 
Young people are susceptible to regression when under strain. Fatigue 
compounds this, with increasing dependence on family support, and 
loss of autonomy, self-motivation and self-determination. 
 
4.5.6.1 Hindering cognition 
TYAs and parents universally described the impact of fatigue on the ability to think clearly. 
  
 ...because my brain isn’t functioning how I would probably say most of my friends’ brains are 
functioning. [TYA3, phaseA] 
 
 ...for instance he can't get his words out, this is a student who’s done a degree, is very, very 
clever and he can't get his words out. [PAR2, phase A] 
 
Fatigue had a consistently detrimental impact on concentration. This was so severe that participants 
described not having the concentration to read, or even watch television [supplementary data page 
348]. 
 
 I can’t concentrate enough on anything, and I can’t read, because by the time I have 
registered one word, and moved onto the next, I can’t string them together, like I don’t have 
the concentration to read more than one word at a time. [TYA9, phase A] 
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Many participants felt that cognitive fatigue adversely affected memory, as well as the ability to 
concentrate [supplementary data, page 348]. 
 
 I have to write lists all the time. [TYA2, FG, phase A]  
 Then I lose my list and forget where I put them... [TYA8, FG, phase A] 
 
There was pervasive distress about the impact of poor cognition on the ability to perform in 
education and work, expressed with comparable vehemence by parents. Poor memory and 
concentration often had a social corollary [supplementary data, page 350] 
 
 And the school expects you to work until 10:00 [pm], which is probably about four hours in 
their eyes. And I am too tired to do that, I can’t do that. [TYA9, phase A] 
 
 Look, [TYA4] is really good, she is really on the ball. When she went back to work, and she 
had to go and learn this new job, she struggled massively to the point where she was coming 
home and crying about it at night... The stress of that learning, she just couldn’t cope with it, 
and we had to slow it all. [PAR4, phase A] 
  
 Yeah, I find concentration quite hard especially on conversations. I zone out with my mum so 
much. And with my friends it's really bad, I just have to keep nodding and trying to like think 
of the end word they've said so I can say something about that. [TYA2, phase A] 
 
The cognitive effect of fatigue was unexpected for some participants, fatigue being thought of as a 
physical tiredness. In a dominant theme, virtually every participant perceived cognitive fatigue to 
have a more detrimental impact than physical fatigue [supplementary data, page 348].  
 
 But it is something that I am quite shocked in myself, because I just assumed that it would be 
my body, because I am not used to standing up so much, and being on my feet all day at 
work, but it is really not. My body could get up and do another day, but mentally I just can’t 
seem to get going that quickly. [TYA10, phase A] 
 
 Well, for me the physical isn’t too bad because I've found ways of controlling it and 
improving it. But the mental stuff I found tricky. [TYA8, FG, phase A] 
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 In contrast, only one TYA, the single participant with a diagnosis of CFS/ME as well as CRF, considered 
the physical aspects of the symptom to be more problematic than the cognitive component, with the 
latter remaining a significant problem.  
     
 And is it the thinking bit or the physical bit, you know, the tiredness of your body that gets you 
the most? [Interviewer]  
 Probably the physical gets me the most, but shortly followed by the... [TYA14, phase A] 
4.5.6.2 Exacerbating emotional reactivity 
The influence of fatigue on emotions was a recurrent theme, expressed by virtually every participant. 
A sense of emotional reactivity was often articulated. 
 
I get really overly emotional as well, so I go one way or the other. I am either quite angry, or 
stressed out about something, and I lash out at them, or I find myself in tears, and it is purely 
because I am so tired, yes. [TYA10, phase A] 
 
Many young patients described the predominant emotion as ‘anger’. Anger was invariably described 
in relation to interactions with family members, rather than friends. The inevitable tensions arising 
from this are considered in more detail in section 4.5.9 (page 147). In contrast, parents tended to 
report that their son or daughter was ‘frustrated’, rather than ‘angry’. Frustrations were invariably 
expressed in relation to the impact of fatigue and, of note, the cognitive impact of fatigue tended to 
be implicated as the source of frustration more than the physical impact [supplementary data page 
349]. 
 
 Mum, she always says I am a bit aggy (sic), so I am getting a bit angry all the time she 
reckons. She reckons my temper has gone a little bit more, so I can snap a bit more. [TYA12, 
phase A]  
 
She gets frustrated a lot more with the mental side of things than she does with the physical 
side of things. [PAR6, FG, phase A] 
  
As well as causing anger and frustration, the affective impact of fatigue was a strong theme, 
expressed particularly by parents. Low or fluctuating mood tended to be described, although one 
parent [PAR6] reported that fatigue provoked anxiety, due to unmet information needs in relation to 
fatigue, a topic that will be discussed further in section 4.5.7.2 (page 133) [supplementary data, page 
349]. 
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And it is quite hard, because I think it is like a mental thing as well, because it brings you 
down as well, because your body doesn’t really feel up to a lot of things. [TYA7, phase A] 
 
I mean I do attribute some of [TYA6]’s anxiety to not knowing that her body just wouldn’t 
recover that quickly, and that she would get these bouts of fatigue. So I do feel that that kind 
of didn’t help with her anxiety. [PAR6, phase A] 
4.5.6.3 Hampering the need to conform 
  A pervasive ramification of fatigue was the impact on the ability of young people to ‘keep up’ with 
their peers, and feel ‘normal’. Interestingly, this emerged as an unsolicited and lively topic of 
conversation independently within both TYA and parent focus groups. TYAs did not tend to discuss 
this topic in their individual interviews, although the matter was raised by a few parents during their 
interviews. 
 
The young participants were clear about wanting to ‘fit in’ and not appear different to their peers. 
Parents were also cognisant of their son or daughter struggling with perceptions of not conforming. 
Interestingly, several parents, but not TYAs, expressed this in terms of the inadvertently unhelpful 
consequences of social networking. Much of the data in this theme emerged in the focus groups, 
rather than individual interviews [supplementary data, page 349]. 
 
... you don't want people to look at you any differently to what they did before. [TYA3, FG, 
phase A] 
 
 Does [social networking] make things worse? [Interviewer]  
 It can do... it’s a double edged sword... [PAR3, FG, phase A]  
 ... they can communicate through it but then, on the other hand, you are seeing what 
everyone’s doing and you're not doing. [PAR8, FG, phase A] 
4.5.6.4 Dependence and demotivation  
Regression to a dependent state, as a consequence of fatigue, was another theme that emerged, 
with parents talking in terms of regression to a less autonomous and more child-like state 
[supplementary data, page 350]. 
 
 I think it has impacted them in as much as they take me places instead of me going on my 
own. [TYA1, phase A] 
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 I would say the other thing that I’ve noticed is he’s just regressed, so sometimes I feel I’m 
dealing with a toddler, sometimes with a 10-year-old. The best we ever get to is an 
adolescent really. [PAR2, phase A] 
 
 Many participants, both TYAs and parents, described fatigue as a state of demotivation. Interest and 
impetus declined, with resulting loss of independence and self-direction [supplementary data, page 
350]. 
  
 Like first of all the first step in a way is kind of accepting it [fatigue] is a demotivated state 
[TYA1, phase A] 
 
  ...because I have got no motivation there, which I would say is another thing that is kind of 
affecting [being able to do things] as well. [TYA3, phase A]  
 Because of the fatigue? [Interviewer]   
 Yes. I have got nothing pushing me to go... [TYA3, phase A] 
4.5.6.5 Theme A1 discussion 
Participants were universally vocal in their descriptions of the negative impact of fatigue on their 
lives. The volume of data relating to the adverse consequences of fatigue was disproportionately 
large, given the focus of this study on intervention co-design. A single question in the topic guide, 
asking about the most distressing aspect of the fatigue experience, led to a flow of largely unsolicited 
information. 
 
The adverse cognitive and emotional consequences of fatigue emerged as dominant themes. The 
perception of impaired concentration and memory was highly detrimental to social functioning and 
to the ability to progress in education and work. Emotional lability was expressed mostly in terms of 
‘anger’ by TYAs and ‘frustration’ by parents, with low mood also featuring strongly. Fatigue, 
furthermore, hindered the stereotypical adolescent need of wanting to appear to conform, while at 
the same time hampering the apparently opposing desire to develop autonomy, independence and 
self-direction. 
 
Contextualising within existing literature 
Irrespective of age, it has long been recognised that the experience of CRF includes both cognitive 
and emotional dimensions, as well as physical tiredness [1,129]. However, much of the existing 
literature tends to suggest that physical fatigue is the predominant experience. 
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Young pre-adolescent children invariably describe fatigue more in terms of its physical impact and 
the effect on sleep, than on the cognitive or emotional impact [178,179]. In older adults, most 
literature also suggests that physical fatigue predominates. In a systematic review comparing 
physical and cognitive fatigue in adult cancer patients, de Raaf and colleagues reported that physical 
fatigue was more prominent than cognitive fatigue [327]. This was particularly the case in those with 
advanced cancer and in those receiving cancer treatment; in survivors there was no clear signal for 
either physical or cognitive fatigue predominating.  
 
Comparison of physical with emotional fatigue is hindered by the fact that most multidimensional 
fatigue measures do not specifically quantify an affective subscale. The exceptions are the Piper 
Fatigue Scale (PFS) and the Multidimensional Fatigue Symptom Inventory (MFSI). The former does 
not include a physical subscale, precluding comparison [328]. The latter is not widely used; the two 
controlled studies using this scale, both involving older adults with cancer after the end of treatment, 
suggested that emotional fatigue was a little worse than physical fatigue; however, there was no 
assessment of whether the small differences reached statistical significance [329,330]. In the TYA 
context, no studies have determined an emotional subscore.  
 
As discussed in section 3.6.1.2 (page 80), only five studies evaluating TYA CRF have reported 
cognitive subscores, all having used the MFS measure. The four involving patients completely, or 
mostly, during cancer treatment revealed worse physical than cognitive fatigue subscores, whereas, 
Keats and colleagues, in a small uncontrolled trial, demonstrated comparable levels of cognitive and 
physical fatigue [218]. Across the wide range of qualitative studies in TYAs conducted in the past, 
none have suggested that cognitive fatigue is particularly problematic in comparison to physical 
fatigue in these young patients [125,131,175-177,179,185,197,220]. 
 
Overall, therefore, although cognitive and emotional fatigue experiences are an undoubted part of 
the fatigue experience in cancer patients of all ages, evidence suggests that physical fatigue tends to 
predominate. After cancer treatment, cognitive and emotional fatigue feature more prominently, but 
there has been no evidence to suggest that they have more of an impact than physical fatigue. 
Therefore, the finding from this study, that the cognitive and emotional aspects of fatigue have a 
worse impact, is important and original. 
 
In terms of the other components of this theme – fatigue hindering the ability to conform, 
development of dependence, loss of life direction and the possible negative impact of social 
networking – these insights, which relate to the characteristic needs of adolescents, are 
unsurprisingly not present in the adult CRF literature. Equivalent consequences of fatigue in older 
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adults relate to the ability to work, take care of family and maintain relationships with family and 
friends [23].  
 
In qualitative studies focused on the TYA experience, a few of the findings in this study have already 
been described. Chiang and colleagues, in a study of Taiwanese children during and after cancer 
treatment, describe ‘lack of motivation’, ‘altered life plans’, feeling ‘distant from peers’ and ‘parental 
over-protectiveness’ [179]. Adolescents attempting to return to school after cancer treatment, 
sometimes no longer ‘fitted in’, and were falling behind with their school work [185]. However, 
unlike in this work, no previous studies in a TYA cancer context have documented hindered 
conforming, development of regression, or negative aspects of social networking. It is noteworthy 
that this past qualitative research used either semi-structured interviews [131,179,185,197] or 
written data from diaries [125]. None involved focus groups or assessed the experience of parents. In 
the present study, the data in relation to conforming largely arose from the focus groups rather semi-
structured interviews, and the insights into regression, dependence and social networking came 
mostly from parents. It is conceivable, therefore, that the methods of data collection used in this 
qualitative study have facilitated emergence of these novel findings. 
 
The insights into the ‘double-edged sword’ of social networking were unanticipated; fatigued TYAs 
become more aware of their perceived inability to conform and ‘keep up’ with their peers. The topic 
arose in the parents’ focus group discussion only. Given that a theme from the TYA participants was 
the need to conform, it is perhaps unsurprising that – in the context of the pervasiveness of social 
media – this matter was not raised by the TYAs themselves. Although this topic has not previously 
arisen in literature relating to TYA CRF, a body of evidence has been emerging in recent years on the 
detrimental and paradoxical impact of social media on psychosocial wellbeing in the young 
generation of ‘digital natives’. Social media use has been correlated with anxiety, depression, body 
image concerns, poor sleep and perceived social isolation [331,332]. Although this evidence may be 
biased by unidentified confounders and parents, in turn, may have been influenced by the prevalent 
reporting of this research in the media, it remains possible that this study finding may represent 
another mechanism by which the impact of fatigue is compounded at a young age. 
 
Integrating with Fatigue in Focus survey 
Given the limited congruence between the findings in this qualitative study and existing literature, it 
is noteworthy that the findings are consistent with those from the preceding survey.  
 
Unlike the evidence from the systematic review, the survey revealed comparable mean MFS general 
(physical) fatigue, sleep/rest fatigue and cognitive fatigue subscores. Cognitive fatigue was therefore 
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an important feature of the fatigue experience of those participating in the survey, although its 
severity was not quantitatively worse. This qualitative study, FICS, therefore builds on the survey 
findings by suggesting that, even when of comparable severity, as defined by the MFS, the impact of 
cognitive fatigue on daily life is considerably worse. 
 
Again, there was some consistency between the survey and FICS in terms of the impact on age-
related developmental needs. In the survey, over a third of participants reported a negative impact 
on each of the following: the ability to be independent, to have relationships with friends and to 
socialise. These problems were also highlighted in the limited survey qualitative data.  
 
Summary 
The main novel outcome from this theme is that cognitive fatigue is perceived as more problematic 
than physical fatigue. This appears to be largely due to the impact of impaired concentration and 
memory on the ability to function socially, and within education or work. In turn, these social 
consequences hinder the ability to conform and result in dependence and loss of autonomy. In short, 
the consequences of cognitive fatigue directly hamper the core developmental needs of adolescence 
and young adulthood. Furthermore, the affective corollary of fatigue magnifies the normal emotional 
reactivity of this young age, compounding the symptom’s negative impact. It is unsurprising, 
therefore, that fatigue was found to be the single most distressing symptom experienced by young 
cancer patients in the systematic review. 
4.5.7 Theme A2: TYA developmental characteristics influence intervention design  
The characteristics of this young age not only influence the experience of fatigue, as described in the 
preceding section but also determine, to a considerable extent, the design of the intervention. 
Participants were remarkably consistent in their opinions on a number of aspects of optimal 
intervention and their needs related closely to the characteristic features of this neurodevelopmental 
stage.  
 
An overview of the relationship between age-related features and intervention design is provided in 
table 4.9. There follows a summary of evidence from participants that both underpinned the 
development of this theme and led to the generation of the prototype intervention. Data relating to 
this theme is presented in three subsections, relating to approach, content and practicalities. The full 
prototype intervention is described in section 4.5.15.1 (page 182). 
 
  
 124 
Table 4.9 Summary of TYA developmental characteristics and influence on intervention design 
 
Characteristic features of TYA age Influence on intervention design [relevant subsections] 
Development of identity and self-
direction 
 The intervention needs to be individualised and flexible, aiming 
to enhance self-motivation and confidence to reach personal 
goals [approach, content, practicalities]. 
 The focus should be on recovery and positivity rather than on 
fatigue or illness [approach, practicalities]. 
 Support is needed explaining fatigue to prospective employers 
and education staff [content]. 
Executive function maturing 
slowly into early adulthood 
 Plans need to be specific and clear [content]. 
 The intervention needs to be age-appropriate, including 
allowing impulsivity, and acceptance of relatively limited 
attentional control [content]. 
Increased reward and sensation-
seeking behaviours 
 Wish for regular, achievable, short-term goals [content]. 
 Information Technology facilitates regular feedback, 
particularly using Apps on a personal mobile device [content]. 
Physical strength and reserve  Physical reserve contributes to periods of over-exertion; 
approaches such as mindfulness are more acceptable than 
energy conservation [content]. 
 Unmet information needs centre on ‘how much to push self’ 
[content]. 
 
4.5.7.1 Age-related influences on intervention approach 
A strong and consistent theme, in relation to the approach of the intervention, was the importance 
of developing confidence in being able to achieve personal goals. Although the word ‘self-efficacy’ 
was not used by any participants, this was the concept being described. Importantly, much of this 
information was unsolicited, as there was no direct question about this concept in the topic guides 
(appendices 7.4.8, page 334; 7.4.9, page 336). Self-motivation, ‘taking control’ and ‘taking charge’ 
were closely related constructs that were also described [supplementary data, page 351]. 
 
If someone is more inclined towards a take charge, one can create one’s own reality sort of 
perspective, then they are more likely to believe that their actions will affect their life. [TYA1, 
phase A] 
 
 I guess it does come down to your role is to give a patient confidence in themselves and their 
own understanding of their fatigue and what they can do and what they can’t do. And your 
role is to give patients confidence that they will recover but that they must find their own 
path to recovery. [PAR14, phase A] 
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After receiving the prototype intervention, TYA3 spoke emphatically about the value of the 
intervention being a catalyst for self-motivation to achieve a meaningful personal goal. 
 
I also spoke to her about things that I’m wanting to change... I think since speaking to [HCP] 
and getting myself in this like mind-set that I’m going to make myself better before Christmas 
has worked, because now I’ve found I’ve got a lot more energy than what I did... [TYA3, 
phase C] 
That’s amazing, what helped you get through that hurdle, that first bit where it all feels 
rubbish? [Interviewer] 
Just keep telling myself that if I want to be who I want, like if I want to be able to have all the 
energy and enjoy my Christmas and enjoy my family and all that, I need to start being strict 
on myself. [TYA3, phase C] 
 
TYA3 provided the following advice in her post-intervention interview, reinforcing the importance of 
the motivation and goal needing to come from an individual, rather than the person delivering the 
intervention. 
 
…basically you can do that on your own because that’s what I’ve been doing. I just think you 
need the motivation behind it, so kind of set a goal with them. So if you say to someone like 
me, so where do you want to be in three months time..? And then they’ll set themselves 
their own goal without even thinking about it. [TYA3, phase C] 
 
The value of a health coaching approach (section 4.5.7.4, page 142) for TYAs was explicitly endorsed 
by the HCP delivering the prototype intervention, emphasising the importance of facilitating self-
motivation to change behaviour, rather than the HCP requesting change [supplementary data, page 
351]. 
 
They did, I feel, you know, did, or could respond quite well to a coaching approach because 
that is very individual. And it is saying what do you want to focus on today? [HCP, phase C] 
 
All participants, TYAs and parents, without exception, were clear that the intervention needed to be 
individualised, to allow young patients to determine their own goals and direction. Young people did 
not want an authoritarian or prescriptive approach, having to passively adhere to others’ goals for 
them [supplementary data, page 351]. 
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I was happy doing things I came up with. When other people told me to do stuff, it just felt 
like another overwhelming thing to do. [TYA1, phase A] 
 
Because the one thing I was worried about this is that you were going to be like ‘Oh you have 
got to have eight hours sleep a night, and do five hours of exercises a day.’ I obviously am 
probably not like that, but I don’t have time, because I would sleep more if I could. And I 
would exercise probably maybe if... [TYA9, phase A] 
 
The importance of positivity, with a corresponding focus on recovery, rather than illness or fatigue, 
was another consistent theme from both young participants and their parents. Whereas parents 
talked directly about a positive approach, young participants tend to express this idea in terms of 
their identity, a sense of wanting to look forward, rather than to be defined by illness and associated 
negative connotations [supplementary data, page 352]. 
 
...so if someone says to you, ‘Oh where are you going?’ you don't want to say, ‘look, oh, a 
fatigue place,’ because then you're instantly like, they’re judging you all in their heads.  
[TYA3, FG, phase A] 
 
[TYA8] didn’t want to be defined by his fatigue or his cancer. [HCP, phase C] 
 
So you want to grab every bit of positivity you can... And if you take a positive approach you 
will get a better outcome, whatever that might be... I think if you focus on being tired, you 
will get tired. If you focus on being energised and awake and achieving something, then you 
are more likely to achieve that. [PAR4, phase A] 
4.5.7.2 Age-related influences on intervention content 
The content of the intervention was strongly influenced by features of this young age. The three 
broad areas of content related to activity promotion, to conservation of energy and to information 
needs.  
 
Activity 
Young participants tended to speak in terms of more concrete, rather than abstract, ideas. Many 
participants expressed dislike for anything vague. 
 
I don’t have any in the middle, I am black and white. [TYA3, phase A] 
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It wasn’t like any... there was no like strategies. [TYA2, FG, phase A] 
They’re very vague on what they want to tell you… [TYA7, FG, phase A] 
 
 Amongst those participants who were keen to be active, there was a very strong desire, with only 
one outlier, for activity to be supported with a specific, structured, individualised plan 
[supplementary data, page 352]. 
 
I would much prefer [an HCP] to say, you can do ten minutes a day of this, this and this, and 
then once you have done that for a week, you can do fifteen minutes a day of this, you 
know? ...and just very clear, especially with the exercises, very clear on how it should be 
done, and the way it should be done, and how long for, because I think that is very key. And 
if you don’t know how long to do it for, and how to progress, it kind of limits the exercise as 
well. [TYA8, phase A] 
 
The single outlier preferred not to be given instructions, and wanted to have freedom to make his 
own decisions spontaneously. 
 
Well, I am not good at deciding on a formal exercise regime and then doing it. I prefer just 
waking up and deciding I am going to do some exercise now. My favourite time is the 
evening. [TYA1, phase A] 
 
Parents too were in favour of specific planning, rather than vague encouragement to exercise. 
Planning was perceived as a way of helping young people build up activity incrementally.  
 
I think an exercise plan would be good. Because I know he just one day said, ‘Oh I am going 
for a run.’ And I also thought he was going to die, he was so out of breath, and was going to 
pass out. But of course he had gone from nothing, to go for a run. [PAR12, phase A] 
 
One parent alluded to the closely scheduled time during cancer treatment, and suggested a potential 
relationship with being prepared to follow an exercise plan.  
 
Yes. I think definitely a programme would work well for [TYA6], because she is quite good at 
following... and obviously with the history of her illness, she has had to follow some strict 
guidelines over the last five or six years. So I think that is the way she works at the moment. 
So, yes, I think perhaps that might be the best thing. Because then again that will give her 
something, so she is able to plan. [PAR6, phase A] 
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One of the many participants who expressed a strong wish for clear planning in phase A (quote 1 
below), indicated his disappointment in phase C that the prototype intervention had not been more 
clear (quote 2). Furthermore, concurrently but outside this study, he proactively sought support from 
a personal trainer at a gym, and was explicit in his praise for the more detailed individualised 
planning (quote 3). 
 
1. It would be quite nice to just have like a schedule or a timetable or something. So 
something like practical that you can do rather than them saying why don't you try out this.  
Like they could give you a week by week something... like this week you’ve got to try out this 
and then you can like feed back and see if it works or not... [TYA2, phase A] 
 
2. The main thing was it wasn’t specific, and it just felt like we were having a chat, but there 
was no plan in place. It is just like what you are told again and again by everyone. They are 
like, ‘Oh yes fatigue is bad, so you have to rest, eat well, exercise, take time out,’ and all of 
that kind of thing. But there is no plan, and it doesn’t really work around your life. [TYA2, 
phase C]   
 
3. So they are doing like a twelve [week] exercise programme which actually has been really 
helpful, because the [personal trainer] has basically created a plan for me week by week to 
get me to be able to run/walk the marathon by [month]... [TYA2, phase C] 
 
After having met the young participants in phase B of the study, including [TYA2], the AHP delivering 
the intervention was also convinced by the need for specific planning, and perceived that this was 
different to her experience with older adults in her usual clinical practice. 
 
I think they want more specific advice so it’s, and I guess that's true of adults as well, but 
they particularly wanted more. So it might be more specific advice around exercise for 
example and the absolute specifics of it like how much do I need to do. And it’s more than 
the usual increase by 10% that we would suggest. So it feels like more of a prescription, if 
you like, that they want. [HCP, phase C] 
That's interesting, so more specific than other adults in some ways? [Interviewer] 
I would say so, yes. [HCP, phase C] 
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As well as wanting clear and specific planning, there was a consistent requirement for activity goals. 
Goals needed to be repeated and short term, rather than vague or long term [supplementary data, 
page 353]. 
 
That is the key to exercise I think. Because if you haven’t got something to aim for, it is kind 
of just... especially when you say I can’t be bothered. If you say I can’t be bothered but you 
have got a target, then you might be like alright I have got something to aim for, I will feel 
better afterwards, rather than I can’t be bothered. [TYA8, phase A] 
So do you think how we motivate everybody when we are doing this, is that quite an 
important thing? [Interviewer] 
Yes. But I think setting smaller goals is better than longer goals. Because if I set a goal that is 
really easy to achieve, or I have to push myself a little bit, but I can achieve it, and then you 
set another one, it feels better. You get that buzz more often, rather than having to set a 
long term one that takes a year to reach. It is kind of, you can lose motivation easier. [TYA8, 
phase A] 
 
As suggested in this preceding quote, at least part of the value of the repeated, short-term goals was 
the sense of achievement or ‘reward’. 
  
Yeah, but I think setting the goals of where you want to be next time you meet is a good 
idea. Hitting that goal would be good. [TYA6, phase A] 
It would be like a reward scheme. [TYA2, phase A] 
 
Another value from goals was the effect of demonstrating progress. Fatigue changes slowly over time 
and regular, short-term goals were considered to help make progress perceptible [supplementary 
data, page 353]. 
 
I need to sit down with someone and maybe get a plan or a day-to-day like exercises or a sort 
of achievement tracker. Just something that just shows you that you are making progress... 
You might wake up really tired thinking, ‘Oh I’m really tired again,’ and slowly it gets better 
but as it’s gone so slow you don’t really notice it. [TYA6, phase A] 
 
The importance of being able to quantify and document progress towards goals was another 
universal theme, amongst the many participants open to the concept of increasing activity.  
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What is it you like about the gym...? [Interviewer] 
Yeah, I think it’s the fact that, the more you do the more you can kind of tell you’ve done 
something. Like on the treadmill you can keep track of what you’re actually doing. [TYA6, 
phase A] 
 
Unsurprisingly, given the age of participants, information technology (IT), and specifically the use of 
mobile applications (Apps) featured repeatedly as a way of achieving this. Only one participant 
acknowledged his own disinterest in IT, while expressing the view that this was still likely to be a 
good approach for many young people.   
 
I wouldn’t necessarily want to download an App, I am not a technology person. I avoid using 
my phone and all sorts of other things like that if I can. But I could see loads of people finding 
that really useful. [TYA1, phase A] 
 
For all other young participants, their enthusiasm for using IT was clear. Parents also raised the 
possibility of harnessing IT to quantify progress, mentioning its additional potential in allowing a 
healthcarer to access the data [supplementary data, page 353]. 
 
I think as well if you are watching what you are doing, you are more conscious about doing it.  
I know that recently I have been trying to make sure I walk 10,000 steps, and it has got it on 
my phone, and I check that every day. And I think it consciously makes you do a bit more 
walking, because you want to hit your target. [TYA4, phase A] 
 
I’m quite a keen walker and I was trying to get him to come and we did the old ‘Map My 
Walk’ App. He’s quite keen on goal setting and so like he’d try and walk a little bit further and 
things like that, we found that quite useful as a tool. [PAR8, phase A] 
 
Yes. So the occupational therapist could link in to say [TYA12’s] details, couldn’t they? And 
say, ‘Well perhaps next week you could do another half a mile?’ [PAR12, phase A] 
 
Energy conservation 
Conserving energy is an established approach to supporting adults with cancer-related and other 
causes of fatigue [333]. Activity pacing, prioritising tasks and planning to avoid excessive energy 
fluctuations are central concepts, and efforts are made to avoid so called ‘boom and bust’, a 
colloquial expression describing a period of considerable physical exertion followed by profound 
fatigue [334]. For the young participants in this study, these concepts were unfamiliar and not 
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meaningful. On a literal level, the words ‘boom and bust’ were difficult to understand, even with 
explanation. 
 
I'm just going to bring things back to the themes of energy conservation and [researcher] has 
been referring to it as like a ‘boom or bust’. And what we mean by that is... you’ve got 
something on, I don't know, party, interview, event, whatever, and you’re just completely ... 
wiped out for the next day, two days... [Interviewer] 
Do you mean you get the weak burst and then all of a sudden you're like you don't want to 
get out of bed? [TYA7, FG, phase A] 
 
Importantly, the concepts were also largely irrelevant. Young participants considered it conventional 
behaviour to have periods of high energy usage, and then to ‘crash’. To attempt to change this was 
not considered acceptable or feasible to many of the participants [supplementary data, page 354]. 
 
It probably... the things that were said don’t really fit into my lifestyle if that makes sense. 
[TYA9, phase C] 
...like I, when I’m at college at things I don’t have a choice... [TYA9, phase C] 
Yeah, because you just have to do a lot and then you crash out? [Interviewer] 
Yeah... yeah the stuff going on in my life isn’t very flexible for those kinds of things. [TYA9, 
phase C] 
 
One participant felt that pacing and energy conservation were so unsuitable for young people that 
too much focus on these could even hinder engagement with a fatigue intervention. 
 
...saying that one should do [pacing and energy conservation] I think that is a way of 
deterring people taking part in the first place. [TYA1, phase A]  
 
There was animated conversation during the young patients’ focus group about the importance of 
‘going out’ and behaving in a perceived ‘normal’ impulsive adolescent way. 
 
...but maybe not a good idea to go to nightclub or to go to [place] or whatever. Where is the 
balance, how important is it to have those times where, okay, it might exhaust you for days 
afterwards but how important is that to still experience those things? [Interviewer] 
You have got to do it. [TYA8, FG, phase A] 
Yeah. [Many voices, general agreement] 
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Whilst you’re young I think... well, I’d do anything now. But then I've got a family where 
everyone’s older so it's... I've seen my sister go from 18 with a baby up (sic) and it's like I 
don't have any of that. So I’m going out enjoying myself, I go to the pub, I go out clubbing 
and things like that. But then I also think like when Sunday comes that's like you sleep all day.  
Non stop. [TYA3, FG, phase A] 
 
As well as energy conservation and pacing being considered irrelevant because of their inherent 
conflict with stereotypical adolescent behaviour of ‘going out’, then ‘crashing’, one young participant 
provided a further interesting insight. 
 
Because with my body I can push myself, so I can do basically anything my friends and other 
people can do. In fact my friend told me that I should carry her bags and stuff.  I didn’t mind, 
because I was full of energy, but she got tired before me. But I think that is to do with me 
pushing myself, not realising that I am getting tired. And then when we got to her house, I 
would just sort of lie down on her bed and just didn’t move for 30 minutes. [TYA1, phase A] 
 
It was apparent from many participants that, consistent with their young age, they had considerable 
physical strength. Even when experiencing fatigue, young people had little difficulty in being 
physically active when they wanted to be. This led to the recurrent theme of wanting to know ‘how 
much to push’ oneself, a significant unmet information need that will be described in the following 
subsection (page 133). 
 
The view that pacing was not inherently acceptable to young people was also expressed with 
conviction by the AHP delivering the prototype intervention. 
 
I got very much a sense that people, particularly around the boom or bust or the activity 
pacing, that's a real challenge for young people, because they want to feel normal and want 
to do the things that other people want to do... I think it’s this sense of wanting and needing 
to fit in... because [TYA3] was saying, ‘I’d rather not do that if it means that I can't be up all 
night and I’d rather not do it’ ...it was almost saying, ‘that doesn’t fit with my life,’ and there 
was less of a willingness I think to change. [HCP, phase C] 
 
Although physical pacing or energy conservation was largely irrelevant, in contrast, meditative and 
mindful approaches were highly acceptable to this young patient cohort [supplementary data, page 
355]. 
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And I found this App quite helpful, this Headspace [a mindfulness App], just because it gives 
you ten minutes out, and I don’t know, I found it just quite helpful in terms of the fatigue 
and everything. So, yes, I just quite recommend that. [TYA2, phase C] 
 
The other thing that seems to go down surprisingly actually quite well was the idea of taking, 
by whatever means, taking some time out during the day. So whether it be through 
mindfulness, relaxation ...a lot of them took on board this idea of taking that time out to 
focus... that idea of topping up and trying the mindfulness App, or one of the mindfulness 
Apps and I think that was useful as well. [HCP, phase C] 
 
Young participants referred to the mind being too active, and appreciated any approach that could 
introduce a meditative focus, whether mindfulness techniques, Tai Chi or yoga [supplementary data, 
page 355]. 
 
...my mind doesn't shut down, so it's like that’s another thing that's causing me to be tired 
and like not wanting to do anything because my head still constantly running. [TYA3, FG, 
phase A] 
 
And [yoga therapist] constantly reminds you throughout, because obviously it is all about 
being mindful... being in that moment. So that is something that I have wanted to work on 
anyway, yes... something like yoga I think for people in my position, should really be 
encouraged. Because it is not just your body, it is the mind as well that it really helps with... 
[TYA10, phase A] 
 
Information needs 
Participants universally expressed unmet information needs. As with other aspects of intervention 
content, the desired information was highly influenced by the developmental characteristics of 
young age. The inherent physical strength of youth meant that fatigued young participants were still 
able to push themselves physically. However, many TYAs, particularly those interested in undertaking 
formal exercise, expressed concern that they did not know ‘how hard to push’. The wish to have 
more information about this appeared to be related to the desire to be given a specific plan with 
repeated short-term goals (section 4.5.7.2, page 127). Clear goals, supported by a therapist, were 
perceived to reduce the risk of over-exertion [supplementary data, page 355]. 
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Because with me, I was getting very into sport, and the doctors didn’t quite know. I kept 
getting mixed messages from one doctor and another about how hard I should push myself, 
how much I should do. [TYA8, phase A] 
 
I guess when you are kind of in this situation you just learn about managing it, and pushing 
yourself a bit too far, and what works and what doesn’t... The nice thing about [a personal 
trainer] was that I had this plan, and then two weeks later we went over it and said what 
works, what doesn’t, and really adjust it. And I knew what I was going to do each day. [TYA2, 
phase C] 
 
A further area of information needs, referred to either directly or implicitly by most participants, 
related to needing to know more about what to expect [supplementary data, page 356]. The 
resulting mismatch between reality and expectations led to considerable interpersonal tensions, a 
theme that will be explored further in section 4.5.9.1 (page 148). 
 
I think probably if they just mentioned it, you know, if someone mentions it and you start like 
at least expecting it a bit. ...I don't know, it just helps with kind of thinking what actually is 
realistic with what you can do afterwards... because I didn’t expect it to hit me that much. 
[TYA2, phase A] 
 
Several parents also alluded to the importance of needing to know what to expect, in relation to 
normal adolescence. Fatigue, sleepiness and a desire to stay in bed in the morning can be considered 
stereotypical features of normal adolescent or young adult life. Parents did not know whether to 
attribute symptoms to this or, more seriously, to being a consequence of cancer and its treatment 
[supplementary data, page 356]. This was a source of internal tension for parents, as will be 
discussed in section 4.5.10.1 (page 154).  
 
Yes, we have not actually been given any information about fatigue. We were told that she 
would be tired, but that would be normal, and that we would just have to wait until she is 
ready. But then also she is 17 years old. Most 17 year olds want to sleep a lot. So again it is 
like how much do we put down to the treatment that she has had, and how much do we put 
down to just her being 17? [PAR6, phase A] 
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A further topic raised by many participants was the need for information that would support them in 
talking to staff at work or higher education institutions. Being able to work or continue in education 
was a clear priority to participants.  
 
...if you had to name one priority at the moment, what would it be? If you needed to conserve 
all your energy for one thing, more than anything else what would be your... [Interviewer] 
College. [Unidentified voice, FG, phase A] 
Work. [Unidentified voice, FG, phase A] 
 
Several participants, whether or not they needed the help themselves, alluded to the importance of 
being able to explain their situation to staff in their place of education or work [supplementary data, 
page 356]. 
 
And kind of ways to raise it with employers rather than just be like, ‘I’m really tired,’ which 
kind of sounds like you're just being lazy... Because with my part time job that I want to go 
into I don't know whether I should ask for it to begin later or whether I should be like sucking 
it up and going in at the normal time. [TYA2, phase A] 
 
So if other people in my situation don’t have as great lecturers or teachers, then it’s 
important to try and push for things. [TYA1, phase C] 
4.5.7.3 Age-related influences on intervention practicalities 
 As well as providing conceptual information on the approach and content of the intervention, 
participants gave views on practical aspects, such as the intervention name (what), method of giving 
information (how), ideal timing relative to the end of cancer treatment (when), location of 
intervention meetings, place of activity (where) and involvement of family members (who). 
Preferences remained consistent with the characteristic features of this young age (table 4.9). 
 
Identity and positivity remained an important theme, in relation to intervention practicalities, as well 
as approach (section 4.5.7.1, page 126). Both young participants and parents were consistent in 
wanting the name of the intervention to focus on positivity and recovery, rather than risking their 
identity becoming defined by fatigue, cancer or medicine [supplementary data, page 357]. 
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Really something like, more of a positive outlook in the name, like... ‘solving fatigue’. [TYA6, 
phase A] 
 
Again, focus on the recovery not the illness. [PAR8, phase A] 
 
I just feel like... I don't know, it’s not a really big deal, but if I'm telling people, if I’m telling 
friends that I’ve gone to a fatigue workshop makes it sound I’m being... give me the 
sympathy sort of thing. But I'm completely against that... [TYA8, FG, phase A] 
 
This concern led to a lack of consensus about whether or not the intervention for fatigue should 
directly include the word ‘fatigue’ within its name. There was a vehement debate about this point 
within the young participants’ focus group, with many differing views. The TYA focus group facilitator 
suggested a vote, and found that the group was virtually evenly split in opinion. Interestingly, the 
young participants spontaneously worked to develop a consensus themselves, and suggested a name 
with two parts, one involving a positive word like ‘recovery’, and the other acknowledging the 
legitimising word ‘fatigue. 
 
...do you have a name that's snappy that you can remember but then if people say, ‘What's 
that?’ then you say it, ‘fatigue study’ or ‘group’ or whatever. Instead of it being like straight in 
‘fatigue’ because it's like... it might not attract certain people 'cause they’ll think, ‘Oh, it’s 
more medical stuff’... [TYA3, FG, phase A] 
Well, just have a name… and then have a subname… ‘Road to Recovery: the Fatigue 
Workshop’. Something like that. [TYA8, FG, phase A] 
 
Another consistent theme was the preference for information to be given in video format, rather 
than written information. The videos needed to be short, in the context of poor concentration. 
Furthermore, participants were clear about their preference for information from experienced peers 
rather than healthcare professionals. This was again a topic of enthusiastic debate in the TYA focus 
group [supplementary data, page 357]. 
 
So what is your best way of learning [TYA 11]...? [Interviewer] 
It would probably be like a video where they tell you, and you can just sit there and listen. 
You don’t even have to watch it. [TYA11, phase A] 
And you don’t even have to read it, any of it? [Interviewer] 
Exactly. [TYA11, phase A] 
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Maybe something you could sort of... maybe done by other teenagers even saying ‘Oh so you 
are feeling tired’ and chatting about ‘Have you thought about doing this?’ Or ‘What about 
that?’ [TYA13, phase A] 
 
But it would have to be very brief. Because I think, not like brief, but... [TYA9, phase A] 
...Succinct, to the point? [Interviewer] 
Yes. [TYA9, phase A] 
 
In terms of the timing of the intervention, participants were universally clear about a preference for 
early fatigue support. Most participants, indeed, would have wanted a fatigue intervention to have 
started before the end of cancer treatment [supplementary data, page 358]. 
 
Yeah, I think as earlier on the better... Probably like once you’ve settled down into it... Yeah 
probably about half way through. Then you can start to work it into your life before you 
finish but you’re already like settled into it. [TYA9, phase A] 
 
Parents also had consistent views, advocating early input, as did the healthcare professional 
delivering the prototype intervention [supplementary data, page 358]. 
 
Yes. I think it probably would have been... as I say, even just even halfway through the 
treatment. [PAR7, phase A] 
 
At the end of treatment? [Interviewer] 
Earlier... I do get the sense that something earlier for everybody would have been useful. 
[HCP, phase C] 
 
Only one participant explicitly stated that intervention would not have been wanted during 
treatment. TYA1 advocated fatigue management being at the point of ending cancer treatment, 
which was the latest timing suggested by any of the participants. 
 
In my perspective, the dominant feeling I had during the treatment was feeling 
overwhelmed. So being asked to do other stuff would just feel overwhelming. [TYA1, phase 
A]  
 
The AHP delivering the prototype intervention raised age-related practical benefits from early 
intervention. During the prototype intervention, it had been difficult to make contact with patients at 
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times. Early involvement, when patients would be attending hospital anyway, could facilitate contact 
with a healthcarer who could then, if preferred, follow up out of hospital. In addition, in the months 
after the end of cancer treatment, there was a perception that young people would be ‘moving on’ 
with their lives. 
 
Seeing people on the ward, when they’re up here, perhaps gives you more of the 
opportunity, if it is more part of the normal way of doing things. So if someone was popping 
in, much like [HCP name] would pop in, or much like the nurses would pop in, then it’s more 
normal... [HCP, phase C] 
 
The getting hold of people... was difficult, but maybe seeing people early. I think the other 
thing is the sense of, once people’s hospital appointments start tailing off, it’s almost like, 
‘That's a different part of my life.’ So you've got this other situation of they’re not really 
wanting to come back or really talk about hospitals or anything to do with that. [HCP, phase 
C] 
 
The young participants further justified seeking early intervention to avoid the sudden drop in 
support that occurs at the time of finishing cancer treatment, with an associated sense of 
abandonment. This is described further in section 4.5.9.3 (page 150) [supplementary data, page 362]. 
 
A prevailing theme that emerged across many topics was the need for the intervention to retain 
flexibility. Diverse opinions were expressed concerning intervention location, acceptable types and 
location of activity, extent of family involvement, and the preferred methods of communication with 
an intervention therapist. Young participants tended not to be ambivalent, and had clear personal 
opinions.  
 
Participants suggested a variety of venues for the intervention, including a non-clinical venue on 
hospital grounds, a public location such as coffee shop or park, home and a clinical hospital location. 
The latter two were the least acceptable locations. For some TYAs, home was a place they wanted to 
have a reason to leave. Two participants pointed out that leaving the house to meet a therapist 
would help the fatigue by enforcing activity [supplementary data, page 359]. 
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I cannot stand sitting in my home. [TYA3, phase A] 
You just want to get out? [Interviewer]  
Yes... I think home is a bad option for me, because if you spend enough time at home, all you 
are doing is sitting longer at home to see someone, whereas if you have to go out... [TYA3, 
phase A] 
 
I would not want to do it at home, my home. Obviously I have felt ill and stuff in my home, 
but nothing has ever... no-one has ever stabbed me in my home or anything… [TYA9, phase 
A] 
I would hope not. [Interviewer] 
 
 And travelling somewhere wouldn’t worry you, no? [Interviewer] 
No. Because it gets you out of the house, it gets you a little bit active. [TYA11, phase A] 
 
A minority of young participants considered home an acceptable location, for reasons of ‘comfort’ 
and ‘convenience’, but even this was not necessarily sufficient reason for the intervention to be 
home-based. 
 
So it wouldn’t be easier to have it at home? Or do you not like the idea of..? [Interviewer] 
Well, for convenience, I suppose. But it seems kind of a waste of someone’s time coming all 
the way out there just to do that. [TYA4, phase A] 
 
A clinical environment in the hospital was almost universally unacceptable to young participants and 
their parents [supplementary data, page 361] 
 
I guess not the hospital because it's quite medical and quite sickening... [TYA2, phase A] 
 
In terms of types of activity, views were, again, remarkably diverse, with no common preferences. 
For some, a formal, structured approach to exercise in a gym environment was desirable. Others 
favoured walking or home-based activity. Young participants were explicit about their need for an 
individualised approach [supplementary data, page 359]. 
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I think if there was a gym that understood what fatigue was, and had someone there, not 
necessarily specialising, but that could help people like me back on... [TYA3, phase A] 
 So a sort of specialist trainer in some kind of way? [Interviewer] 
Yes. [TYA3, phase A] 
 
Also I find it quite hard travelling 'cause I get tired so... if it was at home or just like in your 
garden somewhere, where you didn’t have to travel to, then you wouldn’t have to worry 
about like doing it, exhausting yourself and then having to get back. [TYA2, phase A] 
 
Like some people might not like nature, they might not want to go for walks, they might 
want to go for a run. They might only like sport when it is competitive, or maybe... Yes, they 
might have all sorts of different perspectives. [TYA4, phase A] 
So really the core point that you are saying is it needs to be flexible, and needs to get to the 
essence of who somebody is. And only they can judge that, we can’t. [Interviewer] 
Yes. They have to choose what to do. [TYA4, phase A] 
 
Opinions were divided over whether to involve family members in the fatigue intervention. 
 
My mum would [benefit] though, because she lives with me, she has watched it first hand, I 
think it would help her understand. [TYA3, phase A] 
 
I think if it was my parents personally, I don’t think it would make any difference to them. I 
think that they think they have got their opinions, and I don’t think I would be able to change 
them. [TYA9, phase A] 
 
Disparate views were also expounded on the preferred mode of communication with an intervention 
therapist: email, text, social media and telephone were all suggested. Of note, several of the younger 
participants made it clear that they did not like speaking by telephone, a mode of communication 
considered familiar and generally acceptable amongst older adults. 
 
But speaking on the phone, with just a voice, feels..? [Interviewer] 
No, it feels really weird. [TYA11, phase A] 
Like weird in what way? Like you can’t relax? [Interviewer] 
Yes. Because you have got to sit there with the phone like that, as where with a video call 
you can just stick it on the table, and you can see it, so then you can hear it as well. [TYA11, 
phase A] 
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So telephones are old-fashioned really? [Interviewer] 
Yes, pretty much. That is why they have got all these new latest Android and Apples, all 
touch screens and video calls. [TYA11, phase A] 
 
There was a range of views as to the optimal discipline(s) of the healthcarer(s) providing the 
intervention. The prototype intervention was provided by an AHP who was an occupational therapist 
(OT). Some participants suggested that access to other specialists, if needed, could be helpful, 
specifically in relation to psychological support and support with sleep. There was no perception of 
stigma relating to psychological intervention [supplementary data, page 360]. 
  
 There is another component and it is all to do with what you would call the mind, or the soul, 
or the spirit... So I don’t know how you would introduce that, but I think it is crucial if you 
want to holistically address fatigue. [TYA1, phase A] 
 So emotional support as part of the whole thing is important? [Interviewer] 
 Yes. So either counselling which works for some people, and then access to information 
about mind/soul/spirit ideas, to people who maybe might not find counselling the best 
option. [TYA1, phase A] 
4.5.7.4 Theme A2 discussion 
These data reveal that the design of the fatigue intervention was highly influenced by the age-related 
needs of the young participants. It was striking that, consistent with the adolescent need to 
determine self-direction and identity, participants wanted an individualised and flexible intervention 
that promoted self-determination, control and self-confidence, and avoided being too prescriptive or 
authoritarian in approach. Equally, participants valued a specific, clear and concrete plan, particularly 
in relation to building activity, with a dislike of anything perceived as vague or abstract.  
 
The considerable physical reserve of young age also had a major impact on the intervention design. 
Participants wanted to know ‘how much to push’ physically, when fatigued. Innate physical strength 
meant they could force themselves to be more active, yet they feared a detrimental impact on the 
fatigue. This contributed to the desire for a specific, incremental activity plan, to avoid the risk of 
pushing physically to the point of inadvertent harm. Electronic monitoring of progress was valued, 
with associated perception of reward when goals were achieved. 
 
Physical strength, combined with the age-related need to conform, led to the unanticipated finding 
that energy conservation – a common approach within adult fatigue management that includes 
pacing, planning and task prioritisation – was often seen as irrelevant and unacceptable to TYA 
participants. ‘Boom and bust’ was considered conventional conduct at this age, and there was no 
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inclination to change it. In contrast, mindfulness and other meditative approaches, such as yoga and 
Tai Chi were much more acceptable and valued. Participants were open to psychological approaches 
and supportive of access to psychological input within the intervention, if required. 
 
A further unexpected insight was that young participants had little enthusiasm for a home-based 
intervention, because it was physically easy to travel and also because home had become associated 
with dependence and illness. Hospital was even less desirable as a potential location, with its 
connotations of ill-health and fear. Participants wanted information to be provided in short, peer-
delivered videos, rather than in written format. Being in work or education was a high priority for 
young participants, and they wanted support in explaining fatigue to prospective employers or 
education staff. 
 
These findings lend substantial support to the premise behind this body of research. An age-
appropriate intervention is indeed needed. Outcomes of research in older adults cannot, and should 
not, be extrapolated to young TYA patients [71]. Adolescents have unique health needs and, as 
exemplified by this study, health care for this population needs to be informed by, and developed 
with, adolescents. 
 
Contextualising with existing literature 
Participants confirmed, without labelling it as such, that promotion of self-efficacy, the theoretical 
underpinning for this work, is an approach of great relevance to them. Intervention needs were 
unerringly consistent with those factors known to promote self-efficacy, including goal setting, 
activity planning and provision of feedback on performance [335]. These findings lend support to a 
small body of literature involving young patients with chronic disease; research in adolescents with 
diabetes and juvenile rheumatoid arthritis, for example, has also shown that the concept of self-
efficacy is relevant to young patients [152]. As discussed in section 1.2.4 (page 16), perceived self-
efficacy mediates improved healthcare outcomes in relation to CRF, although it is not known 
whether its importance, in terms of either perceived relevance or health outcomes, varies according 
to age. 
 
The desire for an individualised and positive approach, with personalised goals, and planning for how 
to achieve such goals, fits closely with the premise of health coaching. Health coaching is a positive 
psychological approach that empowers people to self-manage, and focuses on individuals’ goals 
rather than on what healthcare professionals might wish for them to achieve. Interest in a coaching 
approach within healthcare has developed mostly over the last decade; it supports people to achieve 
their aspiration by helping them plan the specific and feasible steps towards the goal [336,337]. As 
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with the concept of self-efficacy, participants described and requested a health coaching type of 
approach, without labelling it as such, reinforcing its acceptability and potential applicability in this 
young age group. Health coaching itself is recognised to be an effective tool for increasing perceived 
self-efficacy for self-management [338,339]. It is not known whether there is a differential impact of 
a coaching approach, according to age [336,340,341].  
 
Many of the intervention content needs of the young participants were found to differ from those of 
older adults, and have not previously been described. Energy conservation, for example, is an 
accepted and effective management approach in fatigued older adults [342]. Indeed, adult patients, 
with fatigue from cancer and multiple sclerosis, have chosen energy conservation as the favoured 
component of intervention [343,344]. For adults with CFS/ME with a mean age of 38 years, adaptive 
pacing therapy was as acceptable as both exercise and cognitive behavioural therapy (CBT) [345]. In 
contrast, this work provides the first evidence that this approach may be less acceptable in younger 
cancer patients. There has been no previous research evaluating energy conservation or pacing for 
fatigued TYAs in any context. In a qualitative study involving adults aged 24-73 with CFS/ME, as well 
as chronic pain conditions, there was a suggestion that older patients found pacing more acceptable 
than younger patients [334]. Interventional studies for CFS/ME in adolescents have, interestingly, not 
evaluated energy conservation or pacing as a defined outcome, the focusing tending to be on CBT 
and promotion of activity [346-349]. 
 
In preference to physical energy conservation, participants were very supportive of mindfulness, a 
form of cognitive training derived from traditional Buddhist meditative skills of awareness and self-
regulation of attention [350]. Mindfulness-based cognitive therapy has been shown to be valuable in 
older adults with CRF [351]. In TYAs with cancer, it has been found to increase quality of life and 
reduce distress, but has not been evaluated in the context of fatigue management [352]. Of interest, 
given participants’ predominantly cognitive fatigue, there is some evidence that mindfulness may 
particularly ameliorate cognitive, rather than, physical fatigue [353]. Out of the cancer context, 
young people are known to find mindfulness acceptable and effective for ‘stress’ and depression 
[354-356]. Given the relatively late maturation of the prefrontal cortex mediating attentional and 
emotional control (section 1.1.2.2, page 6) and the evidence that young people are inherently less 
mindful than older adults, mindfulness is increasingly being taught in UK schools and universities, to 
enhance executive functioning, and the ability to cope with ‘stress’ and negative emotions [357-360]. 
 
The enthusiasm for the cognitive approach of mindfulness highlights another difference between the 
needs of TYAs and older adults. The young participants’ illness perceptions included an appreciation 
of psychological contributors to fatigue, and demonstrated a lack of stigma in relation to 
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psychological approaches. In older adults with CRF, in contrast, there is tendency towards physical 
causal attributions [361]. In the context of CFS/ME, there is a similar difference with age; young 
people are more open to the possibility of psychological explanations, unlike older adults who have a 
more biological focus [362-364]. A high profile UK social marketing campaign from 2009-15, aiming 
to reduce mental health stigma, has reported steady and significant improvements in attitudes, 
particularly within younger age groups [365]. 
 
The co-designed intervention needs to address the pervasive desire of young participants to find out 
‘how much to push’ physically and their related concern that exercise may worsen fatigue, so-called 
activity ‘fear avoidance beliefs’. Such concerns appear to be a feature of younger, rather than older 
patients, and therefore represents a further way that a fatigue intervention designed for young 
patients needs to differ from that for older adults. Fatigue-related activity fear avoidance is well-
recognised to occur in patients with CFS/ME, a relatively young patient cohort; it is considered a core 
feature of the condition, and addressing fear avoidance beliefs has been found to be one of the key 
mediators of symptom improvement (section 4.6.1.3, page 203) [345]. Activity fear avoidance has 
also been demonstrated in a study involving patients with multiple sclerosis-related fatigue, with a 
mean age of 47 years [366]. In contrast, there has been no previous evidence that cancer patients 
experience activity fear avoidance [23,367]. The firmly established health advantages of activity for 
cancer patients may be dispelling fears related to activity [367]. Overall, the finding of fear avoidance 
beliefs in FICS suggests that younger cancer patients may experience concerns that are more 
comparable with those of other younger patients with long-term conditions, than with cancer 
patients as a whole. 
 
Young participants’ enthusiasm for peer-generated videos was interesting and innovative. In older 
adults, no research to date has determined preferences between electronic video-based and written 
information about CRF [58]. A study from over a decade ago confirmed a desire for written, in 
addition to oral, information [368]. Web-based education about CRF has been found to be an 
acceptable approach in adults, including videos of patient stories [156,369]. Some evidence suggests 
that video-based education may be valued in non-malignant conditions [370]. Overall, there is a lack 
of previous evidence on information format preferences for CRF at any age; the finding from this 
study contributes useful information concerning TYA preferences. 
 
The last finding that contrasts with evidence in older adults was the preference for support to be 
provided away from home. Limited evidence suggests that older adult cancer patients have a 
preference for home-based physical activity, although no research has been done in a CRF context 
[371]. In non-cancer illnesses, there is good evidence that adults prefer a home setting, including for 
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cardiac rehabilitation [372], pulmonary rehabilitation [373] and breathlessness self-management 
support [374]. Home-based complex interventions have been found to be as effective as their 
hospital or out-patient counterparts [372,375]. Given the evidence supporting home-based 
intervention, this study finding is novel and important. 
 
Integrating with Fatigue in Focus survey 
Most survey participants did not find advice to exercise helpful, even though this was the approach 
they would most recommend to others. This suggested the existence of barriers to activity, most 
obviously the fatigue itself. This study adds the important insight that fatigue could be a barrier to 
activity because of activity fear avoidance beliefs, rather than by simply preventing activity on a 
physical level. This concept is discussed further in section 5.1.2.2 (page 220). 
 
Summary 
The study has revealed that young cancer patients have significant age-related intervention needs. 
The irrelevance of energy conservation, openness to the cognitive approach of mindfulness, concern 
about potential harm from activity, enthusiasm for peer-generated videos, and low interest in home 
as an intervention location, all differ from research findings in older patients.  
4.5.8 Conceptual model A: Characteristics, Experiences, Needs star model of TYA fatigue 
It has been seen in themes A1 and A2 that the developmental characteristics of young age both 
influence the experience of fatigue and fatigue intervention needs. This can be considered 
conceptually as shown in figure 4.2. 
 
Several conceptual models of fatigue in chronic disease in young patients have been previously 
developed, including in juvenile arthritis and CFS/ME [376,377]. These models consistently attempt 
to conceptualise the complex range and interplay of factors involved in the causes and consequences 
of fatigue. However, no previous models have considered the impact and patient needs through the 
perspective of age-related characteristics. This novel approach clarifies that many of the distinct 
fatigue experiences of TYAs are a function of the developmental characteristics of young age. 
Furthermore, these experiences, in turn, directly influence the features of an age-appropriate 
intervention, allowing a consistent, needs-focused perspective. 
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Figure 4.2 Characteristics, Experiences, Needs (CEN) star model 
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4.5.9 Theme B1: TYAs experience pervasive tensions and misunderstandings 
An unanticipated but pervasive theme was the extent of tensions arising from experiencing, or living 
with someone experiencing, cancer-related fatigue. The outcome of the tension was often described 
by TYA participants in terms of anger, as discussed in section 4.5.6.2 (page 118). 
 
 The thing that personally we have struggled with as a family is when I am tired, I am very 
moody and agitated, and I will lash out. And it flares up my temper, and it can cause issues at 
home, because I will have a falling out with my brother, or I will snap at somebody. [TYA10, 
phase A] 
 
Young participants, almost without exception, described situations where conflict and 
misunderstandings had arisen, both on an intra-personal level (internal) and interpersonal level 
(with, and beyond, family). 
4.5.9.1 Internal tensions 
Adolescence and young adulthood is a period of rapid change and major developmental needs. As 
discussed previously, fatigue frustrates many key developmental needs particularly: a) the ability to 
socialise, b) increasing independence, and the ability to progress c) in education and d) in work. The 
following four quotes encapsulate the internal tensions caused by each of these points respectively. 
 
a) I went for a couple of nights out, and I just found myself losing concentration. Like people 
would be talking about something, and about five minutes later I realised I had not listened 
to a word anyone had just said, and I think, ‘Oh dear, that was rude.’ [TYA12, phase A] 
 
b) And just all the tasks, like my mum had to go and pick up some train tickets yesterday for 
me because I was too tired to do that. So I guess I'm quite reliant on them which I'm quite 
worried about because I want to move out. [TYA2, phase A] 
 
c) So I am going to have to do most of my A-level year potentially with the same kind of 
memory problems, and that really worries me. [TYA9, phase A] 
 
d) But I’m seriously worried about job interviews because I went to one before and I forgot 
what I was saying and so I just kind of went over it. But if it was in a different situation [and] I 
couldn’t go over it, then I don't know what I'd do. And it just sounds like an excuse when 
you’re like, ‘Oh, sorry, I forgot the question.’ [TYA2, FG, phase A] 
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Further tensions arose from unmet information needs. As discussed in the preceding theme, 
participants were often aware of the benefits of activity, while at the same time concerned about the 
potential harms, leading to another source of internal tension [supplementary data, page 355].  
 
I guess also if you don't know whether to just go out and do stuff in spite of it, or whether it 
is better to just be lying down. [TYA2, phase A] 
 
And then also going outside, not just staying inside, going outside and going for a walk for as 
long as I can. But then I have recently realised not too long, because then that is 
counterproductive. [TYA1, phase A] 
 
The other area of unmet information needs, described in section 4.5.7.2 (page 126), was not knowing 
what to expect. This mismatch between reality and expectations was a source of tension for many 
participants, who felt more fatigued than expected particularly when trying to return to ‘normal life’ 
[supplementary data, page 363]. 
 
I think that brings us back to the fatigue because I think the other thing that’s difficult is in his 
mind once he was told cancer-free then the expectation on his part and on other people’s 
part... But of course as soon as you think, ‘Right, I’m back to normality,’ then you’ve got this 
whole business of, ‘if life is normal then it suddenly becomes even more apparent the stuff 
you can’t do.’ [PAR2, phase A] 
 
During my chemotherapy I was so tired... I wasn’t really doing that much anyway for the first 
few weeks, so it wasn’t too much of an issue. If I did feel tired which would be like the middle 
of the afternoon, then it didn’t matter, I could just sit and watch TV and have a sleep if I 
needed it... It is more when you go and do something, like if you are going out for a family 
day or something, then you notice it more don’t you? [TYA12, phase A] 
 
PAR2 further alluded to the particular challenge of this level of uncertainty at a young age, and the 
importance for young people to feel in control. 
 
...another effect of fatigue on [TYA2] which is that you’re living with it, not knowing when it’s 
going to end, you know? It’s a lack of control, which as we all know is a horrendous place to 
be when you can’t determine what’s going to happen to you. By dint of effort, work, doing 
exams, you know? [PAR2, phase C] 
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At least I've had 50 years of living where there have been times when you're not in control 
and you know what it's like. I think it's very difficult when you're in your early 20s to cope 
with that. [PAR2, FG, phase A] 
4.5.9.2 Tensions within family 
A major theme, expressed by more than half of the young participants, was the perception that their 
fatigue was misunderstood by parents, who appeared to attribute fatigue-related behaviour to 
‘laziness’ or ‘disorganisation’ [supplementary data, page 361]. 
 
And so of course they [parents] attribute what I would call fatigue to either laziness, or lack 
of willpower... So they are attributing any kind of thing that could be fatigue onto my poor 
choices... so it is hard for me to gauge how much they understand. I would say that I have 
spoken to them and tried to explain that it is not laziness. Sometimes I have got through, 
sometimes I haven’t, and they do stick to their core beliefs. [TYA1, phase A] 
 
Parents were also perceived to underestimate fatigue, conflating it with the usual tiredness that 
occurs after a busy day. 
 
So the other day I did get quite tense in that I swore at mum because she just turned round 
to me when I was just trying to tell her how fatigued I felt, and that when I was at work I had 
to say, ‘No,’ to some jobs because I ached, and I was tired. And she was just like, ‘Well 
anyone would feel like that on a normal day at work.’ I was like, ‘You don’t get it,’ and then I 
tried to explain it more. [TYA7, phase A] 
 
Thus, as well as the internal tensions from young participants’ expectations being out of keeping with 
reality, TYAs perceived that parents’ expectations were also unrealistic. At the end of cancer 
treatment, they expected life to return to ‘normal’ [supplementary data, page 361] 
 
...when I finished the treatment, my parents automatically tried to get me straight back into 
life, as I would have done before. They were like, ‘You have to get a job, you have to walk 
home from school.’ [TYA9, phase A] 
 
This topic led to a lively topic of conversation in the young participants’ focus group, when TYAs 
discussed how they could enhance parental understanding. 
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Mine think I'm making it up. [TYA1, FG, phase A] 
Yeah, feel the same. Like it kind of feels like they don't understand. [TYA7, FG, phase A] 
They're like you’re off treatment so now go back to normal... Can't we do this kind of thing 
where if a parent doesn't believe us, we like send them to the hospital and they have to 
watch like horrible side effects of chemo and stuff and sit there like... [TYA1, FG, phase A] 
No, I don’t think we should do that…! [Multiple speakers] 
And then they’ll understand... [TYA1, FG, phase A] 
 
Parents were not the only family members with whom there were interpersonal tensions. Siblings 
were also perceived to misunderstand fatigue and its impact. While this point was particularly 
acknowledged by parents (section 4.5.10.2, page 155), TYAs also described this difficulty. 
 
... my siblings are older and my sister especially, she doesn't understand how tired I do get. 
And it’s very much like we end up arguing then because it’s like, ‘Why can you be this tired 
you don't do anything all day,’ and it’s a bit... I think she doesn't understand that, just 
because my chemo has stopped, doesn't mean that all the post [chemo] stuff does stop too. 
[TYA3, FG, phase A] 
4.5.9.3 Tensions beyond family 
Tensions occurred with others too, beyond parents and siblings, with the source of the difficulties 
often attributed to misunderstandings. Friends were particularly perceived to underestimate fatigue, 
thinking of it merely as being ‘tired’ [supplementary data, page 362]. 
 
But with even things like fatigue, nobody really understands. Like just small scenarios like 
nights out, my friend got annoyed at me, because I didn’t want... well, not annoyed, but she 
was a bit like, ‘Why?’ when I said, ‘I really cannot do this night out, because I am struggling to 
stay awake,’ and it was kind of like she didn’t understand. [TYA7, phase A] 
 
There were equivalent tensions with employers. One participant [TYA2] described fearing he would 
be misunderstood by his prospective employer in phase A; subsequently in phase C, he described 
that he had, indeed, been misunderstood in the subsequent months, requiring considerable 
explanation and pressure on his employer before there could be resolution. 
 
I was meant to be starting [training in work], but I was just like I don’t think I can do it. And I 
was asking them about making some adjustments, and they just said, ‘No, we can’t do that.’ 
[TYA2, phase C] 
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But I have made [employer] aware, because I needed a lot of dates off, because of 
appointments and things, but I don’t think they get it, and then that then also makes it worse 
for me mentally. [TYA7, phase A] 
 
The low level of understanding extended even further, beyond family, friends and employers. The 
young participant below was referring to ‘people in general’ and included ‘cancer doctors’.  
 
I don’t feel like people get it; they’re just not very informed most of the time and it’s hard to 
communicate. [TYA14, phase A] 
And what makes it hard? [Interviewer] 
Just a lack of understanding from my point of view. [TYA14, phase A] 
 
Even within this study, one participant considered that the questioning from an interviewer, known 
to her as a healthcare professional, could be implying laziness or ‘lack of effort’. 
 
Yeah, so, even though you are saying... you might just not bother doing it, there might be 
some bits of that intervention that you would actually give a go? Do you think it depends on 
how much effort it requires? [Interviewer] 
Yeah, I suppose. That makes me sound outright lazy though. [TYA5, phase A] 
Oh [TYA5], I’m sorry, I didn’t mean it like that. [Interviewer] 
 
Most of the tension identified in this study arose from a pervasive misunderstanding of fatigue. 
Another source of tension was that young participants felt that staff may be aware that they were 
experiencing fatigue, but expected them simply to cope with it, creating a sense of abandonment 
[supplementary data, page 362]. 
 
Because I guess you leave the hospital, and then you kind of... I don’t know, you are not 
really getting the same level of support that you were before. And it just seems like the 
fatigue is the inevitable consequence, and you just have to like deal with it. [TYA2, phase C] 
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4.5.9.4 Theme B1 discussion 
Young participants described experiencing tensions at multiple levels: internally, within family, and 
beyond family. Underpinning this was the perception that fatigue was not understood, one of the 
most pervasive themes in the study, being expressed in some way by every TYA participant.  
 
Not only did internal tensions arise from expectations being out of keeping with the reality of life 
after cancer treatment, TYAs experienced additional tension from a perception that their parents’ 
expectations also failed to match reality. Parents expected life to return to normal after the end of 
treatment. Young participants felt both personally misunderstood (judged as ‘lazy’ or ‘disorganised’) 
and that the fatigue was misunderstood (conflated with ‘being tired’). Siblings, friends, employers 
and healthcare professionals were all perceived to misunderstand, leading to tensions that 
manifested as frustration and, particularly directed towards parents, anger. 
 
Beyond the extensive misunderstandings about fatigue, the main other source of tension resulted 
from frustrated social, education or work needs. This was discussed in section 4.5.6.1 (page 116) and 
will not be considered further here.  
 
Contextualising with existing literature 
The plethora of multi-level misunderstandings and tensions has not previously been described in 
literature relating to TYA CRF, nor indeed in relation to fatigued older adults with cancer [378,379]. 
These tensions may, in part, explain the review finding that fatigue is a particularly distressing 
symptom in young patients. Such insight is valuable, in terms of intervention development, as 
support to dispel misunderstandings may be effective in reducing fatigue-related distress. 
 
It is noteworthy that, while this appears to be a novel finding in the context of CRF, tensions are well-
described in CFS/ME. Extensive conflict with healthcarers has been documented, with CFS a 
contested diagnosis, leading to delegitimisation and stigmatisation [380]. Tensions with friends have 
also been described in range of qualitative studies involving both adolescents and adults with 
CFS/ME, including bullying from peers, negative attitudes, loss of friendships and a sense of distrust 
[376,381]. In relation to tensions within the family in CFS/ME, findings have been more varied. Most 
reports of family conflict come from studies evaluating the impact of CFS/ME in adults, rather than 
adolescents; non-acceptance, at least initially, appears to be common, leading to a strain on 
relationships, particularly with partners [380,382]. In contrast, in qualitative studies involving 
adolescents with CFS/ME, although some participants do describe more conflict, many others 
perceive an increase in the closeness and protectiveness of family relationships, with no overall 
negative impact in family cohesion [376,381,383]. 
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In adolescents with CFS/ME, therefore, evidence suggests many levels of tension and 
misunderstandings, but greatest with healthcare professionals and least with immediate family 
members. Conversely, FICS participants described considerable tensions with family members, some 
tensions with friends, and little in relation to healthcare staff. This discrepancy between the 
experiences of adolescents with CFS/ME and CRF might occur due to a difference in the perceived 
validity – particularly from the perspective of healthcare professionals – of the underlying diagnosis. 
The aetiology of CRF is indisputable, unlike CFS/ME, leading to greater understanding. The tensions 
between TYAs and family members found in this study are particularly interesting and novel.  
 
Integrating with Fatigue in Focus survey 
Findings from this study are remarkably consistent with both the quantitative and qualitative data 
from the survey. Two-thirds of survey participants perceived friends to have poor understanding, 
with about a third feeling that family and friends lacked understanding. This study illuminates these 
findings, providing insight into the nature of the misunderstandings, for example when fatigued 
individuals perceive that others judge them to be ‘lazy’ or ‘disorganised’, or when there is an evident 
mismatch between imagined expectations and discovered reality. 
 
This study may also provide a potential explanation for the unexpected survey outcome that fatigue 
prevalence appears to be worse in those more than one year after the end of cancer treatment, 
compared to those in the year after treatment. The qualitative evidence of a mismatch between 
expectations and reality could, at least in part, help explain the finding. The expectation that fatigue 
should be settling after the end of treatment, along with attempts to return to ‘normal life’, mean 
that ongoing fatigue is experienced as more significant than it might otherwise have been.  
 
Summary 
The multilevel tensions found in this theme have not previously been described in relation to CRF at 
any age. The fact that there is evidence for tensions occurring particularly in TYAs, rather than adults 
– both in the context of CRF and CFS/ME – suggests that there is an age-related component to the 
frictions that occur. As discussed in section 1.1.2.2 (page 6), in adolescence there is a 
neurodevelopmental propensity to enter into conflict with others, particularly with parents [63]. 
 
These findings have clear implications for intervention design. TYAs need to be empowered to 
communicate proactively and positively, explaining their fatigue experience and needs, rather than 
allowing misunderstandings to generate conflict. It is likely that it would also be valuable for parents 
to be supported within the intervention; this is discussed further in the following theme. 
 154 
4.5.10 Theme B2: Fatigue-related tensions have a detrimental impact on family 
This theme focuses on the perspective of parents. As with their offspring, parents also reported 
experiencing detrimental disharmony. 
 
It affects [TYA5] mostly obviously but it can have a knock-on effect because she feels so tired 
all the time, takes it out on me, quite understandably... And sometimes she sort of gets a bit 
snappy if she’s really tired and of course I’m the one in the firing line which I don’t mind, it’s 
very understandable after what she’s been through. [PAR5, phase A] 
 
Parents alluded to multilevel tensions, experiencing both internal tensions and interpersonal 
tensions across, and beyond, the family. 
4.5.10.1 Internal tensions 
Interviewed parents were aware that much of the frustration, and resulting anger, from young 
patients, was a consequence of the impact of fatigue in social, education or employment terms. After 
the end of cancer treatment, parents wanted to support the young person to re-engage with these 
activities. However, this led to parents themselves experiencing internal uncertainty and tension, 
particularly in relation to how much to push the young person [supplementary data, page 363]. 
 
We had our moments when we would be encouraging him, and we would have little 
arguments I suppose about the fact that... say week two, I am like ‘Well you are a lot better 
this week than last week, so why don’t you come here with me, or do this with me? ...and so 
there is a bit more conflict as time has gone by, because as his parents we feel what are you 
going to do with your life? [PAR13, phase A] 
 
This was a major theme, experienced on some level by all parents except one. PAR8 did describe 
wanting to push her son, but stated that there were no fatigue-related tensions within the family.  
 
...you had to just judge it. If I started pestering him to get up and I was getting nothing or a 
little bit of aggression I would just drop it immediately. I never pushed him like that... so we’d 
never get into an argument about it. [PAR8, phase A] 
So it’s so interesting what you’re saying, [PAR8], which is that fatigue actually didn’t bring 
conflict into your home. [Interviewer] 
Not at all. [PAR8, phase A] 
 
Closely related to the uncertainty about how hard to push their TYA offspring, many parents 
expressed frustration at not knowing what to expect in terms of fatigue severity. As described in 
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section 4.5.7.2 (page 134), considerable unmet information needs were reported, particularly in 
relation to how much of the fatigue was due to cancer and its treatment, and how much was the 
normal tiredness of adolescence [supplementary data, page 356]. 
 
Another significant source of internal tension for parents related to the invisibility of fatigue. Several 
parent participants hinted that fatigue cannot ‘be seen’, alluding also to the related scepticism this 
engendered.   
 
It is quite hard, because he looked all right [PAR13, phase A] 
 
Another parent touched on the invisibility of fatigue, along with her son’s relief that this did not 
prevent his fatigue being understood by her mother. 
 
Potentially, somebody who has had a limb amputation, you would be seeing it.... he looked 
at me and he said, ‘Thank you so much for believing me about the fatigue.’ And I said to him, 
“Well why on earth would I not believe you with the fatigue?” And he said, ‘Obviously most 
people look at me, they don’t know, and I now have hair and all the rest of it.’ So there is 
that aspect. [PAR2, phase C] 
And so such a relief for him to know that he is deeply understood... needing people to know 
that this is invisible but massive in terms of its impact? [Interviewer] 
Yes, yes. [PAR2, phase C] 
4.5.10.2 Tensions within family 
Many parents, as well as young participants, described interpersonal tensions across the family. 
Although a few parents did not volunteer this topic, nobody denied that there was fatigue-related 
conflict across the family. Other than the tensions between parents and young patients described in 
section 4.5.9.2 (page 149), the most commonly expressed area of conflict was between siblings. The 
invisibility and inherent daily variability in fatigue levels led to siblings not understanding, and 
potentially not believing in, the fatigue [supplementary data, page 363]. 
 
[Sister] is at home now, but sometimes she just wants to go into [TYA6]’s bedroom and sort 
of plonk herself on the bed and chat about this and that and the other. And sometimes 
[TYA6] is quite happy to do that, and other times she is really tired. And I don’t think her 
sister can get that, so it is quite difficult, so they bicker a bit about that sometimes. [PAR6, 
phase A] 
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A further challenge for siblings, leading to tension, was the expectation that they would help with 
supporting the young person.  
 
...he [brother] has been the one who’s been home but he has basically, he has been relied 
upon and has done, well, let’s call him a servant. He’s been a servant to [TYA2] nonstop for a 
year... so we’ve had some terrible blow ups because of [brother], all because he’s been 
asking him to do stuff... and of course [TYA2] just absolutely blew up and said, ‘You don’t 
know what the last year’s been like’... and just shouts... and expects him to jump. And I come 
in and say ‘No’... [PAR2, phase A] 
 
In one instance, the unanticipated return of a young adult into the family home led to tensions with a 
younger sibling. Another participant described how the caring role prevented a sibling from going to 
university [supplementary data, page 363]. 
 
It has taken its toll on everybody. So I think that... I haven’t caused problems for them, but I 
was living away from home, so I have come back into the family unit... my sister didn’t go to 
university because she was looking after me, because mum had to go to work, [TYA10, phase 
A] 
 
Several parents also reported on the challenge of not being able to make, or follow through on, 
family plans [supplementary data, page 363]. 
 
It does mean that it is quite difficult to make plans to go... because all of our family live in 
[place], so it is quite a journey anyway. So, yes, it does have an impact in that way, that I 
can’t really make plans to go and see friends and family, because I have got to basically work 
around [TYA6]’s fatigue. [PAR6, phase A] 
 
Although there was extensive evidence of tensions between young participants, parents and siblings, 
only one parent mentioned tension between parents. PAR4 reflected on ‘pushing’ his son to keep 
active and attend work, despite his fatigue. 
 
And I think that if you spoke to my wife, she would probably say I was quite hard in the way I 
pushed it, and do push it. [PAR4, phase A] 
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4.5.10.3 Tensions beyond family 
As with the young participants, parents perceived that extended family and peers did not understand 
fatigue. Two parents made an active choice not to talk to others to avoid causing, or having to 
receive, an emotional reaction [supplementary data, page 364]. 
 
But then I have got them [extended family] sort of ‘How is he getting on, how is he getting 
on?’ And they don’t understand that some days he just wants to lie on the sofa and watch 
television. [PAR12, phase A] 
 
Isolation in part comes from having to cope with the emotional reaction of others around 
you, friends etc. This adds the burden, so it’s easier not to see them. [PAR2, FG, phase A] 
 
Although some social isolation was by choice, parents also experienced a sense of abandonment, as 
discussed poignantly at the parent focus group. 
 
...when I had a chance to kind of sit back and see who was around me there wasn’t really 
anybody around me [PAR6, FG, phase A] 
General agreement 
But I agree with you how you feel that people, you feel like one minute they were there and 
kind of like, where have they gone? [PAR7, FG, phase A] 
 
Paradoxically, as will be discussed in the forthcoming conceptual model (section 4.5.11, page 160), 
although parents were accused by their young offspring of not understanding their fatigue 
predicament, parents easily perceived the misunderstandings of others and rose to the defence of 
their children. 
 
In the middle of all this arguing she... and I said to her, and she’s had loads of people at her, 
‘Are you going to go back to college? Do you want to get a part time job?’ I said to her, ‘If you 
don't want to do anything, don't do anything.’ [PAR3, FG, phase A] 
 
I think there is a little bit about not everybody, not every manager having that understanding 
and patience... I was able to get on the phone to the manager of the shop and say, ‘She 
needs to get off as soon as she needs to get off.' [PAR4, phase A] 
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4.5.10.4 Theme B2 discussion 
The parents of TYA cancer patients reported extensive areas of tension and misunderstanding, with 
notable concordance between their experiences and those of the TYA participants. They were 
similarly coping with internal tensions related to unmet information needs, and multilevel tensions 
beyond the family. The finding of sibling tensions was an important and relatively unexpected theme, 
given the focus of the study on the TYA-parent relationship. Parents provided insight into two 
potential sources of tension: the invisibility of fatigue and its daily fluctuation. Siblings particularly 
struggled with these more nebulous aspects of the symptom.  
 
Contextualising with existing literature 
As discussed in section 2.6.4.2 (page 43), the needs of family caregivers have been increasingly 
recognised over the last decade, with a plethora of research across a wide range of chronic diseases 
recognising the demands on caregivers. While there has been a focus on the caregivers of older adult 
cancer patients [384], parents of younger children with cancer [385], and parents of adolescents with 
paediatric multiple sclerosis[386], there has been little research concerning the experience and 
needs of carers of TYAs with cancer. Sawyer and colleagues recently conducted a large survey of TYA 
cancer patients and parent carers; the considerable unmet support needs were greatest in those 
receiving healthcare within adult, rather than paediatric services [99]. The financial impact on 
families caring for a TYA with cancer has also been estimated, with the significant economic burden 
being greatest when the young patient has a diagnosis of leukaemia [387]. 
 
In relation to care giving for patients with CRF, one small exploratory study has been conducted, 
evaluating the impact of CRF on spousal carers of older adults. Up to a half of the participants 
experienced high levels of strain and depression, with higher levels in those caring for patients with 
more severe fatigue; almost a third reported a reduction in their ability to work [277]. No previous 
research has investigated the impact on caregivers of TYAs with CRF. This qualitative study therefore 
provides the first evidence from the perspective of TYA parent caregivers, revealing a negative 
impact with multilevel sources of tension. 
 
Considerably more research has been conducted into the experiences of caregivers of people with 
CFS/ME. A recent systematic review, evaluating levels of psychological distress in ‘significant others’ 
of patients of all ages with CFS/ME, revealed consistently high levels of distress in the parents of 
fatigued children and adolescents [388]; the TYA age group was not investigated separately. 
Furthermore, amongst studies evaluating the impact of care giving to adolescents with CFS/ME, 
there are notable parallels with the findings of the current study. Crawley and colleagues revealed 
that parents struggled with a similar sense of uncertainty and with having to cope with an ‘invisible 
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illness’, with those around them appearing to discredit their experience [389]. As with CRF, the 
adverse impact on siblings includes ‘conflict’ and ‘resentment’. A study focused on siblings revealed 
frustration with changing roles within the family, resentment that the fatigued sibling may have 
unfair advantages, and difficulty coping with symptom variability and the related inability to plan 
ahead; many siblings did not believe that the CFS/ME was genuine and attributed it to laziness [390]. 
In contrast to the experiences of TYA care givers, evidence regarding older CFS/ME patients is more 
mixed with one qualitative study revealing a resigned acceptance of the CFS/ME diagnosis over time 
and relatively little adverse impact on carers [391]. 
 
The novel findings from this study therefore appear to align remarkably closely with the experiences 
of young people with CFS/ME. Although there is only limited evidence available in older adults with 
CFS/ME or with CRF, it appears that the experiences of parents of TYAs with CRF are more a feature 
of the young age of their offspring, than of the specific underlying cause of the fatigue. This will be 
discussed further in section 4.6.1.1 (page 199). 
 
Integrating with Fatigue in Focus survey 
The survey provided only proxy reports on parental perspectives. Almost half the TYA survey 
participants felt that their fatigue had an impact on their caregiver by causing ‘upset’, ‘frustration’ or 
‘limiting rest time’, with the impact tending to be worse for those caring for a TYA with more severe 
fatigue. The findings in this theme are consistent with the survey, building on them by revealing, 
despite the perception of misunderstandings, the similar perspectives of TYAs and their parents.  
 
Summary 
This theme provides, for the first time, direct evidence from parents of fatigued TYAs of considerable 
burden. A conspicuous degree of congruence was found between the multilevel tensions 
experienced by TYAs and by their parents, supporting the conceptual model in the following section. 
 
There is compelling evidence that the experiences of both parents and siblings of fatigued TYA cancer 
patients are similar to those of CFS/ME care givers. Data from this theme have highlighted the 
hitherto unevaluated topic of the experiences of siblings of young cancer patients, finding evidence 
of loss of trust, frustration and conflict, in the context of fatigue variability and invisibility. 
 
There is clearly a strong argument for including parents and siblings in an age-appropriate fatigue 
intervention. As described in section 4.5.7.3 (page 140), there was a range of views amongst young 
participants as to whether they would want parents to be involved. For those finding such 
involvement acceptable, it is likely that both TYAs and parents would benefit from such support.  
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4.5.11 Conceptual model B: the Concordant Tension Tree 
The concordance between tensions experienced by TYAs and their parents have been conceptualised 
in the model below. It attempts to encapsulate the oxymoron of concordant discord. Although 
tensions between adolescents and parents are well described out of the CRF context, as discussed in 
the preceding section, there has been no previous work suggesting analogous tensions. The potential 
value of this conceptualisation is that it is conceivable that simply supporting communication 
between TYAs and their parents, within a fatigue intervention, could be therapeutic in itself, leading 
to a sharing of similar perspectives and de-escalation of tension. 
 
Figure 4.3 Concordant Tension Tree 
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4.5.12 Theme C1: Fatigue may perpetuate with vicious cycles 
This theme can be encapsulated by a short phrase, stated almost identically by both members of a 
TYA-parent dyad: 
 
The only thing I got told at the beginning was the ‘fatigue breeds fatigue’, which is true. 
[TYA8, phase A] 
 
 ‘Fatigue breeds fatigue’ in my head. [PAR8, phase A] 
 
The pivotal concept raised within this theme was that the fatigue had the potential to worsen simply 
because of its presence. In a variety of ways, fatigue was described as leading to consequences 
which, in turn, could intensify the fatigue itself. This led to vicious cycles developing that could 
perpetuate the symptom. The unhelpful consequences of fatigue included physical inactivity, 
negative thoughts and poor sleep habits, and are described in detail below. 
 
Not only were vicious cycles described, but the converse – virtuous cycles, or cycles of improvement 
– were also reported. PAR6 described this concept in terms of use of energy generating more energy, 
the antithesis of ‘fatigue breeds fatigue’. 
 
...she finds that when she actually gets up and does something it gives her more energy, as 
opposed to when she’s feeling fatigued… before, what she was doing was just spending the 
day in bed, and it was just making her feel worse... [PAR6, phase C] 
Where did [TYA6] and you get this idea that energy breeds energy, the thing that we were 
talking about before? How did that come about? 
I think it’s just something my mum always used to say to me, that if I said, ‘Oh mum, I’m 
really not feeling too well today, can I just like lay on the sofa?’ she’d say, ‘the best thing you 
can do is get up and do something. Whatever it may, just go for a walk,’ she said, ‘because 
you always feel much better doing something.’ When you feel ill and you act ill... you feel 
worse. [PAR6, phase C] 
4.5.12.1 Activity 
One of the most pervasive themes that emerged was the perception that fatigue led to people being 
less active and that, in turn, inactivity had the capacity to make the fatigue worse. Fatigue leading to 
enforced inactivity was described by many young participants. 
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...it's just like a ton of brick pressing on you. It's just like me needing to sit down all the time, 
or needing... you know, when you’re so tired that you can't sleep, almost too tired, it's like 
that and everything slows down and all I want to do is just get onto the sofa and lie down.  
[TYA2, phase A] 
 
I am just sat, and I won’t move. It is like trying to lift a house up off the sofa, it is hard. 
[TYA3, phase A] 
 
Parents also described this intuitive corollary of fatigue but also alluded to the inactivity as a habit, 
compounded by family members undertaking the activities the young person would previously have 
done. 
 
There’s then this habituation which I’m sure you’re going to see with fatigue, where the 
habitual behaviour is… so basically [TYA2] sits on the sofa and just, he’s called [sibling 
name]. And just shouts, ‘[sibling name]!” and expects him to jump. [PAR2, phase A] 
 
You see I would love to say that I do a lot for her because of her fatigue, but I think it is just 
force of habit now. Because she has been ill for so long, I have got into the habit of doing 
everything for her. I think that she is capable of doing a lot more for herself, but I have just 
got into that bad habit of doing it all for her... before she became ill, her and her sister both 
had their set chores... But she doesn’t do any of that now. [PAR6, phase A] 
 
This relative lack of activity, caused both by the fatigue and others’ help with the activities of daily 
living, was frequently described by both young participants and their parents as worsening the 
fatigue itself [supplementary data, page 365]. 
 
...if I just sit around and do nothing I feel even tired-er sometimes. [TYA2, phase A] 
 
Because obviously the more you sit still, whoever you are and whatever you have done, the 
more you feel tired. [PAR7, phase A] 
 
Further weight was given to this concept by the many participants who described the negative 
impact of rest and the positive impact of activity on the fatigue within the same phrase 
[supplementary data, page 365]. 
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Like if I spent a week doing nothing, and staying in bed, my fatigue would get worse. 
Whereas if I get up and walked, or even something small like just a five minute bike ride or 
something, if I did that every day I would feel much better than before, if I didn’t do it, if that 
makes sense? [TYA8, phase A] 
 
This quote also provides an example of an important concept that emerged in all three facets of 
theme C1, and will be highlighted within each section. A small change, ‘a five minute bike ride every 
day’, was considered to have the capacity to lead to a sizeable benefit.   
 
Although no participants used the term ‘vicious cycle’, it was often implicit. 
 
But it's a long haul because... and I think if you’re tired and exhausted through no fault of 
your own, if you then do nothing you get even more tired and exhausted. [PAR3, FG, phase 
A] 
 
Furthermore, the concept of a vicious cycle was invariably understood by participants when it was 
raised in discussion by the interviewer. 
 
... that classic vicious circle where if you are fatigued, you are less active, and if you are less 
active you get unfit, and if you are unfit, you get more fatigue, which I guess is what is behind 
how you know that you wanted to be more active with walking. [Interviewer] 
Yes, yes. [TYA10, phase A] 
So you knew that already? [Interviewer] 
Definitely, yes. [TYA10, phase A] 
 
The description of the benefits from activity included the concept of breaking a vicious cycle, to turn 
the situation into a cycle of improvement. 
 
You just push through the initial thing, and you feel much better afterwards, and then even 
the next day you will feel more motivated to do it than the day before. [TYA8, phase A] 
 
Participants’ narratives often included their views on the mechanisms for the benefit of activity. 
Although at times the mechanism was described in physical terms, such as ‘getting fitter’, more 
participants perceived the mechanism as having a psychological component. Activity was 
considered to help the mind by relieving tension, avoiding self-pity and providing a distraction from 
focusing on fatigue [supplementary data, page 365]. 
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I did find that being active helped not only my tiredness but my mental wellbeing, because 
it kind of like was something positive... I found it kind of like helped my mind as well, but it 
helped the tiredness. Because I felt that the days where I was just at home in bed feeling 
sorry for myself, it didn’t really help much, and you actually made yourself feel worse. It is 
like when I am feeling anxious at home, if I am low, going on a run does help that... [TYA7, 
phase A] 
 
I need to be up and doing something, and then I forget about feeling tired, because I'm 
busy. [TYA10, phase C] 
 
But it is like it is psychological isn’t it...? And if it is helping in your head, then it helps the 
rest of your body. [PAR7, phase A] 
4.5.12.2 Thoughts 
All participants were cognisant of the importance of the mind in the experience of fatigue; no-one 
viewed fatigue as a purely physical symptom. As described above, not only was it recognised that 
inactivity had a negative psychological impact that worsened the perception of fatigue, but it was 
also recognised that the fatigue itself had an impact on thoughts and emotions that could worsen the 
symptom, in a vicious cycle. 
 
The first part of the vicious cycle, the psychological impact of fatigue, has already been described in 
detail in several of the preceding themes. Participants reported tensions resulting from the mismatch 
between expectations and reality, along with pervasive misunderstandings (section 4.5.9, page 147); 
the age-related propensity for emotional reactivity compounded the experience of frustration, anger 
and low mood (section 4.5.6.2, page 118). Furthermore, thinking about the potential meaning of 
fatigue, whether it may be representing a return to ill-health, also exacerbated the emotional impact 
of fatigue. 
 
I think the thing with cancer is, is that there isn’t an end to it... So for us at the minute it is 
every three months. So you are always waiting for the next ‘okay’. So if [TYA4[ gets tired, 
then you are thinking, ‘Oh is there a reason why she is getting tired, is it just because she is 
working, or is she okay...?’ [PAR4, phase A] 
So it is the meaning of the fatigue, rather than the fatigue itself, is the impact on you? 
[Interviewer] 
Yes. [PAR4, phase A] 
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Importantly, participants also recognised the converse, that psychological factors could, in turn, 
influence the feeling of fatigue. This insight was particularly evident in the views of parents, rather 
than TYAs, and most often talked about in terms of the impact of mood on fatigue [supplementary 
data, page 365]. 
 
I think your mood will make you more tired. So if you do sit in a room, it is going to make you 
more tired, and you are going to feel more fatigued. [PAR7, phase A] 
 
We realised that sometimes being happy and having fun can actually give you a boost of 
energy. [PAR14, email, phase A] 
 
Only one young participant expressed a similar insight; her views were expressed in the third person, 
in relation to her friends rather than herself. 
 
I think, like I tried to mention earlier, there is another component and it is all to do with what 
you would call the mind, or the soul, or the spirit... I was talking to people at Uni... and I was 
working out that what they were feeling was fatigue was actually they were just 
psychologically unhappy with where they were. The moment they changed that, they no 
longer felt fatigue. [TYA1, phase A] 
 
As described in relation to activity in the previous section, the quote above again demonstrates the 
emerging theme of small changes having the potential to lead to significant benefit. Although TYA1 
did not explicitly state that dealing with being ‘unhappy with where they were’ would be a small 
change, it could be considered to be implied by the word ‘moment’. 
 
The term ‘vicious cycle’ was clearly well recognised as a concept when described by the researcher to 
participants, although it was not volunteered by participants, who tended to use the term ‘spiral’ 
instead. On two occasions a ‘spiral’ of low mood impacting on fatigue was described, both times 
mediated by low mood influencing activity levels. 
 
...it spirals, because then if my mood is low I want to go out even less, then I don’t get the 
exercise. [TYA1, phase A] 
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Because I think they can start falling into this spiral of, ‘I can’t do it, I don’t want,’ you know, 
‘I can’t do anything,’ and all this negativity... I’ve suffered with a lot of depression in my life 
and I know that no matter how I was feeling, no matter how bad I was feeling, if I could get 
up and walk around or just do something, anything, you don’t even need to have a purpose, 
just walk, I would be better. And then I was able to do something more... But you have to 
take that first bit, literally your first step. [PAR8, phase A] 
 
The focus of thoughts was mentioned by a number of participants; thinking about fatigue could make 
it worse, leading to a ‘self-fulfilling prophecy’. 
 
I think if you focus on being tired, you will get tired. If you focus on being energised and 
awake and achieving something, then you are more likely to achieve that. [PAR4, phase A] 
 
Conversely, moving one’s focus away from the myriad of thoughts, toward a mindful focus on the 
present, was perceived by several young participants as helpful for the fatigue, consistent with the 
findings discussed in section 4.5.7.2 (page 132). 
4.5.12.3 Sleep 
Despite the fact that topic of sleep was not explicitly included in the interview and focus group topic 
guides, virtually every young participant provided unsolicited descriptions of sleep changes, reports 
that were invariably corroborated by their parents. Poor sleep was, unsurprisingly, considered to 
cause fatigue. 
 
Although some participants described needing to sleep more than usual, the main concern was the 
converse, with difficulty getting enough sleep [supplementary data, page 366]. 
 
I can’t go to sleep before 2:00am... I am up at like 7:00am... I am not sleeping. I have got 
sleepers and they are just not... well they do work, but it takes like an hour and a half for 
them to kick in. And then it is only there for a couple of hours, and then I am awake again.  
[TYA11, phase A] 
 
I'm not getting much sleep at all but I don’t think there’s anything that you guys could have 
done about that... I've sort of got into a routine at the minute where I know that I'm not 
going to get much sleep so I just deal with it. Like I've sort of got into the habit now not 
getting much sleep and feeling tired in the mornings, so that’s sort of my routine at the 
minute. [TYA12, phase C] 
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[TYA6] hasn’t actually slept now for about three weeks, it went from her just like sleeping 
sporadically but now she’s just not sleeping at all. [PAR6, phase A, FG] 
 
A number of participants volunteered unhelpful sleep habits they had identified themselves, most 
commonly going to bed too late, or sleeping too late in the morning [supplementary data, page 366]. 
 
There is an aspect of my habits that could help the fatigue, which... I don’t go to bed at good 
times... I have never had a good bedtime routine. So they are attributing any kind of thing 
that could be fatigue onto my poor choices... [TYA1, phase A] 
 
Where she had the exams, there was a reason for her to have to get up in the morning. But 
now I do find that she is sleeping later in the day, and then she is finding it really difficult to 
sleep at night. [PAR6, phase A] 
 
When the subject was raised by the interviewer, many participants did report use of electronic, light-
emitting devices in the bedroom, acknowledging the potential negative impact on sleep 
[supplementary data, page 366]. 
 
He hasn’t been sleeping well... [PAR12, phase A] 
So there is light in the bedroom. [Interviewer] 
Normally have light from the phone. [PAR12, phase A] 
 
As well as sleep-related habits that impacted on the amount of sleep gained, a few participants 
described a state of arousal that hindered sleep. Anxiety related to the cancer diagnosis was 
sometimes implicated [supplementary data, page 366]. 
 
And I think that thinking back on it, one of the biggest issues was that [TYA4] couldn’t sleep.  
And so she didn’t share what was going on in her head with us, but you can guess that the 
fear of the whole thing was meaning that she was having a lot of broken sleep, so she wasn’t 
sleeping solidly through the night. [PAR4, phase A] 
 
Several young participants expressed anxiety or frustration about the difficulty sleeping 
[supplementary data, page 368]. 
 
I'm not getting anywhere near as much as I probably should. I'm not sure why... That’s been 
my main thing that I’ve been worried [about]... [TYA12, phase C] 
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One parent described the fatigue directly making it hard to sleep.  
 
You can get too tired to sleep too, don’t you? So you didn’t sleep last night. [PAR14, phase A]  
 
As with ‘activity’ and ‘thoughts’ above, the same interesting theme emerged, of small changes being 
able to lead to a significant or sizeable benefit. Several TYA and parent participants provided insight 
into how feasible it was to break unhelpful sleep habits, to improve both sleep and fatigue. TYA6 
described the vicious cycle of being too tired to function effectively during the day, with the resulting 
daytime inactivity hindering sleep at night. She broke this cycle by taking medication to help her 
sleep for just two nights [supplementary data, page 367, for full quote].  
 
...but I really didn’t want to take it at first, but I took it for, like, two nights, and then I was 
really well rested. And then I just woke up that day and was, like, I need to do something. 
[TYA6, phase C] 
That’s really interesting. So it was actually taking that medication that got rid of the, sort of, 
vicious circle you were in of being too tired to do other things. [Interviewer] 
Yeah. [TYA6, phase C] 
 
Another participant, TYA3, described a dramatic transformation after receiving the prototype 
intervention, by fixing her sleeping and waking times, and by stopping use of energy drinks to keep 
awake during the day. After receiving the prototype intervention, she said: 
 
I’ve managed to build my energy back up and I’m now doing things that I thought I wouldn’t 
be able to do... [TYA3, phase C] 
...what’s made the difference? [Interviewer] 
I started recording my sleep pattern... So instead of drinking like numerous amount of energy 
drinks to keep yourself awake, I started drinking just water... My sleep pattern, because I was 
like waking up in the night, I just decided I needed to put it on like a time thing, so I set an 
alarm for when I need to go up to bed, and then set an alarm for when I need to get up. 
[TYA3, phase C] 
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TYA3 followed these comments with an implicit acknowledgement of the ‘hurdle’, referring to the 
hardest part when the change was made. This was then followed by increasing improvement, a 
vicious cycle having been broken and turned into the converse, a virtuous cycle. 
 
I mean starting off I thought no, I can’t do this, it’s going to wear me out even more, and 
once you get over that kind of bit of a hurdle… your body is like, ‘I’m not used to this, this 
isn’t right,’ it starts kind of getting better each week, and then it starts getting better each 
day. Like you get to where I am now and I can wake up at like 9 o’clock, and I can be awake 
until gone 11, and I’m fine. [TYA3, phase C] 
 
TYA10 described the benefits of keeping busy during the day. This avoided the unhelpful sleep habit 
of sleeping during the day, and her phrase, ‘it just gets better from there,’ again implied transition 
into a virtuous cycle of improvement. 
 
I think you need something to take your mind off the fact that you feel tired, because once 
you're sucked into something else you forget that you were tired, and then the whole day 
has gone past and you realise that you haven’t actually had to have a sleep in the afternoon, 
say. It just gets better from there. [TYA10, phase C] 
4.5.12.4 Theme C1 discussion 
This theme has described three areas where the emotional and behavioural responses to fatigue 
contributed to the symptom. This provides potential for a vicious cycle, which can perpetuate fatigue 
beyond the underlying trigger, such as cancer treatment, so that it becomes a self-sustaining 
phenomenon. 
 
First, participants noticed that fatigue led to inactivity, both by its direct effect on energy levels and 
because of well-meaning family members trying to help by undertaking the activities themselves. 
However, resting was described by many participants as unhelpful for the fatigue, for both physical 
and psychological reasons. Second, fatigue led to thoughts and emotions, including symptom focus, 
tensions and low mood, with the ‘state of mind’ then appearing to worsen the perception of fatigue. 
Third, unhelpful sleep habits, including use of electronic devices in the bedroom, sleeping during the 
day, and worrying about the impact of lack of sleep, all had the capacity to worsen sleep and 
therefore fatigue. 
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Participants recognised the development of ‘vicious cycles’, either by concurring with the interviewer 
when the term was used, or by volunteering the term ‘spiral’. Furthermore, several participants 
revealed insight into how making small changes, particularly in relation to keeping active during the 
day and developing good sleep habits, could make a big difference to fatigue. In other words, small 
changes were breaking a vicious cycle and allowing the converse, a virtuous cycle of improvement, to 
develop. 
 
Contextualising with existing literature 
The relationships between emotional and behavioural factors and fatigue are well-established, as 
discussed in section 1.1.1.3 (page 3). In a large prospective study of breast cancer survivors, Schmidt 
and colleagues found that chemotherapy use was not associated with long-term fatigue, whereas a 
range of psychological and lifestyle factors did correlate with the symptom [42]. Building on this, in 
another longitudinal cohort study involving breast cancer survivors, Andrykowski and colleagues 
revealed slight worsening of fatigue in the years after the end of cancer treatment; fatigue severity 
was predicted by the emotional and behavioural factors of poor coping, such as preoccupation with 
symptoms, but only in those patients with persistent late fatigue 42 months after the end of 
treatment, and not in those with early fatigue. This suggests that the emotional and behavioural 
factors may have a role in perpetuating fatigue. 
 
Relationships have been found between a number of symptoms – including breathlessness and pain 
– and emotional and behavioural factors; these connections are thought to be mediated through 
activation of the cortico-limbic area of the brain [392,393]. This region subserves awareness of 
threats to survival, and generates avoidance behaviours motivated by emotion, which confer a 
survival advantage in an acute threat to homeostasis [394]. Chronic perceived threats – symptoms 
being defined as a ‘perceived threat to health’ [145] – appear, however, to lead to maladaptive 
emotional and behavioural responses that can inadvertently worsen the symptom [394]. Of note, 
adolescent neurodevelopment has evolved to have a low threshold for picking up perceived threats, 
given the stereotypical context of moving from a safe parental, to a novel, environment (section 
1.1.2, page 7)[66]; it is conceivable that the young brain may have a particular propensity for 
generating such responses to the perceived threat of symptoms. 
 
Previous research supports each of the bidirectional relationships described in this theme, and is 
summarised in the following paragraphs. This evidence does not specifically relate to the TYA CRF 
context; it comes mostly from research evaluating CRF in older adults and CFS/ME.  
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Regarding the connections between fatigue and activity, it is intuitively clear that CRF is a barrier to 
activity, supported by evidence, not least from the survey. The reciprocal, that inactivity contributes 
to fatigue, is consistent with the evidence that exercise ameliorates CRF [56,164,243]. FICS 
participants considered that exercise improved fatigue through physical and, particularly, 
psychological mechanisms, views that are also well evidence-based. Exercise in adults with CRF and 
CFS/ME increases fitness [164,345,395], with reconditioning mediating some of the beneficial effects 
of activity on fatigue [396]. Activity is also known to be psychologically beneficial, improving mood 
and anxiety which, in turn, ameliorates fatigue, as discussed below [345,397,398]. Other factors 
known to mediate the beneficial effects of activity on CRF include improving self-efficacy [399], 
reducing systemic inflammation [400], improving sleep [400], and in CFS/ME rather than CRF, 
reducing activity fear avoidance beliefs [395]. Through a range of mechanisms, therefore, fatigue and 
activity are linked by bidirectional relationships.  
 
The link between fatigue and low mood is well-established in adult CRF and in CFS/ME [401,402]. 
Although the two symptoms often co-occur, as part of an established symptom cluster [403], 
association of the symptoms as a consequence of a shared mechanism has not been proven. Indeed, 
fatigue and depression, although related, appear to be biologically distinct. Fatigue, for example, is 
associated with a hypoactive HPA axis, and depression with the converse, a hyperactive axis 
[404,405]; furthermore, depression responds to paroxetine in patients with cancer, whereas fatigue 
does not [406]. It appears that fatigue and low mood have a causal relationship, rather than sharing a 
common mechanism. However, there is no clear evidence to date as to the predominant direction of 
causality, with conflicting longitudinal studies in adults with breast cancer suggesting that depression 
predicts the onset of fatigue [40], that fatigue precedes depression [407] and that neither symptom 
predicts the onset of the other [408]. A large longitudinal study involving patients with unexplained 
fatigue, including CFS/ME, suggested that each symptom could act as an independent risk factor for 
each other [402]. It seems likely, therefore, that the relationship is bidirectional. 
 
Anxiety also appears to cause, and be caused by, fatigue. As established in the systematic review, 
fatigue is a distressing symptom for TYA cancer patients. Although the evidence for anxiety and 
tension being able to cause fatigue is less strong than it is for depression [401], anxiety has been 
shown to be an independent predictor of CRF in adults [272], and longitudinal follow-up of patients 
with breast cancer suggests that anxiety can predict future fatigue development [40]. It is relevant 
that in the context of the closely related symptom of breathlessness, fMRI evaluation has suggested 
that anxiety may influence the gain of sensory information processing in the paralimbic system, 
therefore changing the perception of symptom intensity [409]. 
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Sleep and fatigue are particularly closely associated, which again appears to be due to the two 
symptoms causing each other, rather than the presence of a shared underlying mechanism. Bower 
and colleagues have demonstrated that, in patients after breast cancer treatment, systemic 
inflammation contributes to fatigue, but not to sleep disturbance [410]. While impaired sleep 
unsurprisingly results in fatigue [41,411], there is ample evidence for the converse. Evidence-based 
models of insomnia involve maladaptive emotional and behavioural responses to daytime fatigue 
that inadvertently worsen the insomnia, further perpetuating the problem [412-415]. Such responses 
include spending more time in bed, napping during the day, irregular sleep-wake schedule, 
catastrophising about the impact of insomnia and nocturnal use of light-emitting electronic devices 
[118,414]. Much of the evidence for perpetuating psycho-behavioural factors comes from studies 
evaluating non-cancer patients with primary insomnia, in which daytime sleepiness and fatigue are 
not always assessed [413,416,417]. There is a smaller volume of evidence for the same processes 
occurring in CRF; Rumble and colleagues’ longitudinal study in adults with breast cancer, found that 
dysfunctional thoughts and behaviours were antecedents of insomnia [411]. 
 
Overall, for each of the vicious cycles relating to activity, thoughts and sleep, there is some evidence 
in the literature for bidirectional relationships with CRF in adults, albeit not in TYAs. The potential for 
reciprocal causality to lead to vicious cycle development has long been conceptualised, particularly 
within the clinical practice of Allied Health Professionals, such as physiotherapists and psychologists 
[418,419]. Vicious cycles of thoughts, emotions and behaviours are believed, for example, to 
maintain affective disorders such as anxiety, depression and insomnia [415,420,421]. Elucidating and 
breaking these cycles is fundamental to the practice of cognitive behavioural therapy (CBT) 
[422,423]. In CFS/ME, psychologists have recently developed a Cognitive and Behavioural Responses 
Questionnaire to measure those responses that are recognised to perpetuate fatigue [424]. 
However, these findings from FICS appear to be the first research report of vicious cycles 
contributing to the perpetuation of cancer-related fatigue. 
 
Furthermore, no research has been found that explicitly acknowledges and examines the possibility 
that making a small cognitive or behavioural change has the potential to lead to a sizeable benefit, by 
breaking the perpetuating vicious cycle and generating the converse, a virtuous cycle of 
improvement. This suggests that this finding may also be a novel insight. 
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Integrating with Fatigue in Focus survey 
These qualitative findings were consistent with a number of survey results: that fatigue is a barrier to 
exercise, that exercise is considered the most helpful approach for fatigue, and that fatigue clusters 
most closely with low mood and anxiety. In addition, these data provide potential explanations for 
survey findings. While the cross-sectional survey could only indicate associations, FICS could assess 
causality because of its qualitative and longitudinal design, revealing bidirectional relationships. The 
unanticipated survey finding that fatigue severity was worse more than one year after the end of 
cancer treatment could, at least in part, be explained by vicious cycles perpetuating the symptoms, 
beyond the initial triggers of cancer diagnosis and treatment. The finding that fatigue treatment was 
considered less successful in those survey participants further from the end of cancer treatment may 
also be explained by the entrenchment of the symptom with vicious cycles. Equally, as discussed in 
section 3.6.1.3 (page 82), these findings could be explained by selection bias or by an increasing 
mismatch between expectations and reality. 
 
Summary 
The existence of bidirectional relationships between fatigue and the domains of activity, thoughts 
and sleep is already established in the literature. However, this study has taken this a step further 
with the insights that vicious cycles may contribute to the persistence of CRF, and that these cycles 
can be broken with relatively small interventions. 
 
This theme not only explains fatigue perpetuation beyond the initial trigger but also contributes to 
the design of the fatigue intervention itself. Insight into vicious cycles may help patients understand 
why a symptom is persisting. Self-efficacy may be enhanced by providing a rationale for how a small 
and feasible change, that breaks a vicious cycle, can make a meaningful difference. These points are 
discussed further in section 4.5.14 (page 180). 
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4.5.13 Theme C2: Responses to fatigue relate to outcomes 
During the course of analysis, a set of associations emerged between responses to fatigue and 
fatigue-related outcomes. Examples of identified responses and outcomes are detailed below. 
 
Table 4.10 Examples of responses and outcomes 
 Positive  Negative  
Responses Proactive approach to activity 
Positive, confident thoughts 
Active self-management of sleep 
Engagement with intervention 
Fearful avoidance of activity 
Negative, overwhelmed thoughts  
Acceptance of poor sleep habits 
Lack of engagement with intervention  
Outcomes Confidence in fatigue management 
Improvement in fatigue severity 
Ability to return to education / work 
Lack of confidence in fatigue self-management 
Unchanging fatigue severity 
Limited return to education / work 
 
In the initial exploratory analysis, participants were divided into four broad categories in relation to 
the extent of positive or active approach, the degree of intervention engagement, and the level of 
improvement in fatigue between the end of cancer treatment and the end of study involvement 
(represented in table 4.11 by + + / + / − / − −). Judgement was based on participants’ own reports of 
their outcomes and the prototype intervention audit (section 4.5.15.1, page 184). The following data 
patterns were found. TYA participants with a positive and proactive approach, in terms of affect or 
activity, achieved better fatigue outcomes than those with negative, fearful or passive attitudes. 
Further, there was a relationship between the extent to which an individual participant took a 
positive or active approach, and the degree of intervention engagement. 
 
Table 4.11 Exploratory tabulation of participant approaches, engagement and fatigue outcomes 
TYA  Positive or active approach     Intervention engagement Improvement in fatigue 
1 + + + 
2 + + + + 
3 + + + 
4* + + − + + 
5 − − − − − − 
6 + − + 
7 + + + + + 
8 + + + + + + 
9 − + − 
10* + + − + + 
11 − − − − − − 
12 + + + + + + 
14 − − NA − − 
+ + most; − − least; * pattern outliers 
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The qualitative and longitudinal nature of the data provided insight into the perceived mechanisms 
driving the positive or negative outcomes. Participants were regrouped according to the 
predominant approach, within the ‘categories of ‘activity’, ‘thoughts and ‘sleep’ (table 4.12), that 
they reported most strongly influenced their outcome. This led to the emergence of the pattern 
shown below.  
 
Table 4.12 Predominant mediating approach for positive outcomes  
Most positive outcomes          Mixed outcomes Least positive outcomes 
    
TYA  Approach TYA  Approach TYA  Approach 
4 
7 
8 
10 
12 
Activity 
Activity 
Activity 
Activity  
Activity 
1 
2 
3 
6 
Thoughts 
Thoughts 
Sleep 
Sleep 
5 
9 
11 
14 
NA 
NA 
NA 
NA 
Activity: regular exercising, ranging from walks to formal gym-based activity 
Thoughts: insight into the influence of thoughts and mood on fatigue; seeking ways to calm the mind 
Sleep: making efforts to improve sleep habits 
NA: not applicable 
 
4.5.13.1 Positive outcomes 
The five participants who described most improvement in their fatigue, and reported the easiest 
reintegration into work and education were the five young people who were most active, 
undertaking regular physical activity each week. Of note, these participants were all active before 
the point of recruitment and needed little encouragement to continue this during the study itself, 
raising questions about the relative importance of innate attitudes and external intervention, as 
discussed below. Two participants, TYA4 and TYA10, while evidently engaged in the research, did 
not feel it necessary to engage with the prototype intervention, as fatigue had already improved 
and their lives were busy with education or work. They are the two outlying points in table 4.11, 
marked with * [supplementary data, page 368]. 
 
So long walks has always been a part of family life. So I try to involve myself more in that, to 
up my energy levels, and I did find that was really helping. [TYA10, phase A] 
 
...but I was at school for the whole time while I was on chemo so my brain was active, it was 
still... but maybe that's why it’s not as bad as some of... [TYA8, FG, phase A]  
Yeah… some other people… [Multiple voices, FG, phase A]  
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Those participants with positive outcomes were often described by others as having a positive 
psychological approach, indeed, although not explicitly named as such by participants, as having self-
efficacy for self-management. For example, the therapist providing the prototype intervention made 
the following comment in relation to TYA7: 
 
She felt very grateful for the diagnosis... because she felt like it had directed her life, and 
now she is studying...which is something she had always wanted to do but never really 
organised herself to do it...she was exercising probably about five times a week and feeling 
the best she had ever felt. [HCP, phase C] 
 
Two of the most active and positive TYA participants were exposed to particularly positive and 
proactive attitudes from their parents [supplementary data, page 368]. 
 
I think if you focus on being tired, you will get tired. If you focus on being energised and 
awake and achieving something, then you are more likely to achieve that... And if you take a 
positive approach you will get a better outcome, whatever that might be. [PAR4, phase A] 
 
We really need to get people to understand that they are responsible for their own health. 
[PAR8, phase A] 
 
While physical activity and a positive approach were most strongly associated with good outcomes, 
active attempts to influence one’s emotions and sleeping were also helpful. Several of the young 
participants with reasonably positive outcomes reported benefit from mindfulness and equivalent 
approaches. As described in section 4.5.12.3 (page 168), for participants TYA3 and TYA6, the 
positive impact of small changes on fatigue was particularly striking: fixing bed and wakening times, 
and two doses of sleeping tablets respectively led to definite improvement in fatigue. Others 
reported that keeping busy during the day led to better night-time sleep and improved fatigue.  
 
... she found that actually when she got up and made herself do something, then she slept 
better than she did if she didn’t. So actually there was some motivation in terms of going to 
work, which was helping her to then sleep better at night afterwards. [PAR4, phase A] 
4.5.13.2 Negative outcomes 
Participants reporting less good outcomes shared some characteristics in their responses to 
experiencing fatigue: negativity, passivity and limited engagement with the intervention. 
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Avoidance of activity, because of a perceived negative impact on fatigue severity, was pervasive 
amongst this group of participants [supplementary data, page 368]. 
 
...at the moment exercise just seems to make it worse. I just end up drained rather than like 
bouncing. [TYA2, phase A] 
 
What do you think made it [fatigue] a little bit better than the summer? [Interviewer] 
Maybe the rest and time I guess. [TYA9, phase C] 
 
Although concerned about possible detrimental consequences of activity, many of these less active 
participants did express some awareness that activity or exercise could be helpful.  
 
So, do you go for walks, or out on a bike? [Interviewer] 
I know that it is something that probably would help. [TYA5, phase A] 
 
Only the dyad TYA14 and PAR14 did not talk about any potential benefits at all, reporting only the 
adverse consequences. TYA14 was the only participant with concurrent CFS/ME and CRF. This is 
discussed further in section 4.5.16.2 (page 193). 
 
“But actually to you, you knew what was going to keep you safe. [PAR14, phase A] 
Safe from...? [Interviewer] 
Being deathly ill from doing too much. [TYA14, phase A] 
 
The participants with most negative outcomes, along with some of those with mixed outcomes, 
tended to articulate negative or overwhelmed thoughts, and express lack of self-efficacy for self-
management [supplementary data, page 368]. They were more likely to feel misunderstood and to 
experience tensions, or to express loss of hope or motivation.  
 
And what, can you kind of identify what’s stopping you from acting on that advice [about 
being active]? 
I don’t know really, lack of motivation then that all stems from other things I guess. I have 
always been like that to some extent. [TYA5, phase A] 
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This same group of participants tended to describe poor sleep patterns and unhelpful sleep habits. 
 
I am not sleeping. I have got sleepers [sleeping tablets] and they are just not... well they do 
work, but it takes like an hour and a half for them to kick in. And then it is only there for a 
couple of hours, and then I am awake again. ...It makes me really tired in the day, but then 
when I try and close my eyes it just... as soon as I close my eyes I am back awake again... Like 
the other night I didn’t go to sleep until 6:00am, and I was awake again at 8:00am. [TYA11, 
phase A] 
 
Participants with the most negative outcomes were those who engaged least with the prototype 
intervention. Only one engaged; TYA9 met the intervention therapist on one occasion only and did 
not respond to follow up. 
4.5.13.3 Theme C2 discussion 
The core finding of this theme was the association between participant responses to fatigue and 
fatigue outcomes. Responses, in terms of three domains described in the previous theme – activity, 
thoughts and sleep – had a relationship with the outcomes of confidence in managing fatigue, the 
degree of improvement in fatigue and the ability to return to education and work. Specifically, 
positive, active, engaged approaches related to better outcomes, whereas negative, passive or 
disengaged approaches were associated with worse outcomes. Other than two participants, who 
wanted to support the research but did not feel they required the prototype intervention as their 
fatigue was already much improved, there was a marked relationship between engagement with 
the prototype fatigue intervention and fatigue outcomes. 
 
There was a suggestion that baseline activity was an important mediator of outcomes. Participants 
achieving the best fatigue outcomes attributed the benefit to activity, and were invariably active 
before the point of recruitment. Conversely, those with the worst outcomes tended to describe 
activity fear avoidance beliefs.  
 
As with the prior theme, the longitudinal and qualitative nature of data allowed causal inferences to 
be drawn, beyond simple descriptions of associations. As well as participants providing insights into 
the mediators of fatigue outcomes, data collection occurring over several months revealed 
temporal patterns in relevant parameters. Two participants, for example, changed sleep behaviours 
and described subsequent benefits in terms of fatigue, suggesting a causal relationship.  
 
The pattern of participants with the better fatigue outcomes already being active at the time of 
recruitment raises important questions. To what extent are fatigue responses inherent? Is 
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intervention needed in those proactive people with high baseline activity? These points will be 
considered in relation to existing literature, below, and also in section 4.6.1.2 (page 202). 
 
Contextualising with existing literature 
It has long been recognised that some characteristics of people living with chronic health conditions 
can influence health outcomes. Two key constructs described in the literature are a) patient 
activation and b) perceived self-efficacy.  
 
Patient activation is a concept developed by Hibbard and colleagues, defined as ‘an individual’s 
knowledge, skill and confidence for managing their health and health care’ [425]. There is robust 
evidence that high activation levels are associated with a wide range of positive health outcomes, 
including parameters of good control of chronic disease, engagement with healthcare services, 
positive experience of healthcare, reduced utilisation of hospital and lower healthcare costs [426]. It 
is a largely inherent characteristic, involving patients’ general approaches and behaviours relating to 
health; there is limited evidence that it can be changed by intervention [427].  
 
As discussed in section 1.2.4 (page 16), perceived self-efficacy is a closely-related concept that refers 
to confidence in achieving specific goals [141]. Unlike patient activation, it is not a trait and thus is 
more amenable to change with intervention [154,155,428]. Perceived self-efficacy has been widely 
used in the context of cancer symptom self-management, and mediates improved outcomes [145-
147,149,150].  
 
Those FICS participants with confidence in their ability to manage fatigue were manifesting high 
self-efficacy for fatigue management. The proactive approach to activity, engagement with 
intervention and ability to return to education or work are broader features suggestive of higher 
patient activation. Both constructs and associated features were associated with better patient 
outcomes in this study, consistent with the literature [429].  
 
The good outcomes in those TYAs with highly activated parents is again congruent with existing 
literature. Parents’ support for activity has been shown to be an independent predictor of activity in 
adolescent cancer survivors, although no research has evaluated such relationships in CRF [430]. 
Open and supportive family relationships predict treatment engagement and adherence in 
adolescent and young adult cancer patients [90]. 
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Integrating with Fatigue in Focus Survey 
Although the survey did evaluate potential fatigue responses to a limited extent, such as 
participants’ views on the best treatments for fatigue, it could only indicate associations, not causal 
relationships; there was no way of differentiating whether these were responses to, or causes of, 
the symptom. There was a suggestion from the survey, a trend that was not statistically significant, 
that participants considering active treatments for fatigue to be better than passive treatments had 
lower fatigue scores. The FICS findings support the suggestion that an active approach in response 
to fatigue may indeed have a causal influence on improved fatigue outcomes. 
 
Summary 
Overall, this theme suggests that active, positive and engaged responses to the experience of 
fatigue were not only associated with, but actually caused, improved fatigue outcomes. These types 
of responses are consistent with high activation or self-efficacy, constructs well-explored in the 
literature, and known to influence health outcomes. 
 
This theme reinforces the theoretical underpinning of this work, that self-efficacy is an important 
predictor of outcomes in TYA cancer-related fatigue. Given that self-efficacy is goal-specific and 
amenable to change with intervention, improving perceived self-efficacy for fatigue self-
management is a suitable objective for the definitive intervention. Participants with an active 
approach, even before receiving the prototype intervention, had improved outcomes that did not 
appear to be related to intervention. The relevance of this to intervention personalisation will be 
considered in section 4.6.1.2 (page 202). 
4.5.14 Conceptual model C: Sleep, Thoughts, Activity (STA) model of TYA fatigue 
The vicious cycles caused by bidirectional relationships between fatigue and the domains of sleep, 
thoughts and activity has led to the development of the following conceptual model (figure 4.4). The 
data underpinning this model are predominantly from theme C1, and also from themes B1 and C2. 
 
This type of model is termed a ‘vicious flower’ maintenance formulation, and is widely used within 
psychology. First conceptualised by Salkovskis and colleagues in relation to treating obsessive 
compulsive disorder, it has since been used in a number of psychological conditions, including 
depression [431,432]. This type of formulation has been previously proposed by Spathis and 
colleagues, in relation to vicious cycles maintaining the symptom of breathlessness in the context of 
advanced cardio-respiratory disease (discussed from a reflexivity perspective in section 4.5.16.3, 
page 196), but has not otherwise been used outside of a psychology context [433].  
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Figure 4.4 Sleep, Thoughts, Activity (STA) conceptual model of TYA CRF 
 
 
 
Each vicious cycle in the conceptual model serves to feed back and worsen the fatigue. The central 
circular arrow demonstrates the suggestion from theme C1 that there is a degree of interaction 
between the three ‘petals’. For example, participants described how activity relieved tension (page 
163); others commented on the relationship between improved sleep and being able to be more 
active (page 176, page 367). The literature supports such interaction between sleep, thoughts and 
activity; tension or distress can lead to sleep disturbance that impacts on CRF [434], and improved 
sleep quality partially mediates the benefit of exercise on CRF [400]. 
 
Cognitive behavioural conceptual models of fatigue have previously been developed in the context of 
several chronic conditions: CFS/ME, rheumatoid arthritis, multiple sclerosis and stroke [435-438]. 
However, this is the first such model generated in the context of CRF for patients at any age. 
Induction of a cognitive behavioural model is consistent with the increasing evidence for 
psychological therapies, including cognitive behavioural therapy (CBT), being effective for CRF in 
older adults [48,56]. Given the adverse impact of cognitive fatigue in TYAs, it is noteworthy that CBT 
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appears to be of particular value for the treatment of cognitive fatigue in adult cancer patients after 
cancer treatment [439]. 
 
This conceptual model has potential to support perceived self-efficacy for fatigue self-management. 
The presence of vicious cycles can make sense of the symptom by explaining how fatigue can persist 
beyond the initial trigger of cancer and its treatment. Given the prevalent therapeutic scepticism 
(section 3.5.5.2, page 73), it may be empowering for patients to understand that benefit can be 
achieved by breaking a vicious cycle. Further motivation may come from understanding that a small 
change, sufficient to interrupt a vicious cycle, may result in a sizeable impact through generation of a 
virtuous cycle of improvement.  
 
From a healthcarer perspective, the proposed model reinforces the value of early intervention, 
before entrenchment of vicious cycles. It could also be professionally motivating, countering any 
professional scepticism, a point explored further in relation to an outlying case (section 4.5.16.2, 
page 192). Use of the model may allow focus on the predominant vicious cycle – the ‘active 
ingredient’ for an individual – increasing intervention efficiency and potentially improving adherence, 
given the impact of fatigue on concentration and memory (section 4.5.6.1 page 116) [440]. Simply 
addressing the misconception driving the predominant vicious cycle for an individual has the 
potential to form a brief and effective intervention, for example: ‘many people get on their phones if 
they’re up at night, but the light from the phone keeps them awake’ (sleep); ‘feeling more fatigued 
one day doesn’t mean you’re getting ill again’ (thoughts); or ‘building up activity slowly over time 
won’t make the fatigue worse’ (activity). 
4.5.15 Co-designed intervention 
The aim of this study was to co-design a non-pharmacological fatigue intervention, by ascertaining 
views on optimal intervention design (study objective 3) and evaluating the experience of having 
received the prototype intervention (study objective 4). During phases A and B of this three phase 
study, the intervention prototype was developed and delivered. In phase C, participants provided 
feedback on the prototype, to refine it further into the ‘trial ready’ co-designed intervention. 
4.5.15.1 Intervention prototype 
The intervention prototype design was informed by the following: 
1) Patient and parent participants views on optimal design, gathered in 21 individual semi-structured 
interviews. 
2) Two focus groups, one of patients and one of parents, providing further design advice. 
3) A co-design meeting discussion involving the research team, a former patient (and PPI lead) and 
the AHP delivering the prototype intervention. 
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Those attending the co-design meeting were provided with a summary of views gathered in phase A. 
The prototype was fundamentally based on the synthesised opinions of TYA and parent participants. 
The research team influenced the prototype in two ways. First, a brief overview of research evidence 
for helpful approaches for CRF was provided to participants during the interviews in phase A; second, 
a small number of pragmatic decisions were made by considering what would be feasible to deliver 
within the practical constraints of the research study: 
 
1. Participants’ aspiration was for the HCP to be available for weekly contact; however, resource 
constraints meant that it was agreed that the intervention prototype would involve a minimum 
of one face-to-face contact with each participant, with subsequent contact by a mutually 
convenient method, such as telephone, email or Skype. If further face-to-face contact was 
clinically indicated, it would be offered only if the AHP had capacity. 
 
2. Although participants suggested that short peer-produced videos would be the optimal way to 
provide information, these had not yet been produced at the time of prototype delivery. 
Information was therefore given with a standardised ‘Tips for managing fatigue’ sheet created by 
the AHP, and by sharing a link to an online Evans Health Lab video on CRF freely available on 
Youtube [441]. 
 
Full guidance on the intended features of the prototype intervention was created for the AHP 
delivering the prototype (appendix 7.4.11, page 339). An overview of the intended prototype is 
provided in the first column of table 4.13. After the intervention delivery phase, a retrospective audit 
of the clinical case notes was undertaken to find out what, in practice, the delivered prototype 
intervention had been documented to involve. Details are provided in the second column of table 
4.13. 
 
The main difference between the intended and delivered intervention was the limited involvement 
of parents. The AHP involved parents if they were present when she met the young patient or there 
was apparent interest in this, but did not proactively try to involve parents; only two parents were 
involved in phase B of the study [PAR3, PAR12]. 
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Table 4.13 Overview comparison of intended and delivered features of prototype intervention 
Intended prototype intervention Delivered prototype intervention 
Intervention name  Road to Recovery: Fatigue Support (R2R) 
Available to all participants. 8/12 participants engaged with intervention (1/12 no 
response to contact, 3/12 no response after first 
telephone or text initial contact).   
Principles 
Flexible and individualised. Evidence in all 8 participants, with every aspect of 
intervention content individualised. 
Involving parents where wanted by YP. Only 2/8 participants involved a parent; the others did 
not proactively request parental inclusion (although not 
asked their views on this). 
Content 
1. Education/guidance 
Electronic, preferably video format. 7/8 participants given link to Dr Evans Health Lab video. 
May include: information about fatigue, 
managing expectations, information 
about improving sleep pattern. 
Individualised information in all 8 participants. 
2. Exercise/activity 
Promotion of activity of YP’s choice. 7/8 participants. 
May include: structured incremental 
activity with clear goals, monitoring using 
health Apps. 
2/7 given general information and 5/7 given specific 
individualised advice. 3/7 documented advice to monitor 
with specific health Apps. 
3. Energy conservation 
May include: analysing priorities, support 
with pacing, short relaxation techniques. 
Evidence in 8/8 participants. In 7/8 participants given 
information about ‘boom and bust’ avoidance, and in 7/8 
encouraged to use mindfulness App (Headspace). 
Process 
Mutually convenient location, and mode 
of communication. 
Location: home (n=2), ward (n=2), non-clinical hospital 
location (n=2), coffee shop (n=1). 
At least one face-to-face meeting, with 
subsequent contact flexible according to 
needs. 
7/8 had one face-to face meeting (none had more than 
one meeting). Main mode of contact other than face to 
face: telephone (n=4), text (n=3), email (n=1). Total 
number of clinical contacts: mean 1.4 (range 1-3). 
Give individualised Tips list as PDF to 
download on phone. 
7/8 participants. 
One letter to YP, with copy to specialist 
healthcare team. 
Letter to YP in 7/8 participants, with copies to consultant 
in 5/8. 
Maximum intervention length three 
months. 
Maximum intervention length 14 weeks (range 1-14 
weeks, mean 5.8 weeks). 
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4.5.15.2 ‘Trial ready’ co-designed intervention 
The interviews undertaken with patient and parent participants in phase C, after having received the 
prototype intervention, provided valuable information that allowed further optimisation of the 
intervention. The AHP, who had delivered the intervention, was also interviewed. 
 
Overview of feedback on prototype intervention 
The majority of the feedback was complimentary; much of this has already been extensively 
described in preceding sections.  
 
There were three areas of particularly positive feedback (section 4.5.7). First, many participants 
spoke about appreciating specific advice on how to build up exercise, given their unmet information 
need relating to ‘how much to push’ (page 133). Second, participants attached much importance to 
people being able to set meaningful personal goals (page 129), to enhance motivation; without 
labelling it as such, participants were supporting a health coaching approach (page 125). Third, 
several participants gave positive feedback on their experience of using App-based short mindfulness 
techniques (page 133). 
 
All these points indicated the single most valued aspect of intervention: the provision of information. 
Even in those parts of the intervention that could be construed as involving behaviour change, 
participants appeared to attach most value to gaining knowledge and to being given information and 
advice. Participants appreciated knowing what to expect, knowing how to build up activity and ‘how 
much to push’, advice on how to speak to a prospective employer, and information about helpful 
sleep habits. As the AHP who delivered the prototype summarised: 
 
 So it’s actually the information sharing is a much more important part of this than I think I've 
given credit before. And therefore it can be a brief and early intervention. [HCP, phase C] 
 
As well as intervention prototype validation, there was also constructive and valuable negative 
feedback. The main point was the wish to have more regular contact with the AHP than was 
provided. This level of contact was considered necessary to support an individualised, specific and 
structured plan (section 4.5.7, page 128). 
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Yes, so if there was kind of more contact with someone, maybe? Even if it was like via choice, 
like email or like phone call? [TYA7, phase C] 
 
But as I say I think that goes along with the fact that he is very disappointed to have just one 
meeting to, as he sees it, to help his fatigue. [PAR2, phase C] 
 
Two other areas of suggestions for change were made. There was much feedback on the irrelevance 
of talking about pacing (section 4.5.7.2, page 131). There was also little interest in the written 
information ‘Tips for managing fatigue’ sheet, which received no positive comments. This is 
consistent with the requests in phase A for individualised information in electronic format, with 
advice from peers rather than healthcarers (section 4.5.7.2, page 136). One participant provided 
negative feedback: 
 
To be honest I saw the sheet and then just looked at it and it wasn’t relevant at that time. I 
put it away and just didn’t look at it again. It may have had something on, but I just didn’t... 
[TYA2, phase C] 
 
‘Trial ready’ co-designed intervention 
The features of the ‘trial ready’ co-designed intervention are summarised in table 4.14. The evidence 
underpinning each of the components of the intervention has already been provided throughout the 
discussion of the six major themes, particularly in relation to theme A2: ‘TYA developmental 
characteristics influence intervention design.’ The intervention content falls within three categories, 
‘activity’, ‘information’ and ‘mindfulness’, with the acronym ‘AIM.’ 
 
An inherent tension in the design of this ‘trial ready’ intervention was the need to balance the 
flexibility and individualisation required by young patients, with the necessity for a well-defined, 
prescriptive intervention that can be reliably and consistently delivered. Intervention fidelity is 
recognised to be particularly challenging in the field of complex interventions; there is some 
evidence that restricting flexibility in intervention delivery can impact negatively on outcomes 
[442,443]. A balance has therefore been struck, seeking to define the ‘trial ready’ intervention as well 
as possible, whilst supporting flexibility by providing principles along with a range of options in each 
category. At this stage, the STA conceptual model has not been included in the intervention because 
it requires further evaluation, as discussed in section 4.6.5.2 (page 210). In the future, its 
incorporation could add value to an intervention by promoting self-efficacy, explaining the 
mechanism for change and providing insight into the ‘active ingredient’ for an individual (section 
4.5.14, page 182). 
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Table 4.14 Features of the ‘trial ready’ fatigue intervention 
‘Trial ready’ fatigue intervention 
Road to Recovery: Fatigue Support (R2R) 
Comments 
Principles  
 Promotes self-efficacy for fatigue self-
management. 
 Flexible and individualised. 
 Health coaching approach. 
 Involving parents at young person’s 
discretion. 
 Provide as early as possible, during cancer 
treatment or at the point of it finishing. 
Proactively ask if want parents to be involved, as 
no evidence from prototype experience that 
patient will raise this. 
No need to continue with constraint of prototype 
intervention timing (during year after end of 
cancer treatment). 
Content (AIM)  
1. Activity 
 Specific support with activity of young 
person’s choice. 
 Structured incremental activity towards 
young person’s own goal. 
 Monitoring using a health App (individualised 
choice). 
Call ‘activity’ rather than ‘exercise’ as more 
inclusive for people who do not want to formally 
exercise. 
Feedback emphasised need for regular contact and 
support with ‘how much to push’ oneself. 
Include addressing fear avoidance beliefs as data 
analysis revealed importance of this concept. 
Promotes self-efficacy through activity planning, 
goal setting and feedback. 
2. Information 
 Individualised content may include: 
information about fatigue, managing 
expectations, sleep hygiene, speaking to 
employer. 
 Range of formats: short videos available on 
social media made by young cancer patients, 
written information for parents. 
Call ‘information’ rather than ‘education’, as this is 
the term TYAs consistently used. 
Minimise leaflets and written information for 
young people. 
Promotes self-efficacy through vicarious 
experience, social comparison and modelling. 
3. Mindfulness 
 Regular periods of ‘time out’ and ‘relaxation’. 
 Mindfulness techniques can be accessed with 
an App such as ‘Headspace’. 
 Yoga and Tai Chi are alternative options. 
‘Time out’ and ‘relaxation’ are more relevant than 
‘energy conservation’ or ‘avoiding boom and bust’. 
Feedback suggested App-based mindfulness 
techniques are particularly acceptable. 
Process  
 Mutually convenient location, mostly out of 
hospital. 
 At least one face-to-face meeting, with 
subsequent individualised contact often by 
email or text. 
 Minimum of one personal letter to TYA, with 
copy to specialist healthcare team. 
 Provision by an AHP, with access to other 
AHPs including a psychologist if needed. 
Individualised, paper ‘tips’ list was unhelpful. 
Avoid constraints of prototype intervention (the 
maximum intervention length was 3 months, and 
delivered by an OT only). 
More regular contact wanted; this could be 
provided by some mode of electronic 
communication. 
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Table 4.15 Techniques to establish the trustworthiness of the research findings [444,445] 
Techniques Comments Quality  
Credibility 
Prolonged 
engagement and 
persistent 
observation 
Every member of the research team, involved directly in the research process, was either a member of the TYA cancer service 
or had collaborated clinically with it over several years. This lead to a deep familiarity and understanding of the research 
context, as well as trust between researchers and clinicians, sufficient to allow individuals to express potentially eccentric or 
uncomfortable perspectives. 
High 
Triangulation There was extensive triangulation on many levels: between sources (TYAs, parents, HCP), between individuals at different 
time points, between researchers (two people involved in interviewing), and between methods of qualitative data collection 
(interviews and focus groups). Triangulation is described in detail in section 4.5.16.1 (page 191). 
High 
Deviant case 
analysis 
Although consistency was high in the triangulation process, two cases provided data that appeared, to some extent, to be 
inconsistent with the prevailing data patterns. Slightly refining the data analysis, so that these deviant views could be fully 
integrated within the whole, was valuable in this study, as described in section 4.5.16.2 (page 192). 
High 
Member-
checking 
Extensive opportunities arose to check the interpretations and conclusions with members of the groups from whom the data 
was obtained. Examples include the sharing of findings from the interviews at the focus groups, the summarising of 
preliminary findings at the co-design meeting and phase C interviews, provision of a formal outcome summary to all 
participants after the study with encouragement to feedback, and many post-study discussions of the findings with 
patientgroups (section 5.2, page 225). 
High 
Support of 
participant 
honesty   
Efforts were made to avoid coercing potential participants to get involved, participants were encouraged to be frank with 
explicit assurance of confidentiality, and participants could withdraw at any time without their care being affected. Some 
participants did, indeed, feel safe to express negative views about healthcare provision, as well as the prototype intervention. 
However, participants were aware that the researchers were clinicians, so it was not possible to mitigate the potential impact 
of this on truth-telling fully. 
Medium 
Peer debriefing  
and scrutiny 
Anna Spathis (AS) had monthly supervisions when aspects of this project could be discussed, and the work was presented to 
peer academics, both locally and nationally, and to the local TYA service healthcare team on several occasions throughout the 
project. The feedback and fresh perspectives challenged assumptions and helped refine insights. AS was, however, the only 
researcher who scrutinised all the data, and undertook the analysis. 
Medium 
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Researcher 
reflective 
commentary 
AS kept an electronic iterative record of observations, reflections and insights throughout the conduct of the study. This 
informal commentary has been valuable in the process of noticing patterns and connections within the data and, therefore, 
supporting data analysis. Researcher reflexivity is discussed further in section 4.5.16.3 (page 195). 
Medium 
Referential 
adequacy 
This involves archiving a section of the data before analysis, and returning to it subsequently to test the validity of the 
preliminary findings; it was not undertaken in this project. 
Low 
Transferability 
Thick description An in depth discussion of each of the key themes of this work has been undertaken, which includes an attempt to 
contextualise the experiences with findings in other patient groups, in different settings and at different times relative to 
medical treatment. For example, it has been particularly valuable to consider the external validity of these findings in relation 
to CFS/ME in adolescents and young adults (section 4.6.1.1, page 199) 
Medium 
Dependability 
External audit No external audit was undertaken to check the research process, and to evaluate independently whether or not the findings 
and their interpretations are supported by the raw data. However, sufficient raw data are provided in sections 4.5.6-4.5.13 
and in appendices 7.4.14-7.4.15, to facilitate the reader in developing his or her own impressions. 
Medium 
Confirmability 
Triangulation This is described above and in section 4.5.16.1 (page 191). High 
Audit trail Electronic records have been kept of every stage of the research process, including the raw data itself, anonymised data, 
steps within data synthesis, process and reflective notes. These are sufficient to provide a clear description of the research 
process, and the choices and decisions made within it. 
Medium 
Reflexivity This is described above and in section 4.5.16.2 (page 192). Medium 
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4.5.16 Trustworthiness of research  
In the preceding sections of this chapter, many findings of potential interest and importance have 
been described. However, before conclusions can be drawn, it is vital to evaluate the trustworthiness 
of this work [446]. How valid and reliable are these research findings? 
 
The value of qualitative research has long been questioned, particularly by those schooled in the 
positivist paradigm of a single reality, found through objective and unbiased measurement [447]. 
Naturalistic inquiry is underpinned by different ontological and epistemological beliefs to scientific 
positivism. It reflects a ‘real world’ complex reality, with emphasis on experiences, perspectives and 
meaning [448]. 
 
In a seminal and widely accepted approach, Lincoln and Guba have developed four constructs to 
evaluate the trustworthiness of qualitative research that correspond closely to the criteria of validity, 
generalisability, reliability and objectivity used by a positivist investigator [445].  
 
1) Credibility. This refers to confidence in the ‘truth’ of the findings. It is one of the most important 
factors in establishing trustworthiness, equivalent to the concept of internal validity in quantitative 
research. 
  
2) Transferability. The applicability of the findings to other contexts corresponds to the positivist 
concepts of external validity and generalisability. 
 
3) Dependability. Analogous to ‘reliability’, this construct considers whether the findings are 
consistent and could be repeated. 
 
4) Confirmability. This considers the objectivity of the research. Confirmability is influenced by the 
neutrality of researchers, and the extent to which the findings are shaped by researcher and 
respondent bias. 
 
Each of these evaluative criteria can be assessed by a series of techniques [444,445]. These 
approaches are summarised in table 4.15, along with a researcher assessment of the relative 
strength of the study in relation to each technique. Without attempting to weight the relative 
importance of the techniques, the overall quality and trustworthiness of this research appears to be 
moderate to high. Three of the techniques, triangulation, deviant case analysis and researcher 
reflexivity are described in detail in the following sections. 
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4.5.16.1 Triangulation 
The design of this study facilitated extensive data triangulation. Data was multi-perspective, 
multiphase and collected with multiple methods (interviews and focus groups). Integration of 
qualitative and quantitative research findings between this study and the survey also provided 
further potential for triangulation; this is considered within the multimethod analysis section in 
chapter 5, as it relates to findings from more than one study.  
 
During data analysis, contemporaneous notes were made of concordance and discordance between 
data sources, between data time points and between methods of data collection. The key finding 
from the triangulation process was the remarkable level of concordance. The overall level of 
consistency is highly supportive of the credibility of the data. An example of the level of congruence 
between a TYA and parent is given below. Further examples of each type of concordance, including 
between data time points and across different methods of data collection, are provided in appendix 
7.4.15 (page 370). 
 
And they [parents] get quite upset seeing that if I’ve got plans and I have to cancel them, 
they can get upset about it. I think that makes them quite upset. [TYA6, phase A] 
 
It is quite upsetting sometimes to see her sort of separating herself from her friends, because 
she doesn’t feel that she can keep up with them. [PAR6, phase A] 
 
While the congruence between one individual at different time points and in different data collection 
contexts (individual interviews versus focus groups) was not unexpected, the virtually universal 
congruence between young people and their parents was notable. This important finding has already 
been described in relation to the tensions experienced by young patients and their families, 
described in theme B2 and modelled in the ‘Concordant Tension Tree’ (section 4.5.11, page 160).  
 
There was only one example of clearly inconsistent triangulation. This was between a young 
participant’s perspective and that of AHP providing the prototype intervention, and is discussed as 
one of the two deviant cases in the following section. There were a number of additional minor and 
unsurprising differences in perspective between TYAs and their parents, which have already been 
described in the theme narratives. Examples of this include: young people considering that fatigue 
makes them feel ‘angry’ whereas parents were more likely to say it caused their child to feel 
‘frustrated’; TYAs talking in terms of having to ‘rely’ on others but parents describing it as 
‘regression’; and young people being more likely to engage with electronic and visual communication 
than their parents, who prefer paper written information. 
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4.5.16.2 Deviant case analysis 
Two outlying cases became apparent during the thematic analysis, each of which allowed the 
analysis to be further refined [449]. Case 1, by revealing a small inconsistency in data triangulation, 
provided insight into the potential role of the ‘small change leading to large benefit’ theme in 
dispelling therapeutic scepticism. Case 2, considering a participant with concurrent CFS/ME, provided 
insights into study generalisability. 
 
Case 1: TYA3 
The perspectives of TYA3 and the AHP providing the intervention were entirely, indeed diametrically, 
different. The AHP identified TYA3 as the single person she was concerned would do least well from 
the intervention, and might not progress well in the future. In contrast, TYA3’s fatigue improved 
enormously, and she gave amongst the most positive feedback on the intervention of any of the 
participants. This conflict in view was the single significant example of incongruence during the 
triangulation process, and is encapsulated in the two quotes below. 
 
I don’t think you’re missing anything, I think how you helped me was just perfect for me, I 
think it kind of depends on everyone and how they take things. [TYA3, phase C] 
 
...with the exception of one person, [TYA3] was probably less engaged in things, and I think 
that was probably a pattern of behaviour. It’s quite difficult to tap into something that might 
be helpful for her really. [HCP, phase C] 
 
As previously described, TYA3 provided details of the factors that had facilitated her recovery from 
fatigue (section 4.5.12.3, page 168). She volunteered the importance of the intervention in 
‘motivating’ people to reach their ‘own goal’, describing a health coaching approach (section 4.5.7.1, 
page 125). This being a patient-led process, the AHP was not easily able to anticipate how TYA3 
would proceed after their consultation. It was evident, in retrospect, that finding out about the 
patient’s personal goal – feeling healthier by Christmas – and ‘planting a few ideas’ was sufficient for 
considerable behaviour change after the intervention. 
 
 So in a way, am I right in understanding that [HCP] kind of planted a few ideas in your mind, 
but you’ve sort of decided which bits make sense to you. And then it sounds like you’ve more 
than done them, and really done them very … in a very determined way. [Interviewer] 
 Yes. [TYA3, phase C] 
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TYA3 simply fixed her sleep time and cut down on energy drinks. The improved sleep led to her 
feeling more energetic during the day; she therefore needed less energy drinks and was able to be 
become more active, leading to a series of interlinked virtuous cycles and a highly positive outcome.  
 
[TYA3] looks the picture of health, she can do things, she puts her mind to it, she’ll go, “Right, 
I’m going to do so and so.”...I mean, yesterday we were at the hospital and then she went ice 
skating last night. [PAR3, phase C]  
 
This triangulation incongruence deepens insight into the potential interventional value of the ‘small 
change, significant benefit’ concept within theme C1 (section 4.5.12, page 161). The AHP scepticism, 
‘difficult to tap into something that might be helpful for her,’ was at odds with the considerable 
subsequent benefit. Understanding the potential benefits from small changes is likely to be 
motivating for healthcare professionals as well as for patients; HCPs would then be better placed to 
enhance the confidence of patients in their capacity to improve their fatigue.  
 
Case 2: TYA14 and PAR14 
This TYA-parent dyad was an outlier in several ways. TYA14 and PAR14 were recruited after the study 
had closed for recruitment and after prototype intervention delivery, because of their desire to 
increase healthcare professionals’ understanding of fatigue; they did not wish to receive the fatigue 
intervention themselves.  
 
In several instances, their views were at one end of the spectrum of opinion across the research 
cohort. They were the only participants who explicitly stated that healthcare professionals did not 
understand their fatigue-related experiences and needs (page 151). Whereas all other participants 
considered cognitive fatigue to be more problematic than physical fatigue, TYA14 described physical 
fatigue as the worst, ‘shortly followed by’ cognitive fatigue (page 118). A final difference was that 
TYA14 was the only participant who did not consider activity to have any potential benefits, reporting 
only the adverse consequences of activity and endorsing rest; the other participants expressing 
activity fear avoidance beliefs still perceived, at some level, the inherent benefits of activity (page 
177). 
 
TYA14 was the only participant with a CFS/ME diagnosis as well as CRF. Qualitative research strives to 
attain maximum variety patient samples, in order to be as ‘information-rich’ as possible [450]. It is 
worth considering whether the diversity provided by this dyad was such that their views risked 
reducing the credibility of the findings, or whether their inclusion did, conversely, enhance the 
research insights. 
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Several arguments support the latter view. TYA14’s views remained within the spectrum of 
perspectives across all participants, albeit at one end. For example, TYA14 still considered cognitive 
fatigue to be highly problematic, along with the other participants. Although, TYA14 and PAR14 were 
the only people to challenge healthcarers’ understanding of fatigue explicitly, this perspective could 
have been in the mind of participants who spoke in general terms about misunderstandings. 
  
I think as far as the fatigue thing goes, everybody goes, ‘Oh, the cancer’s gone, you’re fine 
now.’ [TYA3, phase C] 
 
This study was carried out in a single centre, with core members of the healthcare team also part of 
the wider research team. It is, therefore, unlikely that participants would have felt safe to challenge 
healthcarer perceptions so openly, even in the context of assurances of confidentiality. TYA14, in 
contrast, was speaking with the experience of a CFS/ME diagnosis that predated the cancer, and 
many years of interacting with professionals beyond those in the TYA cancer service. 
 
It is well recognised that people with CFS/ME perceive poor healthcarer understanding, in the 
context of a contested diagnosis (section 4.5.9.4 page 152). Furthermore, the other difference in the 
perspective of TYA14 and PAR14 – activity fear avoidance beliefs – is also highly consistent with 
research findings in CFS/ME, as described in the forthcoming discussion (section 4.6.1.1, page 199). 
 
It can therefore be argued that the subtlety of the differences in perspectives between this dyad and 
the cohort as a whole, along with the consistency of their views with that documented in the CFS/ME 
literature, has not threatened the credibility of the findings. Unlike in a quantitative study where 
outlying data can fundamentally alter results, the ‘thick description’ (page 190) in the thematic 
analysis allows the findings to be appropriately contextualised. Indeed, the relatively small and 
evidence-supported differences in perspective gained from the single participant with concurrent 
CFS/ME reinforces the argument for fatigue being a trans-diagnostic symptom (section 4.6.1.1, page 
200); it is conceivable that the research findings can, at least in part, be generalised to other groups 
of young fatigued people.  
4.5.16.3 Reflexivity 
Reflexivity refers to the consideration of the influence of researchers’ perspectives on the research 
process itself. As stated by Malterud, ‘preconceptions are not the same as bias, unless the researcher 
fails to mention them’ [451]. Rosaldo described the impact of personal position on depth of 
understanding in his poignant account of the death of his wife, which influenced significantly his 
insights in his own research into the experience of rage in bereavement [452].  
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Lincoln and Guba describe three steps that foster reflexivity in research [445]. The first is to report 
researcher values, beliefs and perspectives within any research manuscript of publication. The 
second is to design research that includes multiple investigators. The third is for the researcher to 
record personal reflections on the research process in a reflexive journal. These points are 
considered below. Due to the personal nature of this short account, this section is – uniquely – 
written in the first person. 
 
Multiple investigators 
This research necessarily involved the perspectives of many others. Although I (Anna Spathis) 
undertook every step of the data analysis, during the research conduct phase and both through and 
after the data analysis stage, I undertook extensive and critical dialogue about this study with a 
broad range of individuals. This includes the following: 
 
Psychologist in TYA CFS/ME   
During qualitative data analysis, I corresponded and spoke regularly with a psychologist from another 
centre in the UK working with adolescents with CFS/ME. This was a particularly fruitful collaboration 
that broadened my insights considerably. It led at times to consensus, for example that fatigue is a 
trans-diagnostic symptom, the experience being age-dependent. At other times it led to unresolved 
debate; for example, this research suggested that pacing was of limited relevance to TYAs, whereas it 
remained an important component of the psychologist’s practice. 
 
Assistant with fatigue insight   
Early transcripts were double-coded with a research assistant who had suffered from chronic fatigue 
in a non-cancer context. As well as striving to achieve consensus on the initial coding, the process 
lead to valuable debate and reflection on early findings. 
 
Wider research team   
Throughout this work, most aspects of the research process and findings have been discussed with 
my MD supervisors and with the wider research team (section 4.4.7.2, page 107). The co-design 
process itself involved discussion with research colleagues and other healthcare professionals, 
contributing significantly to the depth of insights and providing scope to redress inherent perspective 
biases. 
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Dialogue after presentations   
This work has been presented at a wide range of meetings, with clinicians and academics, both at the 
host organisations and at other centres nationally. The discussion after such presentations has also 
been highly valuable and reflexive, further fostering the reliability of the study findings. 
 
Reflexive diary 
Although I did not write a formal paper ‘diary’, I made continual additions to an electronic ‘notes’ 
document throughout the entire research process, in order to capture ideas and insights for 
incorporation in the data analyses and discussions throughout this thesis, and to reflect on my own 
position within the research process. Apart from reflections on the practical experience of 
undertaking the research and my considerable personal learning from the process, there were three 
topics of particular importance. All three related to my primary professional role as a clinician 
working with symptomatic patients. 
 
Rapid recruitment 
The ease of recruitment is worthy of reflection given the pervasive challenge of recruiting to clinical 
research, particularly when involving potentially vulnerable participants [326]. I have reflected on 
whether there might have been hope that the intervention would be helpful, despite the primary aim 
of the research being intervention co-design rather than successful fatigue treatment. Participants 
may have volunteered, or the usual healthcare team may have encouraged recruitment, due to such 
hope. Many participants did indeed express benefit from the research, TYAs in terms of fatigue 
support and parents from the experience of the focus group: 
 
I think this has been amazing, knowing that there are other people in this black hole with me 
is great. I thought I was going mad, my child’s disappeared into the demon, you know... 
[PAR3, FG, phase A] 
 
I think it was quite therapeutic though... I think that group where we turned up was really 
helpful. I found it really helpful. [PAR8, phase C] 
 
Although participants explicitly knew that the purpose of the research was to help future 
symptomatic patients rather than themselves, research involvement often leads to participant 
benefit, from a sense of altruism and from the research process itself [453]. Young patients are 
particularly known to be keen to take part in research and to influence future healthcare [136,137]. 
Whilst not possible to exclude the possibility of undue influence, several factors suggest that altruism 
was the predominant driver for recruitment. No evidence emerged that participants misunderstood 
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the research premise. The two participants for whom the study re-opened to recruitment were 
explicit in their desire for others to learn from their experiences, and did not want to receive the 
intervention themselves. Another potential contributor to the ease of recruitment may have been 
that most patients were initially approached by the TYA service Youth Support Co-ordinator; 
evidence suggests that TYA cancer patients in the UK feel that non-clinical Youth Support Co-
ordinators are particularly well-suited to a recruitment role [454]. 
 
Previous model development 
As described in the personal statement in the preface (page iv), I work as a palliative care consultant 
in a clinical service providing an intervention for patients with intractable breathlessness, the 
Cambridge Breathlessness Intervention Service. With the benefit of previous (basic level) cognitive 
behavioural therapy training, over recent years I had noticed that vicious cycles were inadvertently 
worsening breathlessness. This led to proposal of the Breathing, Thinking, Functioning (BTF) clinical 
framework, describing three key vicious cycles [433]. The model has been recognised as a valuable 
educational tool in clinical practice [455,456]. However, although the model describes the content of 
an evidence-based, cost-effective complex intervention [457], the BTF framework itself is empirical, 
being based on clinical observation and experience. 
 
The Sleep, Thoughts, Activity (STA) model described in section 4.5.14 (page 181) has undoubtedly 
been influenced by my experience of developing the BTF clinical framework. I was already cognisant 
of the concept of vicious cycles worsening and perpetuating symptoms, such as breathlessness and 
fatigue, and was therefore in a position to notice the occurrence of these with TYA participants. My 
appraisal of the model’s potential utility in clinical practice (page 182) has also been influenced by my 
clinical experiences of using the BTF framework to support breathlessness management. 
 
I consider that my clinical experience has allowed me to extend the analysis of the relevant data 
about vicious cycles more rapidly and to a greater depth than might otherwise have occurred, 
particularly in relation to the clinical implications of the vicious cycles. On careful reflection, I do not 
believe it has impacted on the credibility of the findings. Although I had the empirical impression 
from clinical experience that perpetuating vicious cycles were occurring in chronic fatigue, I certainly 
did not intend or expect this study, focused on intervention co-design, to generate a model based on 
the emotional and behavioural responses to fatigue. It was the strength of the research data, 
including unsolicited insights such as ‘fatigue breeds fatigue’ [TYA8, PAR8], that led to the 
unanticipated development of theme C1 and resulting STA conceptual model.  
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Prediction of participant outcomes 
As with theme C1, theme C2 – responses to fatigue predict outcomes – was unexpected and strong. I 
became self-aware during the months that the study was running that, as a clinician, I was 
instinctively appraising the likely forward health trajectory of participants. Indeed, during phase C, 
these appraisals were mostly found to be accurate; the theme emerged out of the insight that it was 
those participants with the most positive, proactive, confident and physically active approach who 
achieved the best fatigue and broader health outcomes. 
 
Although, on reflection, I do not believe it would have been possible for me to ignore professional 
experience and clinical acumen, two points still lead me to consider this theme credible. First, I did 
not anticipate the emergence of the theme prior to the research. It was the consistent and strong 
evidence that led to theme development, rather than preconceptions. Second, as described in 
section 4.5.16.2 (page 192), one participant’s outcomes were far from congruent with those 
anticipated. Preconceptions, by definition, played no part in this outlying case where analysis indeed 
led to extension of research insights. 
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4.6 Discussion 
This multiphase, multi-perspective, qualitative study has attained its primary aim of working with 
TYAs and their parents to develop a ‘trial ready’ fatigue intervention. The prototype intervention – 
the outcome of the first phase of individual interviews, focus groups and a co-design meeting – was 
delivered to participants, with subsequent feedback and further amendment resulting in the ‘trial 
ready’ intervention described in section 4.5.15.2 (page 187). The key finding has been the 
clarification that TYAs have unique age-related intervention needs. Consistent with WHO guidance 
[79], research findings relating to older adults cannot be extrapolated to younger patients. This fully 
justifies having carried out this work to design a TYA-focused intervention. 
 
Of particular interest is the extent to which unanticipated insights have emerged from this study, 
beyond description of the ‘trial ready’ intervention. The longitudinal and qualitative design facilitated 
elucidation of causality, with evidence emerging for fatigue leading to emotional and behavioural 
responses that can inadvertently feed back to worsen the symptom. The resulting vicious cycles can 
explain the perpetuation of fatigue beyond the initial trigger of a cancer diagnosis and treatment 
and, importantly, may support effective intervention; small changes, sufficient to break a vicious 
cycle, can lead to relatively large gains, so promoting self-efficacy for fatigue self-management.  
 
Each of the themes has been discussed and contextualised individually in the preceding sections of 
this chapter. This overall discussion seeks to integrate the six themes together into three overarching 
concepts. The integrated findings will be considered both in the context of existing literature and 
relative to the underpinning theoretical framework, before consideration of the strengths and 
limitations of this work, and its implications. 
4.6.1 Integration of themes 
Three overarching concepts have emerged from this study. These can be encapsulated as TYA 
cancer-related fatigue being ‘more about young age than cancer’, ‘more about responses to fatigue 
than the symptom itself’ and ‘more about cognitions than behaviours’. 
4.6.1.1 More about young age than cancer 
As discussed in relation to themes A1, A2 and B1, the experiences and needs of young participants 
were strongly related to the developmental characteristics of their age. Further, they appeared 
similar to those of young people with CFS/ME. Table 4.16 considers features of CRF and CFS/ME 
within the broad categories of ‘younger’ and ‘older’ patients, contextualising FICS findings with other 
relevant literature, much of which has been previously discussed. Although limited by lack of 
evidence in some areas, the table can be seen to demonstrate a general pattern of age appearing to 
have more influence on the fatigue experience than the underlying cause of the symptom. 
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Table 4.16 Features of CRF and CFS/ME in young patients relative to older adults 
 Younger patients [evidence source] Older patients [evidence source] 
CRF CFS/ME CRF CFS/ME 
Illness perceptions, 
causal attributions 
Psychological and 
physical [FICS] 
Psychological and 
physical [362,364] 
Mostly physical 
[361] 
Mostly 
physical [458] 
Adverse impact on 
family from care-giving 
Higher [FICS] Higher [388,389] Limited 
evidence 
Lower [391] 
Activity fear avoidance 
beliefs 
Higher [FICS] Higher [345] Lower [367] Limited 
evidence 
Acceptance of energy 
conservation, pacing 
Lower [FICS] High but relatively 
lower than older 
CFS/ME [334] 
Higher 
[342,343] 
Higher [459] 
 
The relative concordance between young people with different chronic diseases suggests that fatigue 
is a trans-diagnostic symptom, influenced by factors beyond the underlying pathology. Although 
fatigue is highly prevalent in many chronic diseases, it has to date tended to be evaluated using a 
disease-specific approach [460,461]. In a highly relevant recent study, a Dutch team analysed fatigue 
severity data from 15 studies involving 1696 patients with a range of non-malignant chronic diseases 
[461]. The type of chronic disease predicted only 11% of the variance in fatigue severity, whereas a 
range of trans-diagnostic cognitive and behavioural factors increased the predicted variance to 61%. 
Of note, young age was a significant predictor of increased fatigue across the entire patient cohort. 
 
Why might it be that young age has such an influence on the experience of fatigue, irrespective of 
diagnosis? Many of the features of adolescent cognition and behaviour can be explained with a 
neurobiological model of brain development (section 1.1.2.2, page 6),including a focus on self-
identity, seeking independence from parents, getting into conflict, conforming with peers, impulsivity 
and emotional reactivity [66,461]. As outlined in theme A1, fatigue directly hinders many of these 
age-related developmental needs, contributing to the negative and distressing experience of fatigue. 
Importantly, such needs, being age-related, are likely to occur irrespective of the underlying 
diagnosis that triggered the fatigue. Furthermore, as described in theme C2, cognitive and 
behavioural responses to the fatigue in turn influenced the symptom itself. Not only does this mean 
that the fatigue is modified by factors beyond the underlying diagnosis, the cognitive and 
behavioural responses themselves will be influenced by young age, such as development of 
interpersonal tensions or poor sleep due to nocturnal use of electronic devices.  
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There are considerable implications from this integrated theme. It justifies the need to develop an 
age-appropriate intervention, rather than attempt to extrapolate findings from older adults. 
Importantly, it also gives potential for the findings of this research to be generalisable, at least in 
part, beyond the TYA cancer population to other young people experiencing fatigue.  
 
Other than in relation to cancer and CFS/ME, little literature has considered fatigue in the context of 
chronic illness in young patients. A small qualitative study has evaluated the experiences of 
adolescents with paediatric multiple sclerosis, and found that cognitive fatigue had a highly negative 
impact, as in the current study [386]. There have been sporadic reports in paediatric inflammatory 
bowel disease [462], juvenile arthritis [463] and chronic neurological conditions [464]. Type 1 
diabetes is a relatively common, serious chronic illness in children and young people [465]; in a 
cohort of type 1 diabetics with a mean age of 48 years, fatigue was the most troublesome symptom 
of the 34 symptoms assessed and, interestingly, young age was a predictor of fatigue severity [466].  
 
These studies suggest that fatigue is a significant and under-investigated problem in young people 
with a range of chronic conditions, beyond cancer and CFS/ME. Given the apparent trans-diagnostic 
nature of fatigue, there is potential that the findings of this research may be relevant to these other 
young patient groups. The research implications will be discussed in section 4.6.5.2 (page 209). 
4.6.1.2 More about the responses to fatigue than the symptom itself 
With its design allowing inferences of causality, this study has confirmed bidirectional relationships 
between fatigue and a number of cognitive and behavioural factors. Although it is increasingly well 
established that such factors can predict fatigue [461], are associated with fatigue continuing long 
term [42], and can be amended to improve fatigue [56], there has not as yet been any attempt to 
model exactly how such factors interact with the symptom. The novel finding of reciprocal 
relationships, encapsulated in the STA conceptual model (section 4.5.14, page 180), provides a 
mechanism for how fatigue can perpetuate beyond the initial trigger of cancer and its treatment, as 
well as a rationale for how small changes can lead to sizeable outcomes. 
 
The longitudinal study design has also provided a valuable opportunity to examine temporal patterns 
and ‘turning’ or ‘tipping points’ (section 4.2.2.2, page 101). It has generated insights into the 
relationship between fatigue responses and subsequent healthcare outcomes, described in theme 
C2. Those participants with positive fatigue responses tended to avoid the vicious cycles in the STA 
model and had more favourable outcomes. Theme C2 therefore reinforces and validates the premise 
of theme C1.  
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System dynamics is a mathematical methodology developed in the 1950, initially from an 
engineering perspective, to understand complex systems. ‘Tipping points’ are well-recognised, with 
reinforcing feedback loops leading to a new equilibrium, and small changes effecting substantial 
outcomes. Within health, ‘systems thinking’ has been used to understand complex healthcare 
systems as a whole [467]. In recent years, a number of psychopathological states have begun to be 
characterised as complex dynamic systems, with the resulting statistical modelling and simulation 
studies starting to generate clinically relevant insights [468]. For example, in a recent study of the 
first systems model of major depression, the strengths of the links (‘connectivity’) between 
depression and associated symptoms were mathematically shown to impact on system stability 
[469]. The authors identified ‘tipping points’ where small influences led to rapid and significant 
change, and argued that their findings could help elucidate mechanisms for CBT. The findings from 
FICS appear to fit with a system dynamics approach; this is novel in the context of fatigue, and 
potentially worthy of future research evaluation (section 4.6.5.2, page 210). 
 
This overarching concept of the importance of fatigue responses is supported not only by themes C1 
and C2, but also by insights from the co-design process, in relation both to intervention timing and 
personalisation. FICS participants revealed a clear preference for early intervention (section 4.5.7.3, 
page 137). In a qualitative process evaluation of RESTORE, a web-based intervention to enhance self-
efficacy to manage CRF, Foster and colleagues also found that cancer patients expressed the same 
preference, and highlighted the value of identifying a ‘teachable moment’ when recipients of the 
intervention would be most receptive [300]. There is growing evidence for the benefits of early 
supportive care in cancer, in parallel with disease-modifying treatment, with potential to increase 
survival, as well as quality of life [470-472]. This has led to the NHS driving nationwide development 
of Enhanced Supportive Care Services. Furthermore, early CBT has been found to be more helpful 
that later CBT in a number of circumstances, including after surgery and in PTSD [473], and this may, 
at least in part, be due to the prevention of cognitive and behavioural changes becoming ‘entrenched 
and habitual’ [474]. In this context, early fatigue intervention may be more effective than later input 
by preventing the responses that inadvertently perpetuate fatigue from fully establishing.  
 
Fatigue responses are also relevant when considering treatment personalisation. Personalised 
medicine is a key concept in modern healthcare. Rather than a ‘one size fits all’ approach, it uses 
certain health-related characteristics to provide an optimal, individualised approach with maximum 
cost-effectiveness [475]. As described in theme C2, participants with high activation and positive 
responses to fatigue achieved better outcomes. Recognition of these individuals may allow 
determination of those requiring less intensive intervention, for example simply reinforcing and 
supporting their inherent approach. Those FICS patients with lowest activation and engagement 
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were less likely to engage with the prototype intervention. For those individuals, full intervention to 
improve self-efficacy for fatigue self-management may still be valuable, given that self-efficacy is 
goal-focused, less inherent and more amenable to change. However, it may be challenging to 
motivate these patients to engage. Promotion of self-efficacy is likely to be crucial; the potential 
role of the STA model in enhancing self-efficacy will be discussed further in section 4.6.2 (page 205).  
4.6.1.3 More about cognitions than behaviours 
Findings from this study, contextualised within existing literature, generate an argument for the 
relative importance of managing cognitions, rather than behaviours, in the field of TYA CRF 
management. Much of the prototype intervention was cognitive in focus, using mindfulness to 
provide periods of calm awareness, and providing information about many aspects of fatigue, such as 
how to speak with an employer. Further, intervention can involve simply addressing misconceptions 
driving vicious cycles; challenging activity fear avoidance beliefs and misconceptions about sleep 
were important parts of the prototype intervention (section 4.5.14, page 182) 
 
Although many of these approaches may lead to subsequent behaviour change, such as increasing 
activity or speaking with an employer, the benefits reported by participants in phase C were a 
consequence of the initial cognitive step, with participants particularly valuing information giving 
(section 4.5.15.2, page 185). This is consistent with Self-Efficacy Theory as will be discussed below; 
self-efficacy is a cognitive concept that, in turn, mediates behaviour change. The main behavioural 
consequences from the intervention were changing sleep habits, in a small number of participants. 
 
It is increasingly recognised that, in order to intervene successfully, a focus on the brain and 
cognitions is needed. Acknowledgement of the therapeutic value of the placebo effect and the need 
to ‘make mind-set matter’ has grown rapidly with recent years, along with acceptance of the high 
degree to which expectations and beliefs can influence objective healthcare outcomes [476,477].  
 
The value of addressing activity fear avoidance beliefs, rather than the behaviour change of 
increased activity, is increasingly recognised. In 2011, the PACE trial established that, for people with 
CFS/ME across a wide age spectrum, graded exercise therapy (GET) and CBT were effective 
treatment approaches, unlike adaptive pacing therapy [345]. A secondary analysis of the data found 
conclusively that reduction in activity fear avoidance beliefs was the greatest mediator of benefit 
from the intervention, whereas increasing fitness did not mediate treatment effects [395]. An earlier 
study evaluating GET for CFS/ME had also found that those who subjectively improved with 
intervention were not fitter than the rest of the cohort [478]. FICS provides evidence consistent with 
this, suggesting, for the first time, that activity fear avoidance may mediate outcomes in TYA CRF 
(section 4.5.13.2, page 177). 
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Participants favoured mindfulness over the behavioural construct of energy conservation and pacing. 
Mindfulness, a cognitive psychological approach, has been found to be helpful for a range of 
symptoms including breathlessness [479,480], chronic pain [481] and persistent fatigue in older adult 
cancer survivors [482]. Participants in this study, not only divulged their views on the role of the 
‘mind’ in fatigue management, but also valued support to practise mindfulness during the 
intervention prototype. Such evidence, both from existing literature and from FICS, further supports 
the argument that influencing the brain and cognition is of particular importance.  
 
This perspective is increasingly accepted across a range of symptoms. Considering symptoms as a 
‘perceived threat to health’ [145], it is that perception that can be cognitively modulated, without 
necessarily having to follow through to the subsequent step of behaviour change. Breathlessness 
severity, for example, correlates poorly with the severity of underlying respiratory pathology, and 
there is increasing acceptance that successful breathlessness management requires a focus on the 
brain (cognitions) rather than the lungs [483]. In an article entitled ‘Treating breathlessness via the 
brain’, Herigstad and colleagues undertook fMRI imaging of patients throughout pulmonary 
rehabilitation; they revealed that changes in breathlessness correlated with changes in activity in the 
brain’s stimulus valuation network, highlighting the importance of cognitive expectations and 
interpretations of respiratory sensations [409]. 
 
Focusing on cognitive, rather than behavioural, change has a number of positive implications. It may 
increase the effectiveness of intervention; changing health-related behaviour can be difficult and 
often fails [484]. Determinants of behaviour change are mostly cognitive in nature: knowledge, 
social/professional identity, beliefs about capabilities, beliefs about consequences, motivation, goals, 
memory and attention [485]; successful intervention therefore requires cognitive mediation. Another 
important implication is that a cognitive focus gives potential for brief intervention, for example 
giving information or reframing beliefs, rather than waiting for behaviour change.  
4.6.2 Theoretical underpinning 
A number of factors led to the choice to underpin this programme of research with Self-Efficacy 
Theory (section 1.2.4, page 16). This choice has been validated by the study outcomes, both in 
relation to individual themes, and the overarching concepts described in the previous section.  
 
In theme A2, participants described, without labelling it as such, the importance of perceived self-
efficacy (page 124). Their intervention needs were consistent with those known to promote self-
efficacy, including goal setting, activity planning and provision of feedback on performance [335]. In 
his Theory of Self-Efficacy, Bandura posits that two key sources for increasing self-efficacy are 
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‘vicarious experience’ and ‘social persuasion’. The short videos requested by participants would help 
achieve this, with experienced peers demonstrating successful fatigue management [141]. In 
addition, within theme C2, longitudinal analysis revealed a connection between descriptors of self-
efficacy and fatigue outcomes, both in terms of the presence of self-efficacy and good outcomes, and 
the converse (pages 176, 177). A further validation of the relevance of Self-Efficacy Theory to this 
work is that each of the overarching concepts link with self-efficacy, as shown in figure 4.5 below. 
 
Figure 4.5 Interaction between overarching concepts and perceived self-efficacy (PSE) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1. Autonomy and competence are key adolescent developmental needs; these constructs are 
closely related to PSE, the confidence in one’s ability to carry out a task. Autonomy refers to a 
sense of control, and competence to the perception of capability. Research efforts to 
conceptually separate competence and PSE suggest that the main difference is that the latter 
includes the confidence to carry out behaviours, even in challenging circumstances [486]. It is 
recognised that self-efficacy is a particularly important concept during adolescence [487,488]. 
 
2. The STA conceptual model is a cognitive-behavioural formulation describing responses to fatigue. 
Promotion of self-efficacy is one of the mechanisms of change within CBT, and it is intuitively 
reasonable that higher self-efficacy could facilitate response shift [487]. As the model provides a 
rationale for why fatigue persists beyond its trigger, and because it gives the potential for small 
changes leading to larger outcomes, it is conceivable that the model may promote PSE. 
 
3. The Theory of Self-Efficacy sits within Social Cognitive Theory [141]. PSE is a cognitive mediator 
and key determinant of behaviour change and is amenable to change itself. The finding that 
participants needed a primarily cognitive approach to intervention, with subsequent behaviour 
change of secondary importance, sits well with the theory underpinning the intervention.  
PSE and autonomy 
are key needs 
during TYA 
development 
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2. More responses 
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concept that then 
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change 
PERCEIVED SELF-EFFICACY 
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4.6.3 Methodological discussion 
Although co-design is often used in service improvement [489], it is less often used in the design of 
complex interventions. It is therefore worth appraising the methodological aspects of this study. 
 
Whereas use of innovative methods tends to reveal unanticipated process challenges, as with the 
electronic survey, this co-design process has been notably positive. EBCD appeals to young and 
vulnerable patient groups, ‘whose voices are not often considered’; young cancer patients want an 
active part in research, particularly that focusing on quality of life (section 1.1.3, page 10) [107,490].  
 
Consistent with this, FICS led to an unanticipated level of mutual benefit, both for participants and 
researchers. Not only did the process allow design of an acceptable intervention, but the qualitative 
design led to valuable unforeseen research findings. Participants also appeared to benefit (section 
4.5.16.3, page 189). Recruitment was rapid, with clear enthusiasm for involvement; indeed the study 
re-opened to recruitment because two further people actively wished to engage. During final 
interviews, participants often described personal benefit from study involvement, both in altruistic 
and practical terms. There was considerable engagement with the co-design process, with a few 
participants continuing the dialogue with unsolicited telephone and email contact.  
 
Inclusion of both interviews and focus groups was valuable, as they produced different types of data. 
The individual interviews allowed views to emerge without participants influencing, or being 
inhibited by, each other; eliciting tensions between TYAs and parents, for example, may not have 
been captured in shared interviews. The focus groups led to animated discussions on a number of 
topics, such as young people’s desire to ‘fit in’ and a debate about the intervention name, producing 
data less likely to have been generated in an interview context. Overall, therefore, the use of 
multiple methods of data collection was valuable and increased the breadth of research insights. 
4.6.4 Strength and limitations 
4.6.4.1 Strengths 
As discussed in section 4.5.16 (page 188), the multiphase, multi-perspective and multimethod 
approach led to the study findings being of high quality and trustworthiness, particularly due to the 
ability to triangulate data. Specifically, the study scored ‘high’ or ‘medium’ quality for all but one of 
the techniques to assess credibility, transferability, dependability and confirmability. 
4.6.4.2 Limitations 
The main limitations have already been described. Although multiple investigators provided 
invaluable perspectives including initial double-coding, one researcher (Anna Spathis) undertook 
every aspect of the data analysis. While this allowed a single person to have oversight sufficient to 
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integrate all aspects of the considerable dataset, this approach equally risked excessive influence 
from a single perspective, a point reflected upon in section 4.5.16.3 (page 195). 
 
Defining the ‘trial ready’ intervention necessarily involved attempting to balance the need for clearly 
standardised content, to support future intervention fidelity, with participants’ need for it to be 
flexible and individualised (section 4.5.15.2, page 186). The process was made considerably easier by 
the strength of many of the themes. However, there is an inherent tension between standardisation 
and individualisation, and it is possible that the optimal balance was not found. 
 
A number of other limitations need to be considered. Although there was high apparent congruence 
between patients and parents, four TYAs chose not to involve their parents; it is possible that these 
parents may have held different views to their offspring, and that the high concordance was biased 
by this. There was only one formal phase of feedback within the study; the credibility of the findings 
would have been increased further with further cycles of feedback and prototype amendment.  
4.6.5 Implications 
4.6.5.1 Clinical practice and policy 
The primary aim of this work was to co-design an intervention that could then undergo formal 
research evaluation of its effectiveness. However, a number of clinical implications have still arisen. 
 
It would be reasonable to incorporate some aspects of TYA intervention needs into clinical practice, 
without waiting for the results of the definitive trial. Young cancer patients need help explaining 
fatigue, particularly cognitive fatigue, to staff at education or work; exercise advice is most helpful 
when it includes an individualised structured plan; information about mindfulness is likely to be more 
acceptable than energy conservation. An output of this research has been the professional 
production by Macmillan of a series of short peer videos (appendix 7.1.1, page 269); these are 
available on the internet and can be used by clinicians. The evident age-related needs suggest it 
would be optimal for CRF support to be provided by an HCP experienced in providing care to TYAs. 
 
While the review and survey both suggest that proactive patient discussion about fatigue may be 
valuable, FICS builds on this in a number of ways. Early discussion – no later than the end of cancer 
treatment – has now been justified, and it may be valuable to involve parents, if acceptable to their 
TYA family member. Given the largely congruent tensions between TYAs and parents, it is likely that 
a skilled HCP could resolve tensions, building a shared understanding based on mutual concerns. This 
study suggests it would be worthwhile clinicians evaluating potential fatigue responses relating to 
activity, thoughts, emotions and sleep. Although the STA conceptual model requires further research 
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evaluation before it can be used clinically, simply explaining the role these responses and the value of 
small changes could empower and promote self-efficacy. The evidence for bidirectional relationships 
between fatigue and other symptoms lends support to careful concurrent symptom management in 
TYAs, an approach for fatigue management that is already evidence-based in older adults [44]. 
 
The finding that fatigue can be considered a trans-diagnostic symptom, with age-related needs 
potentially being more important than the underlying diagnosis, suggests that symptom- rather than 
diagnosis-based services may be of value, for example involving adolescents with CRF and CFS/ME. 
Indeed, a concept mapping study has been published for the first generic fatigue clinic in the UK, 
albeit attended by patients with a mean age of 62 years. Such an approach would need to be 
carefully evaluated to determine the benefits and any inadvertent harms. 
4.6.5.2 Future research 
There are extensive implications for future research. These predominantly relate to future 
interventional trial design and to evaluating the STA conceptual model. 
 
Future trial design 
An age-appropriate ‘trial ready’ intervention is now ready for evaluation of effectiveness and cost-
effectiveness in a definitive controlled trial that randomises patients between fatigue intervention 
and ‘usual care’. Many aspects of design for the future trial are now clear. The content has been 
established, Activity, Information, Mindfulness (AIM), and is known to be acceptable to young 
patients. The Perceived Self-Efficacy for Fatigue Self-Management (PSEFSM) measure is an 
appropriate primary outcome; it has been validated in cancer patients and this programme of 
research has confirmed the relevance and importance of this concept to fatigued TYAs [148]. As well 
as mediating fatigue outcomes and being amenable to change, the evidence for day-to-day fatigue 
fluctuations (page 155) further suggests that change of PSEFSM would be a more reliable primary 
outcome, than fatigue severity. Optimal timings have been established, with intervention needing to 
be early at, or before the end, of cancer treatment. There needs to be capacity to involve parents. 
  
However, a number of other important matters are still not known. It is therefore, as originally 
planned, necessary to undertake a preliminary feasibility study (section 1.2.1 page 14). Most 
crucially, although recruitment to FICS was rapid, it is not known whether the possibility of 
randomisation to ‘usual care’ is acceptable to young patients. A ‘deferred entry’ trial design, with the 
‘usual care’ group offered the intervention after the primary end point, is an approach previously 
used in palliative care trials to increase acceptability by allowing all participants to receive the 
intervention [457,491]. However, the duration of the FICS intervention (mean 6 weeks, range 1-14 
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weeks, table 4.13, page 184) suggests the need for intervention deferral of at least 2-3 months in the 
‘usual care’ group, which may still hinder recruitment. 
 
A considerable number of secondary measures would be needed. Assessment of fatigue responses 
would be required, potentially including the Cognitive and Behavioural Responses to Symptoms 
questionnaire [424]. Collecting data on the predictors for good outcomes suggested in FICS would be 
valuable, including activation levels, baseline activity and activity fear avoidance beliefs; this would 
not only meet current national research priorities [25], but would support treatment personalisation. 
The usefulness of the study would increase if powered to evaluate outcomes in subgroups with high 
and low baseline activation levels, but knowledge of the standard deviation of each measure in the 
TYA cancer population is unknown. Assessment of biomarkers for systemic inflammation would also 
be valuable (section 5.1.3.2, page 223). It is vital that the acceptability of these many measures is 
tested before embarking on the definitive study, not least with cognitive fatigue potentially 
hindering completion of lengthy questionnaires. 
 
An alternative to a feasibility study could be to move straight to a definitive trial that includes an 
internal pilot phase. Progression from the pilot phase to the main trial would need to be carefully 
planned, with clear progression and modification criteria [492]. An ongoing international drive is 
attempting to promote research efficiency and it is increasingly accepted that an internal pilot phase 
can enhance efficiency, prevent the resource waste and avoid recruitment to a trial that does not 
have the capacity to deliver the definitive outcomes [492]. An internal pilot would still allow testing 
of the acceptability of randomisation to ‘usual care’, and of the many secondary outcome measures. 
However, it would provide less potential to fundamentally amend the study design if significant 
problems become apparent. It is possible that a prospective study funder would consider the risks of 
funding a definitive study, albeit with internal pilot, as too high given the extent of the uncertainties. 
 
Overall, it is clear that the choice of approach would need to be made by an experienced trial 
steering group, with a range of expertise, particularly relating to trials design and health psychology. 
Health economics support to evaluate cost-effectiveness would be important, given the potential to 
impact on a long-term symptom that affects the ability to work and be in education, in a young 
cohort with the possibility of years of health service utilisation and societal contribution ahead. 
 
STA conceptual model evaluation 
As previously discussed, the model may have clinical utility, with its potential to promote self-
efficacy for fatigue self-management and underpin a brief cognitive intervention. 
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A qualitative study is required to test model acceptability and gain feedback, both from patients and 
healthcarers. The model may have utility beyond TYAs, and it would be valuable to recruit 
participants of all ages. The non-pharmacological approaches needed to break the vicious cycles, 
including sleep hygiene measures, promotion of activity and stress or tension management, are all 
facets of the emerging ‘Lifestyle Medicine’ approach. While increasingly popular, it is recognised that 
there is a risk of patients perceiving they are being blamed for their health [493]. It is vital to ensure 
that no harm results from use of the model, and a qualitative study would provide further insight.  
 
A separate evaluation of the model from a system dynamics perspective could be a novel 
collaborative approach, leading to valuable insights. Research partnership with experts in complex 
systems modelling and mathematics, along with health psychologists, would allow quantification of 
the suggestion that a small change can lead to considerable benefit by interrupting a single feedback 
loop, using statistical modelling and simulation techniques. 
 
Other implications 
It would be important to assess the generalisability of the study findings, beyond the TYA cancer 
population. Although this may be particularly relevant to TYAs with CFS/ME, there are other smaller 
groups of young patients where fatigue appears to be a neglected symptom, including those with 
juvenile inflammatory conditions and type 1 diabetes. A mixed-methods study involving a 
diagnostically mixed cohort of young patients could be valuable, and could determine the validity of 
considering fatigue as a trans-diagnostic symptom. 
 
Given the emphasis on cognitions in the study outcomes, it would be interesting to conduct a 
neuroimaging study, involving serial fMRI scans of fatigued patients. As previously discussed, this 
type of research has already been undertaken in other symptoms including chronic pain and 
breathlessness [409,494,495]. It could allow elucidation of the exact brain regions involved in fatigue 
perception, and help determine the importance of so called ‘priors’, the sensation predictions based 
on previous experiences [483]. This could provide an objective, although indirect, measure of fatigue 
perception, could examine the paralimbic brain regions subserving emotional and behavioural 
fatigue responses, and may provide valuable insight into intervention mechanisms of action. 
 
The IT literacy of young patients, combined with the clear demand for technology-based approaches, 
has a range of research implications. A TYA CRF self-management App could be developed, with 
concurrent research evaluation, potentially based around the STA conceptual model. Generic 
mindfulness Apps are widely used, but there have been no previous attempts to provide mindfulness 
techniques that specifically support the experience of fatigue in chronic disease.  
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4.7 Key points 
This Fatigue Intervention Co-design Study has been novel in a range of ways. This has been the first 
attempt to co-design a symptom control complex intervention in TYA cancer patients. The process 
has not only been mutually beneficial, it has determined the unique needs of this young cohort and 
the inadvisability of attempting to extrapolate research findings from older adults to TYAs. The 
multiphase and multi-perspective qualitative study design has also led to findings of interest and 
potential importance. The presence of fatigue-related tensions between TYAs and their parents has 
been established; the tensions are paradoxically concordant and therefore more likely to be 
amenable to brief intervention. Furthermore, the unanticipated insights into the importance of 
responses to fatigue in perpetuating the symptom, determining outcomes and promoting self-
efficacy to self-manage are worthy of further research evaluation. 
 
The key study findings are summarised in table 4.17. The table includes findings from the systematic 
review and survey, to demonstrate the sequential building and synthesis of research findings across 
this thesis. Formal integration of all three studies to generate meta-themes in a multi-method 
synthesis will be undertaken in the following, final chapter.
  
2
1
2 
 
Table 4.17 Fatigue Intervention Co-design Study key points in context 
 
TYA CRF topic Study 1: Systematic review Study 2: Fatigue in Focus survey Study 3: Fatigue Intervention Co-design Study 
Prevalence The prevalence range was 9-
67% after cancer treatment; 
fatigue was the first and 
second most prevalent 
symptom in 11 and 6 of 20 
studies respectively. 
Fatigue was the most prevalent symptom experienced 
by 85% of participants after the end of cancer 
treatment. Cognitive fatigue was particularly 
prevalent, compared to previous studies evaluating 
patients during cancer treatment. 
High prevalence was indirectly supported by rapid 
recruitment of participants within seven weeks. 
Cognitive fatigue was particularly problematic in this 
cohort. 
Temporal 
pattern 
Only one longitudinal study 
has evaluated fatigue beyond 
the end of cancer treatment. 
Fatigue severity was higher more than one year after 
the last cancer treatment, compared to during the 
year after treatment ends. Further research is needed 
to gain insight into the cause(s) of fatigue persistence. 
Insights were generated into the factors that may 
perpetuate fatigue due to vicious cycle formation. 
The mismatch between reality and expectations may 
also worsen fatigue perception. 
Symptom 
correlates 
Physical and psychological 
symptoms most commonly 
associated with fatigue were 
poor sleep and low mood 
respectively. 
Significant correlation was found between fatigue and 
other symptoms, fatigue forming a symptom cluster 
with low mood and anxiety. It could not be 
determined whether this represents association or 
causal relationships. 
Bidirectional causal relationships were found 
between fatigue and low mood, tension and anxiety 
(particularly in relation to fear avoidance of activity), 
and difficulty sleeping. 
Impact The most commonly reported 
impact was ‘distress’, 
followed by fatigue being a 
barrier to physical and to 
social activities. 
Fatigue was the symptom with the worst impact on 
daily life, and an independent predictor of poor 
quality of life. The greatest impact was on exercise, 
school/work attendance and socialising, potentially 
suggesting some sources of fatigue-related distress. 
Further insights were generated into the 
contributors to the negative impact of fatigue, 
including multi-level tensions, and cognitive fatigue 
impacting on socialising and the ability to work or be 
in education. 
  
  
2
1
3 
Parents’ 
perspectives 
No past research has 
evaluated the perspectives of 
parents or other carers. 
Parents were the main carers. Only 13% of 
participants perceived no negative impact on carers, 
with ‘upset’ and ‘frustration’ occurring commonly. A 
third of parents were perceived to misunderstand the 
symptom, although the causes and impact of this have 
not been established. Direct parent views are needed 
in future research. 
Direct parent data built on the proxy data from the 
survey. The negative impact on parents was 
confirmed, with insights into causes including 
extensive tensions and misunderstandings. The 
paradoxically congruent data between individual 
TYAs and their parents suggests amenability to brief 
intervention. 
Management No studies have evaluated an 
intervention with a fatigue 
related primary outcome; 
current clinical practice, in 
terms of symptom 
management, is also 
unknown. 
Most participants, almost 3 out of 5, had been 
recommended a fatigue treatment, most commonly 
advice to exercise. Participants themselves 
recommended active treatments more than rest-
focused ones. However, therapeutic scepticism 
prevails with no treatments apart from blood 
transfusion perceived to be successful.  Interventional 
research is needed, with a design that promotes 
adherence.  
There were multiple age-related fatigue intervention 
needs. Participants valued support explaining 
cognitive fatigue to staff at education or work. 
Advice to exercise was most helpful when it included 
an individualised, structured plan, given physical 
reserve and activity fear avoidance beliefs. Energy 
conservation was irrelevant, with a preference for 
App-based mindfulness techniques. Information was 
most acceptable in short, peer-produced video 
format. 
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5 Research synthesis 
This final chapter seeks to synthesise this work into a connected whole. Three methodologically 
diverse studies have been described, each part of one overall aim: to increase understanding of CRF 
in teenagers and young adults in order to be able to develop an effective fatigue intervention. The 
work has examined the spectrum of the past, present and future, by respectively undertaking a 
systematic literature review, evaluating current clinical practice and co-designing a potential complex 
intervention. 
 
Within each preceding chapter, there has already been detailed discussion of the research findings 
from each study, contextualising with existing literature and with each other. This chapter considers 
overarching findings, with multimethod integration across all three studies. Research outputs are 
described, and the chapter concludes with overall clinical and research recommendations. 
5.1 Multimethod integration 
5.1.1 Integration method 
Multimethod research is characterized by the co-existence of different methodologies [496]. All 
methods have strengths and weaknesses, and their combination can allow the strengths of one 
method to compensate for the weaknesses of another [497]. Although ‘multimethod’ and ‘mixed-
methods’ research are two terms that are often used interchangeably, the two methods differ 
[496,498]. Multimethod research combines any different methods, whereas mixed-methods 
research specifically combines qualitative and quantitative data and can therefore be thought of as a 
subset of the former [496]. In addition, the more the methods influence each other along the 
trajectory of the research process, the more the research can be called ‘mixed-methods’ rather than 
‘multimethod’ [499]. 
 
There are at least forty mixed-methods designs reported in the literature [500]. Of the six most 
commonly used, sequential explanatory design is particularly popular; it involves collecting 
quantitative data first, followed by a qualitative phase that generates further insight into the 
quantitative finding [449]. This approach would appear to suit the quantitative survey and 
subsequent qualitative Fatigue Intervention Co-design Study.  
 
Two factors, however, led to the choice to take a multimethod approach in preference to an 
explanatory sequential mixed-methods design. First, although the intermediate phase, where the 
quantitative data influence the collection of the subsequent qualitative data, did occur, it was only to 
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a partial extent [501]. For example, although FICS was focusing on intervention co-design, 
participants were questioned on how fatigue affects their lives and causes distress, following the 
survey’s finding that fatigue predicts a poor quality of life. However, such integration was not a 
formal, prospectively planned part of the design of the qualitative study. In addition, there were no 
efforts to purposively recruit participants to FICS who might best have been able to provide insight 
into survey findings. It might, for example, have been interesting to gain insight from those survey 
participants who had found exercise advice unhelpful but, paradoxically, would still recommend 
exercise to others. 
 
The second reason for choosing a multimethod approach was that it would allow integration of all 
three studies in this thesis, including the systematic review. Multimethod synthesis allows integration 
of any data type: diverse methodological approaches in the review, quantitative with some 
qualitative data in the survey, and qualitative data in FICS. 
 
Mixed-methods designs have been increasingly defined in the literature, in an effort to standardise 
this rapidly growing, complex and diverse approach [500]. Multimethod integration is much less well 
described, generally only when multimethod and mixed-methods approaches have been conflated or 
not explicitly differentiated [502,503]. It is recognised that the integration of data is frequently 
flawed and rarely described [504]. It was therefore decided that a structured and explicit approach to 
multimethod data integration would be undertaken. 
 
Three main data integration techniques have been described: ‘following a thread’, mixed-methods 
matrix, and triangulation [505]. A mixed-methods matrix requires availability of both data types on 
the same cases; this technique was discounted as the co-design study and survey did not knowingly 
recruit any of the same patients. ‘Following a thread’ involves identifying a question or theme from 
one type of data and then following it across other components. Although the ‘key points’ tables at 
the end of each chapter (pages 44, 96 and 212) appear to have ‘followed a thread’ across the three 
studies, strictly this was not the case. The technique applies earlier, in the data analysis phase, with a 
thread followed from one dataset to another and then back again [506]. This was not possible in this 
work, as the survey analysis was completed before FICS started. 
 
The third and most suitable method is triangulation, a technique used in the data interpretation 
phase in which researchers list findings from each part of the research, and consider whether the 
data within each ‘meta-theme’ agree, are complementary or are dissonant [505,507]. Inter-method 
discrepancies are considered valuable, as exploration can increase the depth of insight; benefits 
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emerge ‘only through the struggle to reconcile discrepant results and may provide a sum that is great 
than the individual qualitative and quantitative parts’ [508]. 
5.1.2 Triangulation of research outcomes 
The outcomes of data triangulation are summarised in the integration matrix in table 5.1. This table 
differs from the cumulative ‘key points’ tables at the end of each chapter in three ways. First, rather 
than selecting points of importance and interest from within each study, findings were selected 
entirely from the perspective of their connection across the studies. Second, the selected findings 
were organised into three broad meta-themes relating to fatigue causes, consequences and 
management [507]. Third, the degree of congruence between studies was categorised according to 
whether findings agreed, were complementary or were dissonant. 
 
The triangulation process revealed a number of interesting findings. None of the integrated findings 
simply ‘agreed’, and most were complementary. The prominence of ‘complementary’ integration 
outcomes are consistent with the diverse methodologies leading to findings that built upon each 
other, rather than being the same. The findings from FICS consistently explained those from the 
quantitative study, the latter describing ‘what’, and the former explaining ‘how’. The qualitative 
approach could determine relationship directionality and delve iteratively into findings of interest, 
helping make sense of the numerical findings. For example, whereas the survey established the 
presence of associations between symptoms, the qualitative data could deepen insight by revealing 
bidirectional causal relationships and their potential therapeutic role.  
 
The dissonant findings were of particular interest and value. Moffatt and colleagues have described 
six ways to explore discrepant findings, albeit in a mixed-methods interventional study context. Five 
of these have potential relevance to this work: treating the methods as fundamentally different, 
exploring the methodological rigour of each component, exploring study population comparability, 
exploring comparability of outcomes for each component, and collecting additional data to make 
further comparisons [509]. The three areas of dissonance in table 5.1 are each explored in the 
following sections, using these approaches. Given the pervasive theme of the importance of 
cognition across this programme of work – the impact of cognitive fatigue experience and co-design 
of a predominantly cognitive intervention – it is perhaps unsurprising that all three areas of 
dissonance relate to aspects of cognition. 
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Table 5.1 Multimethod integration matrix 
Meta-theme Study 1: Systematic review Study 2: Fatigue in Focus survey Study 3: Fatigue Intervention Co-design Study Integration  
Causes 
Fatigue is not 
simply related 
to cancer and 
its treatment. 
Fatigue was associated with a few 
other symptoms, particularly low 
mood and poor sleep.  
Fatigue associated with most symptoms 
tested, and formed a cluster with low 
mood and anxiety (sleep not assessed).  
Fatigue formed bidirectional relationships 
with other symptoms including low mood, 
anxiety, poor sleep. 
Comp. 
There has been no evaluation of 
perceived fatigue causes. 
84% of participants perceived fatigue was 
caused by cancer or its treatment. 
Fatigue perpetuation beyond the trigger of 
cancer or its treatment may be caused by 
vicious cycles of emotional and behavioural 
responses to fatigue, and by a mismatch 
between reality and expectations. 
Comp. 
Only one study evaluated fatigue 
beyond cancer treatment. 
Fatigue persisted beyond the end of 
cancer treatment, and may even worsen. 
Comp. 
Consequences 
Fatigue has 
broad impact 
far beyond the 
physical effect 
on the patient. 
Cognitive fatigue was less severe 
than other fatigue dimensions. 
Cognitive fatigue was as severe as other 
fatigue dimensions. 
Cognitive fatigue had the worst impact, and 
influenced the ability to study and work. 
Diss. 
The impact most commonly 
described was distress, followed by 
impact on the ability to exercise. 
The main impact of fatigue was on the 
ability to exercise, followed by the ability 
to attend school/work and socialise. 
The impact on the ability to exercise was more 
due to fear that exercise may cause harm than 
physical inability. 
Comp/            
diss. 
Impact on parents has not been 
described in the literature. 
Only 13% of young patients felt fatigue 
did not impact negatively on parents. 
Parents described considerable personal 
negative impact from their child’s fatigue. 
Comp. 
Impact on relationships with others 
has not been described. 
Young patients felt misunderstood by 
others, including parents. 
Although multilevel tensions existed, patient 
and parental perspectives were congruent. 
Comp/            
diss. 
Management 
Age -
appropriate 
support may 
address 
therapeutic 
scepticism. 
No research has evaluated current 
fatigue management. There has 
been little interventional research 
and no controlled trial evidence of 
benefit from exercise, despite it 
being the most strongly evidence-
based intervention for fatigue in 
older cancer patients. 
2 in 5 young people had not received 
fatigue support, and less than 1 in 5 
believed fatigue could be treated. 
Young patients and parents described unmet 
fatigue management needs; they require age-
appropriate support, promoting self-efficacy. 
Comp. 
Exercise was the management advice 
most commonly given and most 
recommended by TYAs to others; 
however TYAs did not find it helpful. 
Young patients require individualised 
structured activity support and regular short 
term goals, to avoid concerns about ‘pushing 
too much’ worsening fatigue. 
Comp. 
Comp, complementary; diss, dissonant.
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5.1.2.1 Relative importance of cognitive fatigue 
The systematic review suggested that cognitive fatigue was less severe than physical fatigue, the 
survey revealed comparable cognitive and physical fatigue, while the co-design study found cognitive 
fatigue consistently had the worse impact. Exploration of these apparent discrepancies reveals 
several potential explanations.  
 
First, the studies providing data on cognitive fatigue in the review mostly recruited patients receiving 
cancer treatment, whereas the survey and co-design study involved patients post-treatment (section 
3.6.1.2, page 80). The different study populations restrict comparability of findings; for example, it 
may be that cognitive fatigue is less apparent to individuals during cancer treatment, in comparison 
to later cognitive demands, such as at school or work [168]. 
 
Second, cognitive fatigue quantified in the review and survey cannot be directly compared with the 
qualitative evidence from FICS. The question asked in the topic guide that elicited extensive views on 
cognitive fatigue was, ‘What do you find most distressing about your fatigue?’ Participants were 
describing an undefined but closely-related series of concepts including ‘fatigue severity’, ‘fatigue-
related impact’ and ‘fatigue-related distress.’ 
 
Third, qualitative research has particular utility, compared to quantitative work, for developing new 
ideas and seeking explanations. The open nature of the questioning in FICS allowed participants to 
give their own views, rather than simply being asked to rank pre-defined options in a survey. 
Whereas the survey could only establish that fatigue had a negative impact on the ability to be in 
work or education, the qualitative study was able to question ‘why’ and ‘how’ this occurred, 
unexpectedly eliciting the particular importance of cognitive fatigue. The qualitative data increased 
the depth of understanding. 
 
Resolution of the data incongruity may have been possible with further data collection, if the survey 
and co-design study had been integrated more closely in design and time, in line with a mixed-
methods, rather than, multimethod approach. In retrospect, it could have been valuable to have 
asked survey participants which dimension of fatigue was leading to the negative impacts described. 
In a larger survey, potentially using electronic tablets to encourage responses from those on cancer 
treatment, it may have been possible to compare cognitive fatigue severity between those during 
and after cancer treatment. It would have been illuminating to explore the meanings that FICS 
participants ascribed to the terms ‘severity’ and ‘impact’, and the degree to which these related 
concepts were conflated. 
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5.1.2.2 Redefining exercise ‘ability’ 
Survey participants considered that the aspect of daily life that fatigue most affected was the ‘ability 
to exercise’. The co-design study revealed a subtle, but important, difference; young people 
described physical ability to exercise, but the barrier to activity was the fear that it may worsen the 
fatigue, by ‘pushing’ too hard: activity fear avoidance beliefs. In table 5.1, the integration outcome is 
described as ‘complementary/ dissonant’. ‘Complementary’ reflects a broad interpretation of the 
word ‘ability’ that means that the co-design study findings complement the survey by defining the 
relevant aspect of this meaning; in contrast, use of a narrower definition of ‘ability’, as physical 
capacity, would lead to the findings being interpreted as dissonant. 
 
The literature review findings were apparently consistent with the survey, but too limited to draw 
meaningful conclusions. Six studies described an impact on the ability to exercise. The two 
quantitative studies simply elicited that fatigue was one of a list of barriers to exercise, without 
attempting to establish the mechanism [219,223]. The remaining four were qualitative or mixed 
methods studies that did not report evaluation of the way fatigue impacted on exercise ability, other 
than one study describing ‘parental over-protectiveness’ hindering sport; it is conceivable that this 
reflected parental activity fear avoidance [179].  
 
The difference between physical capacity and activity fear avoidance may appear subtle but, in 
clinical terms, reflects the difference between a behavioural intervention that increases physical 
activity and a cognitive intervention that reframes a perception. As discussed in section 4.6.1.3 (page 
204), behaviour change interventions require considerable engagement, take time and are often 
unsuccessful, whereas a cognitive intervention has potential to work more rapidly and effectively. 
Again, qualitative data has increased the depth of understanding of the quantitative findings. It was 
not anticipated that fatigued participants would describe activity fear avoidance, rather than physical 
incapacity. The exploratory nature of qualitative research, open to emergent themes, led to this 
important insight.  
 
Additional data collection could have been valuable. For example, if it had been possible to 
undertake further survey questioning after these insights from the qualitative study, it would have 
been interesting to ask survey participants to rank or quantify the extent to which exercise was 
limited physically or hindered by fear avoidance. Equally, further exploration within the co-design 
study could have enhanced understanding even further, for example probing to discover the 
respective contexts within which physical incapacity or fear avoidance prevail. 
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5.1.2.3 Less misunderstanding than perceived 
The final incongruent topic relates to misunderstandings between young people and others. The FICS 
findings could be considered dissonant to those of the survey, in that direct discussion with parents 
revealed less misunderstanding than that apparently perceived by TYAs in the survey, and indeed 
with the co-design study itself. Parents’ perceptions were remarkably analogous to their offspring, 
leading to the ‘Concordant Tension Tree’ model (section 4.5.11, page 160). Parents had insight into 
how fatigue is misunderstood with its inherent invisibility, they understood the impact on their child, 
and they were prepared to defend their child against the misunderstandings of others.   
 
The integration outcome in table 5.1 was both complementary and dissonant. The relevant survey 
question was ‘Do you think the effect of fatigue on your life is understood by the people around 
you?’ Considered in the broader meaning of seeking the young person’s perception, the co-design 
findings are congruent with the survey as, in both contexts, the young person perceived 
misunderstanding. Using a more literal sense of whether there were true misunderstandings, rather 
than simply perceptions of misunderstandings, the co-design study generated dissonant findings that 
can be entirely explained by the use of a different study population: parents as well as TYAs. 
 
If there had been an opportunity to undertake a further phase of interviews, it would have been 
interesting to reflect the findings of congruent tensions back to the young participants. How, for 
example, would young participants themselves explain this apparent dissonance? However, 
generation of the ‘Concordant Tension Tree’ model occurred after data collection had ceased, 
precluding this further iterative step. 
5.1.3 Discussion 
Multimethod integration has revealed a complementary relationship between the studies, each 
consistently building on those preceding. All but one outcome in the integration matrix was judged to 
be at least partially ‘complementary’. 
 
There are a number of possible reasons for the high degree of complementarity. First, the three 
studies represent the three timescales of past, present and future: the systematic review described 
research knowledge generated in the past, the survey evaluated current experiences and 
management, and the qualitative study designed a future fatigue treatment. Second, the studies 
involved three diverse methods: narrative synthesis of varied study designs, quantitative multicentre 
survey, and qualitative study involving individual interviews and focus groups. Third, the studies 
incorporated different temporal profiles: the survey provided a cross-sectional perspective, while the 
qualitative study was multiphase and longitudinal in design. 
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While such diversity enriched the insights gained from this programme of work, study heterogeneity 
did lead to a degree of non-comparability of study populations and measures, causing the few 
examples of integration dissonance. The systematic review appraised literature relating to TYAs both 
during and after cancer treatment, the survey attempted the same but only those after the end of 
treatment participated, and FICS recruited only young people within the first year after the end of 
cancer treatment. 
 
The integration matrix reveals that the quantitative survey findings tend to be explained and 
illuminated by the qualitative co-design study. Furthermore, it can be argued that the insights from 
the qualitative study may be most useful, both for future clinical practice and research (section 5.4, 
page 229). While the survey provided evidence for the persistence of fatigue long after the end of 
cancer treatment, the explanation for why this occurs, with generation of vicious cycles, adds further 
insight and creates potential for an effective intervention through targeting the perpetuating 
mechanism. Knowing that fatigue is a barrier to exercise is helpful; however, understanding that the 
mechanism may be activity fear avoidance beliefs rather than physical incapacity increases insight 
into intervention needs. The significance and utility of the qualitative findings is consistent with 
Brannen’s statement: qualitative research is no longer regarded as the ‘poor relation to quantitative 
research that it has been in the past’ [510]. 
 
The strengths and limitations of each study have already been considered within each chapter. As 
part of this final stage, appraising the three studies as an integrated whole, it is worth considering 
overall strengths and limitations in relation to the starting position detailed in chapter 1: the original 
research plan, fatigue pathophysiology, TYA health and underlying theory. 
5.1.3.1 Link back to original research plan 
The overall aim of this programme of research was to increase understanding of the problem of TYA 
CRF in order to be able to develop an effective non-pharmacological fatigue intervention. It is 
submitted that this work has amply realised this core aim.  
 
The integration process has revealed limitations in the approach taken, beyond those of the 
individual studies. In retrospect, it would have been preferable to have made an a priori decision to 
set up the survey and co-design study for a mixed-methods, rather than multimethod analysis [501]. 
Formal integration phases between the studies during their conduct, instead of only after 
completion, could have increased research productivity.  
 
An integration phase between the literature review and survey could have led to survey participants 
being questioned on sleep, an oversight given that poor sleep has been associated with fatigue in 
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past research (section 2.5.6, page 34). Such a phase between the survey and co-design study may 
usefully have influenced the topic guides; for example, given that only one in five survey participants 
believed that fatigue could be treated, it would have been valuable to try to gain qualitative insight 
into this. 
5.1.3.2 Link back to fatigue pathophysiology 
As described in section 1.1.1.3 (page 2), although fatigue is thought to be a consequence of systemic 
inflammation, it is also recognised that this cannot be the only explanation; a number of 
psychological and behavioural factors predict fatigue severity, and treatment of concurrent 
symptoms can improve fatigue. The finding that these factors can be both causes and consequences 
of fatigue, with the resulting potential for symptom perpetuation, contributes considerably to 
understanding their importance. 
 
Having argued beyond the role of systemic inflammation, it must be remembered that the responses 
to fatigue, in themselves, also induce systemic inflammation. Inactivity, low mood, anxiety and poor 
sleep are examples of psycho-behavioural factors associated with higher levels of systemic 
inflammation and neuroinflammation [511-513]. Such inflammation may therefore still have a 
mechanistic role in CRF, but through the psycho-behavioural responses and contributors to fatigue, 
as well as the direct effect of cancer and its treatment. Efforts to reduce systematic inflammation, 
with its adverse consequences on wellbeing and health, could therefore helpfully focus on increasing 
activity, promoting sleep hygiene and reducing tension, rather than simply considering underlying 
chronic disease management. 
 
The design of this research programme precluded further investigation of fatigue pathophysiology. If 
the survey and FICS could have been undertaken concurrently, survey data on cancer stage and 
participant activity would have been helpful to allow comparison of the influence of fatigue triggers 
(cancer stage and treatment) and fatigue responses (including activity, sleep and thoughts). There 
was no capacity to assess measures of systemic inflammation, such as CRP in this work; this would 
however be valuable in future research (section 5.4.2, page 230). 
5.1.3.3 Link back to TYA health 
A key strength of this programme of work has been the focus on the specific needs of this young age, 
with close collaboration between young patients, parents and the research team realising significant 
mutual benefit. Breadth of contact in the multicentre survey and depth of contact in the multiphase 
qualitative study were gained by using novel methodology: electronic patient research survey and 
intervention co-design respectively. 
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Despite the efforts to engage this patient group, there were limitations to access. The youngest 
patients recruited were aged 17, a minimum age of 16 years having been set in both studies because 
of the ethical and practical challenges of recruiting children. Despite the survey being open to 
patients both on, and after, treatment, only those after the end of cancer treatment responded. 
Further research is needed in 13-16 year olds, and in patients during cancer treatment. 
5.1.3.4 Link back to Self-Efficacy Theory 
The co-design study findings have already been theoretically contextualised in section 4.6.2 (page 
205). This theory appears to have been an appropriate choice to underpin this work, not least as it 
underpins the intervention mechanism. In retrospect, considering all three studies as an integrated 
whole, opportunities were missed to maximise insights into perceived self-efficacy for fatigue self-
management.  
 
Self-efficacy was not used as a search term within the systematic review. This had no eventual 
implications, as the broad eligibility of studies meant that no relevant studies were missed; there is 
no existing research evaluating the concept of self-efficacy in TYA CRF. It would however have been 
valuable for the survey to have included questions on participants’ confidence that they could 
improve their fatigue, and to have allowed participants to choose amongst potential factors known 
to promote perceived self-efficacy. Furthermore, the co-design study involved no direct questioning 
about self-efficacy and how to improve it. The fact that unsolicited evidence for the importance of 
building confidence and motivation emerged from the FICS data increases the credibility of the 
findings in relation to self-efficacy (section 4.5.7.1). However, it is possible that further valuable data 
could have been gained by explicit questioning.  
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5.2 Programme research outputs 
This section summarises the key outputs from the three studies described in this thesis. Further 
details are available at appendix 7.1 (page 269). 
5.2.1 Public dialogue 
5.2.1.1 Teenage Cancer Trust Way Forward Programme  
This charitable programme runs two-day residential courses across the UK to help young people 
addressing the issues being faced with a cancer diagnosis. Anna Spathis and Julie Burkin delivered a 
one-hour interactive workshop at four events (East Anglia: March 2017 and March 2018; London and 
South East: Sept 2017 and Sept 2018). Discussion with TYA patients was stimulated by a quiz based 
on research findings.  
5.2.1.2 Shine Cancer Support National Conference 
In May 2018, Anna Spathis delivered the keynote lecture at this conference in London, for over one 
hundred young adults with cancer. This involved discussing fatigue and sharing research findings, 
followed by a ‘chat show style’ dialogue with attendees to promote mutual learning. It was live-
streamed on Facebook, for those unable to attend in person. 
5.2.2 Educational materials  
A series of short peer videos, involving TYAs talking about cancer-fatigue, were a key research 
output. They were requested as the optimal form of information-giving by participants in FICS, and 
subsequently professionally produced by Macmillan Cancer Support. 
 
The trailer and three videos were launched on Facebook in October 2017, with over one million 
cumulative hits since. The following quotes encapsulate the tone of the dialogue: ‘I am really keen to 
see this. Sitting here having a little cry, as I thought it was just me and telling myself to get a grip’; 
‘Thank you for this inspirational video’; ‘I struggle with unpredictable fatigue. This awareness 
campaign is greatly appreciated. I hope that it creates awareness that we are not lazy, we are 
genuine.’  
5.2.3 University of Cambridge research award 
This work resulted in Anna Spathis and Stephen Barclay receiving a University of Cambridge Vice-
Chancellor’s Public Engagement with Research Award in July 2018 (see appendix 7.1.2, page 269, for 
hyperlink to related blog). 
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5.2.4 Dissemination of findings 
By March 2019, Anna Spathis will have delivered three oral presentations, relating to each of the 
three studies, at national conferences, and two further poster presentations (appendix 7.1.3, page 
269). Two peer-reviewed publications have been published at the time of thesis submission, relating 
to the literature review and survey [514,515]. The former was one of the ‘top ten most cited 
publications’ in 2017 for the Journal of Adolescent and Young Adult Oncology, and the latter one of 
the ‘top ten most read publications’ in both 2017 and 2018. This relates to publications since the 
journal’s inception in 2011.  
 
The following papers are planned, based on material in this thesis, to be submitted for publication 
during 2019. 
1. Methodological paper on the multicentre survey innovative electronic survey methods. 
2. Paper describing the Fatigue Intervention Co-design Study and unique needs of TYAs and their 
parents. 
3. Multimethod paper evaluating the impact of cancer-related fatigue on the parents of young 
patients. 
4. Brief report describing the Sleep, Thoughts, Activity conceptual model and its potential clinical 
implications. 
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5.3 Ten key novel findings from integrated research programme 
1. Fatigue is the most common and most distressing symptom experienced by teenagers and young 
adults with cancer. It is the symptom with the worst impact on daily life, and is an independent 
predictor of poor quality of life. 
 
2. Fatigue can persist long after the end of cancer treatment. This may be due to the development 
of emotional and behavioural responses to fatigue that worsen the symptom, forming vicious 
cycles that perpetuate it beyond the original trigger. 
 
3. Cognitive fatigue, with its effect on concentration and memory, has a more negative impact than 
physical fatigue. It influences the ability to work, be in education or socialise, hindering key age-
related developmental needs of conforming and autonomy.  
 
4. Parents contend with considerable adverse consequences, experiencing conflict and unmet 
information needs. Both young patients and their parents describe multilevel interpersonal 
tensions and perceptions of misunderstandings, although these are paradoxically congruent. 
 
5. Despite the enormity of the problem, cancer-related fatigue has been neglected in teenagers and 
young adults with no previous interventional trials focused on this symptom. Fatigue is currently 
inadequately managed in the UK, with many patients not receiving support; most find fatigue 
treatment ineffective and believe the symptom cannot be improved. 
 
6. Teenagers and young adults have demonstrated extensive and unique age-related needs from 
the fatigue intervention. For example, short videos are more acceptable than written 
information. Findings from fatigue management research in older adults cannot be extrapolated 
to younger patients. 
 
7. The co-designed intervention is largely cognitive in approach, for example using mindfulness 
techniques rather than energy conservation. It aims to promote self-efficacy for fatigue self-
management, empowering patients to make small changes to fatigue responses. 
 
8. Although advice to exercise is the commonest approach and most recommended by young 
patients, the main impact of fatigue is on the ability to exercise, and exercise advice tends to be 
unhelpful. Structured support with regular short-term goals is needed, given the physical reserve 
of youth and fear that activity may worsen fatigue. 
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9. Young patients asked for, and helped drive, this programme of work. Recruitment was relatively 
easy, engagement with the research process was high and participants embraced the two 
innovative research methods: electronic survey and intervention co-design. 
 
10. Information has been generated that will optimise the design of the future definitive trial testing 
intervention effectiveness. Early, individualised, predominantly cognitive intervention will be 
provided for patients and parents, with measures including perceived self-efficacy for fatigue 
self-management, return to education or work, healthcare utilisation and biomarkers for 
systemic inflammation. 
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5.4 Ten key recommendations 
The clinical and research implications of each of the three studies have already been described in the 
relevant study chapters. This section gives a synthesised list of overall recommendations in point 
form, for clarity. 
5.4.1 Recommendations for clinical practice and policy 
Although definitive study of the effectiveness of the co-designed intervention has not yet been 
undertaken, it would reasonable to incorporate aspects of TYA intervention needs into clinical 
practice at this stage. The following principles are therefore recommended: 
 
1. Clinicians should proactively enquire about the presence of fatigue in TYA cancer patients at an 
early stage, before the end of cancer treatment. Many patients do not raise this topic and 
subsequently do not gain support. Simple acknowledgement of this ‘invisible’ symptom, along 
with addressing information needs, may be of therapeutic value in itself. 
 
2. Given the close relationship of fatigue with other symptoms, optimal concurrent symptom 
control is important, particularly focusing on insomnia, anxiety, depression and pain. Evaluation 
of emotional and behavioural responses to fatigue, such as poor sleep hygiene or activity fear 
avoidance beliefs, may allow insights to be gained into any perpetuating vicious cycles. 
 
3. When agreed by young patients, involvement of parents and siblings could be valuable, given the 
considerable unmet information needs and perceptions of misunderstandings. Facilitated family 
discussions may reduce tensions and promote mutual understanding. 
 
4. Clinical education could be provided to train healthcare professionals to understand the unique 
needs of fatigued TYAs, including recognising cognitive fatigue, supporting discussion with senior 
staff at patients’ education or work, providing individualised and structured exercise plans, and 
encouraging App-based mindfulness techniques. AHPs and psychologists, with experience of the 
distinct needs of TYAs, may have a particular role in supporting fatigue management. 
 
5. The videos produced as a research output are available on-line, and are likely to be valuable for 
patients and healthcare staff. Access needs to be made easier for those not using social media.  
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5.4.2 Recommendations for future research 
Many implications for research have already been described in relation to the three individual 
studies. The following recommendations form a synthesis of the most important points: 
 
1. A prospective, longitudinal cohort study is needed to ascertain the temporal pattern of fatigue 
during, and after, cancer treatment. International collaboration would facilitate a study large 
enough to have the power to test predictors of fatigue severity and of fatigue perpetuation, 
including cancer stage, fatigue-related expectations and a range of emotional and behavioural 
fatigue responses.  
 
2. The features of the ‘trial ready’ TYA fatigue intervention are now known, including that it will be 
an early, individualised, predominantly cognitive intervention provided for patients and parents. 
Activity support, Information and Mindfulness (A.I.M) will form the key content, and the aim will 
be to promote perceived self-efficacy for fatigue self-management.  
 
3. The definitive randomised controlled trial will require UK-wide senior collaboration, including 
experts in clinical trials and health psychology. A prior feasibility trial or an internal pilot phase is 
needed to confirm that the proposed measures are not excessively burdensome in the context of 
cognitive fatigue, and to determine if randomisation to ‘usual care’ is acceptable. 
 
4. The Sleep, Thoughts, Activity (STA) conceptual model requires evaluation initially with a 
qualitative study, in order to refine it, test its acceptability as a clinical and educational tool, and 
evaluate its role in promoting perceived self-efficacy. Collaboration is needed with health 
psychologists and, potentially, with experts in systems dynamics.  
 
5. Subsequent research could include evaluation of the generalisability of these research findings to 
TYAs with CFS/ME and other chronic conditions, neuroimaging studies, and development of a 
mobile App to support fatigue self-management. Further research is needed in fatigued TYAs 
during cancer treatment and in younger adolescents. 
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5.5 Concluding comments 
 
In the middle of difficulty lies opportunity. 
Einstein 
 
She was quite incredible... she said that it was a blessing that this had happened to her.   
She felt very grateful for the diagnosis... because she felt like it had directed her life,  
and now she is studying... and feeling the best she had ever felt. 
HCP reflection on meeting a young research participant 
 
 
The challenges faced by young cancer patients and their families, already coping with a devastating 
illness, are compounded by fatigue. This thesis describes an effort to counter the prevailing neglect 
of this debilitating and distressing symptom. The programme of research has been inspired, and 
driven by, young cancer patients since its inception. It has been a privilege to work in partnership 
with young patients and their parents, to witness their resilience during adversity, and to promote 
mutual learning from their expertise. 
 
Fatigue can persist, perpetuating beyond the trigger of cancer and its treatment, with potential for 
long term adverse impact at this formative age. This research has started the process of developing 
an intervention, enhancing young patients’ confidence to respond to fatigue with thoughts and 
emotions that propel vicious cycles into virtuous cycles, and empowering them to live life, even if 
limited in length, to the full. 
 
 
Between stimulus and response there is a space. In that space is our power  
to choose our response. In our response lies our growth and our freedom. 
Viktor Frankl 
 
Fatigue breeds fatigue... Energy breeds energy 
Young research participants 
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7 Appendices 
7.1 Research outputs 
7.1.1 Educational materials  
These have been described in section 5.2.2, page 225. Further details, including hyperlinks and hits, 
are as follows: 
 
Video trailer: 24,766 views, 99 shares, 268 likes 
https://www.facebook.com/macmillancancer/videos/10155290388552199/ 
 
Ruth video: 45,974 views, 137 shares, 415 likes 
https://www.facebook.com/macmillancancer/videos/10155326007497199/  
or https://youtu.be/aCrEXJZKyHI  
 
Ellis video: 44,522 views, 199 shares, 485 likes 
https://www.facebook.com/macmillancancer/videos/10155319941992199/  
or https://youtu.be/6XpX5RANLdQ 
 
Faye video: 26,661 views, 108 shares, 299 likes 
https://www.facebook.com/macmillancancer/videos/10155329396727199/  
or https://youtu.be/OHELcqBc6yg  
 
Blog shared on Macmillan social media channels: 
https://community.macmillan.org.uk/blogs/b/community_news/archive/2017/10/10/guest-post-39-
we-need-help-to-live-too-39   
 
A short version of Ellis’ video: over 1,000,000 views 
https://www.facebook.com/StudentProblems/videos/this-is-great-/1533592736767454/ 
7.1.2 University of Cambridge research award 
The University of Cambridge Vice-Chancellor’s Public Engagement with Research Award (July 2018) 
led to the following publicity and related blog:  
 
https://www.cam.ac.uk/news/vice-chancellors-awards-showcase-cambridge-researchers-public-
engagement-and-societal-impact 
 
https://www.phpc.cam.ac.uk/pcu/i-thought-it-was-just-me-mutual-benefit-from-public-involvement-
in-research/ 
7.1.3 National presentations  
7.1.3.1 Oral presentations 
Spathis A, Booth S, Grove S, Hatcher H, Kuhn I, Barclay S. Teenage and young adult CRF: a systematic 
review and narrative synthesis. Oral presentation at Society of Academic Primary Care London and 
South East Regional Meeting, Cambridge, January 2015.  
 
Spathis A, Hatcher H, Booth S, Brimicombe J, Moss W, Barclay S. Conducting healthcare research in 
young adult cancer patients by email alone: feasible, acceptable and efficient. Oral presentation at 
Public Health England Conference: Cancer Data and Outcomes, Manchester, June 2016. 
 
 270 
Spathis A, Chapman A, Burkin J, Hatcher H, Uttenthal B, Robson J, Abbas L, Gibson F, Stone P, Booth 
S, Barclay S. Fatigue Intervention Co-design Study: unique needs of teenagers and young adults with 
CRF. Oral presentation Association of Palliative Medicine Supportive and Palliative Care Conference, 
Harrogate, March 2019. 
7.1.3.2 Poster presentations 
Spathis A, Hatcher H, Booth S, Gibson F, Stone P, Abbas L, Brimicombe J, Thiemann P, McCabe M, 
Campsey R, Hooker L, Moss W, Robson R, Barclay S. A multicentre survey of teenage and young adult 
cancer patients: fatigue is prevalent, poorly managed and perpetuates long-term. Poster 
presentation at NCRI conference, Liverpool, November 2016. 
 
Spathis A, Hatcher H, Booth S, Gibson F, Stone P, Abbas L, Brimicombe J, Thiemann P, McCabe M, 
Campsey R, Hooker L, Moss W, Robson R, Barclay S. A multicentre survey of teenage and young adult 
cancer patients: fatigue is prevalent, poorly managed and perpetuates long-term. Poster 
presentation at Teenage Cancer Trust conference, Edinburgh, December 2016. 
7.1.4 Publications 
7.1.4.1 Published 
Spathis A, Booth S, Grove S, Hatcher H, Kuhn I, Barclay S. Teenage and young adult cancer-related 
fatigue is prevalent, distressing and neglected: it is time to intervene. A systematic literature review 
and narrative synthesis. Journal of Adolescent and Young Adult Oncology. 2015;4(1):3-17. 
 
Spathis A, Hatcher H, Booth S, Gibson F, Stone P, Abbas L, Barclay M, Brimicombe J, Thiemann P, 
McCabe M, Campsey R, Hooker L, Moss W, Robson J, Barclay S. Cancer-related fatigue in adolescents 
and young adults after cancer treatment: persistent and poorly managed. Journal of Adolescent and 
Young Adult Oncology. 2017;6(3):489-493. 
 
The former was one of the ‘top ten most cited publications’ in 2017 for the Journal of Adolescent and 
Young Adult Oncology, and the latter one of the ‘top ten most read publications’ in both 2017 and 
2018. This relates to publications since the journal’s inception in 2011. 
 
These two publications are provided in full in the following pages of this appendix. 
7.1.4.2 In press 
Spathis A, Chapman A, Burkin J, Hatcher H, Uttenthal B, Robson J, Abbas L, Gibson F, Stone P, Booth 
S, Barclay S. Fatigue Intervention Co-design Study: unique needs of teenagers and young adults with 
cancer-related fatigue. For abstract publication in BMJ Supportive and Palliative Care. 
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7.2 Systematic literature review  
7.2.1 Eligibility criteria 
7.2.1.1 Inclusion criteria 
 All study participants have malignant disease, or malignant group presented separately 
 Evaluating any aspect of fatigue (or tiredness, exhaustion, lethargy)  
 Majority participants age 13-24 years at the time of cancer diagnosis or treatment, or 13-24 age 
group presented separately 
 At any time in relation to cancer treatment (before, during or after) 
 Measuring prevalence of fatigue 
 Measuring impact of fatigue 
 Evaluating correlates to fatigue 
 Evaluating any intervention for fatigue, non-pharmacological or pharmacological 
 Examining the experience of the carers of fatigued patients 
 Quantitative and qualitative research methods 
 Studies within peer review journals 
 From January 1981 to November 2013 
 Based within any country 
 Title, abstract and main paper available in English 
7.2.1.2 Exclusion criteria 
 Not diagnosed or treated for cancer aged 13-24 
 Literature reviews 
 Case reports of five or fewer patients 
 Retrospective case note review 
 Phase 1/2 clinical trials 
 Clinical trial of investigational medicinal produce with ten or fewer patients 
 Studies without any original empirical data 
 Laboratory data only 
 Benign tumours 
 Guidelines, comments, editorials 
 Studies evaluating treatment for an adverse effect of cancer treatment 
 Grey literature, except for the TCT conference 
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7.3 Fatigue in Focus multicentre survey 
7.3.1 Priming process 
7.3.1.1 Standardised priming email 
 
This was allowed to be amended slightly by healthcare staff at each site 
 
 
We are setting up the first UK survey focusing on fatigue in young people who have had 
cancer. This is a really important survey as young people keep telling us that fatigue is a big 
problem, but there has not been much research on this yet.  
 
Please look out for an email about this survey early next year. It’ll be quick and easy to 
complete, on your phone or computer, and will just take a few minutes.  
 
We would really appreciate it if you could take part. We need lots of people to join in for the 
survey to be useful. Everyone who completes it will be put into a draw to win an iPad or 
three £50 Amazon vouchers! 
 
The main thing is we want to learn from your experiences and use it to help other patients. 
Help us understand fatigue to help us treat it. 
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7.3.1.2 Poster 
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7.3.2 Survey covering email 
 
Fatigue in Focus. Help us understand it to help us treat it. 
 
Dear (insert patient first name), 
 
I wonder if you could help us with some important research. We would like to invite you 
take part in the first UK survey focusing on fatigue in young people who have had cancer.  
 
Young people keep telling us fatigue is a big problem, but there has not been much research 
on this yet. We want to learn from your experiences, and use it to help other cancer 
patients. If you were able to complete this short survey, we would appreciate it so much. 
 
The survey is easy to complete, just click the link below. We have made it as brief as possible 
– it will take about 4-8 minutes of your time. A participant information sheet is attached to 
this email, giving you more detailed information.  
 
Everyone who completes the survey will be put into a draw to win an iPad or three £50 
Amazon vouchers. The survey is anonymous and there is no way you can be identified from 
the information you provide. 
 
We need to focus on fatigue. Help us understand it to help us treat it.  
 
Thank you very much indeed for considering taking part. 
 
 
 
 
 
Dr Helen Hatcher 
Consultant medical oncologist and TYA service lead 
On behalf of the Fatigue in Focus survey team 
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7.3.3 Patient information sheet 
  
 296 
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7.3.4 IT process instructions 
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 299 
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7.3.5 Research Ethics Committee approval  
 
Decision and signature pages only  
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7.3.6 Survey questionnaire 
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7.3.7 Non-responder analysis comparative histograms 
 
Figure 7.1 Comparative histogram of age at survey for responders and all non-responders 
 
 
 
 
 
 
Figure 7.2 Comparative histogram of age at diagnosis for responders and all non-responders 
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Figure 7.3 Comparative histogram of time since diagnosis for responders and all non-responders 
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7.3.8 Regression diagnostic plots 
7.3.8.1 Diagnostic plots for predictors for fatigue severity  
 
Figure 7.4 Frequency of standardised residuals (dependent variable MFS) 
 
 
 
 
 
Figure 7.5 Normal P-P plot of regression standardised residuals (dependent variable MFS) 
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Figure 7.6 Scatterplot of standardised residuals and predicted values with Loess line (dependent 
variable MFS) 
 
 
 
 
 
 
 
Figure 7.7 Scatterplot of residuals of MFS and low mood severity with Loess line 
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Figure 7.8 Scatterplot of residuals of MFS and lack of appetite severity with Loess line 
 
 
 
 
 
7.3.8.2 Diagnostic plots for predictors for quality of life  
 
Figure 7.9 Frequency of standardised residuals (dependent variable QOL NRS) 
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Figure 7.10 Normal P-P plot of regression standardised residuals (dependent variable MFS) 
 
 
 
 
 
Figure 7.11 Scatterplot of standardised residuals and predicted values with Loess line (dependent 
variable QOL NRS) 
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Figure 7.12 Scatterplot of residuals of QOL NRS score and low mood severity with Loess line 
 
 
 
 
 
 
Figure 7.13 Scatterplot of residuals of QOL NRS and lack of appetite severity with Loess line 
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7.3.9 Symptom cluster based regression model 
 
Table 7.1 Linear model of predictors of fatigue severity using cluster level mean symptom scores 
 
 B  SE B Beta p Tolerance VIF 
Step 1 
Constant 68.12 
(56.63, 77.95) 
4.70 - - - - 
Lack of 
appetite 
cluster 
-13.71 
(-18.16, -9.63) 
2.43 -0.57 <0.001 - - 
Step 2 
Constant 82.63 
(72.38, 91.92) 
4.92 - - - - 
Lack of 
appetite 
cluster 
-9.62 
(-13.41, -5.91) 
2.22 -0.40 <0.001 0.87 1.15 
Low mood 
cluster 
-7.54 
(-10.31, -4.60) 
1.48 -0.47 <0.001 0.87 1.15 
Step 3 
Constant 84.27 
(74.06, 94.44) 
5.36 - - - - 
Lack of 
appetite 
cluster 
-9.00 
(-12.78, -5.30) 
2.37 -0.38 <0.001 0.77 1.30 
Low mood 
cluster 
-7.06 
(-10.29, -3.70) 
1.61 -0.44 <0.001 0.74 1.35 
Pain cluster -2.27 
(-7.66, 2.80) 
2.90 -0.082 0.44 0.68 1.46 
Step 1 adjusted R2 0.33, Step 2 adjusted R2 0.52 (F change=25.8, p<0.001), Step 3 adjusted R2 0.50(F 
change=0.61, p=0.44) 
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Table 7.2 Linear model of predictors of quality of life using cluster level mean symptom scores 
 
 B  SE B Beta p Tolerance VIF 
Step 1 
Constant 12.15 
(10.05, 12.52) 
0.71 - - - - 
Lack of appetite 
cluster 
-0.89 
(-1.25, -0.34) 
0.31 -0.31 0.006 0.77 1.30 
Low mood 
cluster 
-0.48 
 (-1.14, -0.30) 
0.21 -0.26 0.028 0.74 1.35 
Pain cluster -0.80 0.38 -0.24 0.041 0.68 1.46 
Step 2 
Constant 8.61 
(5.14, 10.70) 
1.49 - - - - 
Lack of appetite 
cluster 
-0.51 
(-0.98, 0.003) 
0.33 -0.18 0.13 0.63 1.59 
Low mood 
cluster 
-0.19 
(-0.86, 0.075) 
0.23 -0.10 0.42 0.57 1.75 
Pain cluster -0.70 
 
0.37 -0.21 0.061 0.68 1.48 
Fatigue severity 
(MFS) 
0.042 
(0.011, 0.074) 
0.016 -0.36 0.010 0.48 2.09 
Step 1 adjusted R2 0.38, Step 2 adjusted R2 0.43 (F change=7.12, p=0.01) 
95% bias corrected and accelerated confidence intervals reported in parenthesis 
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7.3.10 Survey supplementary qualitative data 
 
Verbatim as typed by participants, with minor amendments to spelling and punctuation 
Lack of understanding 
Think my partner gets frustrated at the fact and doesn't understand fully. She thinks I'm too lazy 
sometimes. 
 
I brought up my fatigue with doctors. Nothing was suggested apart from trying to rest and gentle 
exercise. However I started having private alternative therapy and my oncologist recommended I 
keep having it. 
 
Fatigue is rarely discussed after finishing chemo and, when it is, staff tend to say that it has nothing to 
do with past treatment and don't offer treatment or suggestions to help. Although mine has 
worsened with the side effects of [condition] and its medication, staff still don’t seem to grasp the 
huge effect this has on my life and struggle to signpost me anywhere. I feel that for longer term 
survivors (3 years plus from end of treatment) there is very little support and awareness about how 
all late effects (fatigue included) still impact your life even though you 'look so well'. 
 
Emotional impact 
Basically, fatigue is ruining my day to day life... I feel like I don't see my family much or my friends and 
I always need to sleep. It's depressing. 
 
From my perspective, when I feel fatigued first I would say it a matter of me taking on a lot more 
mentally than I can achieve... Anxiety is a factor in me staying awake during the night when I wake 
up... Additionally, it makes me feel guilty when I feel too fatigued to do something like cooking myself 
a meal that I know I need to eat, and asking someone else to do it for me.  
 
Impact on work 
My main fatigue is from all the side effects from the treatment of cancer. Since my transplant 10 
years ago I never recovered my strength and it has gone downhill even more. I can't work 9-5 and I 
have tried but it has a consequence on my body. I have tried different career paths and I haven't 
found something suitable. My mother and partner have to support me and I know they don't mind 
but I do because having a job and an income makes you feel like a person.  
 
Perception activity is helpful 
I think healthcare professionals recommend resting or taking regular naps as the best way to lessen 
the fatigue but I have personally found a healthy balanced diet and frequent gentle exercise to be a 
much better answer. The more you do the more you feel capable of doing, but doctors don't tend to 
encourage this in my experience. 
 
I'd like a fatigue support group post treatment as it would be nice to catch up with other patients 
again to discuss how we are all feeling now, and if there's any physio or complimentary therapies that 
can be recommended. 
 
Requests for more research 
Please look at the other aspects of fatigue, for example: spots appearing on the face and body 
through being drained, people’s image changing because they're extremely tired. It also affects the 
physical appearance as well as the mental. 
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7.4 Fatigue Intervention Co-design Study 
7.4.1 Patient information sheet 
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7.4.2 Parent information sheet 
 
  
 326 
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7.4.3 Healthcare professional information sheet 
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7.4.4 Information for Facebook 
 
*This the content of the information, but the exact wording may be amended slightly* 
 
 
Are you suffering from fatigue? And have you completed cancer treatment? 
If so, would you like to take part in some research that will help us design a treatment for 
fatigue? 
 
For many years, young cancer patients have been telling us about their fatigue. It affects 
people in many ways, from feeling weak to having difficulty thinking or concentrating. 
Although it is such a common and distressing problem, there has been no research to find a 
treatment specifically for young people. 
 
Research in older patients shows the benefits of building up activity, while at other times 
resting and conserving energy. Support and information about fatigue can also help. 
However, we need to find out what young people really want. The best way of doing this is 
to work together to design a treatment.  
 
We need your help! 
 
Taking part would involve meeting us one-to-one and in a small focus group. Then you’d get 
the treatment you had helped design. After that, we’d meet once more to get further advice 
from you. We’d also like to include a few parents in this research. 
If you’d be interested, please let us know. We’d really appreciate your help, so we can work 
together to design the best possible treatment. 
 
Thank you for considering taking part. 
Let’s work together to treat fatigue!   
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7.4.5 Patient consent form 
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7.4.6 Parent consent form 
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7.4.7 Research Ethics Committee approval 
 
Decision and signature pages only  
 
  
 332 
   
 333 
 
  
 334 
7.4.8 Patient interview and focus group schedule  
 
 
 335 
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7.4.9 Parent interview and focus group schedule  
 
 
 337 
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7.4.10 Final node structure 
 
Name of node Number of sources Number of references 
Experience of fatigue 40 628 
Concept and importance of fatigue 11 18 
Fatigue pattern 12 20 
Sleep pattern change 11 18 
Factors that help fatigue 23 71 
Factors that worsen or don't help fatigue 22 41 
Concerns about activity 9 20 
Physical impact 6 9 
Emotional impact 19 38 
Emotional impact on family 7 12 
Cognitive impact 19 39 
Relative importance impact type 10 16 
Impact on work, education 15 22 
Impact on social functioning 20 51 
Impact on family social functioning, regression 12 24 
Info needs, what to expect 15 25 
Info needs, how much to push self 14 27 
Info needs, how much to push YP 11 23 
Info needs, other 16 35 
TYA characteristics, need for normality 22 65 
Misunderstandings, tension 25 54 
 
Intervention principles 40 377 
Approach, motivation 18 56 
Flexibility 8 10 
How specific 16 43 
Involvement of family 15 36 
Activity goals, feedback, app 20 60 
Energy conservation 14 38 
Education content 26 56 
Education mode, video 14 32 
Diet advice 9 17 
Sleep advice 8 10 
Psychological support 10 19 
 
Intervention practicalities 35 244 
Intervention name 13 29 
Timing relative to end of cancer treatment 21 47 
Frequency length of contact 10 19 
Location intervention 16 39 
Location activity 6 9 
One to one, family, group, chat room 11 24 
Mode communication 13 27 
Which therapist(s) 1 8 
Helpful aspects prototype 7 24 
Unhelpful aspects prototype 6 18 
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7.4.11 Intervention prototype guidance for Allied Health Professional 
 
 
Intervention prototype 
This has been informed by: 
Patient and parent individual interviews (n=21) 
Patient and parent focus groups (n=2) 
Research team discussion in intervention co-design meeting (n=1) 
 
Intervention name 
Road to Recovery: Fatigue Support (R2R) 
 
General points 
The intervention needs to be very flexible and individualised. 
There is often a degree of tension in the home, with a perception of being considered ‘lazy’; 
young people want parents to be involved and informed. 
Participants describe cognitive fatigue as often more problematic than physical fatigue. 
Positivity, psychological support and building confidence in self-management all underpin the 
intervention. 
 
Content 
1) Education/guidance 
Guidance in electronic and, where possible, video format. While in process of developing our 
own videos (peer-produced), consider Evans Health Lab video (young people) and 
Macmillan fatigue booklet (parents).  
Content for young people to include: managing expectations, impact especially emotionally, 
sleep needs and improving pattern, diet/nutrition. 
Content for parents to include: all of above, also how much to ‘push’. 
 
2) Exercise/activity 
Activity of young person’s choice, but avoiding need to pay – consider ‘exercise referral’. 
Structured incremental activity, with specific daily/weekly goals, and clarity about intensity. 
Monitor/feedback using health Apps (aim to identify ‘top 5’ valued Apps); health App may 
include calories/diet element if relevant. 
 
3) Energy conservation 
Analysing priorities, recognising that may not want to avoid ‘boom and bust’ eg if a night out 
is a priority. 
Support with pacing and planning, coping with variation in energy, strategies to ‘top up’ 
energy. 
Include short relaxation techniques eg short mindfulness. 
 
Process 
Find mutually convenient location: probably public place, not home or hospital. 
Aim for at least one face-to-face meeting. After this (and potentially at introduction stage) can 
communicate by video link eg Facetime. Generally not to use telephone, unless an 
individual’s preferred option. 
Frequency to be mutually determined, potentially up to weekly contact in relation to achieving 
incremental goals.  
Give individual Tip List (up to 10 items) as PDF to download on phone.  
One letter (minimum) will be sent to the young person, with a copy to oncologist/ 
haematologist. 
Intervention length from first contact can be up to 3 months. 
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7.4.13 Framework 1: Participant experiences  
 
 1a. Fatigue pattern and 
influences 
1b. Impact of fatigue 1c. Unmet information needs 1d.Tensions and 
misunderstandings 
TYA1 Non-strenuous exercise, like 
walking in nature, is calming 
Suggests giving control: ‘wiser to 
let people make the mistakes and 
learn themselves, so over exert 
themselves, because then they can 
work out their boundaries’. Talking 
to friends and 'community' is also 
important. ‘Emotional and 
psychological things that weigh you 
down, they also can contribute’. 
Depression may manifest as 
fatigue. Attributes insomnia to 
poor bedtime routine. Perceives 
'overlap' between fatigue and 
PTSD, PTSD symptoms including 
'being numb and not able to focus'. 
The most upsetting impact of fatigue is 
effect on 'my mind', particularly memory 
and concentration hardest. ‘I would be 
OK with [physical stuff] not changing, 
but... I would be distraught if I could not 
improve my mind. A young body can be 
pushed hard. ...with my body I can push 
myself...’ 
Would like to know how much to push 
oneself with exercise as finds walking 
too long 'counterproductive'. 
Did not realise that fatigue was not 
just physical; psychological 
component too. Perceives parents 
'think I'm making it up'. ‘They're like 
you're off treatment so now go back 
to normal’.  
‘And so of course they attribute what 
I would call fatigue to either laziness, 
or lack of willpower... I have spoken 
to them and tried to explain that it is 
not laziness’.   
TYA2 Experiencing worse fatigue than 
during treatment; fatigue persisting 
well after the end of cancer 
treatment: ‘I can't seem to shake it 
off....’ Finds fatigue very 
unpredictable. Sceptical about 
advice to exercise at it seems to 
make fatigue worse, although at 
times it has been helpful. ‘At the 
moment exercise just seems to 
make it worse. I just end up drained 
rather than like bouncing.... If I over 
exercise I just like die at the end 
and the next day I just can't do 
anything’. The mindfulness App  
['Headspace' is very helpful. 
Impact is more than tiredness or 
sleepiness: ‘It’s not really sleepy it's just 
like... a ton of brick pressing on 
you...when you’re so tired that you can't 
sleep... and everything slows down and 
all I want to do is just get onto the sofa 
and lie down’. Particular impact on 
ability to concentrate and 'find words'. I 
zone out... I just have to keep nodding 
and trying to like think of the end word 
they've said so I can say something 
about that. Fatigue being worse in the 
evenings makes it harder to meet 
friends and poor memory leads to 
forgotten social arrangements. Cognitive  
impact worse than physical. Fatigue 
unpredictability makes it hard to make 
Need to know what to expect, 
particularly how long it will last. I was 
expecting it to get better 'cause I wasn't 
having all the treatment, but it didn't, it 
got worse’. Wants information on ‘what 
is normal... this time out of treatment.’ 
More information would have helped 
make realistic plans for future work. ‘It 
just helps with kind of thinking what 
actually is realistic with what you can do 
afterwards’. Would have liked detailed 
information on exercise intensity and 
when 'the point' to stop is: it's quite hard 
to know whether to just go for it or like 
do a little bit and often. 
Acknowledgement of fatigue 'it 
happens' is inadequate; wants 'practical 
Frustrated by how reliant has 
become on family for activities of 
daily living. ‘I don't really want the 
reliance..’Experienced sense of 
abandonment on leaving hospital 
....you leave the hospital... ‘You are 
not really getting the same level of 
support that you were before, and it 
just seems like the fatigue is the 
inevitable consequence, and you just 
have to deal with it’.  
  
3
4
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 1a. Fatigue pattern and 
influences 
1b. Impact of fatigue 1c. Unmet information needs 1d.Tensions and 
misunderstandings 
[continued from previous page] 
plans: ‘so it's quite hard to plan things 
and I'd rather not plan things otherwise 
I’m always cancelling them’. Fatigue 
makes pain more severe and harder to 
cope with. Worried about impact on 
ability during a job interview. Hard to 
say: ‘...Oh sorry, I forgot the question...’  
[continued from previous page] 
solutions' or 'strategies', 'because it's 
really hard to know whether doing 
something is good or just 
counterproductive’. Wants information 
on how to talk to employers: ‘....rather 
than just be like I'm really tired, which 
kind of sounds like you're just being lazy’ 
TYA3 Variability of fatigue is particularly 
hard to cope with: ‘I have a couple 
of days of a major rush, and then 
all of a sudden it is knocked out of 
me and it will take a good five days 
to get back up again’. Describes it 
as being on a 'roller coaster'. Finds 
snacking, a 'sugar rush', can be 
helpful.  
Fatigue causes irritability, and makes 
him 'say things I don't mean'. ‘...because 
my body is so tired, and doesn't want to 
go any longer, sometime [parent] can 
say a simple sentence, and I will blow it 
out of proportion..’ Feels more forgetful, 
and that my brain isn't functioning... 
how most of my friends’ brains are... 
Cognitive worse than physical fatigue. 
Too tired even for TV. Forgets dates: You 
say, oh yeah, I'll meet you [day]... and 
you get like a really awful text... where 
are you? Feeling of burdening friends 
with the fatigue (‘he needs to nap').  
Concerned that exercise may make 
fatigue worse, particularly walking up 
stairs. Needed information about diet, ‘I 
had no idea where to start with diet’. 
‘Family as well... now you're off 
chemo it's like oh, you must be fine... 
So it does cause arguments, a lot of 
arguments... I get seen as being 
lazy... my siblings are older and my 
brother especially, she doesn't 
understand how tired I do get. And 
it’s very much like we end up arguing 
then because it’s like why can you be 
this tired you don't do anything all 
day... I think he doesn't understand 
that just because my chemo has 
stopped doesn't mean that all the 
post stuff does stop too’.   
TYA4 Pacing can be helpful, for example 
resting during the day before an 
evening event. Activity, including 
during cancer treatment, valuable, 
best as 'smaller shorter stints'. ‘If 
you can get out of bed and even 
just go for a walk or something, I 
do think it helps.’ 
Describes having to leave evenings out 
early, whereas ‘before I would probably 
be out until whatever time’. Would like 
to return to 'night-clubbing'. 
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 1a. Fatigue pattern and 
influences 
1b. Impact of fatigue 1c. Unmet information needs 1d.Tensions and 
misunderstandings 
TYA5 Tries to 'sleep it off' but this doesn't 
help fatigue, and may be counter-
productive. 
Fatigue leads to a sense of lack of 
energy. Unable to work or meet friends: 
‘If I've been invited out by a mate or 
something... I rarely actually go because 
I would just be too knackered’. 
 In the interview reacted, half-joking, 
in a way that implied she felt he was 
been seen as lazy. ‘That makes me 
sound outright lazy though’. 
TYA6 Feels daily routine with having to 
'do things' helps fatigue and sleep. 
Broke vicious cycle of poor sleep 
worsening fatigue by 2 nights of 
sleeping tablets. ‘If I spend most of 
the day in bed, I am more tired, 
whereas if I get up and do 
something’ then energy improves. 
Describes impact of emotional 
state; compared to being ill when 
younger; at this age knowing too 
much causes 'worry' which affects 
sleep and fatigue. Activity helpful. 
Impact includes having to cancel social 
plans, and feeling memory is much less 
good. 
Needed information on how to improve 
sleeping pattern. 
Feels fatigue is misunderstood: ...it's 
not just tired... Is aware that the 
fatigue and related frustration has an 
impact on family. Family feel upset 
also when 'I've got plans and I have 
to cancel them'. Peers also do not 
understand: ‘I do think if you don’t 
know … if you haven’t experienced 
fatigue or know what it is, you don’t 
understand fully, you would just 
think, oh you just need a little nap, or 
something...’ 
TYA7 Finds exercise really helps fatigue, 
any activity, including walking. 
Started exercise during treatment. 
Impacted on mental wellbeing; as it 
was 'something positive'. ‘I found it 
kind of like helped my mind as well, 
but helped the tiredness, because I 
felt that the days where I was just 
at home in bed feeling sorry for 
myself... you actually made yourself 
feel worse’. Diet made no 
difference. 
Aware of the psychological impact of 
fatigue, ‘it brings you down as well, 
because your body doesn't really feel up 
to a lot of things’. Also impact on 
concentration, leading to 'doing things 
wrong' at work; at worst times was not 
even able to 'watch a film' (audio easier 
than video). Fatigue hinders feeling 
'normal', ‘you want to act as if nothing's 
happened so you put your all into 
everything as if nothing [had 
happened]...’ 
Finding it hard to understand ‘what's 
just general tiredness and what's 
fatigue’. Wanted more information on 
how to stay active and fit during cancer 
treatment. Advice would need to be 
guidance rather than specific, as 
everyone's needs are different. 
Feels parents do not understand, 
'They're just like get on with it'. 
Similarly employer: ‘...I have made 
them aware... But I don't think they 
get it’ Also friends when cannot go 
out: ‘my friend got annoyed at me’, 
‘So the other day I did get quite tense 
in that I swore at mum... she was just 
like, ‘Well anyone would feel like that 
on a normal day at work’. I was like, 
‘You don’t get it’, and then I tried to 
explain it more’.   
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 1a. Fatigue pattern and 
influences 
1b. Impact of fatigue 1c. Unmet information needs 1d.Tensions and 
misunderstandings 
TYA8 Feels being active is helpful ‘fatigue 
was getting better anyway, just 
through me doing more’. Believes 
that 'fatigue breeds fatigue' and 
solution is to build up activity, rest 
making things worse. Important 
not to push 'it too hard and I was 
dying sort of thing the next day'. 
Describes continuing at school 
through chemotherapy, which kept 
his, ‘brain active and therefore in a 
better state than others'. 
Fatigue has huge impact on cognition, 
particularly concentration, memory and 
writing. Cognitive impact is worse than 
physical. For me the physical isn't too 
bad, as I've found ways of controlling it, 
and improving it [activity], but the 
mental stuff I found tricky. Hard during 
exams, I'd think of the next point... but 
by the time I got to it, I'd forgotten it. 
Impact on exam results, worse the days 
when 'tired and couldn't think straight'. 
Definite social impact, not ‘going out’. 
Is uncertain about how much to 
exercise, as a lot of walking 'can have 
quite an effect a few days afterwards'.  
‘I kept getting mixed messages from one 
doctor and another about how hard I 
should push myself, how much I should 
do.  
 
‘My mum threw my duvet down the 
stairs to get me out of bed.’ 
TYA9 Perception that 'rest' and 'time' 
have made fatigue better. Diet 
made no difference. 
Cognitive fatigue worse than physical 
fatigue, as it can't be seen. ‘I can’t 
concentrate enough on anything, and I 
can’t read, because by the time I have 
registered one word, and moved onto 
the next, I can’t string them together’. 
Really worried about doing exams with 
'memory problems'. 
Was not given verbal information about 
fatigue; only accessed information from 
a charity website. Feels parents have 
information needs and should have a 
written summary: ‘best if they have the 
information... so they know what's going 
on...’ 
Invisibility of fatigue causes 
misunderstandings, just being 
'disorganised'. ‘The most stressful 
part... I will be sitting in school and I 
just can't do anything, and it looks 
like I'm not trying’. Pressure from 
family to get back to normal life, 
including school/job. ‘...my parents 
are saying 'just get up earlier' but I 
can't, because I am so tired all the 
time... and they don't understand’.  
TYA10 Feeling more fatigued months after 
end of cancer treatment than at 
the time of ending treatment, 
‘which I'm very shocked by’. 
Activity helps fatigue and having a 
goal to aim for. ‘Long walks... up 
my energy levels’. Being active also 
reduces day time sleep. Yoga also 
helpful, as incorporates activity, 
relaxation and mindfulness, ‘it is 
not just your body, it is the mind as 
well that it really helps with’. 
However, just exercising the mind 
and not the body 'is not enough'.  
Fatigue leads to being 'overemotional' 
Describes impact of fatigue on memory 
and concentration, ‘I might need 
reminding several times to do 
something’. Considers 'mental fatigue' 
main problem, not 'physical'. I just 
assumed it would be my body... my body 
could get up and do another day, but 
mentally I can't seem to get going’. Huge 
impact on family. I think everybody has 
just been quite exhausted by the whole  
thing, it has taken its toll on everybody... 
my [sibling] didn't go to university 
because she was looking after me... 
Would have liked family to have had 
more information 'I think it could have 
been understood a lot earlier on by 
family and people around me if they had 
perhaps had some information’. 
Emotional impact of fatigue can lead 
to conflict within the family. ‘When 
I'm tired, I am very moody and 
agitated, and I will lash out... And it 
can cause issues at home, because I 
will have a falling out with my 
[family], or I will snap at somebody’. 
Describes manager at work being 
surprised at not wanting to increase 
hours. Feels family think of fatigue in 
physical terms, not understanding 
what it really is. ‘They just think, oh 
well, she has had a long day, so she 
just needs to have some sleep’. 
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 1a. Fatigue pattern and 
influences 
1b. Impact of fatigue 1c. Unmet information needs 1d.Tensions and 
misunderstandings 
TYA11 Relates daytime tiredness to 
difficulty sleeping, sometimes only 
two hours at night. 
Really frustrated by reduction in 
concentration. Hardest part is 'not 
wanting to do anything', because of not 
'having the energy to get up and do it’. 
Perceives that exercise can be harmful: ‘I 
can't do too much because I injure 
myself too badly... If I walked any more I 
would hurt myself’. 
Internal misunderstanding, thought 
meaning of 'fatigue' was not being 
able to eat enough. 
TYA12 Fatigue very variable day to day. 
Not sleeping much. Aware that 
light from electronic devices can 
hinder sleep but ‘I have to be 
honest, I do do that. I do check my 
phone and that’. 
Has been told by family that she is more 
angry than before. Very aware of 
reduction in concentration, impacting on 
education and socially, ‘I found myself 
losing concentration... about five 
minutes later, I realised I had not 
listened to a word anyone had said...’  
Wanted to know how long fatigue would 
last, but was given wide range of 
possibilities, and the cause: ‘I would 
have wanted to know if when I am 
feeling knackered whether it was 
because of my treatment or not’. 
Needed also to know how much to push 
herself physically.  
Frustrated by variation in fatigue. 
Does not think University 
understands and frustrated her 
parents are pushing her to get on 
with University work. ‘She is proper 
ratting on me, on my case, all the 
time.’ 
TYA14 Resting can be helpful. ‘Working 
myself up to doing things isn't very 
helpful... It build up into too much 
and I stop being able to do even the 
littlest things anymore.’ Feels that 
being active can make her ill; can 
become 'deathly ill from doing too 
much'. 
Fatigue leads to being more emotional. 
It also leads to 'brain fog'. Physical 
impact probably worst, but 'closely 
followed' by psychological. 
Needed easily accessible information 
about 'brain fog'.  
‘I don’t feel like people get it; they’re 
just not very informed most of the 
time and it’s hard to communicate... 
lack of understanding from my point 
of view’. 
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 1a. Fatigue pattern and 
influences 
1b. Impact of fatigue 1c. Unmet information needs 1d.Tensions and 
misunderstandings 
PAR2 Fatigue persists and has 
progressively worsened after the 
end of cancer treatment. Feels that 
fatigue is very closely related to his 
mood. Is aware of 'habits forming' 
in relation to fatigue, such as 
relying on siblings for help. 
Fatigue is the 'biggest problem’ with the 
main effect being on cognition and 
concentration, particularly in social 
contexts. Impact of fatigue becomes 
greater the longer from cancer 
treatment, not necessarily because the 
fatigue is actually worse, but because 
the YP is trying to get back into normal 
life. The variability of fatigue has a 
negative impact on the family as well as 
the YP. Emphasises the enormous social 
impact of fatigue and it being difficult to 
'reintegrate'. Part of emotional impact  
of fatigue is that ‘the fatigue is a 
constant reminder of where he has been 
[cancer diagnosis and treatment].’ 
Fatigue particularly hard at this age 
'because up until now his body has never 
not worked'. ‘It's a very tricky age for 
this all to be happening’. Loss of control 
is particularly difficult at this age. 
It is particularly difficult to cope with 
uncertainty of fatigue trajectory: ‘But it 
isn’t really substantially better now, six 
months later, and so when he is looking 
ahead, he doesn’t know, and nobody can 
tell her’. Would have liked to have 
known what to expect. Day to day 
unpredictability also particularly hard. ‘It 
doesn't have any rhyme or reason’. 
Uncertainty about how much should 
have pushed [TYA2], and questioning 
self on hearing other parents' 
approaches in the focus group. Felt  
[TYA2] was particularly frustrated that 
no-one could give a timescale for the 
fatigue, and help manage his 
expectations. Feels much more 
information is needed about 
psychological aspects of fatigue. 
‘I mean, everybody in our house is 
unseated’. Describes that if, for 
example, siblings do not believe in 
the fatigue, it can lead to conflict. .  
Alludes to invisibility of fatigue, 
‘somebody who has had a limb 
amputation, you would be seeing it’. 
Describes great need of [TYA2] to 
'feel believed'. ‘...friends 
...compatriots are just not on the 
same page’. Great reliance on family, 
particularly siblings: ‘...has been a 
servant to [TYA2] nonstop... sits on 
the sofa and ...just shouts [name] 
and expects him to jump.... we've 
had some terrible blow ups because 
of [sibling] all because [TYA2] has 
been asking him to do stuff’.  
PAR3 Reports that [TYA3] feels better 
when she makes and effort and 
'does something'. Having 'nothing 
to do' makes the fatigue worse. If 
you do nothing, it makes you even 
more tired and exhausted. 
Frustration caused by fatigue leads to 
irritability and anger. Relates some of 
this to social isolation caused by fatigue. 
Also aware that [TYA3]’s memory is less 
good. 
 Emotional impact of fatigue affects 
family: ‘...she gets quite angry with 
the world, and then she sort of has a 
go at me and I have a go back’. 
Describes 'double-edged sword' of 
social networking, as aware of what 
peers are able to do. Exhausted by 
dependence of TYA3’s, including 
driving long distances. Feels sibling 
misunderstandings particularly bad. 
PAR4 Belief that fatigue is a 'state of 
mind', where feeling emotionally 
positive and enjoying oneself can 
make the fatigue improve. Also 
'getting up and doing something' 
helped with difficulty sleeping. 
Felt that fatigue made it much harder 
for [TYA4] to learn new things, 
particularly in a work context; this led to 
considerable distress. 
‘I guess the biggest thing is that you 
don't know what normal is, so you don’t 
know how [TYA4] should be, you don't 
really know what to expect’. Would have 
been useful to get more information 
from other parents in a similar situation.  
Tension between partners as to how 
hard to push ‘....my wife would be 
saying to me ‘Don’t push her, don’t 
push her’. And I would say ‘Well she 
is strong enough to say ‘no’ when she 
is not.’ 
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 1a. Fatigue pattern and 
influences 
1b. Impact of fatigue 1c. Unmet information needs 1d.Tensions and 
misunderstandings 
PAR5  Fatigue is the biggest problem of many; 
causes frustration, low mood and 
irritability. Particular frustration when 
‘she sees her mates' lives going forward, 
like cars, jobs, girlfriends. She has sort of 
come to a bit of a standstill’. Impact on 
concentration, not memory. Friends 'not 
coming round any more'. Parental 
dependence. 
Would like to be given ideas for how to 
support [TYA5] when she is frustrated 
with the fatigue.  
‘...it can have a knock-on effect 
because she feels so tired all the 
time, and takes it out on me, quite 
understandably. Describes an impact 
on all family members including 
grandparents. 
PAR6 During holidays she ‘is sleeping 
later in the day, and then she is 
finding it really difficult to sleep at 
night’. Describes tending to watch 
TV in the bedroom, leading to 
getting to bed early but sleeping 
late. Learned that 'energy breeds 
energy' from her own mother. 
Being active is helpful: ‘she finds 
that when she actually gets up and 
does something it gives her more 
energy.... what she was doing was 
just spending the day in bed, and it 
was just making her feel worse.’ 
Fatigue causes significant mood swings. 
‘She gets frustrated a lot more with the 
mental side of things than she does with 
the physical side...’ Particularly aware of 
social impact. ‘It is quite upsetting to see 
her sort of separating herself from her 
friends, because she doesn't feel she can 
keep up with them’. Impact on 
education, falling asleep revising. Social 
impact causes anger: ‘because of the 
amount of stuff she's missed....missing 
out quite a bit on seeing friends, and 
socialising like a normal 17 year old’. 
Impact also on not being able to make 
family plans: ‘you don't know how they'll 
be feeling from one day to the next’. 
‘We have not actually been given any 
information about fatigue. ...how much 
do we put down to the treatment that 
she has had, and how much do we put 
down to just her being 17?’ Fatigue has 
led [TYA6] to feel anxious, as she did not 
know it would continue after the end of 
cancer treatment. Wanting to push 
[TYA6], while it is also 'hard to push...too 
much'. ‘So maybe we could have pushed 
her a bit more, maybe we have pushed 
her too much, we don’t really know’. 
Needs more information about sleep: 
‘now she's just not sleeping at all...at 
what point should I think it's not just 
fatigue, it's something else’. 
Mood swings lead to tensions within 
the family. Describes feeling upset 
and frustrated, particularly seeing 
[TYA6] becoming socially isolated. 
‘She sees all her friends all doing 
normal things, they've all got 
partners and jobs, they're all going 
off to university, and she's still sort of 
there...’ Effect on parents: ‘It does 
have an impact... I can't really make 
plans to go and see friends and 
family, because I have got to 
basically work around [TYA6]’s 
fatigue’.  
PAR7 ‘....obviously the more you sit still, 
whoever you are and whatever you 
have done, the more you feel tired’. 
Exercise has been particularly 
helpful for [TYA7], both physically 
and psychologically. ‘It is like 
psychological, isn't it ...if it is 
helping in your head, then it helps 
the rest of your body... I think your 
mood will make you more tired’. 
Describes [TYA7] as getting very 
frustrated at times, sometimes leading 
to anger. 
Found it hard to differentiate between 
fatigue and 'normal tiredness'. [TYA7] 
had accessed information from the 
Macmillan fatigue booklet, but was not 
age appropriate: ‘it always aims at 
breast cancer more than anything...’  
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 1a. Fatigue pattern and 
influences 
1b. Impact of fatigue 1c. Unmet information needs 1d.Tensions and 
misunderstandings 
PAR8 ‘To me, exercise never worsens 
fatigue. Fatigue breeds fatigue in 
my head.’ Strong views that 
parents are the key to successfully 
managing fatigue, ‘the mums 
almost keep them ill...’ 
Feels that the psychological impact of 
fatigue is worse than physical: ‘It seems 
easier for them to force themselves to do 
something physical...the mental thing 
might lead to... aggression’. Describes 
pronounced regression, with 'wanting 
his blanket back'. ‘... little bald headed 
who even looks like a baby... he acted 
exactly like a young child’. 
Described accessing a variety of leaflets, 
including from Macmillan, relating to 
fitness , but they 'were aimed at older 
people' 
Describes social networking 
potentially making it harder as ‘you 
are seeing what everyone's doing 
and you're not doing’. 
PAR12 Describes poor sleep, and 
acknowledges influence of light 
from electronic device. 
Perceives poor concentration 
problematic, and leading to 
procrastination. ‘....really difficult to sort 
of sit in front of the laptop and apply 
herself.’ 
Would have wanted an 'exercise plan', 
as [TYA12] went from no exercise to 
going for a run: ‘I thought she was going 
to die, he was so out of breath, and was 
going to pass out. But of course she had 
gone from nothing, to go for a run’. 
Aware of being seen as 'nagging' her 
daughter to get on with University 
work. There have been tensions...It 
has been tense because we have 
adapted to life without her, and now 
she is there, and everybody is centred 
around [TYA12], and probably her 
[sibling] has felt a little bit shut 
out..... So it is definitely tense’. 
PAR13 Feels that [TYA13] perceives that 
the gym makes him more tired.  
Feels psychological impact of fatigue for 
[TYA13] has been worse than physical. 
‘The problem... is you don’t know how 
much of it is normal for their age’. 
 ‘And I needed someone to tell me 
that...’ 
Sense of invisibility of fatigue. ‘So to 
look at him, he didn't really look any 
different...’ Arguments occurred 
when trying to help him 'feel more 
normal' by getting dressed, but he 
did not want to. ‘So it was getting 
him to do things... because he would 
say things like ‘You don’t understand, 
I have been through a lot’   
PAR14 Rest, relaxation, avoiding stress are 
all helpful. ‘...being happy and 
having fun can actually give you a 
boost of energy’.  
Fatigue can cause a severe downward 
spiral of depression. It leads also to 
[TYA14] ‘not being able to speak any 
words at all’. 
Needs guidance on how young person 
can 'take control' again. 
Felt healthcarers did not understand 
the fatigue as well as they did, and 
this led to conflict. Perceives that 
pushing to be active can be harmful: 
‘harmful to young people because 
adults can push them into doing 
more than they are physically 
capable of when they don't recognise 
their fatigue, with potentially long 
term, permanent consequences’. 
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7.4.14 Supplementary qualitative data 
 
Theme A1: TYA developmental stage compound the impact of fatigue 
Hindering cognition 
Effect on 
memory and 
concentration 
... like I have started to listen to tapes, because also I couldn’t focus on films 
and things like that. [TYA7, phase A] 
 
My TV is in my cupboard collecting dust. I haven’t watched TV in... we are into 
the seventh month, seven months, eight months last December. [TYA3, phase 
A] 
 
...like I just can’t remember things any more. [TYA2, phase A] 
 
Both really because her memory is not very good at the moment and she has a 
fantastic memory and it’s just like sometimes she just forgets, the silliest things, 
you know, what she went upstairs for, that sort of thing. I do that, but I’m 
nearly sixty, you know. [PAR3, phase A] 
 
Impact on work, 
education and 
socially 
Whereas I’d find at the start of the exam I was alright. But as I went on I would 
start writing the paragraph, think of the next point as you do but by the time I 
got to it I'd forgotten it. That was a bit of a pain. [TYA9, phase A] 
 
And sometimes actually I kept doing things wrong on the tills, and I think that 
could be a struggle. [TYA7, phase A] 
 
But he is finding it really, really difficult to sort of sit in front of the laptop, and 
apply himself, and is procrastinating and putting it off. [PAR12, phase A] 
 
Yeah, I think like especially when I'm having conversations with people and I 
just like forget stuff and it looks like I’m being really rude or just not listening, 
but like I genuinely like forget stuff all the time. [TYA2, FG, phase A] 
 
Do you say, ‘Oh, yeah, I’ll meet you Thursday’, or whatever and then Thursday 
comes and you get like a really awful text... ‘Where are you? Was I meant to be 
meeting you today?’ [TYA3, phase A] 
 
Cognitive fatigue 
versus physical 
fatigue 
And I don’t feel physical fatigue without the mental stuff, I feel the mental... 
sometimes without the physical, but usually both of them with the mental 
more obvious to me, because it is the part of me that I use more than I use my 
body. [TYA9, phase A] 
 
What I found with [TYA6] is that sometimes when she’s having an active day 
she tends to handle that more than if she’s having a mental day. Like when she 
was studying for her exams, for example, that wiped her out a lot more...  
[PAR6, phase A] 
 
Yeah, with this age group it’s more probably important mentally... and also like 
just having conversations with friends otherwise you're kind of out of it, if you 
just get so tired in the conversation you’re just sitting there like unable to 
speak. [TYA2, FG, phase A] 
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...it was so interesting is that the cognitive aspects of fatigue, concentration and 
memory are a bigger problem and they want us to focus more on this. [RES, 
CDM, phase B] 
 
... I was fascinated to hear this from parents and also in a sense from young 
people of actually... it is the cognitive side of the fatigue that’s particularly bad 
and ‘we do want support with that’. And if that’s psychological support ‘we 
want that’. So they didn’t feel like the stigma around support or psychological 
support because they're getting the fact that this is affecting how they think, 
and their memory and concentration. [RES, CDM, phase B] 
Exacerbating emotional reactivity 
‘Anger’ and  
‘frustration’ 
Yeah, I agree, my hearing’s completely off but then when you're tired, or when 
I'm tired or if I’m struggling to hear things then I end up like aggravated and 
angry because it's like I’m trying to process what people are saying but I can't 
hear them, if that makes any sense. [TYA3, FG, phase A] 
 
I know that when I am tired like I would say [like] most of my year group, you 
end up ratty, you end up angry for no reason. And instead of me knowing... to 
kind of just mellow, because I am already wound up, because my body is so 
tired, and doesn’t want to go any longer, sometimes mum can say a simple 
sentence, and I will blow it out of proportion... [TYA3, phase A] 
 
Yes, because if she is tired she gets muddled or she can’t remember things that 
frustrates her. She does get very angry with herself and other people. [PAR3, 
phase A] 
 
She gets frustrated sometimes. She has got really frustrated with it, where she 
has just felt that she is more tired than she should be at her age... [PAR7, phase 
A] 
 
And she gets very frustrated because she sometimes can’t do what she used to 
do and sometimes it makes her feel inadequate. And I get the sense that she 
doesn’t feel she’s as much of a person, if that makes sense. [PAR5, phase A] 
 
Effect on mood ...you can start to lose hope and lose hope of never being able to actually 
achieve that independence and that really spirals you down into depression and 
it can be really serious depression because you know. [PAR14, phase A] 
 
It is like mood swings really, yes. Because like you say one minute her and her 
sister will be laughing their heads off, and then the next minute she will be like 
‘Right I am tired now [sister], go to your room’. [PAR6, phase A] 
 
Hampering the need to conform 
TYA perspectives I think that just comes with our age as well, when you’re under 25 your brain is 
still trying to keep up with what everyone else is doing... [TYA3, FG, phase A] 
 
Yeah, like going out at the weekends and just even generally doing stuff in the 
day, you kind of put your all and I generally don't say, ‘No,’ because I have huge 
fear of missing out. So like I'll go out continuously, like at weekend... you want 
to act as if nothing’s happened... [TYA7, FG phase A] 
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Parent 
perspectives 
Whereas before she was getting very annoyed and frustrated because she was 
watching Facebook and all her friends going out, partying and out with their 
boyfriends and this and that and she said, ‘I can't do that.’ [PAR3, FG, phase A] 
  
...like you said, on Facebook she sees all these people that she knew from 
school that she should be in a friendship group that she would have been 
friends with. So she sees them all doing normal things, they’ve all got partners 
and jobs, they're all going to college, they're all going off to university and she’s 
still sort of there... that's where her anger is coming from because of the 
amount of stuff she’s missed. [PAR6, FG, phase A] 
 
Dependence and demotivation 
Regression to 
dependence 
...and you have this bald headed who even look like a baby but they, he acted 
exactly like a young child. [PAR8, phase A] 
 
Demotivation ...have days where I don’t do anything, it kind of hits me, and I get quite achy 
and tired, and I am just de-motivated, and I just can’t really... [TYA7, phase A] 
 
Literally not even getting dressed and I’m like, you need to motivate you to do 
something. [PAR3, phase A]  
 
But she’s sort of lost that motivation to get out because she’s been so tired. 
[Interviewer]  
Yeah, I think that’s what it is. She doesn’t seem motivated. And she, obviously 
the tiredness isn’t helping. [PAR5, phase A] 
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Theme A2: TYA developmental characteristics influence intervention design 
Intervention approach 
Motivation and 
confidence 
And what is the secret to regaining that hope? [Interviewer] 
I guess understanding that the little things that you do like taking control of 
things are actually important. [TYA14, phase A] 
 
Yeah, I mean I’m trying to work it out myself what… how you could help 
someone, because I think what’s needed is almost like a catalyst or a way of 
moving the progress forward, or like understanding in all sorts of individuals, 
what would help them move forward. [TYA1, phase C] 
 
I don’t like this passive, ‘fix me’ attitude. It’s all, it’s a two-way thing, the 
doctors will do their thing and nurses will do their thing and then you have to 
do your thing, you have to do your part. [PAR 8, phase A] 
 
...definitely the best way for people I think to get over [fatigue] is to keep 
them motivated. [TYA8, phase A]  
 
Health coaching I was almost saying ‘this might be normal for you, it might be normal to stay 
up to 3 or 4 watching American football, because that’s the time it’s on with 
the time difference. That’s OK, but it is going to have an impact.’ And I didn’t 
think there was going to be any change there. But obviously it’s clicked in his 
mind, and he thought, ‘That is a problem for me and I’m going to change it.’ 
So I think that is what he changed, without me saying, ‘You need to change 
this. I was just identifying what the link was really.’ [HCP, phase C] 
 
Individualised, 
own goals 
... so kind of set a goal with them. So if you say to someone like me, so where 
do you want to be in three months time, and I just turn around and be like, 
‘Well I don’t know,’ then you kind of start digging and find out what they    
like, what they want to do, if they go to school, things like that. And then 
they’ll set themselves their own goal without even thinking about it. [TYA3, 
phase C] 
And so is what you’re saying [TYA3], just to check I’ve understood, that it’s 
actually most important for the person themselves to set their goal, and to 
work out the plan to get there, rather than actually, whoever it is, whether it’s 
[HCP] or whoever it is in future treatment, writing down a plan for somebody? 
[Interviewer] 
Yes, because it’s then set to what your body wants not what their body wants. 
And like everyone’s body is different, so you might give a young 14 year old 
the same thing as me and I might be fine with it, but she might be struggling. 
[TYA3, phase C] 
 
...the end goal of playing basketball again, so that’s my motivation from within 
me, rather than most people won’t have an end goal set that will want them 
to be motivated. So I don’t know if it’s just ringing up and setting goals [TYA8, 
phase A] 
 
...the worst thing you can do is sort of shame them into a state of being 
motivated or saying ‘you should do something’ because there’s probably a 
really good reason why people feel demotivated. [TYA1, phase C] 
 
 352 
And I am not really part of the camp that says that you should just give people 
some instructions, and they have to take it like a bitter pill. [TYA1, phase A] 
 
...was there something that all this time you’ve been ill you’ve been thinking ‘I 
wish I could do that’? And, ‘Let’s aim for that…’ [PAR 8, phase A] 
 
But I do think having an end goal is something that… like, I knew I wanted to 
get back into a full time job, and that’s what I've worked towards, and that’s 
what I'm doing. [TYA10, phase C] 
 
The other really big theme is that the intervention must be flexible and 
individualised and almost nothing they want completely planned. [RES, CDM, 
phase B] 
 
Positive approach I think anything that’s offered to him in a positive way is to be taken, because 
he is very disabled in many ways at the moment; he doesn’t want to think he 
is but he is. So I think positive things are great. [PAR2, phase A] 
 
Well I think, I always try and work it backwards from the point where you are 
at, to bring... I try and get [TYA4] from where I think she actually is to the best 
place she can be with sort of like positive thinking, motivation. And I very 
much, we focus on the good things, we don’t focus on the bad things. [PAR4, 
phase A] 
 
Again, focus on the recovery not the illness. You’ve got to always think about 
your recovery, recovery, what can you do. [PAR 8, phase A] 
 
Intervention content: activity 
Specific, 
structured 
regular support 
I would love to just have someone say, ‘This is what you should do this day, 
this is what you should do this day’. And then it just means that it is 
something to focus on as well, isn’t it, rather than you have got something to 
keep your mind onto, and it should be more or less achievable, shouldn’t it? 
...Yes if I could have a regimented plan it would be loads easier, loads easier to 
get back into it. [TYA12, phase A] 
 
Yes, like it felt kind of like any conversation I’ve had was a consultation, yes, in 
a consultation, because it’s kind of like, ‘Oh, how are you doing, how are you 
coping?’ But then that’s kind of like the things that you go through, it kind of 
just felt like a general... [TYA7, phase C] 
Chat? [Interviewer] 
Yes, rather than kind of picking out things that are the worst to then go, 
‘Right, let’s kind of take this and …’ I don’t know. [TYA7, phase C] 
 
...I guess the main thing I kind of thought was lacking maybe was like a plan 
going forward.  I don’t know what... I just thought she might kind of help me 
create like a plan going forward for what worked, what didn’t work. But it just 
more seemed to be a kind of general chat. [TYA2, phase C] 
 
...so the message was a bit hazy, whereas if you just say... all I wanted to see 
was right you can do this, you can do this... [TYA8, phase A] 
 
I was quite surprised because I perhaps wasn't prepared for the bluntness or 
the actual needing facts rather than talking around things if you see what I 
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mean... So I would say that they did want more specifics and absolute detail 
rather than more generic advice. [HCP, phase C] 
 
... there they really want... ‘What do I need to do today, what do I need to do 
tomorrow, what do I need to... where will I be at the end of the week, where 
will I be at the end of the next week, how will I know how I’m doing and how 
often can we be in touch to talk about how I’m doing?’ So it's really specific 
and defined which I think is not surprising but interesting. [RES, CDM, phase 
B]  
 
And then going on to activity, they want a very clear plan of what they’re 
going to do, most people said this. What they’re going to do each week rather 
than just say, you know, ‘Exercise until you feel that your body’s had enough,’ 
is just not good enough because actually they can push themselves, young 
bodies... [RES, CDM, phase B]   
 
...what they want is very definite and it's all trial and error at the moment and 
so people are... some of the young people are literally just breaking 
themselves by doing far too much but they’ve got nothing to go on... [RES, 
CDM, phase B]   
 
Activity goals  You've got to set an overall goal and then you’ve got to set a weekly goal, a 
monthly goal, and lower so if you don't... 'cause if you set one say, ‘You’ve got 
[to] reach this,’ and you don't reach that you're going to be, phew! Whereas if 
you’re setting them and you're constantly getting that buzz, so you’re losing 
weight, so you lose a pound this week you feel good and you keep going... 
[TYA8, FG, phase A] 
 
You could do a sort of chart thing so like if you’re going to do it with [HCP] we 
try different things each week and then she just rings us or emails us and says, 
‘Did you do such and such, did you manage to do that?’ And it's like... like I set 
a week thing, everyday I’ve got something on so like Monday morning you go 
and walk the dogs, Tuesday go and do the [local activity], I've always got 
something on. [TYA3, FG, phase A] 
 
But I do think having an end goal is something that … like, I knew I wanted to 
get back into a full time job, and that’s what I've worked towards, and that’s 
what I'm doing. [TYA10, phase C] 
 
There’s also the reassessment point then, isn’t it? Because it’s sort of checking 
back with them saying, ‘Okay, so you managed that really easily so this week 
actually we can move those a bit,’ Or actually, ‘You haven’t managed that...’, 
really tailored week by week. [HCP, CDM, phase B]   
 
Monitoring 
progress 
I know in my heart that I do, and I am making a difference, but when your 
brain is already in overdrive, and then you are already feeling low, something 
that is not visible straightaway... [TYA3, phase A] 
 
An App to keep track of the good days and bad days would probably help me 
to make progress I think, in help like keeping control of the good and the bad 
days. I think it’ll show me how many I’m having actually per month and per 
week. [TYA6, phase A] 
 
Also in terms of having something to measure your progress by. It would be 
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quite nice to have a little like, I guess mentally, to have a little like reminder or 
thing. Rather than just thinking, I mean to actually see it written down, like, 
‘You’ve walked this many steps and you've done this...’ I guess that's why an 
App might be quite helpful because it’s like a day to day thing. [TYA2, phase A] 
 
So they could compare with each other and you can congratulate each other, 
you know, you can send little ‘well done’ and things like that if they’ve done a 
particularly… or you could have a set goal, you can have goals on this Map My 
Walk. [PAR8, phase A] 
 
Intervention content: energy conservation 
Irrelevance of 
energy 
conservation, 
pacing 
Yeah, like going out at the weekends and just even generally doing stuff in the 
day, you kind of put your all. And I generally don't say, ‘No, ‘because I have 
huge fear of missing out. So like I'll go out continuously, like at weekend and 
then it’ll come down to like Monday or Tuesday or whatever and you just like 
proper feel it like catching up with you. But I still try and like continue... you 
want to act as if nothing’s happened so you put your all into everything... 
[TYA7, FG, phase A] 
 
If you want to do stuff then you just get the fatigue anyway, so you kind of... 
you make the sacrifices and you say, yeah, I’ll get that fatigue... [TYA2, FG, 
phase A] 
 
It depends on the person. Like there are some things that are more important 
than being a bit tired 'cause we’re always a bit tired that’s why we're doing 
this study. [TYA1, FG, phase A] 
 
I still get a feeling that sometimes she tries to run before she can walk, and I 
kind of try and get her to, you know, take time out... pace herself a little bit 
[PAR6, phase C] 
 
I wouldn’t say he used relaxation techniques particularly. He’d just go to bed. 
[PAR8, phase A] 
It’s not a massive teenage thing? [Interviewer] 
No, not really. [PAR8, phase A] 
 
...the key reason why I don’t pace myself is because I get disconnected from 
that. [TYA1, phase A] 
 
...so energy conservation I think for the parents was a huge concept, 
inevitably, and frustration at adolescents tending not to plan and the 
inevitable being boom and bust.... My sense from your focus group is that 
‘boom and bust’ isn’t something they actually recognised which is a word that 
they use with older people... [RES, CDM, phase B]   
 
...so that if they had a big night out they would just expect that they’ll be, you 
know, floored the next day, and that's something that they’re willing to do, to 
live with. [RES, CDM, phase B]     
 
‘I’m young, I’m not prepared to do this, I’m not prepared to stop going night-
clubbing...’ [RES, CDM, phase B]  
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Mindfulness or 
other meditative 
techniques 
... your brain is already in overdrive, [TYA3, phase A] 
 
 [Mindfulness] it’s very in at the moment so... we could use that again. [HCP, 
phase C] 
 
[TYA12] said he was doing the Headspace App, which is the mindfulness App, 
and really took on board some information and was doing really well. [HCP, 
phase C] 
 
[TYA1] also did talk about mindfulness and relaxation and having taster 
session on the ward, for people to go in and actually try. [HCP, phase C] 
 
So part of exercising the mind now is to allow it to be quiet. [TYA1, phase A] 
...So something about almost... I don’t know if you use that word ‘mindful’, 
about being in a still, calm, aware place...? [Interviewer]   
...I prefer the idea of moving meditations like Tai Chi. [TYA1, phase A] 
 
For me the benefit [of yoga] is massive. [TYA10, phase A]  
 
Intervention content: information needs 
‘How hard to 
push’ 
I did it the other day when I went for a run, and I came back, I pushed myself 
as hard as I can. I came back, I weren’t nearly sick, but I was like really ill, like 
feel myself ill... Yes, someone who knows what they are talking about really, 
in terms of how hard they can push you without, well, killing myself basically. 
[TYA12, phase A] 
Yes. And finding I guess that medium ground, that safe ground, for knowing 
that...[Interviewer] 
...push yourself to the extent where you are improving, you are getting better, 
but not to the extent where you feel crap afterwards like I did. [TYA12, phase 
A] 
 
...she told me that I wasn’t allowed to push myself to my limit... So I think in 
the long term it’ll probably help me a bit, like, because she’s given me advice 
on making sure I don’t mess myself up basically. [TYA12, phase C] 
 
It's quite hard to know whether to just go for it, or like do a little bit and often. 
[TYA2, phase A] 
 
And she was just writing about pushing it a bit, and that does happen. Like if 
you do stretch yourself, and spend all day out, and then spend time with 
friends, then it’s kind of normal for that to happen. It doesn’t mean it has just 
suddenly come back. [TYA2, phase C] 
 
So maybe we could have pushed her a bit more, maybe we have pushed her 
too much, we don’t really know. [PAR6, phase A] 
 
...when you set some initial guidance young people think, ‘Well, that’s just too 
easy,’ on day one, day two and so they then go and do ten times too much on 
day three and they can't move... [HCP, CDM, phase B]   
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‘What to expect’ And I also wanted to know if that was still normal, or whether it was just 
totally... I don’t know whether other patients at my stage, at my time out 
from treatment, who had my kind of treatment, were actually at that level 
that I was, or whether someone managing much better. [TYA2, phase C] 
 
So there was still some residual lethargy, and not having... The problem with 
children that age, he was just 18, is you don’t know how much of it is normal 
for their age... We have got a decent size garden, so the dog can run around 
and everything, and I will say ‘Oh I thought you would take him for a walk’.  
And he said, ;I will when I get dressed’ and it is lunch time. But again is that a 
normal teenager? [PAR13, phase A] 
 
I guess the biggest thing is that you don’t know what normal is, so you don’t 
know how [TYA4] should be, you don’t really know what to expect. And then if 
she was tired, then there is obviously that worry about why she was tired, and 
again whether that was normal, or what that was all about. [PAR4, phase A] 
 
But sometimes as I say it is very hard to sort of differentiate between normal 
fatigue, and just normal tiredness. [PAR7, phase A] 
 
Parents’ information needs came through as a big theme as they just want to 
know much more... [RES, CDM, phase B]   
 
How to talk to 
employment or 
education staff 
But I guess ultimately it would be about education. So it has got to be about 
being able to educate companies or managers to understand the benefits of it 
[people with cancer working]... [PAR4, phase A] 
...is there some way that if we, with the young person’s consent, we can join 
them in a meeting with their managers, and try and support and explain 
things, and try to negotiate, and educate in other words, in a very gentle non-
patronising way the managers... [Interviewer] 
 
...having spent more time dealing with fatigue I guess the main thing is that 
it’s important to have those around you, for example, work or university  
or school, be supportive and give you sort of extra time to do things if  
you need that. ...encourage those that have chronic fatigue... to feel  
that it’s okay for them to ask for, I guess ‘special treatment’ is one way of 
putting it. I mean in that it’s sometimes like …because my lecturers are 
wonderful. They gave me extra time for everything, even though I don’t 
always need it. And it allows me to not be stressed and then in itself helps me 
to stay well and it’s not as exhausting because it takes a weight off. [TYA1, 
phase C] 
 
I had sent this e-mail about having to make reasonable adjustments, and they 
just said it is possible to do the first year on a part-time basis which I think just 
would make all the difference and actually enable me to do it rather than just 
to fall at the first hurdle or whatever. ...I only found out about Working With 
Cancer through [charity], and it might be helpful to have a kind of... a place 
where people can go for more information... I didn’t mention anything about 
cancer, I just said, ‘Oh, I have had some medical treatment, and it would work 
better for me to come in later and avoid the tube and the rush hour and 
everything.’ And they said, ‘That’s fine.’ [TYA2, phase C] 
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I think she also gave her some good advice about employment law, which of 
course is partly relevant with the fatigue, because it’s the fatigue that is 
causing him the problems. [PAR2, phase C] 
 
...[information] around work, so getting back into work or university, more 
specifics around what they need to be doing, but on an individual basis. [HCP, 
phase C] 
 
And just saying to him [TYA2] that it’s OK to have a conversation with work to 
say this is what is happening with me, because he hadn’t actually told them 
what was going on for him, and didn’t want that to influence them in any way, 
their perception of him. He did have a conversation with the guy, and they 
were very supportive, and have given him a later starting time, so he didn’t 
have to battle with the tube journey. So I think that may have been helpful. 
[HCP, phase C] 
 
But then it was the more everyday things that caused the real concern like, 
‘How am I going to get up to go to work every day?’ for those that are starting 
jobs or, ‘How am I going to cope with being in eight hours’ worth of lectures?’ 
[RES, CDM, phase B]   
 
Intervention practicalities 
Name of 
intervention 
But not with the word treatment in there because treatment sounds like...? 
[Interviewer] 
...Because that just puts a downer on it. [TYA11, phase A] 
 
...for me I just think anything that sounds a bit negative... but I would rather it 
was called like... like use a word like ‘recovery’ than... [TYA8, FG, phase A] 
Yeah, because then it would still have the same legitimacy because it would 
suggest that you are not quite recovered yet. [TYA1, FG, phase A] 
 
I think I would include ‘fatigue’, because I think it is then something that 
people relate to. I think if it is quite open in ‘wellbeing’, some people will just 
brush it under the carpet. [TYA7, phase A] 
 
Just don't have negative… if you call it ‘fatigue’... you're making it sound like 
it’s bad... [TYA8, FG, phase A] 
But then if you do do it then you're adding like medical legitimacy to it. [TYA2, 
FG, phase A] 
 
What I mean is so you want to call it ‘fatigue’ because it gives it more 
legitimacy, or you could just call it ‘fatigue’ to people and then you can call it 
‘road to recovery’ because that's what you want to focus on. [TYA1, FG, phase 
A] 
 
Videos not 
leaflets 
I’d like if it is a video, it is easier to pay attention to everything you are 
listening to. [TYA9, phase A] 
 
...you know that's the first that they think at that age, this generation, that's 
where they go for information, I mean I wouldn’t think of that but so... I mean 
and then again it's dealing with your peers, isn’t it, it’s getting information 
from peers...? [PAR2, FG, phase A] 
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Just like a video on fatigue, just like common side effects and like what it 
might affect. [TYA2, FG, phase A] 
I think what [TYA2] is saying is like I agree so much, I think we should do it 
though... Do a video, I think we should do it as a group because it just is a 
doctor, as soon as a people person opens that, I don't know if you guys do it? 
Hold on a minute, who actually read all the leaflets you get when you’re first 
diagnosed… [TYA3, FG, phase A] 
I purposely didn’t read them 'cause actually when I tried reading one of 
them... [TYA1, FG, phase A] 
Every single one of them. [TYA2, FG, phase A] 
I got that many… I got hundreds… [Multiple speakers concurrently] 
I got them all but they’re no use… all weird language… [TYA8, FG, phase A] 
So I think that we should do the video because it's more catchy, like if you see 
a group of young people saying this is exactly how it is. There's no medical 
terms in there, we’re just going to say exactly how it is. Whereas you open a 
tab and it's got like a doctor standing there it's like, ‘My name is such and such 
and...’ That's boring, log off... [TYA3, FG, phase A] 
Short, it’s got to be short. [TYA8, FG, phase A] 
Why don’t we do clips... [TYA3, FG, phase A] 
If you're going to go for the young generation. Does anyone here not have 
Facebook? Well, that’s a ‘no’… You need to go for that because it's like 
Facebook, like they’ve proven… one little click or one little picture can go a 
long way. [TYA7, FG, phase A] 
Okay, just get this in my head, so are we talking about making one film, or 
making a couple, people looking at different... [Interviewer] 
Do a series on... Short, like five or ten minutes each. [TYA1, FG, phase A] 
 
Intervention 
timing 
Yes, I think ongoing from the start really. And I think once you have had a 
chance to get it into your head what is happening, and I think maybe a few 
weeks, a month or so into your treatment, I think it is good to start that. 
[TYA4, phase A] 
 
Definitely before I had finished... The sooner the better with that probably. 
[TYA5, phase A] 
 
When you have finished cycle five, going into cycle six, is roughly when you 
would say do it. Because then they have got that last little bit to do, but you 
can get into a routine. [TYA11, phase A] 
And then you can get into a positive thing of right I am moving forward now? 
[Interviewer] 
Yes, yes. You haven’t then got to try and cope with it on your own at home 
with no help. [TYA11, phase A] 
 
From my end it would have been straight after I finished my last bit of 
chemo... Give you something to focus on as well wouldn’t it? That is why as 
soon as I finished having someone to think, ‘This is what you need to do this 
day, this is what you need to get done by the end of this week.’ That would 
have been helpful, I would say. [TYA12, phase A]  
 
Well, I think that it should be done either just before discharge, or on 
discharge. Because if we had some information to take home with us, it might 
have been easier for us to put something in place for her when we got home... 
So I think some sort of advice before taking her home would have been very 
helpful. [PAR6, phase A] 
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...this needs to be early and a feeling of this actually needs to start during 
treatment... because of the sense of hiatus, of life has been hospital , and 
then all of a sudden there's a hole and happily wanting to put this into it. [RES, 
CDM, phase B]   
 
Intervention 
location 
Yes, I would have someone come at home, but I just always... I don’t know, 
sometimes I find it nicer to go out. [TYA7, phase A] 
 
Personally for me it’s just like I have spent so much time [at home] anyway... 
And it’s not that I have got anything private to say, it’s just nice to kind of be 
removed from that setting. And it’s also quite nice to actually get out a bit, 
especially when I was just after treatment, I hadn’t really had many chances 
to get out. And yes I guess it’s just... rather than you having to get a time and 
try and make sure [family members] don’t come in, or what have you. And it 
is just nice to have a specific time just to focus on that, and I guess it’s nice to 
go out for that, well for me... But yes with [HCP] we just met at a cafe nearby 
which was fine, and nicer than going into [town]. So I think going into [town] 
might be quite tiring, but it’s definitely nice not to have it at your house. 
[TYA2, phase C] 
 
Oh no, you can visit [home], no it’s fine. I just don’t think it is conductive for 
combating fatigue, because in order to combat fatigue you would have to do a 
bit of exercise. [TYA1, phase A] 
 
No, not at the hospital... Hospital is too much of a reminder, with cancer. So 
the hospital is, like I dread coming to hospital, and I haven’t even come to see 
the ward. [TYA3, phase A] 
 
From [TYA6’s] perspective I would say anywhere but the hospital. So here 
would be a good place, or home. But... the last thing a patient wants to do is 
come to hospital if they don’t need to be here. So yes, I would say to avoid 
being on a ward or anything like that... [PAR6, phase A] 
 
In terms of pragmatic, practical things, this was another surprising thing... 
young people want to leave home to meet somebody to get support with 
their fatigue because home’s actually where they’re stuck all the time... [RES, 
CDM, phase B]   
 
Location and 
types of activity 
I meant exercise that isn’t too strenuous, but so that I move all my different 
body parts, so like yoga or Tai Chi, following like a YouTube video, and going 
for walks in nature. And I think it is not just that it is walking, it is the setting 
as well, it is calming. [TYA1, phase A] 
 
Because I think you don’t always feel like getting up and going out. So I know 
a lot of the time I wouldn’t have felt like going to a gym, but if it is there you 
can do it in front of the TV or something, in the privacy as well of your own 
home. [TYA4, phase A] 
 
Yes, because it’s then set to what your body wants not what their body wants. 
And like everyone’s body is different. So you might give a young 14 year old 
the same thing as me and I might be fine with it, but she might be struggling, 
or he might be struggling. And I think it just is you need to kind of just sit 
down with them, just jot things and do a mind map and things like that of just 
what they want out of this. [TYA3, phase C] 
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Discipline of 
intervention 
provider 
For some people [a conversation with a sleep specialist] could be helpful, 
because I did find it really hard when I was having sleepless nights. [TYA6, 
phase C] 
 
I don’t think I have got anything specific [to add to the intervention] apart 
from psychological help. [PAR3, phase C] 
From a psychologist do you think? [Interviewer] 
Yes. Yes, well a sort of counselling type thing, whether that is a psychologist or 
something else. [PAR3, phase C] 
 
Another thing was that I was fascinated to hear this from parents and also in a 
sense from young people of actually how it is the cognitive side of the fatigue 
that’s particularly bad and, ‘We do want support with that’ and ‘if that’s 
psychological support we want that.’ So they didn’t feel the stigma around 
support or psychological support because they're getting the fact that this is 
affecting how they think and their memory and concentration. So that's 
another missing element. [RES, CDM, phase B] 
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Theme B1: TYAs experience pervasive tensions and misunderstandings 
Internal tensions 
Mismatch reality 
and expectations 
Well, because during chemo it would get really bad and then it would always 
ease up. But ever since the surgery it just didn’t ease up so I was kind of 
expecting it... to get better 'cause I wasn’t having all the treatment, but it didn’t, 
it got worse. [TYA2, phase A] 
 
I would say now, fatigue is a much bigger problem. [PAR2, phase C] 
And do you feel that is because [TYA2]’s fatigue is, if one can quantify it, actually 
worse in itself, or because... it is impacting more on his life because he is getting 
more back into normal life? [Interviewer] 
I think it’s the latter. [PAR2, phase C] 
Yes. So it’s the expectations. [Interviewer] 
 
Tensions within family 
Parents perceive 
as ‘lazy’ or 
‘disorganised’ 
Yes, because I am tired, because I am just drained mostly. So it does cause 
arguments, a lot of arguments. But it is also... you can be seen, like me 
personally, I get seen as being lazy, because I am not ready to go back to work, I 
am not ready to go back to college and things like that. [TYA3, phase A] 
 
...my parents are saying ‘Just get up earlier’, but I can’t, because I am so tired all 
the time anyway. And they don’t understand how tired I am all the time. And I 
don’t know, because it affects my concentration and my memory and stuff as 
well. And they find it really frustrating that I don’t remember things... And it is 
just kind of frustrating that they don’t understand, they just think that I am being 
disorganised. [TYA9, phase A] 
 
...conflict of home... came up very strongly with a sense of young people that 
parents attributing... are basically saying on some level that they’re lazy and they 
just need to pull themselves together which, obviously, is distressing. [RES, CDM, 
phase B] 
 
Parents 
misunderstand 
Like when I was a bit younger, I think they [parents] understood it quite a lot but 
I don’t think they got how, like I don’t think they understood, it’s not just tired, 
it’s I have to, feel like I have to sleep otherwise I can’t move. [TYA6, phase A] 
 
They just think, ‘Oh well she has had a long day, so she just needs to have a 
sleep.’ [TYA10, phase A]  
 
...they just assume that I have got back to normal maybe, just a tiny bit more 
tired or things. They just don’t seem to get that it still affects my life. [TYA9, 
phase A] 
 
And then at home, I don’t actually think I have ever... I have had arguments,  
well, not arguments, but tension, where I have kind of said, ‘You don’t 
understand.’ ...because I do quite a lot, I do see my friends a lot, and I do            
go out for dinners and I go out for nights out and things. So for them                
they are like well she is getting on with normal life, surely she is fine? [TYA7, 
phase A] 
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...he [TYA2] said, ‘There are so many people whose parents are saying to them 
‘Now come on, now you have got to sort of deal with this.’ [PAR2, phase C] 
 
It’s when I'm like tired and I’m like, I really just need to like... sometimes I get told 
like, well you've just been to work so anyone... they’re just like, ‘Get on with it 
and like...’ [TYA7, FG, phase A] 
Yeah. [TYA1, FG, phase A] 
I don't know I feel... either they care, it kind of feels like they don't actually like... 
I don't know, I can't explain it. [TYA7, FG, phase A] 
I think you’re explaining it really well, I get what you're saying there's just that 
lack of... [Interviewer] 
Subtlety. [TYA1, FG, phase A] 
A lack of understanding maybe? [Interviewer] 
You don't want someone to tiptoe around you but then you don't want someone 
to not understand... [TYA7, FG, phase A] 
 
I think in terms of fatigue, I am not sure how much she [mother] knows about, 
like if she knows I feel fatigued or not. [TYA12, phase A] 
 
Tensions beyond family 
Friends 
misunderstand 
Do you think people of your age who haven’t been through your kind of 
experience, do you think they get it? [Interviewer] 
I do think if you don’t know… if you haven’t experienced fatigue or know what it 
is, you don’t understand fully. You would just think, ‘Oh you just need a little 
nap,’ or something. [TYA6, phase C] 
 
 A few of my friends that I haven’t known for as long, they do always just think, 
‘Oh you're just tired, you’ll be fine. But I haven’t really, like, sat down and 
explained it to them properly, because like… I don’t know, I just haven’t. It hasn’t 
come up in conversation yet. [TYA6, phase C] 
 
Perception of 
abandonment 
I don’t think there is enough support though. There is around the hospital, like I 
have had loads of support out of my treatment, but I don’t think there is enough 
support in the community to get people back on their feet. [TYA3, phase A] 
 
...when I first got told that my treatment was over that was it, it was done, there 
was no safety net and my safety net was here. [TYA3, FG, phase A] 
 
...finishing treatment, and leaving here and not seeing anybody, that might feel 
like that's kind of a difficult time. [HCP, phase C] 
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Theme B2: Fatigue related tensions have a detrimental impact on family 
Internal tensions 
How much to 
push TYA 
I thought there must be a button we could press that could do this easier. So he 
probably thinks I am nagging him, but I am probably shielding him from other 
people who want to see and achieve what he is capable of achieving, which I do 
understand that, but as I say part of me really couldn’t care less. But I don’t want 
him to think that, because I still want to keep his motivation going. So it is difficult 
as a mum. [PAR12, phase A] 
 
It is quite upsetting sometimes to see her sort of separating herself from her 
friends, because she doesn’t feel that she can keep up with them. And so 
sometimes it is difficult not to get annoyed at her, or not to tell her just, ‘Get up it 
is your friends. Tomorrow you are going to be crying, because you didn’t go out 
today, try and make that effort.’ So it is quite frustrating. [PAR6, phase A] 
 
So it was getting him to do things, and trying to make him accept... because he 
would say things like ‘Oh you don’t understand, I have been through a lot, I’m 
tired, I can’t,’ But then with some help and encouragement he would do things. 
[PAR13, phase A] 
 
Tensions within family 
Conflict with 
siblings 
And then I think also maybe that’s where parents, it isn’t so much a problem 
because they are there anyway at a greyer stage in their lives. Also they’ve had ups 
and downs with their children. But that’s where siblings can be thinking, ‘Well, 
what’s this about? They are not being truthful,’ and then you can lose an element 
of trust... And because you can call into trust whether, it’s trust comes in, I mean 
I’ve seen it so many times over the last year, you know, ‘Well how can it be that 
he’s this, this time and that the next?’ whatever it is. ‘How can he be in this state 
now and that state next moment?’ ...So then what does it do? It unseats him and 
everybody’s unseated. I mean everybody in our house is unseated. [PAR2, phase A] 
 
[TYA12] has been independent for three years, and been living away from home, 
and now he is living under our roof, and on our sort of terms. But it has been 
tense, because we have adapted to life without him, and now he is there, and 
everybody is centred around [TYA12] and probably my son has felt a little... his 
brother has felt a little bit shut out. He is 16, he was doing his GCSEs, so that has 
not had a great effect on him, the timing of it. ...So it definitely is tense. [PAR12, 
phase A] 
 
Impact on family 
plans 
When she was quite poorly and she obviously had a lot of fatigue and a lot of 
tiredness, it just, everything stopped. You just didn’t do anything. We would get up 
and go, ‘Well what are we doing today?’ ‘Don’t feel well, don’t feel like it, I’m too 
tired.’ So we didn’t. [PAR3, phase A] 
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Tensions beyond family 
Others 
misunderstand 
Yeah, they [extended family] don’t really understand it. They did when she was 
really poorly because she was poorly but now she is well, you know, they don’t 
really get it. [PAR3, phase A] 
 
I think sometimes she might push herself a bit too far, because she has done too 
much of being normal... well saying normal, and never moaning too much about it 
to friends, that people then think, ‘Oh she is absolutely fine.’  So I think when it 
does come to going out that she feels tired, because she has never said anything 
about anything really, and never really moaned in the past, that they just expect 
her sometimes just to bounce right back up. [PAR7, phase A] 
 
And it just seems to impact, you know, on the whole family because my mother 
worries as well and she’s [age] and she could do without the worry. So I try not to 
talk to her about it if I can help it, because I don’t want to worry her too much.  
[PAR5, phase A] 
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Theme C1: Fatigue may perpetuate with vicious cycles 
Activity 
Impact of activity 
on fatigue 
...sometimes like I feel really tired and then I think, oh, I'll go and do something 
and then I actually feel a bit better afterwards. [TYA2, phase A] 
 
I find if I stay in bed the whole day... the next day I feel worse both mentally 
and physically whereas if I got up and went to the gym the next day... I felt 
more energetic. [TYA8, FG, phase A] 
 
What would you say is the biggest thing that’s helped you cope with it 
[fatigue] so well yourself? [Interviewer] 
Well, everyone’s different, but I’d say like for me, it’s exercise. [TYA7, phase C] 
Keeping active? [Interviewer] 
Yes, I mean, it doesn’t have to be like a run, it can be like a walk somewhere 
or, I don’t know. Yes, I’d say it’s kind of like that, make sure you’re active and 
stuff. [TYA7, phase C] 
And you found that actually being active generates energy in itself? 
[Interviewer] 
Yes. [TYA 7, phase C] 
 
I'm not sure I fully understand how I've managed to minimise my fatigue, but I 
do think it has a lot to do with, like, physical activity... go to a class every week 
and to see an improvement in your level of fitness that way, I think that would 
massively help. [TYA10, phase C] 
 
[TYA6] always says to me, ‘I always feel better when I'm doing something.’ So 
even when she feels like she really can't do anything, she always feels better if 
she gives that little bit of effort and gets up and does something. [PAR6, FG, 
phase A]  
[TYA3] says that too. [PAR3, FG, phase A] 
 
She finds that when she actually gets up and does something it gives her more 
energy, as opposed to when she’s feeling fatigued… before, what she was 
doing was just spending the day in bed, and it was just making her feel worse. 
...So what she is trying to do is when she does feel tired in the afternoon, 
rather than go for a nap, go for a little run on the treadmill, and it kind of 
boosts her energy up again. [PAR6, phase C] 
 
Thoughts 
Impact of mood 
on fatigue 
I believe it [fatigue] is a state of mind. [PAR4, FG, phase A] 
 
...it seems to me it goes hand in glove with his mood... Today for instance we 
walked around [place name], we go every day, we walk, but today we did a very 
short walk and he just kept saying, ‘I’m so tired. I’m so tired.’ But I feel that 
there’s potentially some overlap, which would not be unreasonable, with his 
mood. [PAR2, phase A] 
 
...emotional and psychological things that weigh you down, they also can 
contribute to physical fatigue. [TYA1, phase C] 
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It’s hard to tell but I think a lot of it is psychological because the minute he 
stopped treatment because we’ve been one month out of treatment now, he 
was suddenly active. Like the next day almost... [PAR8, phase A] 
 
Sleep 
Change in sleep She would have had to have gone home and gone ‘I have got to have an 
afternoon nap’. So she would have a sleep in between, where she may not 
necessarily have done that before. [PAR7, phase A] 
 
I would probably have a sleep, and then I would be alright afterwards.  
[Partner] used to laugh at me, because I would have an afternoon or evening 
nap, and then I would be alright again afterwards. [TYA4, phase A] 
 
I do end up just trying to sleep it off most of the time. But that doesn’t really 
work though. [TYA5, phase A] 
...Okay, and do you think... your way of managing it in terms of just going back 
to sleep, do you think that’s almost counter-productive? Is that what you are 
saying, like it has the opposite effect? [Interviewer] 
Sometimes, yeah, I think when I do eventually get up, I sometimes feel worse 
for it I think. [TYA5, phase A] 
 
Unhelpful sleep 
habits 
But I know he struggles to get to sleep, but whether that’s because of his 
lifestyle, and if he doesn’t get in from work until perhaps sort of 10, 11 o’clock, 
he doesn’t want to go straight to bed necessarily. [PAR12, phase C] 
 
It is very difficult to get involved in that, because she spends so much time in 
her room, and then I do say to her ‘Get an early night, because you will feel 
better for it in the morning’. But an early night for [TYA6] is going up to her 
bedroom by 8:00pm, but watching television until about 2:00am. So it is not 
really an early night. [PAR6, phase A] 
 
...what they’ve found is that the light from the phone is one of those 
wavelengths that really wakes up the brain, if that makes sense, even more 
than TV. [Interviewer]  
I have to be honest, I do do that. I do check my phone and that. [TYA6, phase C] 
 
Anxiety and  
sleep 
...last time I was ill when I was younger, I found when I got to this well, this 
stage of being this, well, my fatigue would get less. But this time I find it’s a bit 
more because I’ve known a lot more information about my care... and it’s just 
knowing too much has worried me a lot more. So I haven’t really slept at all… 
I’ll go to bed early but I won’t go to sleep until two o’clock and then I’ll be 
awake every day at 04:00. And it’s like the hot weather as well. It’s quite, it 
does make you a lot more fatigued. [TYA6, phase A] 
 
I did find it really hard when I was having sleepless nights, I found it really hard. 
And obviously a sleep specialist would help you get sleep, and then… it wasn’t 
until I started getting sleep that I thought I have to start getting my life back. 
[TYA6, phase C] 
 
Yeah, and also its if I don’t sleep enough it gets really bad, like if I wake up early 
I feel like exhausted as soon as I get up. And then I just have to lie down all 
morning. [TYA2, phase A] 
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With the sleep [TYA12] I think has been struggling with his sleep. Because he 
won’t talk to anybody about what has gone on in here really. [PAR12, phase A] 
 
Small changes to 
improve sleep 
So, what came first? Was it the sleep and then you enrolled on the course? 
[Interviewer] 
Well one night… there were a couple of nights where I was just, like, I’m just 
too tired, so I did… I have a couple of… some medication that was helping me. 
But I really didn’t want to take it at first, but I took it for, like, two nights, and 
then I was really well rested. And then I just woke up that day and was, like, I 
need to do something. [TYA6, phase C] 
That’s really interesting. So it was actually taking that medication that got rid of 
the, sort of, vicious circle you were in of being too tired to do other things. 
[Interviewer] 
Yeah. [TYA6, phase C] 
And you only took the medication for a couple of days? [Interviewer] 
Yeah, I only took it two nights because I’m not really a medication kind of 
person, I don’t like it. [TYA6, phase C] 
Good for you, yeah. So you made that decision to just break the cycle you were 
in, get a bit more rest. And then do you feel that the [course] has helped your 
sleep, just because you are in a... regular rhythm of life? [Interviewer] 
Yeah definitely. I find, like, if I have a lie in in the morning, or if I spend most of 
the day in bed, I am more tired. Whereas if I get up and do something I feel like 
at night I get a proper sleep because in the day I’m really energetic… [TYA6, 
phase C] 
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Theme C2: Responses to fatigue relate to outcomes 
Positive outcomes 
Positive approach 
to activity 
And it was just things like if you are feeling a bit tired, maybe go for a walk. I 
know on bad days, I just used to literally go around the block, because also the 
fresh air and everything, I used to like standing outside, because it made me feel 
a bit better. But I kind of started to do the exercise, and it kind of just started to 
help, so I just did it more and more. [TYA7, phase A]  
 
But exercise regularly and I’d say that it really helps. [TYA8, FG, phase A] 
 
Do you have anything else that you think would contribute to what good fatigue 
care looks like? [Interviewer] 
...I think just really stay as active as you can throughout your treatment even if you 
don’t always feel like it, it can sometimes help. [TYA4, phase A] 
 
Parents’ 
positivity 
I believe that what doesn’t kill you makes you stronger and I think that is the 
principal we've worked on and luckily for me [TYA4] seems to have the same 
mentality, she’s just eating it up. [PAR4, phase C] 
 
...another thing I did as a mum actually, partly for my other ones, was we stayed 
normal, right. So this going six months off work, forget that, that’s not even. So like 
the older two were due to go on holiday at the end of that first month and 
straightaway the oldest one said, ‘Well we can’t do that now,’ and I said, ‘You 
absolutely go, you have a good time and you come back and you tell him what a 
good time you’ve had, that’s what you do.’ So I gave them permission to [go]. 
[PAR8, phase A] 
 
Negative outcomes 
Activity fear 
avoidance beliefs 
It is a good thing that I am trying to be active, but I can’t do too much because I 
injure myself too badly. [TYA11, phase A] 
 
Do you feel that resting is helpful? [Interviewer]  
Kind of. It helps sometimes and other times it just can’t be helped. [TYA14, phase 
A]   
What did we say on the thing about what helps? [PAR14, phase A, referring to 
document written by TYA14]   
Those things: rest, food and not adding to fatigue with stress and activity. 
[Interviewer, reading the document]  
...It might be good [in the intervention] to provide ways that you can find out 
what’s best for you, like saying the different things that people find are the least 
stressful for them, or the best ways that they can rest. [TYA14, phase A] 
 
Low self-efficacy I know I would sit there and listen to it and think, ‘Yeah, that’s a good idea,’ but I 
probably wouldn’t actually stick to it. [TYA5, phase A] 
 
I would just say I am tired and I don’t think a lot can be done about it... 
Any ideas about what good fatigue management would look like? [Interviewer] 
I don’t think so, no. I don’t think that I have been that brilliant at managing it. No, I 
can’t think of anything. [TYA5, phase A] 
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Working myself up to doing things isn’t very helpful; it’s helpful to a certain extent, 
but then you know, it builds up into too much and I stop being able to do even the 
littlest things any more. [TYA14, phase A] 
 
...then you can start to lose hope, and lose hope of never being able to actually 
achieve that independence. [PAR14, phase A] 
 
 
 
  
 370 
7.4.15 Triangulation of qualitative data between sources, time points and methods 
 
Between sources: TYAs and parents 
Also it's quite unpredictable, 'cause some days 
are way worse than others. So it's quite hard to 
plan things and I'd rather not plan things 
otherwise I’m always cancelling them. [TYA2, 
phase A] 
I guess the one huge difficulty is that fatigue is not, it 
goes up and down, it’s the variability and I think 
that’s very difficult for everybody concerned, it’s 
very difficult for [TYA2], but it’s also very difficult for 
everybody in the family. [PAR2, phase A] 
When I think about it now going back to when I 
first got told that my treatment was over that 
was it, it was done, there was no safety net and 
my safety net was [hospital]. [TYA3, FG, phase A] 
It's a more positive attitude and actually had that all 
the way through her treatment until it ended and 
then there was nothing. I mean you get loads of 
support in this hospital, I know it’s fantastic but it 
felt like there was nothing. [PAR3, FG, phase A] 
I feel like a couple of years ago, or even just a 
year ago, meeting with someone and getting that 
help would have been… it would have been the 
ideal thing for me really. [TYA6, phase A] 
However, a year ago or 18 months ago, when she 
was sort of in the middle of it, or just after 
treatment, I think it would have been very useful to 
have some sort of intervention, definitely. [PAR6, 
phase A] 
I used to walk on the treadmill for about an 
hour... I found it kind of like helped my mind as 
well, but it helped the tiredness, because I felt 
that the days where I was just at home in bed 
feeling sorry for myself, it didn’t really help 
much, and you actually made yourself feel 
worse. [TYA7, phase A] 
 So she just thought if I keep moving, it may help 
with the tiredness... So yes, like lift yes, just lifts her 
that bit. [PAR7, phase A] 
 
 
Do you feel that resting is helpful? [Interviewer]  
Kind of. It helps sometimes. [TYA14, phase A] 
What did we say... about what helps? [Interviewer]    
Those things, rest, food and not adding to fatigue 
with stress and activity. [PAR14, phase A] 
But now all my Uni (sic) work getting back, she is 
proper ratting on me, on my case, all the time.   
...yes, she has been proper naggy (sic) about 
that. [TYA12, phase A] 
So he probably thinks I am nagging him... But I don’t 
want him to think that, because I still want to keep 
his motivation going. So it is difficult as a mum. 
[PAR12, phase A] 
Yeah, I agree, my hearing’s completely off but 
then when you're tired, or when I'm tired or if 
I’m struggling to hear things then I end up like 
aggravated and angry because it's like I’m trying 
to process what people are saying but I can't 
hear them, if that makes any sense. [TYA3, FG, 
phase A] 
She’s lonely, she’s frustrated, she’s like bad 
tempered, what do I do 'cause every time I open my 
mouth I'm wrong. It doesn't help if I suggest she has 
jelly and ice cream, still wrong. [PAR3, FG, phase A] 
It is not that sort of bad food, it is just eating 
heavy loads of food I guess. TYA12, phase A] 
And carbs? [Interviewer] 
Yes. Big pastas, baguettes, that sort of thing, yes 
exactly. [TYA12, phase A] 
 
 
We don’t have the best diet, too high in carbs, and 
too much bread and potatoes and stuff. So [TYA12] 
is conscious of the fact that we probably don’t eat as 
well as we should, and she would say, ‘That was my 
fault.’ And I hold my hands up and say, ‘It is true.’ 
[PAR12, phase A] 
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Between sources: TYAs and healthcare professional providing prototype intervention 
I personally wouldn’t mind seeing a psychologist if 
I knew what kind of psychology they were 
specialising in or what kind of treatment... I’m 
really interested at the moment in something 
called thematic therapy. [TYA1, phase C] 
And I think [TYA1] would find it helpful to see a 
psychologist, but purely for a debate, rather than 
anything. [HCP, phase C]] 
 
How important is it to have those times where, 
okay, it might exhaust you for days afterwards but 
how important is that to still experience those 
things? [Interviewer] 
You have got to do it. [TYA8, FG, phase A] 
Whilst you’re young I think, well I’d do anything 
now...So I’m going out enjoying myself, I go to the 
pub, I go out clubbing and things like that but then 
I also think like when Sunday comes that's like you 
sleep all day. Non stop. [TYA3, FG, phase A] 
I got very much a sense that people, particularly 
around the ‘boom or bust’ or the activity pacing, 
that's a real challenge for young people because 
they want to feel normal and want to do the things 
that other people want to do... It was almost 
saying, ‘That doesn’t fit with my life’ and there was 
less of a willingness I think to change that I guess... 
[TYA3] was saying I’d rather not do that if it means 
that I can't be up all night and I’d rather not do it. 
[HCP, phase C] 
Between time points: phase A and phase C 
The only thing I got told at the beginning was the 
fatigue breeds fatigue, which is true. Like if I spent 
a week doing nothing, and staying in bed, my 
fatigue would get worse, whereas if I get up and 
walked, or even something small like just a five 
minute bike ride or something, if I did that every 
day I would feel much better. [TYA8, phase A] 
Me and my mum were still quite keen on the 
whole fatigue breeds fatigue thing and the fact 
that I’m just getting on with things and really just… 
Every day I’m doing something rather than just 
laying in bed. I think as a whole six months down 
the line… sorry, four or five months down the line, 
so it massively improved. [TYA8, phase C] 
But of course as soon as you think, ‘Right, I’m back 
to normality,’ then you’ve got this whole business 
of, ‘If life is normal then it suddenly becomes even 
more apparent the stuff you can’t do.’ [PAR2, 
phase A] 
 
 
 
I would say now, fatigue is a much bigger problem. 
[PAR2, phase C] 
And do you feel that is because [TYA2’s] fatigue is, 
if one can quantify it, actually worse in itself, or 
because there is a bigger mismatch between... it is 
impacting more on his life because he is getting 
more back into normal life? [Interviewer] 
I think it’s the latter. [PAR2, phase C] 
Yes. So it’s the expectations. [Interviewer] 
Between data collection methods   
I forget everything. The only things I don’t forget 
are things that I shouldn’t remember. Like door 
codes. [TYA3, phase A] 
Do you say, ‘Oh, yeah, I’ll meet you Thursday...’ 
and then Thursday comes and you get like a really 
awful text... ‘Where are you? Was I meant to be 
meeting you today?’ [TYA3, FG, phase A] 
So from a really selfish way, I wasn’t just managing 
[TYA4], I was managing myself, yes? So it was like 
right if I focus on getting [TYA4] to go and work for 
a couple of days, and she actually comes back and 
she says, ‘Yes dad I am alright,’ from that I could 
get a strength. [PAR4, phase A] 
I think I did it for me, right, if I'm honest... So on 
[TYA4’s] worst days, that was it, that’s ‘game over’ 
as far as I was concerned. I didn’t know what to do. 
So I had to encourage her to be strong as much for 
me as anyone, because I could deal with it when 
she was smiling and saying, ‘Yeah, I'm all right, 
dad.’ [PAR4, FG, phase A] 
  
 
 
